data_5jyh_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 5jyh _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 . . . . . 0 N--CA 1.474 0.727 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 57.16 23.64 8.85 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.679 1.191 . . . . 0.0 114.043 -178.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 75.58 -6.18 33.02 Favored Glycine 0 CA--C 1.538 1.508 0 C-N-CA 123.93 0.776 . . . . 0.0 114.879 -173.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 84.2 m -80.96 143.87 32.27 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.088 1.355 . . . . 0.0 112.009 -179.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -151.43 142.77 23.39 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.938 0.895 . . . . 0.0 109.897 168.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 49.25 37.41 11.24 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 178.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 70.98 15.99 6.56 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 126.044 1.738 . . . . 0.0 115.531 -175.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 34.9 t -132.15 148.25 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 125.036 1.335 . . . . 0.0 112.396 -173.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.53 42.66 0.17 Allowed 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 127.455 2.302 . . . . 0.0 113.096 174.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -67.42 -51.27 54.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 O-C-N 120.048 -1.657 . . . . 0.0 112.579 -173.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 27.3 mtpt -90.07 -21.81 22.13 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -175.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 179.31 -176.9 48.11 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 125.294 1.426 . . . . 0.0 112.724 174.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -95.27 151.2 19.45 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.843 1.257 . . . . 0.0 112.822 176.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 40.4 t -98.26 -12.28 21.76 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.423 1.089 . . . . 0.0 111.387 167.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -53.69 -36.04 61.76 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 120.663 -1.273 . . . . 0.0 112.174 -178.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -63.06 -30.26 71.46 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 115.423 1.638 . . . . 0.0 115.423 174.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 56.4 t60 -75.41 -43.27 50.89 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 119.574 1.079 . . . . 0.0 111.614 172.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 93.2 m -80.76 -27.38 36.78 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -177.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.3 -31.08 71.64 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 120.28 -1.512 . . . . 0.0 111.705 173.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.91 -18.95 64.94 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.237 1.015 . . . . 0.0 113.397 171.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -97.25 6.14 48.87 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 126.799 2.039 . . . . 0.0 111.065 169.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.4 t0 54.19 32.51 16.11 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 127.702 2.401 . . . . 0.0 114.488 -169.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.4 mttp -119.24 161.48 20.32 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 126.901 2.08 . . . . 0.0 113.934 -173.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -70.99 146.44 49.42 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 167.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -108.3 139.61 15.19 Favored Glycine 0 N--CA 1.472 1.078 0 C-N-CA 124.65 1.119 . . . . 0.0 111.717 169.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -144.73 126.12 8.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 118.219 1.01 . . . . 0.0 112.022 -177.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 87.8 m -73.69 111.85 9.22 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.825 0.85 . . . . 0.0 112.671 -176.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 38.7 m-70 -108.62 102.92 11.94 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.009 1.323 . . . . 0.0 109.383 169.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.59 -123.86 14.4 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 125.67 1.605 . . . . 0.0 112.934 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 61.2 p -97.05 14.89 24.1 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 126.856 2.062 . . . . 0.0 113.038 175.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -136.28 -173.87 3.52 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 128.938 2.895 . . . . 0.0 111.185 179.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 41.8 t -132.05 161.39 33.33 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.931 1.292 . . . . 0.0 111.488 177.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 67.4 mttt -133.81 142.15 47.74 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 128.503 2.721 . . . . 0.0 106.457 171.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 84.3 m -83.99 134.67 34.63 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 168.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -85.78 -141.53 6.01 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 124.935 1.255 . . . . 0.0 110.961 176.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.9 m -71.7 154.72 92.92 Favored Pre-proline 0 N--CA 1.472 0.669 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 177.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo . . . . . 0 CA--C 1.536 0.58 0 C-N-CA 123.747 2.964 . . . . 0.0 110.184 169.66 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 . . . . . 0 CA--C 1.542 0.658 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 57.98 9.79 1.01 Allowed 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 125.43 1.492 . . . . 0.0 114.191 -170.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 86.65 -3.96 86.6 Favored Glycine 0 CA--C 1.539 1.573 0 C-N-CA 124.757 1.17 . . . . 0.0 115.685 -169.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 79.6 m -80.01 140.5 36.54 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 119.013 1.406 . . . . 0.0 112.727 -179.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -154.28 142.42 20.36 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.591 0.756 . . . . 0.0 110.49 166.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 51.26 37.76 19.5 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -178.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.52 ' ND2' ' H ' ' A' ' 32' ' ' GLY . 12.9 m120 62.59 20.78 12.24 Favored 'General case' 0 CA--C 1.548 0.904 0 N-CA-C 116.04 1.867 . . . . 0.0 116.04 -174.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 59.3 t -125.64 147.75 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 125.825 1.65 . . . . 0.0 111.355 -177.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -76.93 43.92 0.37 Allowed 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 126.326 1.85 . . . . 0.0 112.913 177.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.5 m -69.18 -56.34 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 O-C-N 120.633 -1.292 . . . . 0.0 114.163 -169.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -86.56 -11.62 51.03 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.176 0.99 . . . . 0.0 113.602 -179.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 179.71 171.8 43.07 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.67 1.128 . . . . 0.0 112.134 174.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.411 ' OD1' ' HE3' ' A' ' 18' ' ' LYS . 36.7 t70 -98.02 115.56 28.45 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.141 0.976 . . . . 0.0 112.772 -169.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 16.3 t -68.5 -30.72 69.61 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 121.153 -0.967 . . . . 0.0 112.762 177.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.411 ' HE3' ' OD1' ' A' ' 16' ' ' ASP . 0.0 OUTLIER -54.48 -37.25 65.04 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 117.932 -1.032 . . . . 0.0 111.716 171.763 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 24.9 ttm180 -60.39 -36.33 77.83 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 120.717 1.598 . . . . 0.0 114.788 177.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 36.2 t60 -68.61 -44.75 73.64 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 118.478 0.581 . . . . 0.0 110.968 172.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 89.0 m -76.64 -27.43 55.67 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -177.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.8 tppp? -60.72 -34.11 73.91 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.33 1.452 . . . . 0.0 111.51 173.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.1 -23.66 65.86 Favored 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 173.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -94.95 7.55 45.68 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.258 1.423 . . . . 0.0 112.409 170.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 51.74 40.18 27.01 Favored 'General case' 0 CA--C 1.556 1.178 0 C-N-CA 126.744 2.018 . . . . 0.0 112.745 -172.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 37.1 mttt -122.03 167.15 13.45 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 127.73 2.412 . . . . 0.0 112.6 178.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -83.3 155.84 23.39 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.548 1.139 . . . . 0.0 109.054 168.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -114.12 163.48 12.16 Favored Glycine 0 CA--C 1.546 1.993 0 C-N-CA 125.338 1.446 . . . . 0.0 115.502 -178.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -150.34 128.2 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 126.616 1.966 . . . . 0.0 112.077 177.054 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 69.4 m -85.32 101.64 12.72 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.654 0.781 . . . . 0.0 110.701 170.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.49 ' CD2' ' HB2' ' A' ' 36' ' ' LYS . 10.4 p80 -91.59 98.8 11.87 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 122.688 1.233 . . . . 0.0 108.983 170.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.52 ' H ' ' ND2' ' A' ' 10' ' ' ASN . . . 66.36 -105.84 1.42 Allowed Glycine 0 CA--C 1.53 0.988 0 C-N-CA 125.065 1.317 . . . . 0.0 112.03 -174.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 52.0 p -112.78 14.22 19.88 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 126.925 2.09 . . . . 0.0 113.563 -176.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 21.2 mmmt -134.95 161.24 35.83 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.065 1.346 . . . . 0.0 110.817 177.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 52.8 t -101.32 157.14 17.01 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.649 1.18 . . . . 0.0 111.278 177.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.49 ' HB2' ' CD2' ' A' ' 31' ' ' HIS . 3.5 ttmt -147.65 169.72 19.05 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 128.341 2.656 . . . . 0.0 107.107 169.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 39.5 m -101.38 156.39 17.48 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 122.786 1.279 . . . . 0.0 113.25 172.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -105.72 -133.95 7.72 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 127.365 2.412 . . . . 0.0 110.751 175.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.8 m -78.99 156.31 77.05 Favored Pre-proline 0 CA--C 1.538 0.517 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 175.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo . . . . . 0 CA--C 1.54 0.817 0 C-N-CA 124.486 3.458 . . . . 0.0 112.598 167.743 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 . . . . . 0 CA--C 1.54 0.569 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 55.82 21.01 4.45 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.297 1.439 . . . . 0.0 114.149 -174.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 77.66 -4.67 55.76 Favored Glycine 0 CA--C 1.542 1.771 0 C-N-CA 124.031 0.824 . . . . 0.0 114.986 -171.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 94.8 m -80.59 140.0 35.99 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.134 1.374 . . . . 0.0 112.763 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -151.42 134.12 15.61 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.636 0.775 . . . . 0.0 110.788 166.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 47.01 51.33 13.02 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.851 1.26 . . . . 0.0 113.054 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 26.7 m-20 61.07 7.36 1.53 Allowed 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 117.199 2.296 . . . . 0.0 117.199 -175.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.4 t -116.58 140.11 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 O-C-N 120.648 -1.283 . . . . 0.0 111.335 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -77.74 66.74 3.49 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.883 1.273 . . . . 0.0 110.977 169.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -82.3 -41.94 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 125.227 1.411 . . . . 0.0 112.955 178.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -89.97 -16.87 28.98 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.052 0.941 . . . . 0.0 112.534 178.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 164.94 165.34 22.06 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 125.236 1.398 . . . . 0.0 112.119 172.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -78.01 140.21 39.15 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 117.95 0.875 . . . . 0.0 113.055 177.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -89.13 -23.77 22.39 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.162 1.785 . . . . 0.0 111.173 175.295 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -55.08 -32.73 62.18 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 117.759 -1.115 . . . . 0.0 113.205 176.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.81 -35.35 66.25 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 120.609 1.549 . . . . 0.0 114.48 171.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 40.6 t60 -75.03 -28.41 60.45 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 119.666 1.121 . . . . 0.0 112.731 176.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 86.3 m -79.54 -36.76 37.88 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.888 1.275 . . . . 0.0 112.673 173.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 70.9 tttt -59.31 -32.09 69.74 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.15 1.78 . . . . 0.0 113.157 -178.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.61 -14.83 63.28 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 114.236 1.198 . . . . 0.0 114.236 176.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -117.66 19.33 13.91 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.926 1.69 . . . . 0.0 112.572 175.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.8 t70 56.16 63.61 1.96 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.378 1.471 . . . . 0.0 111.049 -175.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm -147.77 146.52 29.22 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 126.383 1.873 . . . . 0.0 112.803 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 57.1 mm-40 -75.43 156.34 35.42 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 163.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -134.16 150.43 20.0 Favored Glycine 0 N--CA 1.473 1.147 0 O-C-N 121.019 -1.051 . . . . 0.0 113.234 178.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -150.5 143.06 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 125.069 1.348 . . . . 0.0 110.084 -173.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 70.7 m -80.71 117.66 21.58 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 121.248 -0.908 . . . . 0.0 112.483 -175.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 -107.83 97.69 7.38 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.898 1.279 . . . . 0.0 108.353 169.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.06 -114.68 4.86 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 125.213 1.387 . . . . 0.0 112.233 -172.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 72.8 p -112.89 20.6 16.27 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 127.56 2.344 . . . . 0.0 112.143 178.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 22.5 mmtm -136.25 169.33 17.81 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 128.043 2.537 . . . . 0.0 112.169 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 34.7 t -105.81 139.1 40.9 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.642 1.577 . . . . 0.0 112.481 -174.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -123.31 124.62 43.37 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 126.924 2.09 . . . . 0.0 107.605 177.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 73.4 m -83.53 141.6 31.5 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 121.936 0.874 . . . . 0.0 113.358 176.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -111.77 -145.73 10.03 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 127.522 2.486 . . . . 0.0 113.035 -178.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.5 m -63.44 156.07 72.15 Favored Pre-proline 0 N--CA 1.476 0.834 0 C-N-CA 124.546 1.139 . . . . 0.0 114.025 175.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo . . . . . 0 N--CA 1.46 -0.446 0 C-N-CA 123.629 2.886 . . . . 0.0 113.233 179.416 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 . . . . . 0 N--CA 1.469 0.514 0 N-CA-C 115.366 1.617 . . . . 0.0 115.366 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 54.54 29.77 11.88 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.57 1.148 . . . . 0.0 112.929 -172.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.25 -5.56 6.65 Favored Glycine 0 CA--C 1.542 1.749 0 N-CA-C 116.188 1.235 . . . . 0.0 116.188 -171.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 96.5 m -80.98 138.85 36.07 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 118.791 1.295 . . . . 0.0 114.224 -177.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -152.43 141.17 20.96 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.547 0.739 . . . . 0.0 110.287 165.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 47.55 47.35 17.55 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.863 1.265 . . . . 0.0 112.914 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 24.7 m-20 57.71 20.91 6.82 Favored 'General case' 0 CA--C 1.552 1.032 0 N-CA-C 116.33 1.974 . . . . 0.0 116.33 -174.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 62.2 t -130.14 149.7 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 CA-C-N 120.673 1.579 . . . . 0.0 112.137 -177.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.58 53.03 0.68 Allowed 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 127.131 2.172 . . . . 0.0 111.402 174.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -76.98 -50.55 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 O-C-N 119.863 -1.773 . . . . 0.0 112.804 -174.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -84.11 -25.93 29.34 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.799 0.839 . . . . 0.0 112.968 -178.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -179.03 -178.55 48.33 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.108 1.337 . . . . 0.0 112.701 177.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -101.65 104.16 14.99 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 122.496 1.141 . . . . 0.0 112.842 -176.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -63.71 -32.1 73.48 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.659 1.584 . . . . 0.0 113.144 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 5.6 tmmm? -58.82 -20.89 54.5 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 117.538 -1.22 . . . . 0.0 113.106 175.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.3 tpp180 -62.18 -36.32 81.51 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 120.786 1.63 . . . . 0.0 113.4 171.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 8.3 t60 -68.73 -44.52 73.67 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.633 0.773 . . . . 0.0 111.13 173.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 72.0 m -67.0 -37.78 84.82 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 121.496 -0.752 . . . . 0.0 112.252 176.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -63.16 -30.27 71.45 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 120.988 -1.07 . . . . 0.0 112.025 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.37 -23.87 65.64 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.302 1.041 . . . . 0.0 113.298 171.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -93.3 6.27 48.68 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.388 1.475 . . . . 0.0 113.023 170.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . 0.267 0.3 OUTLIER 64.88 35.55 8.37 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 127.547 2.339 . . . . 0.0 114.445 -172.14 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.4 mmtp -127.66 152.81 47.21 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 127.966 2.506 . . . . 0.0 113.391 -174.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -76.79 159.09 30.4 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.256 -0.903 . . . . 0.0 108.913 167.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -140.78 145.21 15.8 Favored Glycine 0 N--CA 1.474 1.187 0 C-N-CA 125.022 1.296 . . . . 0.0 114.547 -178.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -145.37 141.63 22.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 124.878 1.271 . . . . 0.0 110.803 -176.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 90.8 m -77.61 120.48 22.62 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.906 0.86 . . . . 0.0 113.315 -175.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -113.75 100.82 8.75 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.817 1.647 . . . . 0.0 109.404 169.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 64.88 -126.99 32.81 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 125.238 1.399 . . . . 0.0 111.086 -172.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 34.9 p -89.94 19.56 4.78 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 126.31 1.844 . . . . 0.0 114.011 177.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -141.86 163.17 33.63 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.385 1.474 . . . . 0.0 112.22 -174.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.7 t -88.56 157.9 18.46 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.627 1.171 . . . . 0.0 111.674 173.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.6 121.75 15.81 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 126.448 1.899 . . . . 0.0 107.461 171.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 63.3 m -86.11 134.47 33.81 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 -178.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -102.88 -122.63 5.13 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 127.684 2.564 . . . . 0.0 114.727 -169.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.6 m -87.22 156.82 54.19 Favored Pre-proline 0 N--CA 1.477 0.884 0 C-N-CA 125.765 1.626 . . . . 0.0 113.723 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo . . . . . 0 CA--C 1.541 0.845 0 C-N-CA 124.16 3.24 . . . . 0.0 113.322 179.887 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 . . . . . 0 CA--C 1.538 0.501 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 57.5 12.9 1.64 Allowed 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 115.098 1.518 . . . . 0.0 115.098 -175.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 85.08 -5.23 83.71 Favored Glycine 0 CA--C 1.54 1.602 0 C-N-CA 124.739 1.162 . . . . 0.0 115.173 -168.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 81.7 m -84.01 141.36 31.24 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.842 1.321 . . . . 0.0 113.46 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -151.06 134.17 15.98 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.357 0.663 . . . . 0.0 111.129 164.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 47.2 54.64 9.15 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.113 1.365 . . . . 0.0 112.542 -176.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 61.3 m-20 64.69 9.72 5.42 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 116.308 1.966 . . . . 0.0 116.308 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 49.4 t -125.57 147.87 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 CA-C-N 120.547 1.521 . . . . 0.0 111.893 -175.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -74.08 46.66 0.25 Allowed 'General case' 0 CA--C 1.557 1.249 0 C-N-CA 127.083 2.153 . . . . 0.0 112.466 175.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -73.12 -37.02 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 O-C-N 119.738 -1.851 . . . . 0.0 114.73 -170.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 63.7 mtpt -99.58 -18.18 17.48 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.717 1.207 . . . . 0.0 113.233 178.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 179.46 167.34 36.66 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 124.638 1.113 . . . . 0.0 112.53 175.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -87.37 109.37 19.5 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.99 1.716 . . . . 0.0 113.103 -174.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -61.65 -24.56 66.81 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.489 1.515 . . . . 0.0 113.63 176.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.4 tmmm? -50.39 -35.72 29.52 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 120.981 -1.074 . . . . 0.0 111.916 171.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 55.8 ttm-85 -58.61 -41.12 85.15 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 126.483 1.913 . . . . 0.0 114.203 -177.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 36.8 t60 -67.62 -42.98 81.47 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.426 1.09 . . . . 0.0 111.495 175.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 72.0 m -77.26 -27.13 53.1 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.41 -36.8 81.33 Favored 'General case' 0 N--CA 1.476 0.839 0 O-C-N 120.62 -1.3 . . . . 0.0 110.782 169.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.2 -15.06 63.43 Favored 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 171.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -99.78 1.81 43.5 Favored 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 126.34 1.856 . . . . 0.0 111.36 169.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . 0.269 3.4 t0 51.98 44.21 29.68 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 128.188 2.595 . . . . 0.0 114.212 -169.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.4 mttt -126.92 172.8 10.12 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 129.13 2.972 . . . . 0.0 112.845 -178.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -85.55 153.84 22.15 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.89 1.276 . . . . 0.0 109.653 167.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -131.79 151.4 19.78 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 125.525 1.536 . . . . 0.0 114.887 -178.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -153.32 137.31 8.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 125.268 1.427 . . . . 0.0 111.056 -176.105 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 87.3 m -79.92 120.76 24.57 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.28 -0.887 . . . . 0.0 112.137 -177.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 15.9 m-70 -111.58 103.1 11.4 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.667 1.587 . . . . 0.0 109.223 168.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 67.86 -114.79 6.4 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 124.869 1.224 . . . . 0.0 112.112 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 82.7 p -104.06 17.2 24.6 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 126.155 1.782 . . . . 0.0 112.615 173.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 44.9 mmtm -127.96 159.91 33.52 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.448 1.899 . . . . 0.0 112.093 -178.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 43.3 t -100.02 146.0 27.25 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.603 1.161 . . . . 0.0 110.226 170.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -130.35 126.49 37.25 Favored 'General case' 0 C--N 1.333 -0.11 0 C-N-CA 126.392 1.877 . . . . 0.0 106.998 -178.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 61.2 m -87.95 137.27 32.48 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.832 0.825 . . . . 0.0 112.164 176.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -97.16 -137.28 9.48 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 127.35 2.405 . . . . 0.0 112.228 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 33.1 m -73.39 155.14 89.88 Favored Pre-proline 0 CA--C 1.535 0.37 0 N-CA-C 113.939 1.088 . . . . 0.0 113.939 178.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo . . . . . 0 CA--C 1.54 0.784 0 C-N-CA 124.541 3.494 . . . . 0.0 111.407 166.97 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 . . . . . 0 CA--C 1.537 0.446 0 N-CA-C 115.103 1.52 . . . . 0.0 115.103 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 54.65 15.54 1.1 Allowed 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 -171.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 81.17 -5.11 68.18 Favored Glycine 0 CA--C 1.544 1.906 0 C-N-CA 124.646 1.117 . . . . 0.0 115.263 -168.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 74.5 m -77.44 141.52 39.69 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.065 1.346 . . . . 0.0 113.068 178.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -152.15 131.98 13.28 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.098 0.959 . . . . 0.0 112.113 166.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 48.19 54.5 10.15 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.773 1.629 . . . . 0.0 112.745 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 42.4 m-20 62.57 15.35 7.85 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 116.485 2.032 . . . . 0.0 116.485 -179.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 38.4 t -129.07 147.26 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 125.048 1.339 . . . . 0.0 111.079 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 28.0 p-10 -76.33 33.95 0.13 Allowed 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 128.354 2.661 . . . . 0.0 114.266 176.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -58.78 -30.92 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 N-CA-C 116.362 1.986 . . . . 0.0 116.362 -168.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -109.5 -10.14 14.89 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 125.189 1.395 . . . . 0.0 113.133 175.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 168.81 153.53 8.38 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 125.798 1.666 . . . . 0.0 112.252 173.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -85.3 138.54 32.24 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.089 0.956 . . . . 0.0 112.137 175.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.2 p -94.95 -1.43 52.53 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -178.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -63.21 -28.65 70.18 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 120.956 -1.09 . . . . 0.0 112.978 177.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.04 -37.4 85.76 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 121.045 1.748 . . . . 0.0 113.148 173.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 13.1 t60 -62.68 -36.37 82.67 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.34 1.056 . . . . 0.0 111.715 170.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 57.7 m -75.38 -27.83 59.26 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 121.087 -1.008 . . . . 0.0 113.402 171.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 21.6 tptp -66.28 -20.32 66.07 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.188 1.395 . . . . 0.0 112.907 173.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.53 -18.11 64.53 Favored 'General case' 0 CA--C 1.55 0.955 0 O-C-N 121.704 -0.623 . . . . 0.0 112.308 168.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -110.68 15.12 22.16 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 126.953 2.101 . . . . 0.0 111.899 168.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 15.4 t0 56.18 26.32 10.16 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 127.771 2.428 . . . . 0.0 115.2 -174.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 38.8 mttt -109.91 159.57 17.13 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.79 1.636 . . . . 0.0 114.339 -174.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -70.59 149.9 46.61 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 114.727 -1.124 . . . . 0.0 108.006 166.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -136.62 141.63 12.68 Favored Glycine 0 N--CA 1.472 1.069 0 C-N-CA 124.798 1.19 . . . . 0.0 114.83 -176.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.06 131.78 55.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 125.638 1.575 . . . . 0.0 111.903 -168.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 96.9 m -73.07 107.89 5.66 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.208 1.003 . . . . 0.0 112.045 177.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 9.5 m-70 -95.5 91.76 6.33 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.866 2.066 . . . . 0.0 110.069 169.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 66.27 -109.0 2.64 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 124.613 1.101 . . . . 0.0 112.037 -178.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 47.5 p -109.94 26.71 10.35 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 125.938 1.695 . . . . 0.0 113.209 173.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 36.4 mmtm -139.31 174.23 10.73 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 126.977 2.111 . . . . 0.0 111.932 174.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 13.1 t -117.48 157.71 25.79 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.697 1.199 . . . . 0.0 112.388 176.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.9 mtpt -144.47 155.67 43.83 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 128.08 2.552 . . . . 0.0 107.646 172.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 23.8 m -107.0 149.11 27.89 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -95.32 -117.47 3.13 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 127.034 2.254 . . . . 0.0 113.779 -176.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.9 m -106.41 163.87 16.09 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 126.399 1.88 . . . . 0.0 111.432 169.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_exo . . . . . 0 CA--C 1.538 0.682 0 C-N-CA 124.494 3.463 . . . . 0.0 113.849 170.434 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 . . . . . 0 CA--C 1.54 0.593 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 53.77 26.13 5.73 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.919 1.288 . . . . 0.0 113.535 -173.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.02 0.72 21.99 Favored Glycine 0 CA--C 1.539 1.567 0 O-C-N 121.057 -1.027 . . . . 0.0 115.445 -171.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 76.2 m -97.7 141.92 30.13 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.16 1.384 . . . . 0.0 113.713 -170.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -150.6 132.46 15.08 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.161 167.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 47.36 54.67 9.24 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.628 1.571 . . . . 0.0 113.331 178.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 64.03 14.84 8.79 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 116.811 2.152 . . . . 0.0 116.811 -177.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.5 t -131.58 146.66 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 O-C-N 120.567 -1.333 . . . . 0.0 111.827 -177.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -76.51 50.13 0.65 Allowed 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.852 1.661 . . . . 0.0 112.179 170.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -77.93 -30.79 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 125.618 1.567 . . . . 0.0 114.073 -177.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 23.4 mmmt -95.26 -30.72 13.83 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -174.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -175.61 -138.69 2.88 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 124.958 1.266 . . . . 0.0 112.62 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -124.78 140.25 53.1 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -108.27 -19.57 13.43 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 129.276 3.03 . . . . 0.0 111.369 174.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 11.6 tppt? -38.64 -51.57 1.65 Allowed 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 127.199 2.199 . . . . 0.0 112.321 169.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 42.3 mtm180 -63.4 -25.56 68.34 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 -176.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 65.1 t60 -73.75 -45.71 50.22 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 119.186 0.903 . . . . 0.0 111.975 173.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 71.1 m -76.13 -28.63 57.5 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 178.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.05 -28.43 70.08 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.747 1.219 . . . . 0.0 112.267 175.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.24 -26.45 63.85 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.391 1.076 . . . . 0.0 113.258 172.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -88.2 8.53 26.65 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 125.844 1.657 . . . . 0.0 111.615 168.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . 0.265 11.5 t0 56.18 31.3 18.08 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 128.167 2.587 . . . . 0.0 115.061 -173.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 36.3 mttt -117.22 169.17 9.67 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 127.453 2.301 . . . . 0.0 113.798 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -79.65 150.91 30.8 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.421 1.488 . . . . 0.0 108.477 167.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -110.99 151.03 17.8 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 125.755 1.645 . . . . 0.0 113.708 175.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -150.41 137.88 13.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 125.346 1.458 . . . . 0.0 109.002 175.097 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 68.3 m -77.93 126.34 30.69 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 121.046 -1.034 . . . . 0.0 112.878 -174.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -122.08 114.43 20.9 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.211 1.404 . . . . 0.0 109.229 169.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 64.13 -124.51 30.28 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 124.464 1.03 . . . . 0.0 111.721 -173.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 70.3 p -104.6 29.2 6.33 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 125.997 1.719 . . . . 0.0 112.405 170.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 41.2 mmtm -136.73 165.07 26.78 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.405 1.882 . . . . 0.0 110.686 -176.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 12.6 t -92.19 160.37 15.2 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.633 1.173 . . . . 0.0 110.294 173.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.0 tmtt? -145.97 137.92 25.17 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 127.024 2.13 . . . . 0.0 106.294 173.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 57.2 m -93.48 135.45 34.72 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -176.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -85.31 -127.35 1.79 Allowed Glycine 0 CA--C 1.528 0.866 0 C-N-CA 126.538 2.018 . . . . 0.0 112.286 178.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 31.5 m -89.03 155.08 49.81 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 124.666 1.186 . . . . 0.0 113.014 176.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo . . . . . 0 C--O 1.239 0.525 0 C-N-CA 124.742 3.628 . . . . 0.0 111.309 167.462 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 . . . . . 0 N--CA 1.476 0.854 0 CA-C-O 121.431 0.634 . . . . 0.0 111.617 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 50.75 16.78 0.34 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.477 1.911 . . . . 0.0 115.223 -172.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 71.35 0.67 39.01 Favored Glycine 0 CA--C 1.535 1.294 0 O-C-N 120.965 -1.084 . . . . 0.0 115.002 -173.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 99.8 m -90.74 137.09 32.63 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 118.2 1.0 . . . . 0.0 112.835 -173.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -151.7 141.97 22.38 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.303 1.041 . . . . 0.0 110.175 165.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 51.15 39.08 22.66 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 178.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 57.88 28.44 16.07 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 126.281 1.832 . . . . 0.0 114.786 -173.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 46.2 t -132.01 145.03 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 125.416 1.486 . . . . 0.0 110.585 179.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -77.51 50.85 0.84 Allowed 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.598 1.559 . . . . 0.0 112.236 173.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -75.94 -41.95 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 124.963 1.305 . . . . 0.0 113.722 -175.162 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 25.0 mmmt -90.04 -19.4 24.44 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.012 0.925 . . . . 0.0 112.797 -173.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -178.5 -146.76 6.67 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 124.701 1.143 . . . . 0.0 112.588 178.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 -124.22 126.97 47.01 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.881 1.272 . . . . 0.0 113.947 177.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -86.49 -18.42 31.68 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.635 1.974 . . . . 0.0 111.56 171.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -48.46 -51.32 27.61 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 117.408 -1.282 . . . . 0.0 111.378 169.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -52.82 -42.58 65.26 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-N 120.267 1.394 . . . . 0.0 113.104 -175.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 71.8 t60 -63.18 -43.53 97.95 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.161 0.984 . . . . 0.0 112.235 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 92.9 m -84.24 -25.71 29.21 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.57 -35.55 78.11 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 120.833 -1.167 . . . . 0.0 110.221 173.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.06 -12.85 61.59 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 171.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -102.4 7.88 40.29 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 126.564 1.946 . . . . 0.0 112.193 169.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . 0.261 2.6 t0 58.22 35.87 25.3 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 128.263 2.625 . . . . 0.0 114.198 -172.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.2 mttt -129.89 164.17 24.76 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 127.588 2.355 . . . . 0.0 115.37 -172.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -69.29 144.96 53.44 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.045 1.738 . . . . 0.0 109.383 165.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -109.41 141.11 15.96 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 125.413 1.482 . . . . 0.0 112.599 169.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.45 135.37 31.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-N 118.666 1.233 . . . . 0.0 111.239 174.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 86.6 m -74.8 115.36 14.3 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 122.078 0.942 . . . . 0.0 113.262 -176.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 5.0 m-70 -100.07 100.28 11.13 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 126.24 1.816 . . . . 0.0 107.65 168.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 63.55 -114.41 6.83 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 124.411 1.005 . . . . 0.0 111.977 -178.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 44.8 p -102.42 16.49 26.12 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 126.168 1.787 . . . . 0.0 113.653 174.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 48.8 mmtm -130.25 165.6 22.08 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.867 2.067 . . . . 0.0 111.019 -175.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 20.4 t -97.6 157.61 15.94 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.042 0.937 . . . . 0.0 110.868 172.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.14 126.5 14.0 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 126.151 1.78 . . . . 0.0 106.314 175.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 39.4 m -82.26 142.34 32.19 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 119.119 0.872 . . . . 0.0 112.141 -178.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -102.28 -118.48 4.42 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 125.725 1.631 . . . . 0.0 113.456 -173.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.9 m -91.55 159.68 38.26 Favored Pre-proline 0 N--CA 1.472 0.658 0 C-N-CA 126.314 1.846 . . . . 0.0 112.559 174.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo . . . . . 0 CA--C 1.536 0.621 0 C-N-CA 124.098 3.198 . . . . 0.0 112.556 179.288 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 . . . . . 0 N--CA 1.478 0.942 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 54.16 15.74 1.0 Allowed 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 -177.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.36 4.87 52.88 Favored Glycine 0 CA--C 1.537 1.425 0 O-C-N 121.179 -0.95 . . . . 0.0 114.842 -173.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 92.0 m -91.28 135.78 33.56 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.458 1.103 . . . . 0.0 112.084 -179.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -151.68 135.38 16.3 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.096 0.958 . . . . 0.0 111.955 167.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 48.46 52.77 13.1 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.3 1.44 . . . . 0.0 112.72 -179.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 57.3 m-20 63.71 8.26 3.63 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 127.254 2.222 . . . . 0.0 116.686 -177.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.0 t -126.24 147.85 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 CA-C-N 119.592 1.087 . . . . 0.0 111.504 -176.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -77.44 39.46 0.26 Allowed 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 126.916 2.086 . . . . 0.0 113.06 172.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -63.06 -26.74 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 126.054 1.741 . . . . 0.0 113.907 -178.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.5 mmmm -104.65 -13.76 15.84 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.237 1.415 . . . . 0.0 114.519 -175.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 166.94 -141.13 6.71 Favored Glycine 0 N--CA 1.471 0.992 0 CA-C-N 120.112 1.324 . . . . 0.0 114.699 174.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -117.13 124.28 48.82 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.704 1.201 . . . . 0.0 113.718 -170.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -104.54 -30.35 10.07 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 127.53 2.332 . . . . 0.0 111.284 176.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.3 tmmm? -53.16 -40.21 64.13 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 121.11 -0.994 . . . . 0.0 112.391 175.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 43.9 mtp180 -64.3 -27.69 69.21 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 63.7 t60 -70.68 -46.65 62.78 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 118.867 0.758 . . . . 0.0 111.335 170.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 86.8 m -72.34 -30.31 64.62 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.435 ' HA ' ' HE2' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -62.55 -30.69 71.5 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 120.536 -1.352 . . . . 0.0 112.14 173.996 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -75.47 -11.98 60.15 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 124.304 1.042 . . . . 0.0 112.902 173.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -102.79 4.91 38.41 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 126.528 1.931 . . . . 0.0 111.378 168.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . 0.273 5.7 t0 57.68 40.37 26.58 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 129.354 3.061 . . . . 0.0 115.886 -171.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.7 mttt -129.96 171.59 12.61 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.303 1.841 . . . . 0.0 113.871 -177.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -79.11 156.47 28.28 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.921 1.688 . . . . 0.0 109.141 166.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -126.58 144.92 15.42 Favored Glycine 0 CA--C 1.537 1.46 0 C-N-CA 125.332 1.444 . . . . 0.0 115.102 176.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -147.43 144.06 19.68 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 124.558 1.143 . . . . 0.0 109.564 -178.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 88.8 m -86.76 122.91 31.31 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.112 -0.993 . . . . 0.0 112.86 -174.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 19.0 m-70 -114.71 104.22 11.76 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 125.582 1.553 . . . . 0.0 110.019 169.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 60.65 -121.52 26.87 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 123.827 0.727 . . . . 0.0 111.67 -173.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 60.7 p -91.42 8.8 34.51 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 126.215 1.806 . . . . 0.0 114.167 179.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -131.91 160.96 34.21 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.709 1.603 . . . . 0.0 112.94 -172.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 38.7 t -93.23 140.06 29.94 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.828 1.251 . . . . 0.0 110.766 172.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.63 121.13 29.66 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 127.142 2.177 . . . . 0.0 105.799 178.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 57.2 m -78.03 141.73 38.68 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 119.043 0.838 . . . . 0.0 112.687 -177.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -89.68 -135.11 5.64 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 126.549 2.023 . . . . 0.0 111.868 175.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 33.7 m -83.93 159.61 59.83 Favored Pre-proline 0 CA--C 1.539 0.534 0 C-N-CA 123.99 0.916 . . . . 0.0 113.318 -178.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo . . . . . 0 CA--C 1.536 0.58 0 C-N-CA 124.63 3.553 . . . . 0.0 111.516 167.608 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 . . . . . 0 N--CA 1.471 0.592 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 56.09 14.14 1.38 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.505 1.522 . . . . 0.0 114.169 -174.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 83.69 -7.43 69.53 Favored Glycine 0 CA--C 1.538 1.493 0 C-N-CA 125.347 1.451 . . . . 0.0 115.0 -171.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 82.8 m -76.33 143.79 40.57 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.229 1.011 . . . . 0.0 113.232 177.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -156.36 139.97 15.97 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.988 1.315 . . . . 0.0 109.953 166.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 48.92 44.33 22.24 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.667 1.187 . . . . 0.0 113.859 -179.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 16.7 m-20 61.18 15.91 6.76 Favored 'General case' 0 CA--C 1.553 1.074 0 N-CA-C 116.316 1.969 . . . . 0.0 116.316 -174.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 59.4 t -126.49 149.92 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 125.379 1.472 . . . . 0.0 111.849 -176.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -79.06 42.33 0.47 Allowed 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 127.082 2.153 . . . . 0.0 114.61 178.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -64.22 -42.62 96.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 O-C-N 120.584 -1.322 . . . . 0.0 113.566 -171.412 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 36.2 mmtm -96.36 -19.19 19.4 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 174.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 172.3 168.48 33.78 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 124.343 0.973 . . . . 0.0 112.694 177.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -98.37 129.67 45.02 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.474 0.709 . . . . 0.0 112.715 -174.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -64.34 -15.55 60.56 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 126.641 1.976 . . . . 0.0 113.507 171.245 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? -41.98 -51.49 4.42 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.52 1.528 . . . . 0.0 112.113 168.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 60.1 mtm180 -68.55 -25.57 64.98 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.047 1.128 . . . . 0.0 114.047 -168.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -81.88 -36.53 28.07 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.932 1.293 . . . . 0.0 112.789 174.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 99.1 m -79.25 -33.24 43.73 Favored 'General case' 0 CA--C 1.546 0.817 0 O-C-N 121.06 -1.025 . . . . 0.0 113.08 174.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 18.8 tptp -63.64 -28.57 70.0 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.67 1.188 . . . . 0.0 112.422 177.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.69 -25.91 66.74 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.874 1.27 . . . . 0.0 113.365 171.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -103.76 10.2 36.73 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.842 1.657 . . . . 0.0 112.067 174.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 64.78 30.3 12.34 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 128.28 2.632 . . . . 0.0 115.312 -177.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.2 mttp -115.93 163.48 15.82 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 126.648 1.979 . . . . 0.0 112.869 177.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -78.79 152.27 31.51 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 166.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -107.75 159.98 14.19 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 125.836 1.684 . . . . 0.0 113.226 172.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -150.14 135.9 11.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 124.906 1.282 . . . . 0.0 111.011 171.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 91.4 m -76.91 118.81 19.87 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.449 0.642 . . . . 0.0 112.273 -179.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 19.3 m-70 -116.2 111.58 20.39 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.627 1.571 . . . . 0.0 109.125 169.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 63.5 -117.08 10.21 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 125.964 1.745 . . . . 0.0 111.228 -173.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.4 p -108.44 23.93 13.79 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.636 1.574 . . . . 0.0 112.377 173.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 42.0 mmtm -138.59 169.27 18.09 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.934 1.294 . . . . 0.0 112.913 -178.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 41.7 t -99.59 148.11 24.65 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.372 1.469 . . . . 0.0 111.937 -178.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -139.9 133.78 30.71 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 126.902 2.081 . . . . 0.0 105.974 174.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 63.0 m -84.73 142.67 29.68 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 119.592 1.087 . . . . 0.0 112.834 -178.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -89.71 -138.36 6.95 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 126.26 1.886 . . . . 0.0 111.239 171.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.6 m -77.86 154.48 80.62 Favored Pre-proline 0 CA--C 1.537 0.475 0 N-CA-C 114.055 1.131 . . . . 0.0 114.055 178.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo . . . . . 0 CA--C 1.54 0.798 0 C-N-CA 124.238 3.292 . . . . 0.0 110.758 166.306 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 . . . . . 0 N--CA 1.468 0.446 0 N-CA-C 112.708 0.632 . . . . 0.0 112.708 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 60.58 7.96 1.55 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.52 1.928 . . . . 0.0 114.975 -178.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 88.02 -3.18 85.83 Favored Glycine 0 CA--C 1.543 1.84 0 C-N-CA 124.701 1.143 . . . . 0.0 114.729 -168.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 87.3 m -79.03 141.88 37.04 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.553 1.141 . . . . 0.0 112.01 175.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -152.4 135.8 15.94 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.798 0.839 . . . . 0.0 110.714 168.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 47.95 51.47 14.39 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.405 1.482 . . . . 0.0 113.228 179.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 62.62 11.22 4.62 Favored 'General case' 0 CA--C 1.551 1.017 0 N-CA-C 117.389 2.366 . . . . 0.0 117.389 -175.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 38.2 t -124.2 146.53 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 CA-C-N 119.73 1.15 . . . . 0.0 111.965 -177.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -74.91 35.92 0.11 Allowed 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 127.698 2.399 . . . . 0.0 113.483 177.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -60.1 -43.8 93.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 -168.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -96.97 -18.05 19.68 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 178.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 171.4 169.64 34.55 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 125.553 1.549 . . . . 0.0 113.002 174.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -86.84 142.81 27.8 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 121.959 0.885 . . . . 0.0 112.996 175.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.8 p -97.79 -10.66 24.41 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.628 1.171 . . . . 0.0 113.149 169.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.1 tmmm? -63.3 -28.09 69.78 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-O 118.115 -0.945 . . . . 0.0 113.251 -176.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 44.9 mtm180 -63.81 -35.23 79.92 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 120.013 1.279 . . . . 0.0 113.596 170.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -67.76 -35.41 78.66 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.433 1.093 . . . . 0.0 111.904 174.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 90.0 m -75.21 -39.02 60.44 Favored 'General case' 0 CA--C 1.547 0.865 0 O-C-N 120.909 -1.119 . . . . 0.0 112.533 170.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -62.28 -28.63 69.85 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 120.748 -1.22 . . . . 0.0 112.791 178.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.57 -25.89 60.64 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.47 1.108 . . . . 0.0 113.152 171.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -115.47 21.01 14.38 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.684 1.594 . . . . 0.0 112.048 -179.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.2 t0 56.96 60.56 2.96 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 126.407 1.883 . . . . 0.0 111.431 -175.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 31.9 mmtm -145.44 147.68 32.47 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 126.071 1.748 . . . . 0.0 113.308 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -72.53 156.42 39.03 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 162.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -141.6 136.11 7.2 Favored Glycine 0 N--CA 1.468 0.788 0 C-N-CA 124.385 0.993 . . . . 0.0 112.684 -179.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.0 140.18 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 C-N-CA 124.595 1.158 . . . . 0.0 110.675 -172.123 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 73.0 m -68.13 118.07 10.8 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.019 0.528 . . . . 0.0 112.408 -177.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 -108.63 98.69 8.16 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.965 1.706 . . . . 0.0 108.783 169.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 61.35 -114.81 7.07 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 124.176 0.893 . . . . 0.0 111.402 -174.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 58.6 p -107.01 27.43 9.0 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 127.337 2.255 . . . . 0.0 114.045 174.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -137.95 174.27 10.74 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 126.726 2.01 . . . . 0.0 111.219 172.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 9.1 t -97.17 166.68 11.46 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.746 1.218 . . . . 0.0 111.435 172.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.55 118.57 8.23 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.337 1.455 . . . . 0.0 108.633 173.116 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 73.9 m -84.48 129.57 34.84 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -178.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -99.72 -139.32 10.75 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 127.407 2.432 . . . . 0.0 113.941 -175.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.6 m -72.8 154.78 91.1 Favored Pre-proline 0 N--CA 1.473 0.722 0 C-N-CA 125.051 1.34 . . . . 0.0 113.398 176.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo . . . . . 0 CA--C 1.532 0.4 0 C-N-CA 124.28 3.32 . . . . 0.0 114.031 -178.078 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 . . . . . 0 CA--C 1.539 0.537 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 56.44 28.52 13.78 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.811 1.245 . . . . 0.0 113.662 -177.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 71.51 -5.14 11.34 Favored Glycine 0 CA--C 1.541 1.691 0 N-CA-C 115.411 0.924 . . . . 0.0 115.411 -174.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 74.4 m -79.46 135.0 36.54 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.705 1.202 . . . . 0.0 112.792 -178.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -148.08 134.97 20.12 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.214 1.006 . . . . 0.0 111.104 167.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 47.66 49.08 16.75 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.09 1.356 . . . . 0.0 113.65 179.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 65.96 10.93 7.35 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 127.436 2.294 . . . . 0.0 116.513 -176.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.9 t -126.06 147.95 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 124.951 1.3 . . . . 0.0 112.288 -176.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -78.72 40.64 0.39 Allowed 'General case' 0 CA--C 1.558 1.264 0 C-N-CA 127.234 2.214 . . . . 0.0 113.708 176.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.5 m -70.86 -23.39 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 C-N-CA 125.777 1.631 . . . . 0.0 115.325 -172.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -109.05 -8.81 15.12 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.696 1.198 . . . . 0.0 112.984 173.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 158.09 169.33 21.55 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 125.452 1.501 . . . . 0.0 112.435 174.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -89.19 144.93 25.75 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.157 0.983 . . . . 0.0 112.706 177.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 42.4 t -92.65 -15.23 27.05 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.455 0.702 . . . . 0.0 112.375 170.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -53.29 -35.39 60.05 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 120.679 -1.263 . . . . 0.0 111.709 177.497 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 11.9 mtp-105 -55.77 -43.31 76.6 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 115.071 1.508 . . . . 0.0 115.071 169.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 62.4 t60 -67.83 -40.04 83.83 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 119.845 1.202 . . . . 0.0 112.302 177.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 93.0 m -75.61 -32.28 60.22 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 123.54 0.736 . . . . 0.0 112.443 177.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.435 ' O ' ' HE2' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -62.01 -30.4 70.93 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 127.132 2.173 . . . . 0.0 112.168 174.825 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.19 -24.89 67.47 Favored 'General case' 0 CA--C 1.549 0.918 0 O-C-N 121.554 -0.716 . . . . 0.0 112.534 173.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -107.95 18.88 20.73 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.416 1.886 . . . . 0.0 113.597 168.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 60.66 26.32 16.05 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 126.114 1.765 . . . . 0.0 115.724 177.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.6 mttp -110.22 162.12 14.91 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 127.653 2.381 . . . . 0.0 113.272 175.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -76.39 153.2 35.93 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.96 0.904 . . . . 0.0 110.1 166.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -125.49 142.66 13.94 Favored Glycine 0 N--CA 1.475 1.276 0 C-N-CA 125.726 1.631 . . . . 0.0 113.506 173.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.93 133.09 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 124.883 1.273 . . . . 0.0 111.322 -170.307 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 74.5 m -75.07 114.82 14.0 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.132 0.492 . . . . 0.0 111.677 -179.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 7.6 m-70 -107.76 100.98 10.31 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.726 2.01 . . . . 0.0 109.134 172.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 64.19 -115.62 8.11 Favored Glycine 0 CA--C 1.527 0.844 0 C-N-CA 124.839 1.209 . . . . 0.0 112.055 -177.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 75.9 p -105.38 15.76 26.7 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.97 1.308 . . . . 0.0 112.586 178.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -141.35 -171.09 3.22 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 128.651 2.78 . . . . 0.0 110.47 -175.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 52.7 t -134.71 158.08 45.05 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 114.282 1.215 . . . . 0.0 114.282 -176.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 68.6 mttt -136.19 149.86 48.77 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 129.49 3.116 . . . . 0.0 107.908 169.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 78.3 m -89.81 152.8 21.11 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 121.626 0.727 . . . . 0.0 112.073 170.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -107.71 -112.82 3.66 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 126.205 1.859 . . . . 0.0 114.124 -172.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.9 m -104.9 157.35 34.39 Favored Pre-proline 0 N--CA 1.475 0.788 0 C-N-CA 126.522 1.929 . . . . 0.0 113.155 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo . . . . . 0 CA--C 1.537 0.645 0 C-N-CA 124.083 3.188 . . . . 0.0 111.413 173.725 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 . . . . . 0 N--CA 1.473 0.715 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 55.71 24.81 7.56 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.301 1.44 . . . . 0.0 114.132 -175.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 72.93 -4.69 21.81 Favored Glycine 0 CA--C 1.542 1.723 0 O-C-N 121.23 -0.919 . . . . 0.0 115.226 -171.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 88.0 m -84.33 142.62 30.06 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.057 1.343 . . . . 0.0 112.644 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -153.29 140.94 19.94 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.289 1.035 . . . . 0.0 110.278 167.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 46.51 47.58 14.22 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.201 1.4 . . . . 0.0 113.543 178.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 21.6 m-20 64.52 17.4 10.83 Favored 'General case' 0 CA--C 1.551 0.985 0 N-CA-C 116.132 1.901 . . . . 0.0 116.132 -177.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 40.7 t -132.81 148.19 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.57 1.148 . . . . 0.0 112.498 -176.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -73.15 37.52 0.08 Allowed 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 128.055 2.542 . . . . 0.0 114.092 173.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -63.76 -33.38 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 O-C-N 120.28 -1.513 . . . . 0.0 114.293 -171.423 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -104.53 -19.92 13.85 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.426 1.091 . . . . 0.0 113.725 178.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 173.5 177.06 42.45 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 124.951 1.262 . . . . 0.0 112.491 174.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -87.18 158.13 19.2 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 117.737 0.768 . . . . 0.0 111.987 174.169 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.6 p -120.61 -5.31 9.75 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 170.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -61.16 -31.72 71.45 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 117.519 -1.229 . . . . 0.0 112.025 177.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 47.6 mtm180 -58.32 -38.94 78.11 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-N 120.458 1.481 . . . . 0.0 113.622 170.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 18.6 t60 -65.2 -38.83 91.7 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 119.261 0.937 . . . . 0.0 112.628 174.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 97.3 m -72.89 -33.0 65.77 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 118.801 0.728 . . . . 0.0 112.727 171.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -66.34 -27.62 68.03 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 120.322 -1.486 . . . . 0.0 111.848 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.65 -5.63 16.65 Favored 'General case' 0 CA--C 1.551 1.008 0 N-CA-C 114.044 1.127 . . . . 0.0 114.044 169.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -121.86 19.21 10.98 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 127.583 2.353 . . . . 0.0 112.017 171.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 61.46 29.52 18.46 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.277 1.431 . . . . 0.0 113.518 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.3 mmtp -124.01 153.55 41.15 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 128.222 2.609 . . . . 0.0 112.538 -175.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -78.53 158.52 28.54 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.282 1.033 . . . . 0.0 108.361 166.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -138.7 145.66 17.11 Favored Glycine 0 N--CA 1.476 1.328 0 C-N-CA 124.943 1.259 . . . . 0.0 114.745 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -147.37 147.63 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 126.077 1.751 . . . . 0.0 110.882 -172.309 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 71.1 m -77.51 116.94 18.48 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 113.731 1.012 . . . . 0.0 113.731 -174.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -109.03 103.59 12.65 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.477 1.511 . . . . 0.0 108.562 168.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 66.34 -114.86 6.86 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 124.142 0.877 . . . . 0.0 111.85 -176.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 69.8 p -107.22 22.04 16.6 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.993 1.717 . . . . 0.0 112.384 175.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 37.0 mmtm -139.67 170.33 16.09 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.42 1.888 . . . . 0.0 112.29 -172.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 16.7 t -109.49 133.22 53.34 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.347 1.059 . . . . 0.0 112.576 -178.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.8 tptt -118.71 129.4 55.25 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 126.615 1.966 . . . . 0.0 107.137 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 68.6 m -86.46 145.4 26.84 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.39 -125.8 5.14 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 127.161 2.315 . . . . 0.0 113.752 -172.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 28.9 m -84.08 160.45 57.63 Favored Pre-proline 0 N--CA 1.471 0.583 0 C-N-CA 124.993 1.317 . . . . 0.0 113.242 177.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo . . . . . 0 CA--C 1.538 0.717 0 C-N-CA 124.426 3.418 . . . . 0.0 113.564 168.082 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 . . . . . 0 N--CA 1.472 0.658 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 59.04 19.0 6.81 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.423 1.489 . . . . 0.0 114.62 -171.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 73.86 -0.29 52.15 Favored Glycine 0 CA--C 1.552 2.38 0 N-CA-C 115.803 1.081 . . . . 0.0 115.803 -168.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 97.8 m -81.81 137.47 35.29 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 120.84 -1.388 . . . . 0.0 113.095 178.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -151.12 134.32 16.04 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.247 1.019 . . . . 0.0 111.337 166.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 48.74 51.71 15.28 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.814 1.646 . . . . 0.0 113.736 -178.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 61.12 13.82 5.0 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 126.905 2.082 . . . . 0.0 116.398 -175.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.4 t -127.26 144.72 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-N 119.683 1.129 . . . . 0.0 111.663 -177.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -72.8 31.83 0.06 Allowed 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.595 1.558 . . . . 0.0 114.493 175.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -53.71 -32.08 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 O-C-N 120.327 -1.483 . . . . 0.0 114.601 -171.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -106.0 -6.96 18.37 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 177.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 167.37 150.83 6.65 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-N 119.599 1.09 . . . . 0.0 114.547 169.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -71.55 108.92 5.18 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.603 1.161 . . . . 0.0 113.777 -174.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -69.37 -29.91 67.8 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.787 2.035 . . . . 0.0 113.034 176.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.66 -34.11 67.03 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 120.745 -1.222 . . . . 0.0 112.132 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.3 mtm180 -60.74 -36.29 78.52 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 175.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 51.7 t60 -64.43 -39.71 94.35 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.885 0.874 . . . . 0.0 111.381 176.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 80.6 m -79.36 -32.73 43.28 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.246 0.619 . . . . 0.0 112.474 175.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.92 -31.25 71.55 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 120.503 -1.373 . . . . 0.0 111.697 173.003 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.5 -9.21 40.14 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.495 1.118 . . . . 0.0 113.832 171.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -116.91 12.5 14.71 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.298 1.839 . . . . 0.0 112.096 169.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 49.99 46.4 24.43 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.587 1.955 . . . . 0.0 113.587 -171.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.4 mmtt -122.21 162.4 21.46 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 127.33 2.252 . . . . 0.0 112.223 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -76.62 145.54 38.81 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.081 0.952 . . . . 0.0 109.305 167.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -133.13 138.05 9.83 Favored Glycine 0 N--CA 1.472 1.086 0 C-N-CA 124.501 1.048 . . . . 0.0 114.643 -179.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -149.81 141.74 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 125.368 1.467 . . . . 0.0 110.538 -172.075 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 84.0 m -78.55 116.83 19.2 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -179.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 -98.62 94.06 6.46 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.754 1.622 . . . . 0.0 109.466 168.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 63.24 -96.14 0.16 Allowed Glycine 0 CA--C 1.529 0.924 0 C-N-CA 125.188 1.375 . . . . 0.0 111.323 -176.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.7 p -118.58 14.97 13.68 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 127.52 2.328 . . . . 0.0 113.874 -173.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -138.58 168.6 19.44 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 127.25 2.22 . . . . 0.0 112.683 174.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 28.9 t -98.09 141.81 30.57 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.415 1.486 . . . . 0.0 110.733 171.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -128.87 120.56 26.45 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.081 1.352 . . . . 0.0 109.238 179.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 60.9 m -87.32 128.77 35.17 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.153 0.798 . . . . 0.0 113.153 -177.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -99.12 -126.82 5.75 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 126.522 2.01 . . . . 0.0 114.238 -169.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 16.8 m -75.9 152.74 84.77 Favored Pre-proline 0 N--CA 1.473 0.694 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 177.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo . . . . . 0 CA--C 1.535 0.574 0 C-N-CA 124.158 3.239 . . . . 0.0 110.987 174.137 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 . . . . . 0 N--CA 1.477 0.892 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 56.27 12.05 0.92 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.268 1.827 . . . . 0.0 115.471 -177.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.53 0.73 84.95 Favored Glycine 0 CA--C 1.541 1.712 0 N-CA-C 115.401 0.92 . . . . 0.0 115.401 -169.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 89.0 m -85.15 139.81 31.41 Favored 'General case' 0 C--O 1.236 0.39 0 O-C-N 121.037 -1.272 . . . . 0.0 112.421 178.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -151.12 131.01 13.28 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 167.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 44.49 55.0 6.02 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.43 1.892 . . . . 0.0 112.994 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 56.0 m-80 64.01 16.48 9.96 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 127.003 2.121 . . . . 0.0 116.173 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 19.8 t -124.93 147.45 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 O-C-N 120.935 -1.103 . . . . 0.0 111.396 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.85 37.4 0.18 Allowed 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 127.414 2.286 . . . . 0.0 112.493 176.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -68.32 -45.36 82.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 -168.369 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 25.4 mmmt -101.92 -14.24 17.29 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 -169.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 171.98 168.95 34.17 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-N 119.376 0.989 . . . . 0.0 115.19 174.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -87.5 81.3 7.82 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.02 1.728 . . . . 0.0 113.398 -171.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -46.28 -26.95 0.9 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 127.066 2.146 . . . . 0.0 113.831 171.281 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -32.37 -48.82 0.19 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.79 2.036 . . . . 0.0 112.485 166.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 55.2 mtm180 -66.57 -36.73 83.35 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 -171.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 15.7 t60 -68.64 -33.46 74.06 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-N 120.081 1.309 . . . . 0.0 112.3 176.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 71.5 m -80.76 -39.17 27.33 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 121.588 -0.695 . . . . 0.0 111.488 175.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -62.19 -32.8 73.49 Favored 'General case' 0 CA--C 1.53 0.206 0 O-C-N 120.54 -1.35 . . . . 0.0 112.072 177.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.1 -22.35 50.31 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.433 1.093 . . . . 0.0 113.595 174.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -121.27 23.04 10.65 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.874 1.669 . . . . 0.0 111.807 177.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 31.3 t0 56.57 55.79 6.14 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.957 1.703 . . . . 0.0 112.728 177.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm -138.77 151.62 47.24 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 127.647 2.379 . . . . 0.0 111.805 177.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -72.35 145.0 48.05 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 166.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -118.08 134.71 11.18 Favored Glycine 0 N--CA 1.469 0.846 0 C-N-CA 124.076 0.846 . . . . 0.0 112.607 175.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -144.07 140.18 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 125.201 1.401 . . . . 0.0 110.35 -177.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 99.9 m -78.68 114.82 17.92 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -174.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -107.63 103.06 12.27 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 126.879 2.072 . . . . 0.0 108.64 173.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 61.83 -116.59 9.57 Favored Glycine 0 CA--C 1.532 1.099 0 N-CA-C 111.109 -0.797 . . . . 0.0 111.109 -173.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 76.0 p -101.21 14.32 32.34 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 125.333 1.453 . . . . 0.0 114.128 175.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -127.69 165.13 20.61 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.989 1.715 . . . . 0.0 112.503 -173.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 46.8 t -104.45 121.41 43.37 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.382 1.073 . . . . 0.0 110.405 177.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 48.7 tptt -97.08 120.86 38.23 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 126.746 2.018 . . . . 0.0 106.693 177.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 59.5 m -84.85 137.9 32.88 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 123.612 0.57 . . . . 0.0 111.617 171.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -119.64 -124.96 3.29 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 126.158 1.837 . . . . 0.0 114.526 -169.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 15.3 m -83.59 157.54 64.21 Favored Pre-proline 0 N--CA 1.47 0.562 0 C-N-CA 125.966 1.706 . . . . 0.0 113.585 -179.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo . . . . . 0 CA--C 1.537 0.649 0 C-N-CA 123.862 3.041 . . . . 0.0 114.44 -178.035 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 . . . . . 0 N--CA 1.476 0.875 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 54.15 19.45 2.14 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 126.193 1.797 . . . . 0.0 114.24 -172.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 76.34 -2.98 55.51 Favored Glycine 0 CA--C 1.542 1.721 0 C-N-CA 124.955 1.264 . . . . 0.0 115.692 -170.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 78.4 m -77.28 134.89 38.43 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.689 1.196 . . . . 0.0 112.132 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -146.14 136.28 23.69 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.655 0.782 . . . . 0.0 111.575 168.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 44.83 49.3 9.05 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.264 1.425 . . . . 0.0 112.744 -176.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 63.61 26.03 14.52 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 126.742 2.017 . . . . 0.0 115.023 175.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 49.7 t -136.97 145.99 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 125.996 1.718 . . . . 0.0 111.027 178.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -75.69 49.31 0.5 Allowed 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 126.041 1.736 . . . . 0.0 113.645 174.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -71.44 -51.53 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 O-C-N 120.166 -1.584 . . . . 0.0 113.894 -173.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -91.16 -9.19 46.36 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.02 0.928 . . . . 0.0 113.249 -172.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 176.01 172.98 41.29 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 126.512 2.006 . . . . 0.0 111.048 169.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -94.06 144.41 25.5 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 179.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 44.0 t -100.52 -10.66 20.83 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.144 0.977 . . . . 0.0 112.236 169.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -51.19 -43.23 61.3 Favored 'General case' 0 N--CA 1.466 0.337 0 O-C-N 120.799 -1.188 . . . . 0.0 111.663 178.291 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.5 mtm180 -56.39 -41.83 76.9 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 175.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 11.7 t60 -61.47 -46.76 88.67 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.621 0.768 . . . . 0.0 111.156 177.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 92.2 m -80.12 -29.2 38.91 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -178.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 23.8 tptp -67.71 -22.95 65.23 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 120.764 -1.21 . . . . 0.0 113.008 175.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.18 -27.26 69.24 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 118.793 0.724 . . . . 0.0 112.305 168.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -101.95 7.78 41.29 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 126.952 2.101 . . . . 0.0 111.984 171.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . 0.28 1.8 t70 54.63 33.61 19.62 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 129.1 2.96 . . . . 0.0 115.8 -175.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 28.9 mttt -109.66 163.22 13.68 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 127.603 2.361 . . . . 0.0 113.168 174.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -69.89 144.05 52.59 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.202 1.401 . . . . 0.0 109.18 167.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -95.45 151.72 20.11 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 123.875 0.75 . . . . 0.0 112.371 169.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.41 117.96 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 118.686 1.243 . . . . 0.0 110.777 -178.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 98.4 m -82.06 108.42 15.53 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.294 171.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 27.6 p80 -104.91 8.55 34.65 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 176.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 170.76 -134.45 3.13 Favored Glycine 0 CA--C 1.523 0.566 0 C-N-CA 123.83 0.729 . . . . 0.0 111.93 179.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 42.6 p -82.04 13.95 3.09 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 126.663 1.985 . . . . 0.0 112.289 168.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -149.22 170.37 18.63 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 128.978 2.911 . . . . 0.0 109.413 -172.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 14.9 t -128.76 173.68 10.12 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.022 1.329 . . . . 0.0 113.255 -176.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.0 mtpt -155.74 169.32 24.64 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 130.097 3.359 . . . . 0.0 107.244 178.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 59.8 m -104.27 148.81 25.92 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.87 0.868 . . . . 0.0 112.365 168.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -98.19 -119.9 4.11 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 126.985 2.231 . . . . 0.0 112.589 -177.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 19.5 m -100.59 159.03 30.77 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 126.499 1.92 . . . . 0.0 112.765 175.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo . . . . . 0 CA--C 1.542 0.901 0 C-N-CA 124.997 3.798 . . . . 0.0 113.912 168.5 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 . . . . . 0 CA--C 1.542 0.652 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 56.61 17.78 3.26 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.468 1.907 . . . . 0.0 114.581 -177.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 84.11 -9.32 63.9 Favored Glycine 0 CA--C 1.538 1.506 0 C-N-CA 124.771 1.176 . . . . 0.0 115.135 -170.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 92.7 m -80.35 139.33 36.62 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.436 1.094 . . . . 0.0 113.05 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -152.35 134.35 14.9 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.666 0.786 . . . . 0.0 110.61 168.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 49.6 49.32 20.18 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.675 1.19 . . . . 0.0 113.996 178.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 60.32 21.11 10.61 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 126.32 1.848 . . . . 0.0 115.547 -178.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 69.4 t -132.08 149.37 32.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 125.523 1.529 . . . . 0.0 110.035 -178.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.39 39.0 0.19 Allowed 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 126.806 2.043 . . . . 0.0 111.749 178.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -58.67 -44.5 89.92 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 N-CA-C 115.243 1.571 . . . . 0.0 115.243 -165.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -91.98 -26.44 18.38 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.954 0.902 . . . . 0.0 111.469 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 173.14 173.99 39.91 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 125.843 1.687 . . . . 0.0 112.959 178.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -84.3 142.81 29.95 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.065 0.946 . . . . 0.0 112.957 175.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.7 p -102.18 -0.03 33.84 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.786 1.234 . . . . 0.0 114.151 174.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.4 tmmm? -53.36 -45.1 69.04 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 118.138 -0.934 . . . . 0.0 111.136 173.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 44.4 mtm180 -60.63 -37.21 80.72 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.543 1.065 . . . . 0.0 113.261 -176.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 10.7 t60 -61.76 -46.57 89.0 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.272 1.029 . . . . 0.0 112.313 173.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 84.9 m -72.95 -31.29 64.48 Favored 'General case' 0 CA--C 1.545 0.783 0 O-C-N 121.187 -0.946 . . . . 0.0 112.308 176.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 41.3 tptt -65.24 -21.59 66.76 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 126.023 1.729 . . . . 0.0 112.764 177.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.86 -17.63 17.56 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.755 0.822 . . . . 0.0 112.765 168.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -123.56 15.25 9.54 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 126.766 2.027 . . . . 0.0 112.699 172.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 22.5 t70 65.04 14.85 9.64 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 128.395 2.678 . . . . 0.0 115.387 -175.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.3 mmtp -84.17 149.38 26.2 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 126.526 1.93 . . . . 0.0 111.637 178.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -71.37 137.32 48.29 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 124.245 1.018 . . . . 0.0 108.559 167.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -110.76 128.89 8.99 Favored Glycine 0 N--CA 1.471 1.013 0 C-N-CA 123.907 0.765 . . . . 0.0 111.927 173.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.37 143.07 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 124.501 1.12 . . . . 0.0 111.152 -177.513 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 77.7 m -79.13 115.13 18.6 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -174.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 27.7 m-70 -112.22 104.17 12.35 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.36 1.464 . . . . 0.0 108.568 168.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.79 -122.79 23.06 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 124.226 0.917 . . . . 0.0 111.933 -173.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 40.1 p -101.7 21.34 14.61 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 127.054 2.141 . . . . 0.0 113.088 178.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -139.15 163.21 33.04 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 126.137 1.775 . . . . 0.0 112.169 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 6.4 t -86.05 157.41 20.08 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.429 168.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 6.0 tmtm? -131.65 126.35 34.44 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 168.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 79.4 m -83.88 130.53 34.91 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 120.805 0.335 . . . . 0.0 110.849 173.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -97.97 -131.6 7.2 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 125.468 1.508 . . . . 0.0 113.502 -171.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 28.9 m -87.31 168.2 18.44 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 125.054 1.341 . . . . 0.0 109.983 168.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo . . . . . 0 CA--C 1.542 0.88 0 C-N-CA 123.854 3.036 . . . . 0.0 113.301 169.293 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 . . . . . 0 N--CA 1.47 0.557 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 59.71 5.19 0.65 Allowed 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 115.853 1.797 . . . . 0.0 115.853 -175.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 92.13 -3.62 76.81 Favored Glycine 0 CA--C 1.542 1.752 0 C-N-CA 125.401 1.477 . . . . 0.0 114.657 -168.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 96.3 m -78.7 136.82 37.53 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -154.63 141.49 19.14 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.401 1.08 . . . . 0.0 111.316 165.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 51.53 40.48 27.05 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.961 1.304 . . . . 0.0 114.391 177.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 24.7 m-20 64.62 21.11 12.35 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 126.504 1.922 . . . . 0.0 115.917 -174.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 40.4 t -134.42 147.08 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 125.164 1.386 . . . . 0.0 112.458 -176.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -76.94 53.32 0.93 Allowed 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 127.029 2.132 . . . . 0.0 112.113 173.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -80.4 -36.43 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 124.929 1.292 . . . . 0.0 114.239 -174.443 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -96.98 -3.65 41.23 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.47 1.108 . . . . 0.0 112.995 177.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 159.47 170.18 23.72 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 125.769 1.652 . . . . 0.0 113.049 172.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -87.35 107.98 18.77 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.332 1.053 . . . . 0.0 113.398 -176.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -62.06 -26.14 68.09 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.751 1.621 . . . . 0.0 112.356 174.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -43.71 -44.69 6.69 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.278 1.431 . . . . 0.0 110.416 167.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 8.7 ttm180 -64.14 -26.24 68.44 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 115.058 1.503 . . . . 0.0 115.058 -178.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 67.4 t60 -77.05 -42.73 37.24 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 120.596 -1.315 . . . . 0.0 111.428 171.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 92.2 m -70.84 -29.43 65.56 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 121.817 -0.552 . . . . 0.0 111.91 175.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 51.7 tptt -68.54 -27.1 65.79 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.726 2.01 . . . . 0.0 114.16 177.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.17 -16.16 61.34 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.615 0.766 . . . . 0.0 112.783 169.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -110.8 4.28 19.75 Favored 'General case' 0 CA--C 1.556 1.205 0 C-N-CA 127.296 2.238 . . . . 0.0 112.018 170.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . 0.287 3.7 t70 59.61 37.6 22.48 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 129.258 3.023 . . . . 0.0 115.211 -173.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.4 mttp -116.12 160.29 20.55 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.868 2.067 . . . . 0.0 115.145 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -66.69 144.4 56.39 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.209 1.403 . . . . 0.0 109.003 167.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -131.1 136.1 8.62 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 125.043 1.306 . . . . 0.0 115.297 178.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -138.55 138.27 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 124.171 0.988 . . . . 0.0 112.057 -179.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 90.9 m -77.28 104.7 7.94 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.872 0.869 . . . . 0.0 113.123 -178.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 27.5 m-70 -90.77 92.52 8.84 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 123.662 0.785 . . . . 0.0 109.004 167.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.9 -116.57 6.91 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 124.628 1.108 . . . . 0.0 112.417 -172.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 63.4 p -99.95 11.8 38.39 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.965 1.706 . . . . 0.0 113.993 177.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -129.97 160.19 34.38 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.208 1.403 . . . . 0.0 111.541 178.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 34.6 t -98.32 147.52 24.59 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.976 1.31 . . . . 0.0 110.647 179.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 30.9 ttmt -141.53 124.76 16.44 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 125.073 1.349 . . . . 0.0 108.191 -178.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 19.4 m -89.15 144.64 25.97 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -171.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -107.08 -131.01 6.58 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 126.569 2.033 . . . . 0.0 113.212 -175.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.6 m -73.42 158.96 85.86 Favored Pre-proline 0 N--CA 1.473 0.692 0 C-N-CA 124.209 1.003 . . . . 0.0 113.668 172.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo . . . . . 0 CA--C 1.535 0.526 0 C-N-CA 123.503 2.802 . . . . 0.0 111.248 171.696 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 . . . . . 0 C--O 1.224 -0.245 0 CA-C-O 121.506 0.67 . . . . 0.0 111.477 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 61.26 -2.22 0.24 Allowed 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.583 1.553 . . . . 0.0 114.7 -174.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 96.18 -9.1 67.53 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 125.489 1.519 . . . . 0.0 113.831 -169.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 70.9 m -89.46 141.6 28.42 Favored 'General case' 0 C--O 1.236 0.354 0 O-C-N 121.511 -0.994 . . . . 0.0 113.469 -175.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -154.38 139.83 17.76 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.173 0.989 . . . . 0.0 109.93 165.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 51.55 44.7 28.92 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.788 1.235 . . . . 0.0 114.189 177.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 60.51 17.34 7.23 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 126.223 1.809 . . . . 0.0 115.602 -174.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 41.6 t -126.75 148.05 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.865 1.266 . . . . 0.0 111.881 -177.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -76.0 40.37 0.2 Allowed 'General case' 0 CA--C 1.558 1.271 0 C-N-CA 128.686 2.794 . . . . 0.0 111.947 177.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -74.89 -54.53 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 C-N-CA 126.105 1.762 . . . . 0.0 113.544 -170.02 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -78.71 -7.46 57.75 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.106 1.363 . . . . 0.0 112.545 -172.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 162.1 -171.09 37.92 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 125.863 1.697 . . . . 0.0 111.482 175.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -95.75 120.95 36.92 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -176.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.5 t -77.59 -20.17 54.42 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.667 1.187 . . . . 0.0 112.636 170.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 8.8 tppt? -44.92 -50.78 10.3 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.594 1.558 . . . . 0.0 111.013 172.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 42.4 mtm180 -64.77 -26.64 68.44 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 115.676 1.732 . . . . 0.0 115.676 -173.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 59.6 t60 -72.81 -37.06 67.64 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 119.272 0.942 . . . . 0.0 112.032 174.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 93.0 m -84.88 -29.72 25.01 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.437 0.695 . . . . 0.0 112.863 177.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.76 -29.12 66.52 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 126.138 1.775 . . . . 0.0 112.317 171.533 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.99 -19.77 54.13 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.5 1.12 . . . . 0.0 113.859 171.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -114.38 9.34 16.84 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 127.192 2.197 . . . . 0.0 111.789 176.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.4 t70 57.18 38.96 29.14 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 126.815 2.046 . . . . 0.0 113.594 -171.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.9 mmtp -119.23 156.85 29.16 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 128.175 2.59 . . . . 0.0 112.073 -176.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -76.68 147.71 37.27 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 124.199 0.999 . . . . 0.0 109.643 168.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.16 154.56 19.11 Favored Glycine 0 CA--C 1.542 1.755 0 C-N-CA 125.059 1.314 . . . . 0.0 114.247 173.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -151.67 136.87 10.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 125.954 1.701 . . . . 0.0 110.211 175.254 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 93.9 m -84.18 118.02 23.87 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -174.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -101.96 91.4 4.34 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.347 1.859 . . . . 0.0 108.956 168.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 64.71 -118.7 13.01 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.392 0.996 . . . . 0.0 112.112 -176.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 54.2 p -89.84 11.63 19.66 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 126.633 1.973 . . . . 0.0 113.846 174.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm -131.08 166.57 20.77 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 126.306 1.843 . . . . 0.0 112.14 -171.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 47.3 t -121.47 135.2 55.06 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.452 1.501 . . . . 0.0 111.26 -175.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 12.4 tptt -123.16 153.65 39.74 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 128.762 2.825 . . . . 0.0 107.776 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 63.9 m -111.93 127.64 55.92 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 113.707 1.002 . . . . 0.0 113.707 -173.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -87.39 -130.7 3.17 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 126.518 2.009 . . . . 0.0 113.95 -176.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 25.4 m -80.57 161.1 65.52 Favored Pre-proline 0 CA--C 1.532 0.285 0 C-N-CA 125.726 1.611 . . . . 0.0 112.711 176.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo . . . . . 0 CA--C 1.537 0.626 0 C-N-CA 123.992 3.128 . . . . 0.0 112.411 168.077 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 . . . . . 0 N--CA 1.474 0.737 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 54.54 20.11 2.7 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.111 1.365 . . . . 0.0 114.024 -169.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 71.58 0.11 37.77 Favored Glycine 0 CA--C 1.534 1.279 0 O-C-N 120.684 -1.26 . . . . 0.0 115.04 -177.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 72.8 m -88.29 136.82 32.8 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.984 0.913 . . . . 0.0 112.847 -175.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -150.4 139.09 20.72 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.253 1.021 . . . . 0.0 111.263 166.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 48.65 48.34 19.89 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.145 1.378 . . . . 0.0 113.64 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 47.8 m-20 65.48 12.97 8.57 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 126.164 1.786 . . . . 0.0 115.668 -177.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.9 t -130.34 146.4 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 124.615 1.166 . . . . 0.0 112.002 -175.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -74.24 43.23 0.17 Allowed 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 127.422 2.289 . . . . 0.0 113.951 172.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -69.56 -39.22 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 O-C-N 120.892 -1.13 . . . . 0.0 113.689 -174.329 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -92.66 -19.18 22.11 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -174.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 176.5 -150.06 10.2 Favored Glycine 0 CA--C 1.534 1.278 0 N-CA-C 115.882 1.113 . . . . 0.0 115.882 178.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -105.65 135.21 47.48 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.572 1.549 . . . . 0.0 113.961 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -109.47 -24.06 11.2 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 129.049 2.94 . . . . 0.0 110.633 170.248 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 12.9 tppt? -40.15 -52.6 2.56 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 126.083 1.753 . . . . 0.0 111.975 169.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 60.5 mtm180 -61.8 -30.54 70.88 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 114.527 1.306 . . . . 0.0 114.527 -174.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 68.7 t60 -69.55 -44.08 71.64 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 118.99 0.814 . . . . 0.0 111.62 175.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 91.4 m -78.09 -30.65 49.66 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 179.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 49.8 tptt -65.8 -20.75 66.37 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.441 1.896 . . . . 0.0 113.387 176.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.65 -29.99 70.15 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.906 0.882 . . . . 0.0 111.929 169.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 -91.22 6.35 45.48 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 126.166 1.786 . . . . 0.0 111.674 168.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.6 t70 52.8 36.68 22.0 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 127.825 2.45 . . . . 0.0 113.999 -170.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.8 mttt -112.61 160.03 18.27 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.777 2.031 . . . . 0.0 113.004 178.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 53.4 mm-40 -67.74 142.93 56.12 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 124.62 1.168 . . . . 0.0 109.907 167.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -113.77 135.15 12.3 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 125.276 1.417 . . . . 0.0 113.795 175.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -142.35 132.73 24.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 124.463 1.105 . . . . 0.0 110.633 -170.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 84.5 m -78.2 113.93 16.61 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -173.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 22.4 m-70 -105.78 104.78 14.57 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.917 1.687 . . . . 0.0 108.088 169.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 70.84 -118.12 7.37 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 125.034 1.302 . . . . 0.0 111.322 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 63.0 p -103.83 16.27 26.74 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.455 1.502 . . . . 0.0 112.544 174.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 49.5 mmtm -132.45 163.84 27.88 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.169 1.788 . . . . 0.0 112.104 -173.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 11.0 t -87.87 156.48 19.36 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.052 0.941 . . . . 0.0 111.083 170.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.73 145.06 30.71 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 127.645 2.378 . . . . 0.0 105.91 170.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 38.4 m -98.81 143.55 29.03 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -178.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -98.64 -117.14 3.78 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 126.712 2.101 . . . . 0.0 113.893 -175.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.5 m -103.4 162.55 19.7 Favored Pre-proline 0 CA--C 1.538 0.492 0 C-N-CA 126.906 2.082 . . . . 0.0 111.78 176.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_exo . . . . . 0 CA--C 1.537 0.627 0 C-N-CA 124.743 3.629 . . . . 0.0 112.914 168.958 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.914 0 CA-C-O 118.198 -0.906 . . . . 0.0 110.117 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -146.69 -14.67 0.43 Allowed 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 115.984 1.846 . . . . 0.0 115.984 -178.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -77.36 -37.82 51.48 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 119.319 0.963 . . . . 0.0 112.75 175.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -137.65 -0.92 2.1 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 172.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 57.16 23.64 8.85 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.679 1.191 . . . . 0.0 114.043 -178.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 75.58 -6.18 33.02 Favored Glycine 0 CA--C 1.538 1.508 0 C-N-CA 123.93 0.776 . . . . 0.0 114.879 -173.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 84.2 m -80.96 143.87 32.27 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.088 1.355 . . . . 0.0 112.009 -179.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -151.43 142.77 23.39 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.938 0.895 . . . . 0.0 109.897 168.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 49.25 37.41 11.24 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 178.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 70.98 15.99 6.56 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 126.044 1.738 . . . . 0.0 115.531 -175.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 34.9 t -132.15 148.25 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 125.036 1.335 . . . . 0.0 112.396 -173.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.53 42.66 0.17 Allowed 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 127.455 2.302 . . . . 0.0 113.096 174.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -67.42 -51.27 54.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 O-C-N 120.048 -1.657 . . . . 0.0 112.579 -173.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 27.3 mtpt -90.07 -21.81 22.13 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -175.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 179.31 -176.9 48.11 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 125.294 1.426 . . . . 0.0 112.724 174.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -95.27 151.2 19.45 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.843 1.257 . . . . 0.0 112.822 176.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 40.4 t -98.26 -12.28 21.76 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.423 1.089 . . . . 0.0 111.387 167.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -53.69 -36.04 61.76 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 120.663 -1.273 . . . . 0.0 112.174 -178.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -63.06 -30.26 71.46 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 115.423 1.638 . . . . 0.0 115.423 174.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 56.4 t60 -75.41 -43.27 50.89 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 119.574 1.079 . . . . 0.0 111.614 172.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 93.2 m -80.76 -27.38 36.78 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -177.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.3 -31.08 71.64 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 120.28 -1.512 . . . . 0.0 111.705 173.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.91 -18.95 64.94 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.237 1.015 . . . . 0.0 113.397 171.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -97.25 6.14 48.87 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 126.799 2.039 . . . . 0.0 111.065 169.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.4 t0 54.19 32.51 16.11 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 127.702 2.401 . . . . 0.0 114.488 -169.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.4 mttp -119.24 161.48 20.32 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 126.901 2.08 . . . . 0.0 113.934 -173.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -70.99 146.44 49.42 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 167.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -108.3 139.61 15.19 Favored Glycine 0 N--CA 1.472 1.078 0 C-N-CA 124.65 1.119 . . . . 0.0 111.717 169.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -144.73 126.12 8.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 118.219 1.01 . . . . 0.0 112.022 -177.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 87.8 m -73.69 111.85 9.22 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.825 0.85 . . . . 0.0 112.671 -176.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 38.7 m-70 -108.62 102.92 11.94 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.009 1.323 . . . . 0.0 109.383 169.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.59 -123.86 14.4 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 125.67 1.605 . . . . 0.0 112.934 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 61.2 p -97.05 14.89 24.1 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 126.856 2.062 . . . . 0.0 113.038 175.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -136.28 -173.87 3.52 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 128.938 2.895 . . . . 0.0 111.185 179.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 41.8 t -132.05 161.39 33.33 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.931 1.292 . . . . 0.0 111.488 177.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 67.4 mttt -133.81 142.15 47.74 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 128.503 2.721 . . . . 0.0 106.457 171.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 84.3 m -83.99 134.67 34.63 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 168.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -85.78 -141.53 6.01 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 124.935 1.255 . . . . 0.0 110.961 176.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.9 m -71.7 154.72 92.92 Favored Pre-proline 0 N--CA 1.472 0.669 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 177.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -62.47 137.24 63.59 Favored 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 123.747 2.964 . . . . 0.0 110.184 169.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.5 pp -73.33 -33.72 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 C-N-CA 123.275 0.63 . . . . 0.0 110.87 -172.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 66.3 m -74.49 130.26 39.27 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 125.936 1.694 . . . . 0.0 112.042 -174.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 28.8 p90 -149.47 145.99 27.18 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 123.92 0.888 . . . . 0.0 112.625 173.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 68.7 tp . . . . . 0 C--O 1.252 1.22 0 C-N-CA 126.586 1.955 . . . . 0.0 111.423 179.849 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.636 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -137.04 -33.27 0.77 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.885 1.674 . . . . 0.0 112.749 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 23.1 p30 -68.69 -37.88 79.9 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.46 1.504 . . . . 0.0 113.342 -176.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -88.01 3.16 49.87 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.111 1.365 . . . . 0.0 111.903 172.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 57.98 9.79 1.01 Allowed 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 125.43 1.492 . . . . 0.0 114.191 -170.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 86.65 -3.96 86.6 Favored Glycine 0 CA--C 1.539 1.573 0 C-N-CA 124.757 1.17 . . . . 0.0 115.685 -169.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 79.6 m -80.01 140.5 36.54 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 119.013 1.406 . . . . 0.0 112.727 -179.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -154.28 142.42 20.36 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.591 0.756 . . . . 0.0 110.49 166.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 51.26 37.76 19.5 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -178.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.52 ' ND2' ' H ' ' A' ' 32' ' ' GLY . 12.9 m120 62.59 20.78 12.24 Favored 'General case' 0 CA--C 1.548 0.904 0 N-CA-C 116.04 1.867 . . . . 0.0 116.04 -174.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 59.3 t -125.64 147.75 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 125.825 1.65 . . . . 0.0 111.355 -177.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -76.93 43.92 0.37 Allowed 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 126.326 1.85 . . . . 0.0 112.913 177.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.5 m -69.18 -56.34 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 O-C-N 120.633 -1.292 . . . . 0.0 114.163 -169.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -86.56 -11.62 51.03 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.176 0.99 . . . . 0.0 113.602 -179.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 179.71 171.8 43.07 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.67 1.128 . . . . 0.0 112.134 174.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.411 ' OD1' ' HE3' ' A' ' 18' ' ' LYS . 36.7 t70 -98.02 115.56 28.45 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.141 0.976 . . . . 0.0 112.772 -169.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 16.3 t -68.5 -30.72 69.61 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 121.153 -0.967 . . . . 0.0 112.762 177.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.411 ' HE3' ' OD1' ' A' ' 16' ' ' ASP . 0.0 OUTLIER -54.48 -37.25 65.04 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 117.932 -1.032 . . . . 0.0 111.716 171.763 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 24.9 ttm180 -60.39 -36.33 77.83 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 120.717 1.598 . . . . 0.0 114.788 177.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 36.2 t60 -68.61 -44.75 73.64 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 118.478 0.581 . . . . 0.0 110.968 172.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 89.0 m -76.64 -27.43 55.67 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -177.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.8 tppp? -60.72 -34.11 73.91 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.33 1.452 . . . . 0.0 111.51 173.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.1 -23.66 65.86 Favored 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 173.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -94.95 7.55 45.68 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.258 1.423 . . . . 0.0 112.409 170.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 51.74 40.18 27.01 Favored 'General case' 0 CA--C 1.556 1.178 0 C-N-CA 126.744 2.018 . . . . 0.0 112.745 -172.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 37.1 mttt -122.03 167.15 13.45 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 127.73 2.412 . . . . 0.0 112.6 178.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -83.3 155.84 23.39 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.548 1.139 . . . . 0.0 109.054 168.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -114.12 163.48 12.16 Favored Glycine 0 CA--C 1.546 1.993 0 C-N-CA 125.338 1.446 . . . . 0.0 115.502 -178.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -150.34 128.2 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 126.616 1.966 . . . . 0.0 112.077 177.054 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 69.4 m -85.32 101.64 12.72 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.654 0.781 . . . . 0.0 110.701 170.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.49 ' CD2' ' HB2' ' A' ' 36' ' ' LYS . 10.4 p80 -91.59 98.8 11.87 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 122.688 1.233 . . . . 0.0 108.983 170.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.52 ' H ' ' ND2' ' A' ' 10' ' ' ASN . . . 66.36 -105.84 1.42 Allowed Glycine 0 CA--C 1.53 0.988 0 C-N-CA 125.065 1.317 . . . . 0.0 112.03 -174.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 52.0 p -112.78 14.22 19.88 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 126.925 2.09 . . . . 0.0 113.563 -176.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 21.2 mmmt -134.95 161.24 35.83 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.065 1.346 . . . . 0.0 110.817 177.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 52.8 t -101.32 157.14 17.01 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.649 1.18 . . . . 0.0 111.278 177.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.49 ' HB2' ' CD2' ' A' ' 31' ' ' HIS . 3.5 ttmt -147.65 169.72 19.05 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 128.341 2.656 . . . . 0.0 107.107 169.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 39.5 m -101.38 156.39 17.48 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 122.786 1.279 . . . . 0.0 113.25 172.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -105.72 -133.95 7.72 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 127.365 2.412 . . . . 0.0 110.751 175.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.8 m -78.99 156.31 77.05 Favored Pre-proline 0 CA--C 1.538 0.517 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 175.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -51.0 147.21 19.83 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 124.486 3.458 . . . . 0.0 112.598 167.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.8 pp -64.6 -27.32 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 N-CA-C 115.892 1.812 . . . . 0.0 115.892 -169.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -160.98 29.86 0.14 Allowed 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.395 1.078 . . . . 0.0 112.251 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -132.25 15.8 4.58 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 125.64 1.576 . . . . 0.0 114.347 -168.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.3 tp . . . . . 0 C--O 1.253 1.267 0 C-N-CA 126.335 1.854 . . . . 0.0 111.365 173.229 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.769 0 N-CA-C 110.515 -0.18 . . . . 0.0 110.515 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -117.05 -46.37 2.72 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.288 1.435 . . . . 0.0 112.06 177.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 36.9 p30 -156.21 -37.35 0.08 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.628 1.171 . . . . 0.0 113.915 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -121.54 3.04 10.2 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 -171.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 55.82 21.01 4.45 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.297 1.439 . . . . 0.0 114.149 -174.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 77.66 -4.67 55.76 Favored Glycine 0 CA--C 1.542 1.771 0 C-N-CA 124.031 0.824 . . . . 0.0 114.986 -171.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 94.8 m -80.59 140.0 35.99 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.134 1.374 . . . . 0.0 112.763 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -151.42 134.12 15.61 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.636 0.775 . . . . 0.0 110.788 166.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 47.01 51.33 13.02 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.851 1.26 . . . . 0.0 113.054 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 26.7 m-20 61.07 7.36 1.53 Allowed 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 117.199 2.296 . . . . 0.0 117.199 -175.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.4 t -116.58 140.11 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 O-C-N 120.648 -1.283 . . . . 0.0 111.335 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -77.74 66.74 3.49 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.883 1.273 . . . . 0.0 110.977 169.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -82.3 -41.94 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 125.227 1.411 . . . . 0.0 112.955 178.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -89.97 -16.87 28.98 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.052 0.941 . . . . 0.0 112.534 178.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 164.94 165.34 22.06 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 125.236 1.398 . . . . 0.0 112.119 172.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -78.01 140.21 39.15 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 117.95 0.875 . . . . 0.0 113.055 177.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -89.13 -23.77 22.39 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.162 1.785 . . . . 0.0 111.173 175.295 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -55.08 -32.73 62.18 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 117.759 -1.115 . . . . 0.0 113.205 176.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.81 -35.35 66.25 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 120.609 1.549 . . . . 0.0 114.48 171.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 40.6 t60 -75.03 -28.41 60.45 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 119.666 1.121 . . . . 0.0 112.731 176.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 86.3 m -79.54 -36.76 37.88 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.888 1.275 . . . . 0.0 112.673 173.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 70.9 tttt -59.31 -32.09 69.74 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.15 1.78 . . . . 0.0 113.157 -178.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.61 -14.83 63.28 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 114.236 1.198 . . . . 0.0 114.236 176.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -117.66 19.33 13.91 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.926 1.69 . . . . 0.0 112.572 175.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.8 t70 56.16 63.61 1.96 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.378 1.471 . . . . 0.0 111.049 -175.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm -147.77 146.52 29.22 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 126.383 1.873 . . . . 0.0 112.803 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 57.1 mm-40 -75.43 156.34 35.42 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 163.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -134.16 150.43 20.0 Favored Glycine 0 N--CA 1.473 1.147 0 O-C-N 121.019 -1.051 . . . . 0.0 113.234 178.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -150.5 143.06 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 125.069 1.348 . . . . 0.0 110.084 -173.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 70.7 m -80.71 117.66 21.58 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 121.248 -0.908 . . . . 0.0 112.483 -175.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 -107.83 97.69 7.38 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.898 1.279 . . . . 0.0 108.353 169.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.06 -114.68 4.86 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 125.213 1.387 . . . . 0.0 112.233 -172.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 72.8 p -112.89 20.6 16.27 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 127.56 2.344 . . . . 0.0 112.143 178.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 22.5 mmtm -136.25 169.33 17.81 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 128.043 2.537 . . . . 0.0 112.169 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 34.7 t -105.81 139.1 40.9 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.642 1.577 . . . . 0.0 112.481 -174.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -123.31 124.62 43.37 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 126.924 2.09 . . . . 0.0 107.605 177.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 73.4 m -83.53 141.6 31.5 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 121.936 0.874 . . . . 0.0 113.358 176.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -111.77 -145.73 10.03 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 127.522 2.486 . . . . 0.0 113.035 -178.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.5 m -63.44 156.07 72.15 Favored Pre-proline 0 N--CA 1.476 0.834 0 C-N-CA 124.546 1.139 . . . . 0.0 114.025 175.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -66.69 149.22 83.86 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 123.629 2.886 . . . . 0.0 113.233 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.4 pp -77.21 -8.27 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.842 0.857 . . . . 0.0 113.052 178.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.0 m -79.99 74.06 6.76 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.557 1.543 . . . . 0.0 112.093 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -81.49 -43.93 18.13 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.259 1.424 . . . . 0.0 113.628 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.3 pp . . . . . 0 C--O 1.251 1.173 0 C-N-CA 125.872 1.669 . . . . 0.0 112.995 -169.811 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.982 0 CA-C-O 119.498 -0.287 . . . . 0.0 110.305 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -131.04 -33.84 1.51 Allowed 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 114.639 1.348 . . . . 0.0 114.639 -169.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -137.7 -50.28 0.6 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.946 0.898 . . . . 0.0 112.943 -178.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -127.43 4.53 6.25 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 115.366 1.617 . . . . 0.0 115.366 -169.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 54.54 29.77 11.88 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.57 1.148 . . . . 0.0 112.929 -172.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.25 -5.56 6.65 Favored Glycine 0 CA--C 1.542 1.749 0 N-CA-C 116.188 1.235 . . . . 0.0 116.188 -171.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 96.5 m -80.98 138.85 36.07 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 118.791 1.295 . . . . 0.0 114.224 -177.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -152.43 141.17 20.96 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.547 0.739 . . . . 0.0 110.287 165.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 47.55 47.35 17.55 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.863 1.265 . . . . 0.0 112.914 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 24.7 m-20 57.71 20.91 6.82 Favored 'General case' 0 CA--C 1.552 1.032 0 N-CA-C 116.33 1.974 . . . . 0.0 116.33 -174.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 62.2 t -130.14 149.7 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 CA-C-N 120.673 1.579 . . . . 0.0 112.137 -177.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.58 53.03 0.68 Allowed 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 127.131 2.172 . . . . 0.0 111.402 174.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -76.98 -50.55 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 O-C-N 119.863 -1.773 . . . . 0.0 112.804 -174.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -84.11 -25.93 29.34 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.799 0.839 . . . . 0.0 112.968 -178.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -179.03 -178.55 48.33 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.108 1.337 . . . . 0.0 112.701 177.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -101.65 104.16 14.99 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 122.496 1.141 . . . . 0.0 112.842 -176.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -63.71 -32.1 73.48 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.659 1.584 . . . . 0.0 113.144 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 5.6 tmmm? -58.82 -20.89 54.5 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 117.538 -1.22 . . . . 0.0 113.106 175.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.3 tpp180 -62.18 -36.32 81.51 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 120.786 1.63 . . . . 0.0 113.4 171.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 8.3 t60 -68.73 -44.52 73.67 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.633 0.773 . . . . 0.0 111.13 173.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 72.0 m -67.0 -37.78 84.82 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 121.496 -0.752 . . . . 0.0 112.252 176.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -63.16 -30.27 71.45 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 120.988 -1.07 . . . . 0.0 112.025 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.37 -23.87 65.64 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.302 1.041 . . . . 0.0 113.298 171.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -93.3 6.27 48.68 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.388 1.475 . . . . 0.0 113.023 170.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . 0.267 0.3 OUTLIER 64.88 35.55 8.37 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 127.547 2.339 . . . . 0.0 114.445 -172.14 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.4 mmtp -127.66 152.81 47.21 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 127.966 2.506 . . . . 0.0 113.391 -174.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -76.79 159.09 30.4 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.256 -0.903 . . . . 0.0 108.913 167.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -140.78 145.21 15.8 Favored Glycine 0 N--CA 1.474 1.187 0 C-N-CA 125.022 1.296 . . . . 0.0 114.547 -178.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -145.37 141.63 22.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 124.878 1.271 . . . . 0.0 110.803 -176.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 90.8 m -77.61 120.48 22.62 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.906 0.86 . . . . 0.0 113.315 -175.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -113.75 100.82 8.75 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.817 1.647 . . . . 0.0 109.404 169.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 64.88 -126.99 32.81 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 125.238 1.399 . . . . 0.0 111.086 -172.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 34.9 p -89.94 19.56 4.78 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 126.31 1.844 . . . . 0.0 114.011 177.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -141.86 163.17 33.63 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.385 1.474 . . . . 0.0 112.22 -174.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.7 t -88.56 157.9 18.46 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.627 1.171 . . . . 0.0 111.674 173.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.6 121.75 15.81 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 126.448 1.899 . . . . 0.0 107.461 171.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 63.3 m -86.11 134.47 33.81 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 -178.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -102.88 -122.63 5.13 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 127.684 2.564 . . . . 0.0 114.727 -169.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.6 m -87.22 156.82 54.19 Favored Pre-proline 0 N--CA 1.477 0.884 0 C-N-CA 125.765 1.626 . . . . 0.0 113.723 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -63.7 146.34 92.14 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 124.16 3.24 . . . . 0.0 113.322 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.8 pp -78.31 -16.55 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 N-CA-C 115.528 1.677 . . . . 0.0 115.528 -171.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.2 p -63.15 117.38 6.44 Favored 'General case' 0 C--O 1.238 0.478 0 O-C-N 121.185 -0.947 . . . . 0.0 111.733 -178.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -89.68 63.95 6.37 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.938 1.295 . . . . 0.0 111.267 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.2 pp . . . . . 0 C--O 1.25 1.098 0 C-N-CA 126.842 2.057 . . . . 0.0 113.195 174.791 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.699 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -144.08 134.62 24.79 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.67 1.588 . . . . 0.0 110.793 -173.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 12.3 m-80 63.64 -20.68 0.06 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 128.945 2.898 . . . . 0.0 115.876 175.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -132.63 8.22 4.18 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 57.5 12.9 1.64 Allowed 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 115.098 1.518 . . . . 0.0 115.098 -175.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 85.08 -5.23 83.71 Favored Glycine 0 CA--C 1.54 1.602 0 C-N-CA 124.739 1.162 . . . . 0.0 115.173 -168.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 81.7 m -84.01 141.36 31.24 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.842 1.321 . . . . 0.0 113.46 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -151.06 134.17 15.98 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.357 0.663 . . . . 0.0 111.129 164.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 47.2 54.64 9.15 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.113 1.365 . . . . 0.0 112.542 -176.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 61.3 m-20 64.69 9.72 5.42 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 116.308 1.966 . . . . 0.0 116.308 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 49.4 t -125.57 147.87 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 CA-C-N 120.547 1.521 . . . . 0.0 111.893 -175.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -74.08 46.66 0.25 Allowed 'General case' 0 CA--C 1.557 1.249 0 C-N-CA 127.083 2.153 . . . . 0.0 112.466 175.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -73.12 -37.02 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 O-C-N 119.738 -1.851 . . . . 0.0 114.73 -170.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 63.7 mtpt -99.58 -18.18 17.48 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.717 1.207 . . . . 0.0 113.233 178.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 179.46 167.34 36.66 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 124.638 1.113 . . . . 0.0 112.53 175.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -87.37 109.37 19.5 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.99 1.716 . . . . 0.0 113.103 -174.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -61.65 -24.56 66.81 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.489 1.515 . . . . 0.0 113.63 176.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.4 tmmm? -50.39 -35.72 29.52 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 120.981 -1.074 . . . . 0.0 111.916 171.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 55.8 ttm-85 -58.61 -41.12 85.15 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 126.483 1.913 . . . . 0.0 114.203 -177.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 36.8 t60 -67.62 -42.98 81.47 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.426 1.09 . . . . 0.0 111.495 175.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 72.0 m -77.26 -27.13 53.1 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.41 -36.8 81.33 Favored 'General case' 0 N--CA 1.476 0.839 0 O-C-N 120.62 -1.3 . . . . 0.0 110.782 169.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.2 -15.06 63.43 Favored 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 171.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -99.78 1.81 43.5 Favored 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 126.34 1.856 . . . . 0.0 111.36 169.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . 0.269 3.4 t0 51.98 44.21 29.68 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 128.188 2.595 . . . . 0.0 114.212 -169.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.4 mttt -126.92 172.8 10.12 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 129.13 2.972 . . . . 0.0 112.845 -178.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -85.55 153.84 22.15 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.89 1.276 . . . . 0.0 109.653 167.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -131.79 151.4 19.78 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 125.525 1.536 . . . . 0.0 114.887 -178.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -153.32 137.31 8.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 125.268 1.427 . . . . 0.0 111.056 -176.105 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 87.3 m -79.92 120.76 24.57 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.28 -0.887 . . . . 0.0 112.137 -177.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 15.9 m-70 -111.58 103.1 11.4 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.667 1.587 . . . . 0.0 109.223 168.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 67.86 -114.79 6.4 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 124.869 1.224 . . . . 0.0 112.112 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 82.7 p -104.06 17.2 24.6 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 126.155 1.782 . . . . 0.0 112.615 173.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 44.9 mmtm -127.96 159.91 33.52 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.448 1.899 . . . . 0.0 112.093 -178.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 43.3 t -100.02 146.0 27.25 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.603 1.161 . . . . 0.0 110.226 170.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -130.35 126.49 37.25 Favored 'General case' 0 C--N 1.333 -0.11 0 C-N-CA 126.392 1.877 . . . . 0.0 106.998 -178.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 61.2 m -87.95 137.27 32.48 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.832 0.825 . . . . 0.0 112.164 176.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -97.16 -137.28 9.48 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 127.35 2.405 . . . . 0.0 112.228 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 33.1 m -73.39 155.14 89.88 Favored Pre-proline 0 CA--C 1.535 0.37 0 N-CA-C 113.939 1.088 . . . . 0.0 113.939 178.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -51.86 146.96 26.77 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 124.541 3.494 . . . . 0.0 111.407 166.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.5 pp -59.55 -25.18 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 114.944 1.461 . . . . 0.0 114.944 -174.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 8.6 t 48.25 110.85 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 127.458 2.303 . . . . 0.0 116.922 169.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -70.67 -2.61 15.02 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.706 1.203 . . . . 0.0 114.019 171.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 58.8 tp . . . . . 0 C--O 1.253 1.246 0 C-N-CA 126.172 1.789 . . . . 0.0 109.257 168.326 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.992 0 CA-C-O 119.869 -0.11 . . . . 0.0 110.865 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -124.73 -40.51 2.19 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 -168.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 30.8 p-10 -161.91 -35.32 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 114.903 1.446 . . . . 0.0 114.903 -177.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -117.7 3.73 12.32 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 115.103 1.52 . . . . 0.0 115.103 -171.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 54.65 15.54 1.1 Allowed 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 -171.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 81.17 -5.11 68.18 Favored Glycine 0 CA--C 1.544 1.906 0 C-N-CA 124.646 1.117 . . . . 0.0 115.263 -168.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 74.5 m -77.44 141.52 39.69 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.065 1.346 . . . . 0.0 113.068 178.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -152.15 131.98 13.28 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.098 0.959 . . . . 0.0 112.113 166.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 48.19 54.5 10.15 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.773 1.629 . . . . 0.0 112.745 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 42.4 m-20 62.57 15.35 7.85 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 116.485 2.032 . . . . 0.0 116.485 -179.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 38.4 t -129.07 147.26 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 125.048 1.339 . . . . 0.0 111.079 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 28.0 p-10 -76.33 33.95 0.13 Allowed 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 128.354 2.661 . . . . 0.0 114.266 176.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -58.78 -30.92 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 N-CA-C 116.362 1.986 . . . . 0.0 116.362 -168.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -109.5 -10.14 14.89 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 125.189 1.395 . . . . 0.0 113.133 175.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 168.81 153.53 8.38 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 125.798 1.666 . . . . 0.0 112.252 173.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -85.3 138.54 32.24 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.089 0.956 . . . . 0.0 112.137 175.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.2 p -94.95 -1.43 52.53 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -178.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -63.21 -28.65 70.18 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 120.956 -1.09 . . . . 0.0 112.978 177.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.04 -37.4 85.76 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 121.045 1.748 . . . . 0.0 113.148 173.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 13.1 t60 -62.68 -36.37 82.67 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.34 1.056 . . . . 0.0 111.715 170.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 57.7 m -75.38 -27.83 59.26 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 121.087 -1.008 . . . . 0.0 113.402 171.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 21.6 tptp -66.28 -20.32 66.07 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.188 1.395 . . . . 0.0 112.907 173.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.53 -18.11 64.53 Favored 'General case' 0 CA--C 1.55 0.955 0 O-C-N 121.704 -0.623 . . . . 0.0 112.308 168.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -110.68 15.12 22.16 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 126.953 2.101 . . . . 0.0 111.899 168.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 15.4 t0 56.18 26.32 10.16 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 127.771 2.428 . . . . 0.0 115.2 -174.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 38.8 mttt -109.91 159.57 17.13 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.79 1.636 . . . . 0.0 114.339 -174.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -70.59 149.9 46.61 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 114.727 -1.124 . . . . 0.0 108.006 166.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -136.62 141.63 12.68 Favored Glycine 0 N--CA 1.472 1.069 0 C-N-CA 124.798 1.19 . . . . 0.0 114.83 -176.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.06 131.78 55.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 125.638 1.575 . . . . 0.0 111.903 -168.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 96.9 m -73.07 107.89 5.66 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.208 1.003 . . . . 0.0 112.045 177.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 9.5 m-70 -95.5 91.76 6.33 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.866 2.066 . . . . 0.0 110.069 169.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 66.27 -109.0 2.64 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 124.613 1.101 . . . . 0.0 112.037 -178.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 47.5 p -109.94 26.71 10.35 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 125.938 1.695 . . . . 0.0 113.209 173.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 36.4 mmtm -139.31 174.23 10.73 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 126.977 2.111 . . . . 0.0 111.932 174.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 13.1 t -117.48 157.71 25.79 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.697 1.199 . . . . 0.0 112.388 176.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.9 mtpt -144.47 155.67 43.83 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 128.08 2.552 . . . . 0.0 107.646 172.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 23.8 m -107.0 149.11 27.89 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -95.32 -117.47 3.13 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 127.034 2.254 . . . . 0.0 113.779 -176.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.9 m -106.41 163.87 16.09 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 126.399 1.88 . . . . 0.0 111.432 169.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_exo -48.66 142.91 17.49 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 124.494 3.463 . . . . 0.0 113.849 170.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.7 pp -65.8 -14.78 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 N-CA-C 115.065 1.505 . . . . 0.0 115.065 -175.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.3 p -51.91 129.74 27.62 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.264 1.426 . . . . 0.0 113.124 -172.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -81.19 -14.83 57.17 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.403 1.481 . . . . 0.0 113.523 -176.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 57.7 tp . . . . . 0 C--O 1.253 1.237 0 C-N-CA 126.582 1.953 . . . . 0.0 110.276 175.297 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.047 0 N-CA-C 112.033 0.382 . . . . 0.0 112.033 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -152.66 -38.61 0.11 Allowed 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.813 1.245 . . . . 0.0 113.995 178.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 28.4 p30 -146.83 -40.37 0.2 Allowed 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 125.566 1.546 . . . . 0.0 114.737 -169.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -124.05 24.5 8.2 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.494 1.917 . . . . 0.0 113.072 177.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 53.77 26.13 5.73 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.919 1.288 . . . . 0.0 113.535 -173.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.02 0.72 21.99 Favored Glycine 0 CA--C 1.539 1.567 0 O-C-N 121.057 -1.027 . . . . 0.0 115.445 -171.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 76.2 m -97.7 141.92 30.13 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.16 1.384 . . . . 0.0 113.713 -170.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -150.6 132.46 15.08 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.161 167.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 47.36 54.67 9.24 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.628 1.571 . . . . 0.0 113.331 178.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 64.03 14.84 8.79 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 116.811 2.152 . . . . 0.0 116.811 -177.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.5 t -131.58 146.66 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 O-C-N 120.567 -1.333 . . . . 0.0 111.827 -177.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -76.51 50.13 0.65 Allowed 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.852 1.661 . . . . 0.0 112.179 170.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -77.93 -30.79 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 125.618 1.567 . . . . 0.0 114.073 -177.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 23.4 mmmt -95.26 -30.72 13.83 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -174.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -175.61 -138.69 2.88 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 124.958 1.266 . . . . 0.0 112.62 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -124.78 140.25 53.1 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -108.27 -19.57 13.43 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 129.276 3.03 . . . . 0.0 111.369 174.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 11.6 tppt? -38.64 -51.57 1.65 Allowed 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 127.199 2.199 . . . . 0.0 112.321 169.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 42.3 mtm180 -63.4 -25.56 68.34 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 -176.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 65.1 t60 -73.75 -45.71 50.22 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 119.186 0.903 . . . . 0.0 111.975 173.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 71.1 m -76.13 -28.63 57.5 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 178.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.05 -28.43 70.08 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.747 1.219 . . . . 0.0 112.267 175.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.24 -26.45 63.85 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.391 1.076 . . . . 0.0 113.258 172.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -88.2 8.53 26.65 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 125.844 1.657 . . . . 0.0 111.615 168.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . 0.265 11.5 t0 56.18 31.3 18.08 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 128.167 2.587 . . . . 0.0 115.061 -173.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 36.3 mttt -117.22 169.17 9.67 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 127.453 2.301 . . . . 0.0 113.798 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -79.65 150.91 30.8 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.421 1.488 . . . . 0.0 108.477 167.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -110.99 151.03 17.8 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 125.755 1.645 . . . . 0.0 113.708 175.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -150.41 137.88 13.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 125.346 1.458 . . . . 0.0 109.002 175.097 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 68.3 m -77.93 126.34 30.69 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 121.046 -1.034 . . . . 0.0 112.878 -174.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -122.08 114.43 20.9 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.211 1.404 . . . . 0.0 109.229 169.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 64.13 -124.51 30.28 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 124.464 1.03 . . . . 0.0 111.721 -173.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 70.3 p -104.6 29.2 6.33 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 125.997 1.719 . . . . 0.0 112.405 170.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 41.2 mmtm -136.73 165.07 26.78 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.405 1.882 . . . . 0.0 110.686 -176.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 12.6 t -92.19 160.37 15.2 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.633 1.173 . . . . 0.0 110.294 173.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.0 tmtt? -145.97 137.92 25.17 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 127.024 2.13 . . . . 0.0 106.294 173.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 57.2 m -93.48 135.45 34.72 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -176.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -85.31 -127.35 1.79 Allowed Glycine 0 CA--C 1.528 0.866 0 C-N-CA 126.538 2.018 . . . . 0.0 112.286 178.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 31.5 m -89.03 155.08 49.81 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 124.666 1.186 . . . . 0.0 113.014 176.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -53.1 142.05 55.88 Favored 'Trans proline' 0 C--O 1.239 0.525 0 C-N-CA 124.742 3.628 . . . . 0.0 111.309 167.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.0 pp -68.36 -32.95 57.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-O 119.022 -0.513 . . . . 0.0 111.925 -178.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.9 t -68.38 134.13 49.77 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 123.494 0.718 . . . . 0.0 111.979 -173.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -90.23 -6.52 55.14 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.866 0.866 . . . . 0.0 113.174 177.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.255 1.378 0 C-N-CA 128.129 2.571 . . . . 0.0 112.688 176.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.839 0 N-CA-C 111.448 0.166 . . . . 0.0 111.448 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.1 tpmt? -141.29 -51.02 0.43 Allowed 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -167.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -66.91 -30.22 70.31 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 119.837 1.199 . . . . 0.0 111.873 -168.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -131.01 16.54 5.13 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.205 1.402 . . . . 0.0 111.617 165.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 50.75 16.78 0.34 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.477 1.911 . . . . 0.0 115.223 -172.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 71.35 0.67 39.01 Favored Glycine 0 CA--C 1.535 1.294 0 O-C-N 120.965 -1.084 . . . . 0.0 115.002 -173.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 99.8 m -90.74 137.09 32.63 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 118.2 1.0 . . . . 0.0 112.835 -173.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -151.7 141.97 22.38 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.303 1.041 . . . . 0.0 110.175 165.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 51.15 39.08 22.66 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 178.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 57.88 28.44 16.07 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 126.281 1.832 . . . . 0.0 114.786 -173.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 46.2 t -132.01 145.03 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 125.416 1.486 . . . . 0.0 110.585 179.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -77.51 50.85 0.84 Allowed 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.598 1.559 . . . . 0.0 112.236 173.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -75.94 -41.95 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 124.963 1.305 . . . . 0.0 113.722 -175.162 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 25.0 mmmt -90.04 -19.4 24.44 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.012 0.925 . . . . 0.0 112.797 -173.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -178.5 -146.76 6.67 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 124.701 1.143 . . . . 0.0 112.588 178.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 -124.22 126.97 47.01 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.881 1.272 . . . . 0.0 113.947 177.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -86.49 -18.42 31.68 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.635 1.974 . . . . 0.0 111.56 171.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -48.46 -51.32 27.61 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 117.408 -1.282 . . . . 0.0 111.378 169.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -52.82 -42.58 65.26 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-N 120.267 1.394 . . . . 0.0 113.104 -175.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 71.8 t60 -63.18 -43.53 97.95 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.161 0.984 . . . . 0.0 112.235 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 92.9 m -84.24 -25.71 29.21 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.57 -35.55 78.11 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 120.833 -1.167 . . . . 0.0 110.221 173.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.06 -12.85 61.59 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 171.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -102.4 7.88 40.29 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 126.564 1.946 . . . . 0.0 112.193 169.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . 0.261 2.6 t0 58.22 35.87 25.3 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 128.263 2.625 . . . . 0.0 114.198 -172.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.2 mttt -129.89 164.17 24.76 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 127.588 2.355 . . . . 0.0 115.37 -172.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -69.29 144.96 53.44 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.045 1.738 . . . . 0.0 109.383 165.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -109.41 141.11 15.96 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 125.413 1.482 . . . . 0.0 112.599 169.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.45 135.37 31.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-N 118.666 1.233 . . . . 0.0 111.239 174.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 86.6 m -74.8 115.36 14.3 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 122.078 0.942 . . . . 0.0 113.262 -176.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 5.0 m-70 -100.07 100.28 11.13 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 126.24 1.816 . . . . 0.0 107.65 168.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 63.55 -114.41 6.83 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 124.411 1.005 . . . . 0.0 111.977 -178.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 44.8 p -102.42 16.49 26.12 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 126.168 1.787 . . . . 0.0 113.653 174.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 48.8 mmtm -130.25 165.6 22.08 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.867 2.067 . . . . 0.0 111.019 -175.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 20.4 t -97.6 157.61 15.94 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.042 0.937 . . . . 0.0 110.868 172.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.14 126.5 14.0 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 126.151 1.78 . . . . 0.0 106.314 175.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 39.4 m -82.26 142.34 32.19 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 119.119 0.872 . . . . 0.0 112.141 -178.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -102.28 -118.48 4.42 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 125.725 1.631 . . . . 0.0 113.456 -173.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.9 m -91.55 159.68 38.26 Favored Pre-proline 0 N--CA 1.472 0.658 0 C-N-CA 126.314 1.846 . . . . 0.0 112.559 174.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -65.89 157.79 57.31 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 124.098 3.198 . . . . 0.0 112.556 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.1 pp -71.17 -0.34 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 175.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 55.9 m -70.75 56.71 0.18 Allowed 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 129.253 3.021 . . . . 0.0 113.508 175.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -60.92 -20.54 62.27 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 124.97 1.308 . . . . 0.0 114.469 -171.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.6 pt? . . . . . 0 C--O 1.255 1.348 0 C-N-CA 126.645 1.978 . . . . 0.0 113.198 174.996 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.999 0 CA-C-O 118.478 -0.773 . . . . 0.0 110.834 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -146.56 -37.79 0.23 Allowed 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 115.146 1.536 . . . . 0.0 115.146 175.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 18.1 p30 -142.38 -46.16 0.33 Allowed 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.753 1.221 . . . . 0.0 113.96 178.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -114.65 16.92 17.45 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.699 1.6 . . . . 0.0 112.742 177.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 54.16 15.74 1.0 Allowed 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 -177.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.36 4.87 52.88 Favored Glycine 0 CA--C 1.537 1.425 0 O-C-N 121.179 -0.95 . . . . 0.0 114.842 -173.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 92.0 m -91.28 135.78 33.56 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.458 1.103 . . . . 0.0 112.084 -179.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -151.68 135.38 16.3 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.096 0.958 . . . . 0.0 111.955 167.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 48.46 52.77 13.1 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.3 1.44 . . . . 0.0 112.72 -179.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 57.3 m-20 63.71 8.26 3.63 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 127.254 2.222 . . . . 0.0 116.686 -177.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.0 t -126.24 147.85 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 CA-C-N 119.592 1.087 . . . . 0.0 111.504 -176.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -77.44 39.46 0.26 Allowed 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 126.916 2.086 . . . . 0.0 113.06 172.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -63.06 -26.74 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 126.054 1.741 . . . . 0.0 113.907 -178.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.5 mmmm -104.65 -13.76 15.84 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.237 1.415 . . . . 0.0 114.519 -175.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 166.94 -141.13 6.71 Favored Glycine 0 N--CA 1.471 0.992 0 CA-C-N 120.112 1.324 . . . . 0.0 114.699 174.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -117.13 124.28 48.82 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.704 1.201 . . . . 0.0 113.718 -170.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -104.54 -30.35 10.07 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 127.53 2.332 . . . . 0.0 111.284 176.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.3 tmmm? -53.16 -40.21 64.13 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 121.11 -0.994 . . . . 0.0 112.391 175.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 43.9 mtp180 -64.3 -27.69 69.21 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 63.7 t60 -70.68 -46.65 62.78 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 118.867 0.758 . . . . 0.0 111.335 170.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 86.8 m -72.34 -30.31 64.62 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.435 ' HA ' ' HE2' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -62.55 -30.69 71.5 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 120.536 -1.352 . . . . 0.0 112.14 173.996 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -75.47 -11.98 60.15 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 124.304 1.042 . . . . 0.0 112.902 173.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -102.79 4.91 38.41 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 126.528 1.931 . . . . 0.0 111.378 168.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . 0.273 5.7 t0 57.68 40.37 26.58 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 129.354 3.061 . . . . 0.0 115.886 -171.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.7 mttt -129.96 171.59 12.61 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.303 1.841 . . . . 0.0 113.871 -177.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -79.11 156.47 28.28 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.921 1.688 . . . . 0.0 109.141 166.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -126.58 144.92 15.42 Favored Glycine 0 CA--C 1.537 1.46 0 C-N-CA 125.332 1.444 . . . . 0.0 115.102 176.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -147.43 144.06 19.68 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 124.558 1.143 . . . . 0.0 109.564 -178.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 88.8 m -86.76 122.91 31.31 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.112 -0.993 . . . . 0.0 112.86 -174.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 19.0 m-70 -114.71 104.22 11.76 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 125.582 1.553 . . . . 0.0 110.019 169.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 60.65 -121.52 26.87 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 123.827 0.727 . . . . 0.0 111.67 -173.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 60.7 p -91.42 8.8 34.51 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 126.215 1.806 . . . . 0.0 114.167 179.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -131.91 160.96 34.21 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.709 1.603 . . . . 0.0 112.94 -172.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 38.7 t -93.23 140.06 29.94 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.828 1.251 . . . . 0.0 110.766 172.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.63 121.13 29.66 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 127.142 2.177 . . . . 0.0 105.799 178.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 57.2 m -78.03 141.73 38.68 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 119.043 0.838 . . . . 0.0 112.687 -177.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -89.68 -135.11 5.64 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 126.549 2.023 . . . . 0.0 111.868 175.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 33.7 m -83.93 159.61 59.83 Favored Pre-proline 0 CA--C 1.539 0.534 0 C-N-CA 123.99 0.916 . . . . 0.0 113.318 -178.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -54.47 144.9 60.22 Favored 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 124.63 3.553 . . . . 0.0 111.516 167.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.7 pp -70.56 -7.02 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 N-CA-C 117.098 2.258 . . . . 0.0 117.098 -167.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 85.2 p -94.38 15.29 18.01 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.562 1.545 . . . . 0.0 114.421 169.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 50.39 63.52 2.17 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 129.713 3.205 . . . . 0.0 114.837 171.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.3 mp . . . . . 0 C--O 1.248 1.005 0 C-N-CA 126.232 1.813 . . . . 0.0 112.871 179.425 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.927 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -143.95 -33.49 0.41 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 126.998 2.119 . . . . 0.0 113.043 178.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -78.43 -40.89 34.48 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.263 1.025 . . . . 0.0 112.211 -177.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -105.55 3.21 29.09 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.456 1.025 . . . . 0.0 113.725 168.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 56.09 14.14 1.38 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.505 1.522 . . . . 0.0 114.169 -174.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 83.69 -7.43 69.53 Favored Glycine 0 CA--C 1.538 1.493 0 C-N-CA 125.347 1.451 . . . . 0.0 115.0 -171.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 82.8 m -76.33 143.79 40.57 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.229 1.011 . . . . 0.0 113.232 177.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -156.36 139.97 15.97 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.988 1.315 . . . . 0.0 109.953 166.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 48.92 44.33 22.24 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.667 1.187 . . . . 0.0 113.859 -179.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 16.7 m-20 61.18 15.91 6.76 Favored 'General case' 0 CA--C 1.553 1.074 0 N-CA-C 116.316 1.969 . . . . 0.0 116.316 -174.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 59.4 t -126.49 149.92 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 125.379 1.472 . . . . 0.0 111.849 -176.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -79.06 42.33 0.47 Allowed 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 127.082 2.153 . . . . 0.0 114.61 178.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -64.22 -42.62 96.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 O-C-N 120.584 -1.322 . . . . 0.0 113.566 -171.412 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 36.2 mmtm -96.36 -19.19 19.4 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 174.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 172.3 168.48 33.78 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 124.343 0.973 . . . . 0.0 112.694 177.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -98.37 129.67 45.02 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.474 0.709 . . . . 0.0 112.715 -174.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -64.34 -15.55 60.56 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 126.641 1.976 . . . . 0.0 113.507 171.245 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? -41.98 -51.49 4.42 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.52 1.528 . . . . 0.0 112.113 168.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 60.1 mtm180 -68.55 -25.57 64.98 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.047 1.128 . . . . 0.0 114.047 -168.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -81.88 -36.53 28.07 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.932 1.293 . . . . 0.0 112.789 174.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 99.1 m -79.25 -33.24 43.73 Favored 'General case' 0 CA--C 1.546 0.817 0 O-C-N 121.06 -1.025 . . . . 0.0 113.08 174.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 18.8 tptp -63.64 -28.57 70.0 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.67 1.188 . . . . 0.0 112.422 177.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.69 -25.91 66.74 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.874 1.27 . . . . 0.0 113.365 171.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -103.76 10.2 36.73 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.842 1.657 . . . . 0.0 112.067 174.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 64.78 30.3 12.34 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 128.28 2.632 . . . . 0.0 115.312 -177.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.2 mttp -115.93 163.48 15.82 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 126.648 1.979 . . . . 0.0 112.869 177.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -78.79 152.27 31.51 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 166.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -107.75 159.98 14.19 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 125.836 1.684 . . . . 0.0 113.226 172.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -150.14 135.9 11.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 124.906 1.282 . . . . 0.0 111.011 171.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 91.4 m -76.91 118.81 19.87 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.449 0.642 . . . . 0.0 112.273 -179.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 19.3 m-70 -116.2 111.58 20.39 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.627 1.571 . . . . 0.0 109.125 169.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 63.5 -117.08 10.21 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 125.964 1.745 . . . . 0.0 111.228 -173.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.4 p -108.44 23.93 13.79 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.636 1.574 . . . . 0.0 112.377 173.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 42.0 mmtm -138.59 169.27 18.09 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.934 1.294 . . . . 0.0 112.913 -178.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 41.7 t -99.59 148.11 24.65 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.372 1.469 . . . . 0.0 111.937 -178.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -139.9 133.78 30.71 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 126.902 2.081 . . . . 0.0 105.974 174.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 63.0 m -84.73 142.67 29.68 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 119.592 1.087 . . . . 0.0 112.834 -178.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -89.71 -138.36 6.95 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 126.26 1.886 . . . . 0.0 111.239 171.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.6 m -77.86 154.48 80.62 Favored Pre-proline 0 CA--C 1.537 0.475 0 N-CA-C 114.055 1.131 . . . . 0.0 114.055 178.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -54.73 137.1 73.7 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 124.238 3.292 . . . . 0.0 110.758 166.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.5 pp -62.99 -22.92 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 O-C-N 120.971 -1.081 . . . . 0.0 113.731 -174.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.2 m 53.72 45.19 28.47 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 118.033 2.605 . . . . 0.0 118.033 167.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -115.24 -17.1 11.43 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 125.025 1.33 . . . . 0.0 114.574 169.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 34.0 tp . . . . . 0 C--O 1.25 1.091 0 C-N-CA 126.163 1.785 . . . . 0.0 111.163 -178.145 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.788 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -146.78 -28.0 0.39 Allowed 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 114.879 1.437 . . . . 0.0 114.879 -177.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 39.9 p30 -82.11 -38.98 24.0 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 -176.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -117.64 0.93 12.17 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.745 1.218 . . . . 0.0 112.708 169.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 60.58 7.96 1.55 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.52 1.928 . . . . 0.0 114.975 -178.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 88.02 -3.18 85.83 Favored Glycine 0 CA--C 1.543 1.84 0 C-N-CA 124.701 1.143 . . . . 0.0 114.729 -168.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 87.3 m -79.03 141.88 37.04 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.553 1.141 . . . . 0.0 112.01 175.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -152.4 135.8 15.94 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.798 0.839 . . . . 0.0 110.714 168.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 47.95 51.47 14.39 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.405 1.482 . . . . 0.0 113.228 179.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 62.62 11.22 4.62 Favored 'General case' 0 CA--C 1.551 1.017 0 N-CA-C 117.389 2.366 . . . . 0.0 117.389 -175.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 38.2 t -124.2 146.53 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 CA-C-N 119.73 1.15 . . . . 0.0 111.965 -177.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -74.91 35.92 0.11 Allowed 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 127.698 2.399 . . . . 0.0 113.483 177.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -60.1 -43.8 93.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 -168.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -96.97 -18.05 19.68 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 178.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 171.4 169.64 34.55 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 125.553 1.549 . . . . 0.0 113.002 174.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -86.84 142.81 27.8 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 121.959 0.885 . . . . 0.0 112.996 175.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.8 p -97.79 -10.66 24.41 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.628 1.171 . . . . 0.0 113.149 169.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.1 tmmm? -63.3 -28.09 69.78 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-O 118.115 -0.945 . . . . 0.0 113.251 -176.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 44.9 mtm180 -63.81 -35.23 79.92 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 120.013 1.279 . . . . 0.0 113.596 170.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -67.76 -35.41 78.66 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.433 1.093 . . . . 0.0 111.904 174.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 90.0 m -75.21 -39.02 60.44 Favored 'General case' 0 CA--C 1.547 0.865 0 O-C-N 120.909 -1.119 . . . . 0.0 112.533 170.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -62.28 -28.63 69.85 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 120.748 -1.22 . . . . 0.0 112.791 178.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.57 -25.89 60.64 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.47 1.108 . . . . 0.0 113.152 171.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -115.47 21.01 14.38 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.684 1.594 . . . . 0.0 112.048 -179.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.2 t0 56.96 60.56 2.96 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 126.407 1.883 . . . . 0.0 111.431 -175.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 31.9 mmtm -145.44 147.68 32.47 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 126.071 1.748 . . . . 0.0 113.308 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -72.53 156.42 39.03 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 162.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -141.6 136.11 7.2 Favored Glycine 0 N--CA 1.468 0.788 0 C-N-CA 124.385 0.993 . . . . 0.0 112.684 -179.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.0 140.18 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 C-N-CA 124.595 1.158 . . . . 0.0 110.675 -172.123 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 73.0 m -68.13 118.07 10.8 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.019 0.528 . . . . 0.0 112.408 -177.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 -108.63 98.69 8.16 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.965 1.706 . . . . 0.0 108.783 169.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 61.35 -114.81 7.07 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 124.176 0.893 . . . . 0.0 111.402 -174.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 58.6 p -107.01 27.43 9.0 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 127.337 2.255 . . . . 0.0 114.045 174.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -137.95 174.27 10.74 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 126.726 2.01 . . . . 0.0 111.219 172.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 9.1 t -97.17 166.68 11.46 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.746 1.218 . . . . 0.0 111.435 172.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.55 118.57 8.23 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.337 1.455 . . . . 0.0 108.633 173.116 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 73.9 m -84.48 129.57 34.84 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -178.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -99.72 -139.32 10.75 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 127.407 2.432 . . . . 0.0 113.941 -175.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.6 m -72.8 154.78 91.1 Favored Pre-proline 0 N--CA 1.473 0.722 0 C-N-CA 125.051 1.34 . . . . 0.0 113.398 176.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.53 157.79 52.12 Favored 'Trans proline' 0 CA--C 1.532 0.4 0 C-N-CA 124.28 3.32 . . . . 0.0 114.031 -178.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.5 pp -104.27 -39.58 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -168.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 21.3 m -63.01 130.4 44.53 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.102 0.961 . . . . 0.0 111.962 -169.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 8.4 p90 -139.68 -4.97 1.38 Allowed 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 114.967 1.469 . . . . 0.0 114.967 -169.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.8 pp . . . . . 0 C--O 1.257 1.468 0 C-N-CA 126.982 2.113 . . . . 0.0 112.581 170.719 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.699 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 23.1 ttpp -108.88 -35.26 6.42 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.953 1.701 . . . . 0.0 112.053 -168.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -71.59 -18.3 62.24 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.693 -0.629 . . . . 0.0 112.566 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -103.23 -2.34 27.4 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.346 0.658 . . . . 0.0 111.873 167.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 56.44 28.52 13.78 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.811 1.245 . . . . 0.0 113.662 -177.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 71.51 -5.14 11.34 Favored Glycine 0 CA--C 1.541 1.691 0 N-CA-C 115.411 0.924 . . . . 0.0 115.411 -174.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 74.4 m -79.46 135.0 36.54 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.705 1.202 . . . . 0.0 112.792 -178.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -148.08 134.97 20.12 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.214 1.006 . . . . 0.0 111.104 167.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 47.66 49.08 16.75 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.09 1.356 . . . . 0.0 113.65 179.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 65.96 10.93 7.35 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 127.436 2.294 . . . . 0.0 116.513 -176.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.9 t -126.06 147.95 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 124.951 1.3 . . . . 0.0 112.288 -176.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -78.72 40.64 0.39 Allowed 'General case' 0 CA--C 1.558 1.264 0 C-N-CA 127.234 2.214 . . . . 0.0 113.708 176.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.5 m -70.86 -23.39 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 C-N-CA 125.777 1.631 . . . . 0.0 115.325 -172.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -109.05 -8.81 15.12 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.696 1.198 . . . . 0.0 112.984 173.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 158.09 169.33 21.55 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 125.452 1.501 . . . . 0.0 112.435 174.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -89.19 144.93 25.75 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.157 0.983 . . . . 0.0 112.706 177.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 42.4 t -92.65 -15.23 27.05 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.455 0.702 . . . . 0.0 112.375 170.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -53.29 -35.39 60.05 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 120.679 -1.263 . . . . 0.0 111.709 177.497 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 11.9 mtp-105 -55.77 -43.31 76.6 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 115.071 1.508 . . . . 0.0 115.071 169.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 62.4 t60 -67.83 -40.04 83.83 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 119.845 1.202 . . . . 0.0 112.302 177.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 93.0 m -75.61 -32.28 60.22 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 123.54 0.736 . . . . 0.0 112.443 177.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.435 ' O ' ' HE2' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -62.01 -30.4 70.93 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 127.132 2.173 . . . . 0.0 112.168 174.825 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.19 -24.89 67.47 Favored 'General case' 0 CA--C 1.549 0.918 0 O-C-N 121.554 -0.716 . . . . 0.0 112.534 173.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -107.95 18.88 20.73 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.416 1.886 . . . . 0.0 113.597 168.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 60.66 26.32 16.05 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 126.114 1.765 . . . . 0.0 115.724 177.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.6 mttp -110.22 162.12 14.91 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 127.653 2.381 . . . . 0.0 113.272 175.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -76.39 153.2 35.93 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.96 0.904 . . . . 0.0 110.1 166.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -125.49 142.66 13.94 Favored Glycine 0 N--CA 1.475 1.276 0 C-N-CA 125.726 1.631 . . . . 0.0 113.506 173.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.93 133.09 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 124.883 1.273 . . . . 0.0 111.322 -170.307 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 74.5 m -75.07 114.82 14.0 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.132 0.492 . . . . 0.0 111.677 -179.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 7.6 m-70 -107.76 100.98 10.31 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.726 2.01 . . . . 0.0 109.134 172.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 64.19 -115.62 8.11 Favored Glycine 0 CA--C 1.527 0.844 0 C-N-CA 124.839 1.209 . . . . 0.0 112.055 -177.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 75.9 p -105.38 15.76 26.7 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.97 1.308 . . . . 0.0 112.586 178.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -141.35 -171.09 3.22 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 128.651 2.78 . . . . 0.0 110.47 -175.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 52.7 t -134.71 158.08 45.05 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 114.282 1.215 . . . . 0.0 114.282 -176.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 68.6 mttt -136.19 149.86 48.77 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 129.49 3.116 . . . . 0.0 107.908 169.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 78.3 m -89.81 152.8 21.11 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 121.626 0.727 . . . . 0.0 112.073 170.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -107.71 -112.82 3.66 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 126.205 1.859 . . . . 0.0 114.124 -172.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.9 m -104.9 157.35 34.39 Favored Pre-proline 0 N--CA 1.475 0.788 0 C-N-CA 126.522 1.929 . . . . 0.0 113.155 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -64.69 141.55 73.01 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 124.083 3.188 . . . . 0.0 111.413 173.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.7 pp -69.42 -8.97 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 N-CA-C 115.386 1.624 . . . . 0.0 115.386 -172.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 78.6 p -90.16 8.5 32.64 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.66 1.584 . . . . 0.0 114.464 169.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 41.44 58.36 2.7 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 129.61 3.164 . . . . 0.0 114.379 172.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 78.3 mt . . . . . 0 C--O 1.251 1.137 0 C-N-CA 126.639 1.976 . . . . 0.0 113.257 -176.482 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.877 0 N-CA-C 110.365 -0.235 . . . . 0.0 110.365 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -134.45 -40.78 0.8 Allowed 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -169.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -163.03 -40.76 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 114.62 1.341 . . . . 0.0 114.62 -169.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -127.41 1.22 6.3 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -169.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 55.71 24.81 7.56 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.301 1.44 . . . . 0.0 114.132 -175.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 72.93 -4.69 21.81 Favored Glycine 0 CA--C 1.542 1.723 0 O-C-N 121.23 -0.919 . . . . 0.0 115.226 -171.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 88.0 m -84.33 142.62 30.06 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.057 1.343 . . . . 0.0 112.644 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -153.29 140.94 19.94 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.289 1.035 . . . . 0.0 110.278 167.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 46.51 47.58 14.22 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.201 1.4 . . . . 0.0 113.543 178.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 21.6 m-20 64.52 17.4 10.83 Favored 'General case' 0 CA--C 1.551 0.985 0 N-CA-C 116.132 1.901 . . . . 0.0 116.132 -177.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 40.7 t -132.81 148.19 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.57 1.148 . . . . 0.0 112.498 -176.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -73.15 37.52 0.08 Allowed 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 128.055 2.542 . . . . 0.0 114.092 173.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -63.76 -33.38 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 O-C-N 120.28 -1.513 . . . . 0.0 114.293 -171.423 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -104.53 -19.92 13.85 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.426 1.091 . . . . 0.0 113.725 178.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 173.5 177.06 42.45 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 124.951 1.262 . . . . 0.0 112.491 174.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -87.18 158.13 19.2 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 117.737 0.768 . . . . 0.0 111.987 174.169 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.6 p -120.61 -5.31 9.75 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 170.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -61.16 -31.72 71.45 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 117.519 -1.229 . . . . 0.0 112.025 177.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 47.6 mtm180 -58.32 -38.94 78.11 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-N 120.458 1.481 . . . . 0.0 113.622 170.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 18.6 t60 -65.2 -38.83 91.7 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 119.261 0.937 . . . . 0.0 112.628 174.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 97.3 m -72.89 -33.0 65.77 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 118.801 0.728 . . . . 0.0 112.727 171.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -66.34 -27.62 68.03 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 120.322 -1.486 . . . . 0.0 111.848 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.65 -5.63 16.65 Favored 'General case' 0 CA--C 1.551 1.008 0 N-CA-C 114.044 1.127 . . . . 0.0 114.044 169.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -121.86 19.21 10.98 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 127.583 2.353 . . . . 0.0 112.017 171.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 61.46 29.52 18.46 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.277 1.431 . . . . 0.0 113.518 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.3 mmtp -124.01 153.55 41.15 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 128.222 2.609 . . . . 0.0 112.538 -175.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -78.53 158.52 28.54 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.282 1.033 . . . . 0.0 108.361 166.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -138.7 145.66 17.11 Favored Glycine 0 N--CA 1.476 1.328 0 C-N-CA 124.943 1.259 . . . . 0.0 114.745 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -147.37 147.63 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 126.077 1.751 . . . . 0.0 110.882 -172.309 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 71.1 m -77.51 116.94 18.48 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 113.731 1.012 . . . . 0.0 113.731 -174.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -109.03 103.59 12.65 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.477 1.511 . . . . 0.0 108.562 168.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 66.34 -114.86 6.86 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 124.142 0.877 . . . . 0.0 111.85 -176.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 69.8 p -107.22 22.04 16.6 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.993 1.717 . . . . 0.0 112.384 175.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 37.0 mmtm -139.67 170.33 16.09 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.42 1.888 . . . . 0.0 112.29 -172.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 16.7 t -109.49 133.22 53.34 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.347 1.059 . . . . 0.0 112.576 -178.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.8 tptt -118.71 129.4 55.25 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 126.615 1.966 . . . . 0.0 107.137 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 68.6 m -86.46 145.4 26.84 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.39 -125.8 5.14 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 127.161 2.315 . . . . 0.0 113.752 -172.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 28.9 m -84.08 160.45 57.63 Favored Pre-proline 0 N--CA 1.471 0.583 0 C-N-CA 124.993 1.317 . . . . 0.0 113.242 177.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -51.74 152.43 13.15 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 124.426 3.418 . . . . 0.0 113.564 168.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.9 pp -83.37 -9.08 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 N-CA-C 116.049 1.87 . . . . 0.0 116.049 -177.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 25.7 t -49.77 130.13 20.8 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 126.657 1.983 . . . . 0.0 114.557 -170.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -143.97 -178.72 6.07 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.017 1.727 . . . . 0.0 112.454 -176.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.4 pt? . . . . . 0 C--O 1.252 1.233 0 C-N-CA 125.404 1.482 . . . . 0.0 113.835 173.771 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.794 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -111.62 -37.2 5.26 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 127.867 2.467 . . . . 0.0 112.172 -175.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 35.5 m120 -65.56 -29.57 70.2 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.638 1.175 . . . . 0.0 111.048 177.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -84.25 -0.99 54.46 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.549 1.14 . . . . 0.0 113.072 168.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 59.04 19.0 6.81 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.423 1.489 . . . . 0.0 114.62 -171.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 73.86 -0.29 52.15 Favored Glycine 0 CA--C 1.552 2.38 0 N-CA-C 115.803 1.081 . . . . 0.0 115.803 -168.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 97.8 m -81.81 137.47 35.29 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 120.84 -1.388 . . . . 0.0 113.095 178.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -151.12 134.32 16.04 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.247 1.019 . . . . 0.0 111.337 166.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 48.74 51.71 15.28 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.814 1.646 . . . . 0.0 113.736 -178.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 61.12 13.82 5.0 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 126.905 2.082 . . . . 0.0 116.398 -175.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.4 t -127.26 144.72 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-N 119.683 1.129 . . . . 0.0 111.663 -177.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -72.8 31.83 0.06 Allowed 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.595 1.558 . . . . 0.0 114.493 175.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -53.71 -32.08 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 O-C-N 120.327 -1.483 . . . . 0.0 114.601 -171.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -106.0 -6.96 18.37 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 177.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 167.37 150.83 6.65 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-N 119.599 1.09 . . . . 0.0 114.547 169.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -71.55 108.92 5.18 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.603 1.161 . . . . 0.0 113.777 -174.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -69.37 -29.91 67.8 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.787 2.035 . . . . 0.0 113.034 176.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.66 -34.11 67.03 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 120.745 -1.222 . . . . 0.0 112.132 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.3 mtm180 -60.74 -36.29 78.52 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 175.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 51.7 t60 -64.43 -39.71 94.35 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.885 0.874 . . . . 0.0 111.381 176.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 80.6 m -79.36 -32.73 43.28 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.246 0.619 . . . . 0.0 112.474 175.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.92 -31.25 71.55 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 120.503 -1.373 . . . . 0.0 111.697 173.003 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.5 -9.21 40.14 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.495 1.118 . . . . 0.0 113.832 171.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -116.91 12.5 14.71 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.298 1.839 . . . . 0.0 112.096 169.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 49.99 46.4 24.43 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.587 1.955 . . . . 0.0 113.587 -171.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.4 mmtt -122.21 162.4 21.46 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 127.33 2.252 . . . . 0.0 112.223 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -76.62 145.54 38.81 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.081 0.952 . . . . 0.0 109.305 167.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -133.13 138.05 9.83 Favored Glycine 0 N--CA 1.472 1.086 0 C-N-CA 124.501 1.048 . . . . 0.0 114.643 -179.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -149.81 141.74 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 125.368 1.467 . . . . 0.0 110.538 -172.075 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 84.0 m -78.55 116.83 19.2 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -179.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 -98.62 94.06 6.46 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.754 1.622 . . . . 0.0 109.466 168.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 63.24 -96.14 0.16 Allowed Glycine 0 CA--C 1.529 0.924 0 C-N-CA 125.188 1.375 . . . . 0.0 111.323 -176.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.7 p -118.58 14.97 13.68 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 127.52 2.328 . . . . 0.0 113.874 -173.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -138.58 168.6 19.44 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 127.25 2.22 . . . . 0.0 112.683 174.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 28.9 t -98.09 141.81 30.57 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.415 1.486 . . . . 0.0 110.733 171.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -128.87 120.56 26.45 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.081 1.352 . . . . 0.0 109.238 179.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 60.9 m -87.32 128.77 35.17 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.153 0.798 . . . . 0.0 113.153 -177.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -99.12 -126.82 5.75 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 126.522 2.01 . . . . 0.0 114.238 -169.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 16.8 m -75.9 152.74 84.77 Favored Pre-proline 0 N--CA 1.473 0.694 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 177.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -69.35 149.14 69.13 Favored 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 124.158 3.239 . . . . 0.0 110.987 174.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.0 pp -70.79 -13.9 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 -169.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 13.4 p -86.17 9.59 17.05 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.748 1.619 . . . . 0.0 114.537 168.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 46.06 33.66 1.77 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 130.339 3.456 . . . . 0.0 116.135 172.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 19.3 tp . . . . . 0 C--O 1.255 1.378 0 C-N-CA 125.89 1.676 . . . . 0.0 111.624 174.748 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.76 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 7.5 mmpt? -145.21 -37.66 0.27 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.429 1.492 . . . . 0.0 113.902 -168.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -70.54 -26.63 63.65 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 118.669 -0.681 . . . . 0.0 112.762 -169.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -138.14 5.01 2.51 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.184 0.994 . . . . 0.0 112.593 166.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 56.27 12.05 0.92 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.268 1.827 . . . . 0.0 115.471 -177.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.53 0.73 84.95 Favored Glycine 0 CA--C 1.541 1.712 0 N-CA-C 115.401 0.92 . . . . 0.0 115.401 -169.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 89.0 m -85.15 139.81 31.41 Favored 'General case' 0 C--O 1.236 0.39 0 O-C-N 121.037 -1.272 . . . . 0.0 112.421 178.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -151.12 131.01 13.28 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 167.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 44.49 55.0 6.02 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.43 1.892 . . . . 0.0 112.994 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 56.0 m-80 64.01 16.48 9.96 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 127.003 2.121 . . . . 0.0 116.173 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 19.8 t -124.93 147.45 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 O-C-N 120.935 -1.103 . . . . 0.0 111.396 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.85 37.4 0.18 Allowed 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 127.414 2.286 . . . . 0.0 112.493 176.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -68.32 -45.36 82.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 -168.369 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 25.4 mmmt -101.92 -14.24 17.29 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 -169.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 171.98 168.95 34.17 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-N 119.376 0.989 . . . . 0.0 115.19 174.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -87.5 81.3 7.82 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.02 1.728 . . . . 0.0 113.398 -171.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -46.28 -26.95 0.9 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 127.066 2.146 . . . . 0.0 113.831 171.281 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -32.37 -48.82 0.19 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.79 2.036 . . . . 0.0 112.485 166.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 55.2 mtm180 -66.57 -36.73 83.35 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 -171.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 15.7 t60 -68.64 -33.46 74.06 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-N 120.081 1.309 . . . . 0.0 112.3 176.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 71.5 m -80.76 -39.17 27.33 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 121.588 -0.695 . . . . 0.0 111.488 175.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -62.19 -32.8 73.49 Favored 'General case' 0 CA--C 1.53 0.206 0 O-C-N 120.54 -1.35 . . . . 0.0 112.072 177.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.1 -22.35 50.31 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.433 1.093 . . . . 0.0 113.595 174.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -121.27 23.04 10.65 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.874 1.669 . . . . 0.0 111.807 177.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 31.3 t0 56.57 55.79 6.14 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.957 1.703 . . . . 0.0 112.728 177.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm -138.77 151.62 47.24 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 127.647 2.379 . . . . 0.0 111.805 177.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -72.35 145.0 48.05 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 166.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -118.08 134.71 11.18 Favored Glycine 0 N--CA 1.469 0.846 0 C-N-CA 124.076 0.846 . . . . 0.0 112.607 175.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -144.07 140.18 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 125.201 1.401 . . . . 0.0 110.35 -177.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 99.9 m -78.68 114.82 17.92 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -174.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -107.63 103.06 12.27 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 126.879 2.072 . . . . 0.0 108.64 173.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 61.83 -116.59 9.57 Favored Glycine 0 CA--C 1.532 1.099 0 N-CA-C 111.109 -0.797 . . . . 0.0 111.109 -173.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 76.0 p -101.21 14.32 32.34 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 125.333 1.453 . . . . 0.0 114.128 175.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -127.69 165.13 20.61 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.989 1.715 . . . . 0.0 112.503 -173.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 46.8 t -104.45 121.41 43.37 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.382 1.073 . . . . 0.0 110.405 177.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 48.7 tptt -97.08 120.86 38.23 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 126.746 2.018 . . . . 0.0 106.693 177.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 59.5 m -84.85 137.9 32.88 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 123.612 0.57 . . . . 0.0 111.617 171.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -119.64 -124.96 3.29 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 126.158 1.837 . . . . 0.0 114.526 -169.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 15.3 m -83.59 157.54 64.21 Favored Pre-proline 0 N--CA 1.47 0.562 0 C-N-CA 125.966 1.706 . . . . 0.0 113.585 -179.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -65.17 159.55 46.36 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 123.862 3.041 . . . . 0.0 114.44 -178.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.4 HD13 ' H ' ' A' ' 43' ' ' TYR . 2.4 pp -114.74 -35.48 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -173.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 13.6 m 46.73 31.5 1.44 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 127.407 2.283 . . . . 0.0 116.993 174.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.4 ' H ' HD13 ' A' ' 41' ' ' ILE . 7.3 p90 -131.27 167.08 19.82 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 126.965 2.106 . . . . 0.0 112.326 170.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.5 pt? . . . . . 0 C--O 1.252 1.219 0 N-CA-C 116.089 1.885 . . . . 0.0 116.089 -175.549 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.592 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -92.65 -23.9 18.83 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.629 1.571 . . . . 0.0 112.491 -168.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -62.62 -28.08 69.66 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.189 0.596 . . . . 0.0 112.142 167.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -99.46 -1.59 38.15 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 168.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 54.15 19.45 2.14 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 126.193 1.797 . . . . 0.0 114.24 -172.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 76.34 -2.98 55.51 Favored Glycine 0 CA--C 1.542 1.721 0 C-N-CA 124.955 1.264 . . . . 0.0 115.692 -170.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 78.4 m -77.28 134.89 38.43 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.689 1.196 . . . . 0.0 112.132 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -146.14 136.28 23.69 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.655 0.782 . . . . 0.0 111.575 168.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 44.83 49.3 9.05 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.264 1.425 . . . . 0.0 112.744 -176.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 63.61 26.03 14.52 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 126.742 2.017 . . . . 0.0 115.023 175.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 49.7 t -136.97 145.99 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 125.996 1.718 . . . . 0.0 111.027 178.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -75.69 49.31 0.5 Allowed 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 126.041 1.736 . . . . 0.0 113.645 174.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -71.44 -51.53 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 O-C-N 120.166 -1.584 . . . . 0.0 113.894 -173.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -91.16 -9.19 46.36 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.02 0.928 . . . . 0.0 113.249 -172.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 176.01 172.98 41.29 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 126.512 2.006 . . . . 0.0 111.048 169.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -94.06 144.41 25.5 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 179.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 44.0 t -100.52 -10.66 20.83 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.144 0.977 . . . . 0.0 112.236 169.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -51.19 -43.23 61.3 Favored 'General case' 0 N--CA 1.466 0.337 0 O-C-N 120.799 -1.188 . . . . 0.0 111.663 178.291 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.5 mtm180 -56.39 -41.83 76.9 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 175.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 11.7 t60 -61.47 -46.76 88.67 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.621 0.768 . . . . 0.0 111.156 177.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 92.2 m -80.12 -29.2 38.91 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -178.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 23.8 tptp -67.71 -22.95 65.23 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 120.764 -1.21 . . . . 0.0 113.008 175.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.18 -27.26 69.24 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 118.793 0.724 . . . . 0.0 112.305 168.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -101.95 7.78 41.29 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 126.952 2.101 . . . . 0.0 111.984 171.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . 0.28 1.8 t70 54.63 33.61 19.62 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 129.1 2.96 . . . . 0.0 115.8 -175.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 28.9 mttt -109.66 163.22 13.68 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 127.603 2.361 . . . . 0.0 113.168 174.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -69.89 144.05 52.59 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.202 1.401 . . . . 0.0 109.18 167.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -95.45 151.72 20.11 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 123.875 0.75 . . . . 0.0 112.371 169.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.41 117.96 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 118.686 1.243 . . . . 0.0 110.777 -178.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 98.4 m -82.06 108.42 15.53 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.294 171.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 27.6 p80 -104.91 8.55 34.65 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 176.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 170.76 -134.45 3.13 Favored Glycine 0 CA--C 1.523 0.566 0 C-N-CA 123.83 0.729 . . . . 0.0 111.93 179.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 42.6 p -82.04 13.95 3.09 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 126.663 1.985 . . . . 0.0 112.289 168.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -149.22 170.37 18.63 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 128.978 2.911 . . . . 0.0 109.413 -172.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 14.9 t -128.76 173.68 10.12 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.022 1.329 . . . . 0.0 113.255 -176.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.0 mtpt -155.74 169.32 24.64 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 130.097 3.359 . . . . 0.0 107.244 178.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 59.8 m -104.27 148.81 25.92 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.87 0.868 . . . . 0.0 112.365 168.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -98.19 -119.9 4.11 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 126.985 2.231 . . . . 0.0 112.589 -177.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 19.5 m -100.59 159.03 30.77 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 126.499 1.92 . . . . 0.0 112.765 175.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -50.27 140.35 34.11 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 124.997 3.798 . . . . 0.0 113.912 168.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.7 pp -82.1 -25.84 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 O-C-N 121.417 -0.802 . . . . 0.0 113.018 -177.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 7.3 m 43.57 40.77 3.04 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 128.757 2.823 . . . . 0.0 117.808 168.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -147.39 -29.5 0.35 Allowed 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 115.694 1.738 . . . . 0.0 115.694 178.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 17.8 tp . . . . . 0 C--O 1.245 0.842 0 C-N-CA 126.977 2.111 . . . . 0.0 111.123 179.595 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.829 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -133.99 -31.18 1.16 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.714 1.606 . . . . 0.0 112.762 -178.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -87.46 -21.49 25.5 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.35 0.871 . . . . 0.0 113.35 -170.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -131.94 -4.56 3.56 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.696 0.798 . . . . 0.0 112.533 166.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 56.61 17.78 3.26 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.468 1.907 . . . . 0.0 114.581 -177.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 84.11 -9.32 63.9 Favored Glycine 0 CA--C 1.538 1.506 0 C-N-CA 124.771 1.176 . . . . 0.0 115.135 -170.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 92.7 m -80.35 139.33 36.62 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.436 1.094 . . . . 0.0 113.05 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -152.35 134.35 14.9 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.666 0.786 . . . . 0.0 110.61 168.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 49.6 49.32 20.18 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.675 1.19 . . . . 0.0 113.996 178.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 60.32 21.11 10.61 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 126.32 1.848 . . . . 0.0 115.547 -178.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 69.4 t -132.08 149.37 32.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 125.523 1.529 . . . . 0.0 110.035 -178.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.39 39.0 0.19 Allowed 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 126.806 2.043 . . . . 0.0 111.749 178.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -58.67 -44.5 89.92 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 N-CA-C 115.243 1.571 . . . . 0.0 115.243 -165.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -91.98 -26.44 18.38 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.954 0.902 . . . . 0.0 111.469 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 173.14 173.99 39.91 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 125.843 1.687 . . . . 0.0 112.959 178.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -84.3 142.81 29.95 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.065 0.946 . . . . 0.0 112.957 175.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.7 p -102.18 -0.03 33.84 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.786 1.234 . . . . 0.0 114.151 174.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.4 tmmm? -53.36 -45.1 69.04 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 118.138 -0.934 . . . . 0.0 111.136 173.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 44.4 mtm180 -60.63 -37.21 80.72 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.543 1.065 . . . . 0.0 113.261 -176.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 10.7 t60 -61.76 -46.57 89.0 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.272 1.029 . . . . 0.0 112.313 173.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 84.9 m -72.95 -31.29 64.48 Favored 'General case' 0 CA--C 1.545 0.783 0 O-C-N 121.187 -0.946 . . . . 0.0 112.308 176.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 41.3 tptt -65.24 -21.59 66.76 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 126.023 1.729 . . . . 0.0 112.764 177.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.86 -17.63 17.56 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.755 0.822 . . . . 0.0 112.765 168.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -123.56 15.25 9.54 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 126.766 2.027 . . . . 0.0 112.699 172.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 22.5 t70 65.04 14.85 9.64 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 128.395 2.678 . . . . 0.0 115.387 -175.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.3 mmtp -84.17 149.38 26.2 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 126.526 1.93 . . . . 0.0 111.637 178.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -71.37 137.32 48.29 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 124.245 1.018 . . . . 0.0 108.559 167.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -110.76 128.89 8.99 Favored Glycine 0 N--CA 1.471 1.013 0 C-N-CA 123.907 0.765 . . . . 0.0 111.927 173.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.37 143.07 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 124.501 1.12 . . . . 0.0 111.152 -177.513 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 77.7 m -79.13 115.13 18.6 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -174.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 27.7 m-70 -112.22 104.17 12.35 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.36 1.464 . . . . 0.0 108.568 168.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.79 -122.79 23.06 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 124.226 0.917 . . . . 0.0 111.933 -173.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 40.1 p -101.7 21.34 14.61 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 127.054 2.141 . . . . 0.0 113.088 178.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -139.15 163.21 33.04 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 126.137 1.775 . . . . 0.0 112.169 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 6.4 t -86.05 157.41 20.08 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.429 168.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 6.0 tmtm? -131.65 126.35 34.44 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 168.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 79.4 m -83.88 130.53 34.91 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 120.805 0.335 . . . . 0.0 110.849 173.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -97.97 -131.6 7.2 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 125.468 1.508 . . . . 0.0 113.502 -171.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 28.9 m -87.31 168.2 18.44 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 125.054 1.341 . . . . 0.0 109.983 168.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -46.75 144.15 8.22 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 123.854 3.036 . . . . 0.0 113.301 169.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.6 pp -58.26 -46.89 88.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -170.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . 0.266 24.0 p 59.39 22.55 10.99 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 118.795 2.887 . . . . 0.0 118.795 -176.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 20.8 p90 -142.39 -75.77 0.28 Allowed 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 126.459 1.903 . . . . 0.0 113.259 169.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 56.5 tp . . . . . 0 C--O 1.252 1.211 0 C-N-CA 126.148 1.779 . . . . 0.0 112.941 -172.42 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.795 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -140.73 112.16 7.38 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.806 1.642 . . . . 0.0 111.894 -171.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 28.2 m-20 61.39 -19.58 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 128.756 2.823 . . . . 0.0 117.404 174.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -123.36 2.87 9.12 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.939 1.295 . . . . 0.0 113.311 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 59.71 5.19 0.65 Allowed 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 115.853 1.797 . . . . 0.0 115.853 -175.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 92.13 -3.62 76.81 Favored Glycine 0 CA--C 1.542 1.752 0 C-N-CA 125.401 1.477 . . . . 0.0 114.657 -168.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 96.3 m -78.7 136.82 37.53 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -154.63 141.49 19.14 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.401 1.08 . . . . 0.0 111.316 165.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 51.53 40.48 27.05 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.961 1.304 . . . . 0.0 114.391 177.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 24.7 m-20 64.62 21.11 12.35 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 126.504 1.922 . . . . 0.0 115.917 -174.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 40.4 t -134.42 147.08 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 125.164 1.386 . . . . 0.0 112.458 -176.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -76.94 53.32 0.93 Allowed 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 127.029 2.132 . . . . 0.0 112.113 173.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -80.4 -36.43 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 124.929 1.292 . . . . 0.0 114.239 -174.443 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -96.98 -3.65 41.23 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.47 1.108 . . . . 0.0 112.995 177.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 159.47 170.18 23.72 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 125.769 1.652 . . . . 0.0 113.049 172.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -87.35 107.98 18.77 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.332 1.053 . . . . 0.0 113.398 -176.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -62.06 -26.14 68.09 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.751 1.621 . . . . 0.0 112.356 174.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -43.71 -44.69 6.69 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.278 1.431 . . . . 0.0 110.416 167.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 8.7 ttm180 -64.14 -26.24 68.44 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 115.058 1.503 . . . . 0.0 115.058 -178.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 67.4 t60 -77.05 -42.73 37.24 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 120.596 -1.315 . . . . 0.0 111.428 171.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 92.2 m -70.84 -29.43 65.56 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 121.817 -0.552 . . . . 0.0 111.91 175.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 51.7 tptt -68.54 -27.1 65.79 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.726 2.01 . . . . 0.0 114.16 177.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.17 -16.16 61.34 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.615 0.766 . . . . 0.0 112.783 169.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -110.8 4.28 19.75 Favored 'General case' 0 CA--C 1.556 1.205 0 C-N-CA 127.296 2.238 . . . . 0.0 112.018 170.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . 0.287 3.7 t70 59.61 37.6 22.48 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 129.258 3.023 . . . . 0.0 115.211 -173.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.4 mttp -116.12 160.29 20.55 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.868 2.067 . . . . 0.0 115.145 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -66.69 144.4 56.39 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.209 1.403 . . . . 0.0 109.003 167.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -131.1 136.1 8.62 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 125.043 1.306 . . . . 0.0 115.297 178.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -138.55 138.27 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 124.171 0.988 . . . . 0.0 112.057 -179.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 90.9 m -77.28 104.7 7.94 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.872 0.869 . . . . 0.0 113.123 -178.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 27.5 m-70 -90.77 92.52 8.84 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 123.662 0.785 . . . . 0.0 109.004 167.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.9 -116.57 6.91 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 124.628 1.108 . . . . 0.0 112.417 -172.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 63.4 p -99.95 11.8 38.39 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.965 1.706 . . . . 0.0 113.993 177.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -129.97 160.19 34.38 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.208 1.403 . . . . 0.0 111.541 178.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 34.6 t -98.32 147.52 24.59 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.976 1.31 . . . . 0.0 110.647 179.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 30.9 ttmt -141.53 124.76 16.44 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 125.073 1.349 . . . . 0.0 108.191 -178.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 19.4 m -89.15 144.64 25.97 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -171.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -107.08 -131.01 6.58 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 126.569 2.033 . . . . 0.0 113.212 -175.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.6 m -73.42 158.96 85.86 Favored Pre-proline 0 N--CA 1.473 0.692 0 C-N-CA 124.209 1.003 . . . . 0.0 113.668 172.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -64.56 149.75 89.36 Favored 'Trans proline' 0 CA--C 1.535 0.526 0 C-N-CA 123.503 2.802 . . . . 0.0 111.248 171.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.506 HD12 ' H ' ' A' ' 43' ' ' TYR . 2.2 pp -77.24 -29.47 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 O-C-N 121.532 -0.73 . . . . 0.0 112.688 -174.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.0 m 45.21 33.65 1.21 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 128.803 2.841 . . . . 0.0 118.344 169.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.506 ' H ' HD12 ' A' ' 41' ' ' ILE . 1.4 p90 -147.4 -64.14 0.27 Allowed 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 114.513 1.301 . . . . 0.0 114.513 173.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.252 1.187 0 CA-C-N 120.575 1.534 . . . . 0.0 113.108 -178.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.083 0 CA-C-O 118.909 -0.567 . . . . 0.0 110.72 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -140.69 -148.88 0.26 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.287 1.035 . . . . 0.0 111.708 -178.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 16.4 p-10 -49.43 -39.88 34.54 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 127.84 2.456 . . . . 0.0 112.603 178.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -110.28 19.91 18.37 Favored 'General case' 0 C--O 1.224 -0.245 0 C-N-CA 125.401 1.48 . . . . 0.0 111.477 -179.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 61.26 -2.22 0.24 Allowed 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.583 1.553 . . . . 0.0 114.7 -174.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 96.18 -9.1 67.53 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 125.489 1.519 . . . . 0.0 113.831 -169.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 70.9 m -89.46 141.6 28.42 Favored 'General case' 0 C--O 1.236 0.354 0 O-C-N 121.511 -0.994 . . . . 0.0 113.469 -175.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -154.38 139.83 17.76 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.173 0.989 . . . . 0.0 109.93 165.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 51.55 44.7 28.92 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.788 1.235 . . . . 0.0 114.189 177.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 60.51 17.34 7.23 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 126.223 1.809 . . . . 0.0 115.602 -174.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 41.6 t -126.75 148.05 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.865 1.266 . . . . 0.0 111.881 -177.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -76.0 40.37 0.2 Allowed 'General case' 0 CA--C 1.558 1.271 0 C-N-CA 128.686 2.794 . . . . 0.0 111.947 177.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -74.89 -54.53 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 C-N-CA 126.105 1.762 . . . . 0.0 113.544 -170.02 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -78.71 -7.46 57.75 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.106 1.363 . . . . 0.0 112.545 -172.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 162.1 -171.09 37.92 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 125.863 1.697 . . . . 0.0 111.482 175.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -95.75 120.95 36.92 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -176.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.5 t -77.59 -20.17 54.42 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.667 1.187 . . . . 0.0 112.636 170.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 8.8 tppt? -44.92 -50.78 10.3 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.594 1.558 . . . . 0.0 111.013 172.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 42.4 mtm180 -64.77 -26.64 68.44 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 115.676 1.732 . . . . 0.0 115.676 -173.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 59.6 t60 -72.81 -37.06 67.64 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 119.272 0.942 . . . . 0.0 112.032 174.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 93.0 m -84.88 -29.72 25.01 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.437 0.695 . . . . 0.0 112.863 177.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.76 -29.12 66.52 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 126.138 1.775 . . . . 0.0 112.317 171.533 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.99 -19.77 54.13 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.5 1.12 . . . . 0.0 113.859 171.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -114.38 9.34 16.84 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 127.192 2.197 . . . . 0.0 111.789 176.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.4 t70 57.18 38.96 29.14 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 126.815 2.046 . . . . 0.0 113.594 -171.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.9 mmtp -119.23 156.85 29.16 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 128.175 2.59 . . . . 0.0 112.073 -176.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -76.68 147.71 37.27 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 124.199 0.999 . . . . 0.0 109.643 168.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.16 154.56 19.11 Favored Glycine 0 CA--C 1.542 1.755 0 C-N-CA 125.059 1.314 . . . . 0.0 114.247 173.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -151.67 136.87 10.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 125.954 1.701 . . . . 0.0 110.211 175.254 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 93.9 m -84.18 118.02 23.87 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -174.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -101.96 91.4 4.34 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.347 1.859 . . . . 0.0 108.956 168.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 64.71 -118.7 13.01 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.392 0.996 . . . . 0.0 112.112 -176.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 54.2 p -89.84 11.63 19.66 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 126.633 1.973 . . . . 0.0 113.846 174.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm -131.08 166.57 20.77 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 126.306 1.843 . . . . 0.0 112.14 -171.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 47.3 t -121.47 135.2 55.06 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.452 1.501 . . . . 0.0 111.26 -175.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 12.4 tptt -123.16 153.65 39.74 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 128.762 2.825 . . . . 0.0 107.776 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 63.9 m -111.93 127.64 55.92 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 113.707 1.002 . . . . 0.0 113.707 -173.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -87.39 -130.7 3.17 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 126.518 2.009 . . . . 0.0 113.95 -176.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 25.4 m -80.57 161.1 65.52 Favored Pre-proline 0 CA--C 1.532 0.285 0 C-N-CA 125.726 1.611 . . . . 0.0 112.711 176.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo -52.19 145.6 34.19 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 123.992 3.128 . . . . 0.0 112.411 168.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.7 pp -66.36 -47.01 85.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 -169.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . 0.258 68.6 m 44.3 25.43 0.12 Allowed 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 119.035 2.976 . . . . 0.0 119.035 -177.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -153.51 -49.71 0.1 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.506 1.923 . . . . 0.0 113.181 167.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 18.0 tp . . . . . 0 C--O 1.254 1.294 0 CA-C-O 115.822 -2.037 . . . . 0.0 113.848 178.588 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.919 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -135.85 -59.08 0.76 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.922 1.289 . . . . 0.0 113.646 -172.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 38.4 p-10 -136.24 -35.34 0.76 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.33 1.452 . . . . 0.0 114.621 -168.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -133.96 14.86 3.93 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.398 1.879 . . . . 0.0 112.977 -179.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 54.54 20.11 2.7 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.111 1.365 . . . . 0.0 114.024 -169.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 71.58 0.11 37.77 Favored Glycine 0 CA--C 1.534 1.279 0 O-C-N 120.684 -1.26 . . . . 0.0 115.04 -177.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 72.8 m -88.29 136.82 32.8 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.984 0.913 . . . . 0.0 112.847 -175.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -150.4 139.09 20.72 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.253 1.021 . . . . 0.0 111.263 166.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 48.65 48.34 19.89 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.145 1.378 . . . . 0.0 113.64 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 47.8 m-20 65.48 12.97 8.57 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 126.164 1.786 . . . . 0.0 115.668 -177.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.9 t -130.34 146.4 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 124.615 1.166 . . . . 0.0 112.002 -175.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -74.24 43.23 0.17 Allowed 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 127.422 2.289 . . . . 0.0 113.951 172.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -69.56 -39.22 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 O-C-N 120.892 -1.13 . . . . 0.0 113.689 -174.329 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -92.66 -19.18 22.11 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -174.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 176.5 -150.06 10.2 Favored Glycine 0 CA--C 1.534 1.278 0 N-CA-C 115.882 1.113 . . . . 0.0 115.882 178.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -105.65 135.21 47.48 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.572 1.549 . . . . 0.0 113.961 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -109.47 -24.06 11.2 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 129.049 2.94 . . . . 0.0 110.633 170.248 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 12.9 tppt? -40.15 -52.6 2.56 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 126.083 1.753 . . . . 0.0 111.975 169.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 60.5 mtm180 -61.8 -30.54 70.88 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 114.527 1.306 . . . . 0.0 114.527 -174.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 68.7 t60 -69.55 -44.08 71.64 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 118.99 0.814 . . . . 0.0 111.62 175.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 91.4 m -78.09 -30.65 49.66 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 179.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 49.8 tptt -65.8 -20.75 66.37 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.441 1.896 . . . . 0.0 113.387 176.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.65 -29.99 70.15 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.906 0.882 . . . . 0.0 111.929 169.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 -91.22 6.35 45.48 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 126.166 1.786 . . . . 0.0 111.674 168.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.6 t70 52.8 36.68 22.0 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 127.825 2.45 . . . . 0.0 113.999 -170.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.8 mttt -112.61 160.03 18.27 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.777 2.031 . . . . 0.0 113.004 178.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 53.4 mm-40 -67.74 142.93 56.12 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 124.62 1.168 . . . . 0.0 109.907 167.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -113.77 135.15 12.3 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 125.276 1.417 . . . . 0.0 113.795 175.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -142.35 132.73 24.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 124.463 1.105 . . . . 0.0 110.633 -170.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 84.5 m -78.2 113.93 16.61 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -173.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 22.4 m-70 -105.78 104.78 14.57 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.917 1.687 . . . . 0.0 108.088 169.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 70.84 -118.12 7.37 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 125.034 1.302 . . . . 0.0 111.322 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 63.0 p -103.83 16.27 26.74 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.455 1.502 . . . . 0.0 112.544 174.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 49.5 mmtm -132.45 163.84 27.88 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.169 1.788 . . . . 0.0 112.104 -173.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 11.0 t -87.87 156.48 19.36 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.052 0.941 . . . . 0.0 111.083 170.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.73 145.06 30.71 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 127.645 2.378 . . . . 0.0 105.91 170.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 38.4 m -98.81 143.55 29.03 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -178.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -98.64 -117.14 3.78 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 126.712 2.101 . . . . 0.0 113.893 -175.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.5 m -103.4 162.55 19.7 Favored Pre-proline 0 CA--C 1.538 0.492 0 C-N-CA 126.906 2.082 . . . . 0.0 111.78 176.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_exo -47.3 141.21 14.03 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 124.743 3.629 . . . . 0.0 112.914 168.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.5 pp -67.47 -32.76 58.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 O-C-N 121.359 -0.838 . . . . 0.0 112.301 -178.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 55.4 17.27 2.09 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 129.469 3.108 . . . . 0.0 118.34 169.689 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -161.51 -31.84 0.05 OUTLIER 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 117.956 2.576 . . . . 0.0 117.956 172.204 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.5 tm? . . . . . 0 C--O 1.254 1.336 0 C-N-CA 125.76 1.624 . . . . 0.0 112.265 -171.553 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 . . . . . 0 N--CA 1.474 0.727 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 57.16 23.64 8.85 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.679 1.191 . . . . 0.0 114.043 -178.397 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 75.58 -6.18 33.02 Favored Glycine 0 CA--C 1.538 1.508 0 C-N-CA 123.93 0.776 . . . . 0.0 114.879 -173.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 84.2 m -80.96 143.87 32.27 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.088 1.355 . . . . 0.0 112.009 -179.126 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -151.43 142.77 23.39 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.938 0.895 . . . . 0.0 109.897 168.063 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 49.25 37.41 11.24 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 178.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 70.98 15.99 6.56 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 126.044 1.738 . . . . 0.0 115.531 -175.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 34.9 t -132.15 148.25 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 125.036 1.335 . . . . 0.0 112.396 -173.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.53 42.66 0.17 Allowed 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 127.455 2.302 . . . . 0.0 113.096 174.046 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -67.42 -51.27 54.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 O-C-N 120.048 -1.657 . . . . 0.0 112.579 -173.438 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 27.3 mtpt -90.07 -21.81 22.13 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -175.044 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 179.31 -176.9 48.11 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 125.294 1.426 . . . . 0.0 112.724 174.187 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -95.27 151.2 19.45 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.843 1.257 . . . . 0.0 112.822 176.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 40.4 t -98.26 -12.28 21.76 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.423 1.089 . . . . 0.0 111.387 167.598 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -53.69 -36.04 61.76 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 120.663 -1.273 . . . . 0.0 112.174 -178.098 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -63.06 -30.26 71.46 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 115.423 1.638 . . . . 0.0 115.423 174.108 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 56.4 t60 -75.41 -43.27 50.89 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 119.574 1.079 . . . . 0.0 111.614 172.417 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 93.2 m -80.76 -27.38 36.78 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -177.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.3 -31.08 71.64 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 120.28 -1.512 . . . . 0.0 111.705 173.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.91 -18.95 64.94 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.237 1.015 . . . . 0.0 113.397 171.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -97.25 6.14 48.87 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 126.799 2.039 . . . . 0.0 111.065 169.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.4 t0 54.19 32.51 16.11 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 127.702 2.401 . . . . 0.0 114.488 -169.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.4 mttp -119.24 161.48 20.32 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 126.901 2.08 . . . . 0.0 113.934 -173.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -70.99 146.44 49.42 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 167.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -108.3 139.61 15.19 Favored Glycine 0 N--CA 1.472 1.078 0 C-N-CA 124.65 1.119 . . . . 0.0 111.717 169.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -144.73 126.12 8.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 118.219 1.01 . . . . 0.0 112.022 -177.714 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 87.8 m -73.69 111.85 9.22 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.825 0.85 . . . . 0.0 112.671 -176.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 38.7 m-70 -108.62 102.92 11.94 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.009 1.323 . . . . 0.0 109.383 169.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.59 -123.86 14.4 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 125.67 1.605 . . . . 0.0 112.934 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 61.2 p -97.05 14.89 24.1 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 126.856 2.062 . . . . 0.0 113.038 175.358 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -136.28 -173.87 3.52 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 128.938 2.895 . . . . 0.0 111.185 179.039 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 41.8 t -132.05 161.39 33.33 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.931 1.292 . . . . 0.0 111.488 177.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 67.4 mttt -133.81 142.15 47.74 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 128.503 2.721 . . . . 0.0 106.457 171.229 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 84.3 m -83.99 134.67 34.63 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 168.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -85.78 -141.53 6.01 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 124.935 1.255 . . . . 0.0 110.961 176.097 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.9 m -71.7 154.72 92.92 Favored Pre-proline 0 N--CA 1.472 0.669 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 177.471 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo . . . . . 0 CA--C 1.536 0.58 0 C-N-CA 123.747 2.964 . . . . 0.0 110.184 169.66 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 . . . . . 0 CA--C 1.542 0.658 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 57.98 9.79 1.01 Allowed 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 125.43 1.492 . . . . 0.0 114.191 -170.231 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 86.65 -3.96 86.6 Favored Glycine 0 CA--C 1.539 1.573 0 C-N-CA 124.757 1.17 . . . . 0.0 115.685 -169.376 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 79.6 m -80.01 140.5 36.54 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 119.013 1.406 . . . . 0.0 112.727 -179.216 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -154.28 142.42 20.36 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.591 0.756 . . . . 0.0 110.49 166.023 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 51.26 37.76 19.5 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -178.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 62.59 20.78 12.24 Favored 'General case' 0 CA--C 1.548 0.904 0 N-CA-C 116.04 1.867 . . . . 0.0 116.04 -174.381 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 59.3 t -125.64 147.75 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 125.825 1.65 . . . . 0.0 111.355 -177.354 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -76.93 43.92 0.37 Allowed 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 126.326 1.85 . . . . 0.0 112.913 177.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.5 m -69.18 -56.34 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 O-C-N 120.633 -1.292 . . . . 0.0 114.163 -169.149 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -86.56 -11.62 51.03 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.176 0.99 . . . . 0.0 113.602 -179.243 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 179.71 171.8 43.07 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.67 1.128 . . . . 0.0 112.134 174.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.416 ' OD1' ' HE3' ' A' ' 18' ' ' LYS . 36.7 t70 -98.02 115.56 28.45 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.141 0.976 . . . . 0.0 112.772 -169.355 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 16.3 t -68.5 -30.72 69.61 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 121.153 -0.967 . . . . 0.0 112.762 177.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.416 ' HE3' ' OD1' ' A' ' 16' ' ' ASP . 0.0 OUTLIER -54.48 -37.25 65.04 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 117.932 -1.032 . . . . 0.0 111.716 171.763 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 24.9 ttm180 -60.39 -36.33 77.83 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 120.717 1.598 . . . . 0.0 114.788 177.322 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 36.2 t60 -68.61 -44.75 73.64 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 118.478 0.581 . . . . 0.0 110.968 172.576 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 89.0 m -76.64 -27.43 55.67 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -177.55 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.8 tppp? -60.72 -34.11 73.91 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.33 1.452 . . . . 0.0 111.51 173.411 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.1 -23.66 65.86 Favored 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 173.222 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -94.95 7.55 45.68 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.258 1.423 . . . . 0.0 112.409 170.123 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 51.74 40.18 27.01 Favored 'General case' 0 CA--C 1.556 1.178 0 C-N-CA 126.744 2.018 . . . . 0.0 112.745 -172.021 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 37.1 mttt -122.03 167.15 13.45 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 127.73 2.412 . . . . 0.0 112.6 178.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -83.3 155.84 23.39 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.548 1.139 . . . . 0.0 109.054 168.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -114.12 163.48 12.16 Favored Glycine 0 CA--C 1.546 1.993 0 C-N-CA 125.338 1.446 . . . . 0.0 115.502 -178.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -150.34 128.2 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 126.616 1.966 . . . . 0.0 112.077 177.054 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 69.4 m -85.32 101.64 12.72 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.654 0.781 . . . . 0.0 110.701 170.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.505 ' CD2' ' HB2' ' A' ' 36' ' ' LYS . 10.4 p80 -91.59 98.8 11.87 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 122.688 1.233 . . . . 0.0 108.983 170.307 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 66.36 -105.84 1.42 Allowed Glycine 0 CA--C 1.53 0.988 0 C-N-CA 125.065 1.317 . . . . 0.0 112.03 -174.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 52.0 p -112.78 14.22 19.88 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 126.925 2.09 . . . . 0.0 113.563 -176.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 21.2 mmmt -134.95 161.24 35.83 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.065 1.346 . . . . 0.0 110.817 177.245 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 52.8 t -101.32 157.14 17.01 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.649 1.18 . . . . 0.0 111.278 177.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.505 ' HB2' ' CD2' ' A' ' 31' ' ' HIS . 3.5 ttmt -147.65 169.72 19.05 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 128.341 2.656 . . . . 0.0 107.107 169.729 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 39.5 m -101.38 156.39 17.48 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 122.786 1.279 . . . . 0.0 113.25 172.245 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -105.72 -133.95 7.72 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 127.365 2.412 . . . . 0.0 110.751 175.051 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.8 m -78.99 156.31 77.05 Favored Pre-proline 0 CA--C 1.538 0.517 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 175.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo . . . . . 0 CA--C 1.54 0.817 0 C-N-CA 124.486 3.458 . . . . 0.0 112.598 167.743 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 . . . . . 0 CA--C 1.54 0.569 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 55.82 21.01 4.45 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.297 1.439 . . . . 0.0 114.149 -174.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 77.66 -4.67 55.76 Favored Glycine 0 CA--C 1.542 1.771 0 C-N-CA 124.031 0.824 . . . . 0.0 114.986 -171.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 94.8 m -80.59 140.0 35.99 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.134 1.374 . . . . 0.0 112.763 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -151.42 134.12 15.61 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.636 0.775 . . . . 0.0 110.788 166.466 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 47.01 51.33 13.02 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.851 1.26 . . . . 0.0 113.054 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 26.7 m-20 61.07 7.36 1.53 Allowed 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 117.199 2.296 . . . . 0.0 117.199 -175.072 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.4 t -116.58 140.11 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 O-C-N 120.648 -1.283 . . . . 0.0 111.335 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -77.74 66.74 3.49 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.883 1.273 . . . . 0.0 110.977 169.095 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -82.3 -41.94 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 125.227 1.411 . . . . 0.0 112.955 178.739 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -89.97 -16.87 28.98 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.052 0.941 . . . . 0.0 112.534 178.48 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 164.94 165.34 22.06 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 125.236 1.398 . . . . 0.0 112.119 172.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -78.01 140.21 39.15 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 117.95 0.875 . . . . 0.0 113.055 177.227 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -89.13 -23.77 22.39 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.162 1.785 . . . . 0.0 111.173 175.295 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -55.08 -32.73 62.18 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 117.759 -1.115 . . . . 0.0 113.205 176.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.81 -35.35 66.25 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 120.609 1.549 . . . . 0.0 114.48 171.239 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 40.6 t60 -75.03 -28.41 60.45 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 119.666 1.121 . . . . 0.0 112.731 176.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 86.3 m -79.54 -36.76 37.88 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.888 1.275 . . . . 0.0 112.673 173.281 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 70.9 tttt -59.31 -32.09 69.74 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.15 1.78 . . . . 0.0 113.157 -178.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.61 -14.83 63.28 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 114.236 1.198 . . . . 0.0 114.236 176.052 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -117.66 19.33 13.91 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.926 1.69 . . . . 0.0 112.572 175.187 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.8 t70 56.16 63.61 1.96 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.378 1.471 . . . . 0.0 111.049 -175.179 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm -147.77 146.52 29.22 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 126.383 1.873 . . . . 0.0 112.803 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 57.1 mm-40 -75.43 156.34 35.42 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 163.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -134.16 150.43 20.0 Favored Glycine 0 N--CA 1.473 1.147 0 O-C-N 121.019 -1.051 . . . . 0.0 113.234 178.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -150.5 143.06 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 125.069 1.348 . . . . 0.0 110.084 -173.411 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 70.7 m -80.71 117.66 21.58 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 121.248 -0.908 . . . . 0.0 112.483 -175.164 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 -107.83 97.69 7.38 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.898 1.279 . . . . 0.0 108.353 169.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.06 -114.68 4.86 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 125.213 1.387 . . . . 0.0 112.233 -172.663 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 72.8 p -112.89 20.6 16.27 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 127.56 2.344 . . . . 0.0 112.143 178.03 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 22.5 mmtm -136.25 169.33 17.81 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 128.043 2.537 . . . . 0.0 112.169 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 34.7 t -105.81 139.1 40.9 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.642 1.577 . . . . 0.0 112.481 -174.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -123.31 124.62 43.37 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 126.924 2.09 . . . . 0.0 107.605 177.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 73.4 m -83.53 141.6 31.5 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 121.936 0.874 . . . . 0.0 113.358 176.162 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -111.77 -145.73 10.03 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 127.522 2.486 . . . . 0.0 113.035 -178.302 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.5 m -63.44 156.07 72.15 Favored Pre-proline 0 N--CA 1.476 0.834 0 C-N-CA 124.546 1.139 . . . . 0.0 114.025 175.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo . . . . . 0 N--CA 1.46 -0.446 0 C-N-CA 123.629 2.886 . . . . 0.0 113.233 179.416 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 . . . . . 0 N--CA 1.469 0.514 0 N-CA-C 115.366 1.617 . . . . 0.0 115.366 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 54.54 29.77 11.88 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.57 1.148 . . . . 0.0 112.929 -172.292 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.25 -5.56 6.65 Favored Glycine 0 CA--C 1.542 1.749 0 N-CA-C 116.188 1.235 . . . . 0.0 116.188 -171.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 96.5 m -80.98 138.85 36.07 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 118.791 1.295 . . . . 0.0 114.224 -177.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -152.43 141.17 20.96 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.547 0.739 . . . . 0.0 110.287 165.302 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 47.55 47.35 17.55 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.863 1.265 . . . . 0.0 112.914 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 24.7 m-20 57.71 20.91 6.82 Favored 'General case' 0 CA--C 1.552 1.032 0 N-CA-C 116.33 1.974 . . . . 0.0 116.33 -174.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 62.2 t -130.14 149.7 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 CA-C-N 120.673 1.579 . . . . 0.0 112.137 -177.391 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.58 53.03 0.68 Allowed 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 127.131 2.172 . . . . 0.0 111.402 174.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -76.98 -50.55 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 O-C-N 119.863 -1.773 . . . . 0.0 112.804 -174.386 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -84.11 -25.93 29.34 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.799 0.839 . . . . 0.0 112.968 -178.156 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -179.03 -178.55 48.33 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.108 1.337 . . . . 0.0 112.701 177.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -101.65 104.16 14.99 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 122.496 1.141 . . . . 0.0 112.842 -176.084 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -63.71 -32.1 73.48 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.659 1.584 . . . . 0.0 113.144 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 5.6 tmmm? -58.82 -20.89 54.5 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 117.538 -1.22 . . . . 0.0 113.106 175.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.3 tpp180 -62.18 -36.32 81.51 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 120.786 1.63 . . . . 0.0 113.4 171.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 8.3 t60 -68.73 -44.52 73.67 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.633 0.773 . . . . 0.0 111.13 173.197 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 72.0 m -67.0 -37.78 84.82 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 121.496 -0.752 . . . . 0.0 112.252 176.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -63.16 -30.27 71.45 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 120.988 -1.07 . . . . 0.0 112.025 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.37 -23.87 65.64 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.302 1.041 . . . . 0.0 113.298 171.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -93.3 6.27 48.68 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.388 1.475 . . . . 0.0 113.023 170.324 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . 0.267 0.3 OUTLIER 64.88 35.55 8.37 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 127.547 2.339 . . . . 0.0 114.445 -172.14 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.4 mmtp -127.66 152.81 47.21 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 127.966 2.506 . . . . 0.0 113.391 -174.179 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -76.79 159.09 30.4 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.256 -0.903 . . . . 0.0 108.913 167.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -140.78 145.21 15.8 Favored Glycine 0 N--CA 1.474 1.187 0 C-N-CA 125.022 1.296 . . . . 0.0 114.547 -178.438 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -145.37 141.63 22.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 124.878 1.271 . . . . 0.0 110.803 -176.214 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 90.8 m -77.61 120.48 22.62 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.906 0.86 . . . . 0.0 113.315 -175.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -113.75 100.82 8.75 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.817 1.647 . . . . 0.0 109.404 169.285 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 64.88 -126.99 32.81 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 125.238 1.399 . . . . 0.0 111.086 -172.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 34.9 p -89.94 19.56 4.78 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 126.31 1.844 . . . . 0.0 114.011 177.275 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -141.86 163.17 33.63 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.385 1.474 . . . . 0.0 112.22 -174.571 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.7 t -88.56 157.9 18.46 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.627 1.171 . . . . 0.0 111.674 173.268 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.6 121.75 15.81 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 126.448 1.899 . . . . 0.0 107.461 171.384 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 63.3 m -86.11 134.47 33.81 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 -178.041 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -102.88 -122.63 5.13 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 127.684 2.564 . . . . 0.0 114.727 -169.292 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.6 m -87.22 156.82 54.19 Favored Pre-proline 0 N--CA 1.477 0.884 0 C-N-CA 125.765 1.626 . . . . 0.0 113.723 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo . . . . . 0 CA--C 1.541 0.845 0 C-N-CA 124.16 3.24 . . . . 0.0 113.322 179.887 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 . . . . . 0 CA--C 1.538 0.501 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 57.5 12.9 1.64 Allowed 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 115.098 1.518 . . . . 0.0 115.098 -175.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 85.08 -5.23 83.71 Favored Glycine 0 CA--C 1.54 1.602 0 C-N-CA 124.739 1.162 . . . . 0.0 115.173 -168.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 81.7 m -84.01 141.36 31.24 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.842 1.321 . . . . 0.0 113.46 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -151.06 134.17 15.98 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.357 0.663 . . . . 0.0 111.129 164.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 47.2 54.64 9.15 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.113 1.365 . . . . 0.0 112.542 -176.527 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 61.3 m-20 64.69 9.72 5.42 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 116.308 1.966 . . . . 0.0 116.308 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 49.4 t -125.57 147.87 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 CA-C-N 120.547 1.521 . . . . 0.0 111.893 -175.101 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -74.08 46.66 0.25 Allowed 'General case' 0 CA--C 1.557 1.249 0 C-N-CA 127.083 2.153 . . . . 0.0 112.466 175.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -73.12 -37.02 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 O-C-N 119.738 -1.851 . . . . 0.0 114.73 -170.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 63.7 mtpt -99.58 -18.18 17.48 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.717 1.207 . . . . 0.0 113.233 178.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 179.46 167.34 36.66 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 124.638 1.113 . . . . 0.0 112.53 175.095 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -87.37 109.37 19.5 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.99 1.716 . . . . 0.0 113.103 -174.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -61.65 -24.56 66.81 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.489 1.515 . . . . 0.0 113.63 176.32 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.4 tmmm? -50.39 -35.72 29.52 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 120.981 -1.074 . . . . 0.0 111.916 171.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 55.8 ttm-85 -58.61 -41.12 85.15 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 126.483 1.913 . . . . 0.0 114.203 -177.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 36.8 t60 -67.62 -42.98 81.47 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.426 1.09 . . . . 0.0 111.495 175.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 72.0 m -77.26 -27.13 53.1 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.41 -36.8 81.33 Favored 'General case' 0 N--CA 1.476 0.839 0 O-C-N 120.62 -1.3 . . . . 0.0 110.782 169.744 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.2 -15.06 63.43 Favored 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 171.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -99.78 1.81 43.5 Favored 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 126.34 1.856 . . . . 0.0 111.36 169.241 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . 0.269 3.4 t0 51.98 44.21 29.68 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 128.188 2.595 . . . . 0.0 114.212 -169.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.4 mttt -126.92 172.8 10.12 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 129.13 2.972 . . . . 0.0 112.845 -178.241 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -85.55 153.84 22.15 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.89 1.276 . . . . 0.0 109.653 167.183 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -131.79 151.4 19.78 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 125.525 1.536 . . . . 0.0 114.887 -178.49 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -153.32 137.31 8.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 125.268 1.427 . . . . 0.0 111.056 -176.105 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 87.3 m -79.92 120.76 24.57 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.28 -0.887 . . . . 0.0 112.137 -177.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 15.9 m-70 -111.58 103.1 11.4 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.667 1.587 . . . . 0.0 109.223 168.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 67.86 -114.79 6.4 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 124.869 1.224 . . . . 0.0 112.112 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 82.7 p -104.06 17.2 24.6 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 126.155 1.782 . . . . 0.0 112.615 173.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 44.9 mmtm -127.96 159.91 33.52 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.448 1.899 . . . . 0.0 112.093 -178.265 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 43.3 t -100.02 146.0 27.25 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.603 1.161 . . . . 0.0 110.226 170.041 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -130.35 126.49 37.25 Favored 'General case' 0 C--N 1.333 -0.11 0 C-N-CA 126.392 1.877 . . . . 0.0 106.998 -178.145 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 61.2 m -87.95 137.27 32.48 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.832 0.825 . . . . 0.0 112.164 176.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -97.16 -137.28 9.48 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 127.35 2.405 . . . . 0.0 112.228 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 33.1 m -73.39 155.14 89.88 Favored Pre-proline 0 CA--C 1.535 0.37 0 N-CA-C 113.939 1.088 . . . . 0.0 113.939 178.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo . . . . . 0 CA--C 1.54 0.784 0 C-N-CA 124.541 3.494 . . . . 0.0 111.407 166.97 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 . . . . . 0 CA--C 1.537 0.446 0 N-CA-C 115.103 1.52 . . . . 0.0 115.103 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 54.65 15.54 1.1 Allowed 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 -171.293 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 81.17 -5.11 68.18 Favored Glycine 0 CA--C 1.544 1.906 0 C-N-CA 124.646 1.117 . . . . 0.0 115.263 -168.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 74.5 m -77.44 141.52 39.69 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.065 1.346 . . . . 0.0 113.068 178.142 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -152.15 131.98 13.28 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.098 0.959 . . . . 0.0 112.113 166.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 48.19 54.5 10.15 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.773 1.629 . . . . 0.0 112.745 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 42.4 m-20 62.57 15.35 7.85 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 116.485 2.032 . . . . 0.0 116.485 -179.119 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 38.4 t -129.07 147.26 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 125.048 1.339 . . . . 0.0 111.079 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 28.0 p-10 -76.33 33.95 0.13 Allowed 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 128.354 2.661 . . . . 0.0 114.266 176.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -58.78 -30.92 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 N-CA-C 116.362 1.986 . . . . 0.0 116.362 -168.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -109.5 -10.14 14.89 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 125.189 1.395 . . . . 0.0 113.133 175.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 168.81 153.53 8.38 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 125.798 1.666 . . . . 0.0 112.252 173.519 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -85.3 138.54 32.24 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.089 0.956 . . . . 0.0 112.137 175.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.2 p -94.95 -1.43 52.53 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -178.256 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -63.21 -28.65 70.18 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 120.956 -1.09 . . . . 0.0 112.978 177.315 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.04 -37.4 85.76 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 121.045 1.748 . . . . 0.0 113.148 173.132 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 13.1 t60 -62.68 -36.37 82.67 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.34 1.056 . . . . 0.0 111.715 170.287 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 57.7 m -75.38 -27.83 59.26 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 121.087 -1.008 . . . . 0.0 113.402 171.35 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 21.6 tptp -66.28 -20.32 66.07 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.188 1.395 . . . . 0.0 112.907 173.61 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.53 -18.11 64.53 Favored 'General case' 0 CA--C 1.55 0.955 0 O-C-N 121.704 -0.623 . . . . 0.0 112.308 168.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -110.68 15.12 22.16 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 126.953 2.101 . . . . 0.0 111.899 168.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 15.4 t0 56.18 26.32 10.16 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 127.771 2.428 . . . . 0.0 115.2 -174.025 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 38.8 mttt -109.91 159.57 17.13 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.79 1.636 . . . . 0.0 114.339 -174.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -70.59 149.9 46.61 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 114.727 -1.124 . . . . 0.0 108.006 166.145 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -136.62 141.63 12.68 Favored Glycine 0 N--CA 1.472 1.069 0 C-N-CA 124.798 1.19 . . . . 0.0 114.83 -176.147 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.06 131.78 55.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 125.638 1.575 . . . . 0.0 111.903 -168.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 96.9 m -73.07 107.89 5.66 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.208 1.003 . . . . 0.0 112.045 177.291 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 9.5 m-70 -95.5 91.76 6.33 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.866 2.066 . . . . 0.0 110.069 169.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 66.27 -109.0 2.64 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 124.613 1.101 . . . . 0.0 112.037 -178.278 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 47.5 p -109.94 26.71 10.35 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 125.938 1.695 . . . . 0.0 113.209 173.302 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 36.4 mmtm -139.31 174.23 10.73 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 126.977 2.111 . . . . 0.0 111.932 174.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 13.1 t -117.48 157.71 25.79 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.697 1.199 . . . . 0.0 112.388 176.612 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.9 mtpt -144.47 155.67 43.83 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 128.08 2.552 . . . . 0.0 107.646 172.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 23.8 m -107.0 149.11 27.89 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -95.32 -117.47 3.13 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 127.034 2.254 . . . . 0.0 113.779 -176.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.9 m -106.41 163.87 16.09 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 126.399 1.88 . . . . 0.0 111.432 169.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_exo . . . . . 0 CA--C 1.538 0.682 0 C-N-CA 124.494 3.463 . . . . 0.0 113.849 170.434 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 . . . . . 0 CA--C 1.54 0.593 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 53.77 26.13 5.73 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.919 1.288 . . . . 0.0 113.535 -173.167 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.02 0.72 21.99 Favored Glycine 0 CA--C 1.539 1.567 0 O-C-N 121.057 -1.027 . . . . 0.0 115.445 -171.625 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 76.2 m -97.7 141.92 30.13 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.16 1.384 . . . . 0.0 113.713 -170.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -150.6 132.46 15.08 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.161 167.049 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 47.36 54.67 9.24 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.628 1.571 . . . . 0.0 113.331 178.618 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 64.03 14.84 8.79 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 116.811 2.152 . . . . 0.0 116.811 -177.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.5 t -131.58 146.66 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 O-C-N 120.567 -1.333 . . . . 0.0 111.827 -177.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -76.51 50.13 0.65 Allowed 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.852 1.661 . . . . 0.0 112.179 170.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -77.93 -30.79 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 125.618 1.567 . . . . 0.0 114.073 -177.453 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 23.4 mmmt -95.26 -30.72 13.83 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -174.13 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -175.61 -138.69 2.88 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 124.958 1.266 . . . . 0.0 112.62 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -124.78 140.25 53.1 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -108.27 -19.57 13.43 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 129.276 3.03 . . . . 0.0 111.369 174.232 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 11.6 tppt? -38.64 -51.57 1.65 Allowed 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 127.199 2.199 . . . . 0.0 112.321 169.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 42.3 mtm180 -63.4 -25.56 68.34 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 -176.235 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 65.1 t60 -73.75 -45.71 50.22 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 119.186 0.903 . . . . 0.0 111.975 173.344 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 71.1 m -76.13 -28.63 57.5 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 178.262 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.421 ' HA ' ' HE2' ' A' ' 22' ' ' LYS . 0.5 OUTLIER -63.05 -28.43 70.08 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.747 1.219 . . . . 0.0 112.267 175.729 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.24 -26.45 63.85 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.391 1.076 . . . . 0.0 113.258 172.01 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -88.2 8.53 26.65 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 125.844 1.657 . . . . 0.0 111.615 168.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . 0.265 11.5 t0 56.18 31.3 18.08 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 128.167 2.587 . . . . 0.0 115.061 -173.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 36.3 mttt -117.22 169.17 9.67 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 127.453 2.301 . . . . 0.0 113.798 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -79.65 150.91 30.8 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.421 1.488 . . . . 0.0 108.477 167.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -110.99 151.03 17.8 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 125.755 1.645 . . . . 0.0 113.708 175.308 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -150.41 137.88 13.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 125.346 1.458 . . . . 0.0 109.002 175.097 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 68.3 m -77.93 126.34 30.69 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 121.046 -1.034 . . . . 0.0 112.878 -174.367 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -122.08 114.43 20.9 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.211 1.404 . . . . 0.0 109.229 169.264 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 64.13 -124.51 30.28 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 124.464 1.03 . . . . 0.0 111.721 -173.386 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 70.3 p -104.6 29.2 6.33 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 125.997 1.719 . . . . 0.0 112.405 170.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 41.2 mmtm -136.73 165.07 26.78 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.405 1.882 . . . . 0.0 110.686 -176.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 12.6 t -92.19 160.37 15.2 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.633 1.173 . . . . 0.0 110.294 173.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.0 tmtt? -145.97 137.92 25.17 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 127.024 2.13 . . . . 0.0 106.294 173.356 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 57.2 m -93.48 135.45 34.72 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -176.304 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -85.31 -127.35 1.79 Allowed Glycine 0 CA--C 1.528 0.866 0 C-N-CA 126.538 2.018 . . . . 0.0 112.286 178.026 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 31.5 m -89.03 155.08 49.81 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 124.666 1.186 . . . . 0.0 113.014 176.241 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo . . . . . 0 C--O 1.239 0.525 0 C-N-CA 124.742 3.628 . . . . 0.0 111.309 167.462 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 . . . . . 0 N--CA 1.476 0.854 0 CA-C-O 121.431 0.634 . . . . 0.0 111.617 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 50.75 16.78 0.34 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.477 1.911 . . . . 0.0 115.223 -172.445 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 71.35 0.67 39.01 Favored Glycine 0 CA--C 1.535 1.294 0 O-C-N 120.965 -1.084 . . . . 0.0 115.002 -173.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 99.8 m -90.74 137.09 32.63 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 118.2 1.0 . . . . 0.0 112.835 -173.017 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -151.7 141.97 22.38 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.303 1.041 . . . . 0.0 110.175 165.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 51.15 39.08 22.66 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 178.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 57.88 28.44 16.07 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 126.281 1.832 . . . . 0.0 114.786 -173.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 46.2 t -132.01 145.03 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 125.416 1.486 . . . . 0.0 110.585 179.047 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -77.51 50.85 0.84 Allowed 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.598 1.559 . . . . 0.0 112.236 173.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -75.94 -41.95 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 124.963 1.305 . . . . 0.0 113.722 -175.162 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 25.0 mmmt -90.04 -19.4 24.44 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.012 0.925 . . . . 0.0 112.797 -173.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -178.5 -146.76 6.67 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 124.701 1.143 . . . . 0.0 112.588 178.233 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 -124.22 126.97 47.01 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.881 1.272 . . . . 0.0 113.947 177.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -86.49 -18.42 31.68 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.635 1.974 . . . . 0.0 111.56 171.584 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -48.46 -51.32 27.61 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 117.408 -1.282 . . . . 0.0 111.378 169.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -52.82 -42.58 65.26 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-N 120.267 1.394 . . . . 0.0 113.104 -175.716 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 71.8 t60 -63.18 -43.53 97.95 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.161 0.984 . . . . 0.0 112.235 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 92.9 m -84.24 -25.71 29.21 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.57 -35.55 78.11 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 120.833 -1.167 . . . . 0.0 110.221 173.621 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.06 -12.85 61.59 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 171.269 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -102.4 7.88 40.29 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 126.564 1.946 . . . . 0.0 112.193 169.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . 0.261 2.6 t0 58.22 35.87 25.3 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 128.263 2.625 . . . . 0.0 114.198 -172.628 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.2 mttt -129.89 164.17 24.76 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 127.588 2.355 . . . . 0.0 115.37 -172.315 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -69.29 144.96 53.44 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.045 1.738 . . . . 0.0 109.383 165.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -109.41 141.11 15.96 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 125.413 1.482 . . . . 0.0 112.599 169.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.45 135.37 31.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-N 118.666 1.233 . . . . 0.0 111.239 174.6 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 86.6 m -74.8 115.36 14.3 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 122.078 0.942 . . . . 0.0 113.262 -176.62 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 5.0 m-70 -100.07 100.28 11.13 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 126.24 1.816 . . . . 0.0 107.65 168.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 63.55 -114.41 6.83 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 124.411 1.005 . . . . 0.0 111.977 -178.176 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 44.8 p -102.42 16.49 26.12 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 126.168 1.787 . . . . 0.0 113.653 174.32 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 48.8 mmtm -130.25 165.6 22.08 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.867 2.067 . . . . 0.0 111.019 -175.435 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 20.4 t -97.6 157.61 15.94 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.042 0.937 . . . . 0.0 110.868 172.512 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.14 126.5 14.0 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 126.151 1.78 . . . . 0.0 106.314 175.405 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 39.4 m -82.26 142.34 32.19 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 119.119 0.872 . . . . 0.0 112.141 -178.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -102.28 -118.48 4.42 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 125.725 1.631 . . . . 0.0 113.456 -173.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.9 m -91.55 159.68 38.26 Favored Pre-proline 0 N--CA 1.472 0.658 0 C-N-CA 126.314 1.846 . . . . 0.0 112.559 174.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo . . . . . 0 CA--C 1.536 0.621 0 C-N-CA 124.098 3.198 . . . . 0.0 112.556 179.288 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 . . . . . 0 N--CA 1.478 0.942 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 54.16 15.74 1.0 Allowed 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 -177.01 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.36 4.87 52.88 Favored Glycine 0 CA--C 1.537 1.425 0 O-C-N 121.179 -0.95 . . . . 0.0 114.842 -173.021 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 92.0 m -91.28 135.78 33.56 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.458 1.103 . . . . 0.0 112.084 -179.194 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -151.68 135.38 16.3 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.096 0.958 . . . . 0.0 111.955 167.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 48.46 52.77 13.1 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.3 1.44 . . . . 0.0 112.72 -179.29 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 57.3 m-20 63.71 8.26 3.63 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 127.254 2.222 . . . . 0.0 116.686 -177.159 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.0 t -126.24 147.85 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 CA-C-N 119.592 1.087 . . . . 0.0 111.504 -176.258 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -77.44 39.46 0.26 Allowed 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 126.916 2.086 . . . . 0.0 113.06 172.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -63.06 -26.74 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 126.054 1.741 . . . . 0.0 113.907 -178.667 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.5 mmmm -104.65 -13.76 15.84 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.237 1.415 . . . . 0.0 114.519 -175.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 166.94 -141.13 6.71 Favored Glycine 0 N--CA 1.471 0.992 0 CA-C-N 120.112 1.324 . . . . 0.0 114.699 174.376 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -117.13 124.28 48.82 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.704 1.201 . . . . 0.0 113.718 -170.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -104.54 -30.35 10.07 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 127.53 2.332 . . . . 0.0 111.284 176.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.3 tmmm? -53.16 -40.21 64.13 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 121.11 -0.994 . . . . 0.0 112.391 175.422 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 43.9 mtp180 -64.3 -27.69 69.21 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 63.7 t60 -70.68 -46.65 62.78 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 118.867 0.758 . . . . 0.0 111.335 170.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 86.8 m -72.34 -30.31 64.62 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.471 ' HA ' ' HE2' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -62.55 -30.69 71.5 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 120.536 -1.352 . . . . 0.0 112.14 173.996 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -75.47 -11.98 60.15 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 124.304 1.042 . . . . 0.0 112.902 173.549 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -102.79 4.91 38.41 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 126.528 1.931 . . . . 0.0 111.378 168.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . 0.273 5.7 t0 57.68 40.37 26.58 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 129.354 3.061 . . . . 0.0 115.886 -171.425 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.7 mttt -129.96 171.59 12.61 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.303 1.841 . . . . 0.0 113.871 -177.214 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -79.11 156.47 28.28 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.921 1.688 . . . . 0.0 109.141 166.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -126.58 144.92 15.42 Favored Glycine 0 CA--C 1.537 1.46 0 C-N-CA 125.332 1.444 . . . . 0.0 115.102 176.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -147.43 144.06 19.68 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 124.558 1.143 . . . . 0.0 109.564 -178.445 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 88.8 m -86.76 122.91 31.31 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.112 -0.993 . . . . 0.0 112.86 -174.292 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 19.0 m-70 -114.71 104.22 11.76 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 125.582 1.553 . . . . 0.0 110.019 169.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 60.65 -121.52 26.87 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 123.827 0.727 . . . . 0.0 111.67 -173.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 60.7 p -91.42 8.8 34.51 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 126.215 1.806 . . . . 0.0 114.167 179.13 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -131.91 160.96 34.21 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.709 1.603 . . . . 0.0 112.94 -172.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 38.7 t -93.23 140.06 29.94 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.828 1.251 . . . . 0.0 110.766 172.514 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.63 121.13 29.66 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 127.142 2.177 . . . . 0.0 105.799 178.824 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 57.2 m -78.03 141.73 38.68 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 119.043 0.838 . . . . 0.0 112.687 -177.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -89.68 -135.11 5.64 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 126.549 2.023 . . . . 0.0 111.868 175.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 33.7 m -83.93 159.61 59.83 Favored Pre-proline 0 CA--C 1.539 0.534 0 C-N-CA 123.99 0.916 . . . . 0.0 113.318 -178.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo . . . . . 0 CA--C 1.536 0.58 0 C-N-CA 124.63 3.553 . . . . 0.0 111.516 167.608 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 . . . . . 0 N--CA 1.471 0.592 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 56.09 14.14 1.38 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.505 1.522 . . . . 0.0 114.169 -174.252 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 83.69 -7.43 69.53 Favored Glycine 0 CA--C 1.538 1.493 0 C-N-CA 125.347 1.451 . . . . 0.0 115.0 -171.704 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 82.8 m -76.33 143.79 40.57 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.229 1.011 . . . . 0.0 113.232 177.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -156.36 139.97 15.97 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.988 1.315 . . . . 0.0 109.953 166.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 48.92 44.33 22.24 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.667 1.187 . . . . 0.0 113.859 -179.199 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 16.7 m-20 61.18 15.91 6.76 Favored 'General case' 0 CA--C 1.553 1.074 0 N-CA-C 116.316 1.969 . . . . 0.0 116.316 -174.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 59.4 t -126.49 149.92 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 125.379 1.472 . . . . 0.0 111.849 -176.006 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -79.06 42.33 0.47 Allowed 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 127.082 2.153 . . . . 0.0 114.61 178.103 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -64.22 -42.62 96.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 O-C-N 120.584 -1.322 . . . . 0.0 113.566 -171.412 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 36.2 mmtm -96.36 -19.19 19.4 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 174.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 172.3 168.48 33.78 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 124.343 0.973 . . . . 0.0 112.694 177.26 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -98.37 129.67 45.02 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.474 0.709 . . . . 0.0 112.715 -174.06 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -64.34 -15.55 60.56 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 126.641 1.976 . . . . 0.0 113.507 171.245 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? -41.98 -51.49 4.42 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.52 1.528 . . . . 0.0 112.113 168.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 60.1 mtm180 -68.55 -25.57 64.98 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.047 1.128 . . . . 0.0 114.047 -168.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -81.88 -36.53 28.07 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.932 1.293 . . . . 0.0 112.789 174.704 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 99.1 m -79.25 -33.24 43.73 Favored 'General case' 0 CA--C 1.546 0.817 0 O-C-N 121.06 -1.025 . . . . 0.0 113.08 174.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 18.8 tptp -63.64 -28.57 70.0 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.67 1.188 . . . . 0.0 112.422 177.265 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.69 -25.91 66.74 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.874 1.27 . . . . 0.0 113.365 171.139 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -103.76 10.2 36.73 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.842 1.657 . . . . 0.0 112.067 174.278 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 64.78 30.3 12.34 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 128.28 2.632 . . . . 0.0 115.312 -177.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.2 mttp -115.93 163.48 15.82 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 126.648 1.979 . . . . 0.0 112.869 177.217 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -78.79 152.27 31.51 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 166.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -107.75 159.98 14.19 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 125.836 1.684 . . . . 0.0 113.226 172.285 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -150.14 135.9 11.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 124.906 1.282 . . . . 0.0 111.011 171.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 91.4 m -76.91 118.81 19.87 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.449 0.642 . . . . 0.0 112.273 -179.152 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 19.3 m-70 -116.2 111.58 20.39 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.627 1.571 . . . . 0.0 109.125 169.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 63.5 -117.08 10.21 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 125.964 1.745 . . . . 0.0 111.228 -173.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.4 p -108.44 23.93 13.79 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.636 1.574 . . . . 0.0 112.377 173.247 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 42.0 mmtm -138.59 169.27 18.09 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.934 1.294 . . . . 0.0 112.913 -178.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 41.7 t -99.59 148.11 24.65 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.372 1.469 . . . . 0.0 111.937 -178.24 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -139.9 133.78 30.71 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 126.902 2.081 . . . . 0.0 105.974 174.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 63.0 m -84.73 142.67 29.68 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 119.592 1.087 . . . . 0.0 112.834 -178.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -89.71 -138.36 6.95 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 126.26 1.886 . . . . 0.0 111.239 171.296 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.6 m -77.86 154.48 80.62 Favored Pre-proline 0 CA--C 1.537 0.475 0 N-CA-C 114.055 1.131 . . . . 0.0 114.055 178.226 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo . . . . . 0 CA--C 1.54 0.798 0 C-N-CA 124.238 3.292 . . . . 0.0 110.758 166.306 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 . . . . . 0 N--CA 1.468 0.446 0 N-CA-C 112.708 0.632 . . . . 0.0 112.708 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 60.58 7.96 1.55 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.52 1.928 . . . . 0.0 114.975 -178.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 88.02 -3.18 85.83 Favored Glycine 0 CA--C 1.543 1.84 0 C-N-CA 124.701 1.143 . . . . 0.0 114.729 -168.077 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 87.3 m -79.03 141.88 37.04 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.553 1.141 . . . . 0.0 112.01 175.401 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -152.4 135.8 15.94 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.798 0.839 . . . . 0.0 110.714 168.168 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 47.95 51.47 14.39 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.405 1.482 . . . . 0.0 113.228 179.097 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 62.62 11.22 4.62 Favored 'General case' 0 CA--C 1.551 1.017 0 N-CA-C 117.389 2.366 . . . . 0.0 117.389 -175.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 38.2 t -124.2 146.53 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 CA-C-N 119.73 1.15 . . . . 0.0 111.965 -177.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -74.91 35.92 0.11 Allowed 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 127.698 2.399 . . . . 0.0 113.483 177.163 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -60.1 -43.8 93.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 -168.652 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -96.97 -18.05 19.68 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 178.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 171.4 169.64 34.55 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 125.553 1.549 . . . . 0.0 113.002 174.146 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -86.84 142.81 27.8 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 121.959 0.885 . . . . 0.0 112.996 175.403 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.8 p -97.79 -10.66 24.41 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.628 1.171 . . . . 0.0 113.149 169.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.1 tmmm? -63.3 -28.09 69.78 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-O 118.115 -0.945 . . . . 0.0 113.251 -176.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 44.9 mtm180 -63.81 -35.23 79.92 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 120.013 1.279 . . . . 0.0 113.596 170.271 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -67.76 -35.41 78.66 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.433 1.093 . . . . 0.0 111.904 174.311 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 90.0 m -75.21 -39.02 60.44 Favored 'General case' 0 CA--C 1.547 0.865 0 O-C-N 120.909 -1.119 . . . . 0.0 112.533 170.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -62.28 -28.63 69.85 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 120.748 -1.22 . . . . 0.0 112.791 178.21 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.57 -25.89 60.64 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.47 1.108 . . . . 0.0 113.152 171.533 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -115.47 21.01 14.38 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.684 1.594 . . . . 0.0 112.048 -179.042 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.2 t0 56.96 60.56 2.96 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 126.407 1.883 . . . . 0.0 111.431 -175.746 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 31.9 mmtm -145.44 147.68 32.47 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 126.071 1.748 . . . . 0.0 113.308 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -72.53 156.42 39.03 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 162.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -141.6 136.11 7.2 Favored Glycine 0 N--CA 1.468 0.788 0 C-N-CA 124.385 0.993 . . . . 0.0 112.684 -179.515 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.0 140.18 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 C-N-CA 124.595 1.158 . . . . 0.0 110.675 -172.123 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 73.0 m -68.13 118.07 10.8 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.019 0.528 . . . . 0.0 112.408 -177.739 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 -108.63 98.69 8.16 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.965 1.706 . . . . 0.0 108.783 169.289 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 61.35 -114.81 7.07 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 124.176 0.893 . . . . 0.0 111.402 -174.506 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 58.6 p -107.01 27.43 9.0 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 127.337 2.255 . . . . 0.0 114.045 174.623 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -137.95 174.27 10.74 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 126.726 2.01 . . . . 0.0 111.219 172.012 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 9.1 t -97.17 166.68 11.46 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.746 1.218 . . . . 0.0 111.435 172.526 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.55 118.57 8.23 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.337 1.455 . . . . 0.0 108.633 173.116 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 73.9 m -84.48 129.57 34.84 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -178.272 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -99.72 -139.32 10.75 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 127.407 2.432 . . . . 0.0 113.941 -175.61 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.6 m -72.8 154.78 91.1 Favored Pre-proline 0 N--CA 1.473 0.722 0 C-N-CA 125.051 1.34 . . . . 0.0 113.398 176.587 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo . . . . . 0 CA--C 1.532 0.4 0 C-N-CA 124.28 3.32 . . . . 0.0 114.031 -178.078 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 . . . . . 0 CA--C 1.539 0.537 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 56.44 28.52 13.78 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.811 1.245 . . . . 0.0 113.662 -177.264 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 71.51 -5.14 11.34 Favored Glycine 0 CA--C 1.541 1.691 0 N-CA-C 115.411 0.924 . . . . 0.0 115.411 -174.306 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 74.4 m -79.46 135.0 36.54 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.705 1.202 . . . . 0.0 112.792 -178.48 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -148.08 134.97 20.12 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.214 1.006 . . . . 0.0 111.104 167.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 47.66 49.08 16.75 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.09 1.356 . . . . 0.0 113.65 179.224 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 65.96 10.93 7.35 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 127.436 2.294 . . . . 0.0 116.513 -176.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.9 t -126.06 147.95 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 124.951 1.3 . . . . 0.0 112.288 -176.641 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -78.72 40.64 0.39 Allowed 'General case' 0 CA--C 1.558 1.264 0 C-N-CA 127.234 2.214 . . . . 0.0 113.708 176.029 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.5 m -70.86 -23.39 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 C-N-CA 125.777 1.631 . . . . 0.0 115.325 -172.683 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -109.05 -8.81 15.12 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.696 1.198 . . . . 0.0 112.984 173.718 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 158.09 169.33 21.55 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 125.452 1.501 . . . . 0.0 112.435 174.025 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -89.19 144.93 25.75 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.157 0.983 . . . . 0.0 112.706 177.27 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 42.4 t -92.65 -15.23 27.05 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.455 0.702 . . . . 0.0 112.375 170.299 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -53.29 -35.39 60.05 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 120.679 -1.263 . . . . 0.0 111.709 177.497 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 11.9 mtp-105 -55.77 -43.31 76.6 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 115.071 1.508 . . . . 0.0 115.071 169.776 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 62.4 t60 -67.83 -40.04 83.83 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 119.845 1.202 . . . . 0.0 112.302 177.593 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 93.0 m -75.61 -32.28 60.22 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 123.54 0.736 . . . . 0.0 112.443 177.335 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.437 ' O ' ' HE2' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -62.01 -30.4 70.93 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 127.132 2.173 . . . . 0.0 112.168 174.825 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.19 -24.89 67.47 Favored 'General case' 0 CA--C 1.549 0.918 0 O-C-N 121.554 -0.716 . . . . 0.0 112.534 173.453 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -107.95 18.88 20.73 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.416 1.886 . . . . 0.0 113.597 168.589 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 60.66 26.32 16.05 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 126.114 1.765 . . . . 0.0 115.724 177.286 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.6 mttp -110.22 162.12 14.91 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 127.653 2.381 . . . . 0.0 113.272 175.028 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -76.39 153.2 35.93 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.96 0.904 . . . . 0.0 110.1 166.068 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -125.49 142.66 13.94 Favored Glycine 0 N--CA 1.475 1.276 0 C-N-CA 125.726 1.631 . . . . 0.0 113.506 173.733 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.93 133.09 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 124.883 1.273 . . . . 0.0 111.322 -170.307 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 74.5 m -75.07 114.82 14.0 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.132 0.492 . . . . 0.0 111.677 -179.305 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 7.6 m-70 -107.76 100.98 10.31 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.726 2.01 . . . . 0.0 109.134 172.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 64.19 -115.62 8.11 Favored Glycine 0 CA--C 1.527 0.844 0 C-N-CA 124.839 1.209 . . . . 0.0 112.055 -177.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 75.9 p -105.38 15.76 26.7 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.97 1.308 . . . . 0.0 112.586 178.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -141.35 -171.09 3.22 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 128.651 2.78 . . . . 0.0 110.47 -175.064 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 52.7 t -134.71 158.08 45.05 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 114.282 1.215 . . . . 0.0 114.282 -176.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 68.6 mttt -136.19 149.86 48.77 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 129.49 3.116 . . . . 0.0 107.908 169.59 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 78.3 m -89.81 152.8 21.11 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 121.626 0.727 . . . . 0.0 112.073 170.461 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -107.71 -112.82 3.66 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 126.205 1.859 . . . . 0.0 114.124 -172.356 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.9 m -104.9 157.35 34.39 Favored Pre-proline 0 N--CA 1.475 0.788 0 C-N-CA 126.522 1.929 . . . . 0.0 113.155 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo . . . . . 0 CA--C 1.537 0.645 0 C-N-CA 124.083 3.188 . . . . 0.0 111.413 173.725 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 . . . . . 0 N--CA 1.473 0.715 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 55.71 24.81 7.56 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.301 1.44 . . . . 0.0 114.132 -175.389 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 72.93 -4.69 21.81 Favored Glycine 0 CA--C 1.542 1.723 0 O-C-N 121.23 -0.919 . . . . 0.0 115.226 -171.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 88.0 m -84.33 142.62 30.06 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.057 1.343 . . . . 0.0 112.644 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -153.29 140.94 19.94 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.289 1.035 . . . . 0.0 110.278 167.119 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 46.51 47.58 14.22 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.201 1.4 . . . . 0.0 113.543 178.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 21.6 m-20 64.52 17.4 10.83 Favored 'General case' 0 CA--C 1.551 0.985 0 N-CA-C 116.132 1.901 . . . . 0.0 116.132 -177.708 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 40.7 t -132.81 148.19 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.57 1.148 . . . . 0.0 112.498 -176.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -73.15 37.52 0.08 Allowed 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 128.055 2.542 . . . . 0.0 114.092 173.717 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -63.76 -33.38 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 O-C-N 120.28 -1.513 . . . . 0.0 114.293 -171.423 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -104.53 -19.92 13.85 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.426 1.091 . . . . 0.0 113.725 178.444 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 173.5 177.06 42.45 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 124.951 1.262 . . . . 0.0 112.491 174.317 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -87.18 158.13 19.2 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 117.737 0.768 . . . . 0.0 111.987 174.169 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.6 p -120.61 -5.31 9.75 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 170.333 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -61.16 -31.72 71.45 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 117.519 -1.229 . . . . 0.0 112.025 177.556 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 47.6 mtm180 -58.32 -38.94 78.11 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-N 120.458 1.481 . . . . 0.0 113.622 170.617 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 18.6 t60 -65.2 -38.83 91.7 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 119.261 0.937 . . . . 0.0 112.628 174.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 97.3 m -72.89 -33.0 65.77 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 118.801 0.728 . . . . 0.0 112.727 171.117 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -66.34 -27.62 68.03 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 120.322 -1.486 . . . . 0.0 111.848 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.65 -5.63 16.65 Favored 'General case' 0 CA--C 1.551 1.008 0 N-CA-C 114.044 1.127 . . . . 0.0 114.044 169.537 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -121.86 19.21 10.98 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 127.583 2.353 . . . . 0.0 112.017 171.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 61.46 29.52 18.46 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.277 1.431 . . . . 0.0 113.518 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.3 mmtp -124.01 153.55 41.15 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 128.222 2.609 . . . . 0.0 112.538 -175.273 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -78.53 158.52 28.54 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.282 1.033 . . . . 0.0 108.361 166.255 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -138.7 145.66 17.11 Favored Glycine 0 N--CA 1.476 1.328 0 C-N-CA 124.943 1.259 . . . . 0.0 114.745 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -147.37 147.63 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 126.077 1.751 . . . . 0.0 110.882 -172.309 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 71.1 m -77.51 116.94 18.48 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 113.731 1.012 . . . . 0.0 113.731 -174.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -109.03 103.59 12.65 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.477 1.511 . . . . 0.0 108.562 168.326 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 66.34 -114.86 6.86 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 124.142 0.877 . . . . 0.0 111.85 -176.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 69.8 p -107.22 22.04 16.6 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.993 1.717 . . . . 0.0 112.384 175.123 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 37.0 mmtm -139.67 170.33 16.09 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.42 1.888 . . . . 0.0 112.29 -172.539 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 16.7 t -109.49 133.22 53.34 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.347 1.059 . . . . 0.0 112.576 -178.009 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.8 tptt -118.71 129.4 55.25 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 126.615 1.966 . . . . 0.0 107.137 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 68.6 m -86.46 145.4 26.84 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.39 -125.8 5.14 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 127.161 2.315 . . . . 0.0 113.752 -172.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 28.9 m -84.08 160.45 57.63 Favored Pre-proline 0 N--CA 1.471 0.583 0 C-N-CA 124.993 1.317 . . . . 0.0 113.242 177.658 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo . . . . . 0 CA--C 1.538 0.717 0 C-N-CA 124.426 3.418 . . . . 0.0 113.564 168.082 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 . . . . . 0 N--CA 1.472 0.658 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 59.04 19.0 6.81 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.423 1.489 . . . . 0.0 114.62 -171.08 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 73.86 -0.29 52.15 Favored Glycine 0 CA--C 1.552 2.38 0 N-CA-C 115.803 1.081 . . . . 0.0 115.803 -168.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 97.8 m -81.81 137.47 35.29 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 120.84 -1.388 . . . . 0.0 113.095 178.327 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -151.12 134.32 16.04 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.247 1.019 . . . . 0.0 111.337 166.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 48.74 51.71 15.28 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.814 1.646 . . . . 0.0 113.736 -178.107 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 61.12 13.82 5.0 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 126.905 2.082 . . . . 0.0 116.398 -175.095 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.4 t -127.26 144.72 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-N 119.683 1.129 . . . . 0.0 111.663 -177.617 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -72.8 31.83 0.06 Allowed 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.595 1.558 . . . . 0.0 114.493 175.6 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -53.71 -32.08 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 O-C-N 120.327 -1.483 . . . . 0.0 114.601 -171.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -106.0 -6.96 18.37 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 177.572 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 167.37 150.83 6.65 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-N 119.599 1.09 . . . . 0.0 114.547 169.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -71.55 108.92 5.18 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.603 1.161 . . . . 0.0 113.777 -174.662 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -69.37 -29.91 67.8 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.787 2.035 . . . . 0.0 113.034 176.528 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.66 -34.11 67.03 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 120.745 -1.222 . . . . 0.0 112.132 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.3 mtm180 -60.74 -36.29 78.52 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 175.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 51.7 t60 -64.43 -39.71 94.35 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.885 0.874 . . . . 0.0 111.381 176.339 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 80.6 m -79.36 -32.73 43.28 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.246 0.619 . . . . 0.0 112.474 175.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.92 -31.25 71.55 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 120.503 -1.373 . . . . 0.0 111.697 173.003 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.5 -9.21 40.14 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.495 1.118 . . . . 0.0 113.832 171.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -116.91 12.5 14.71 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.298 1.839 . . . . 0.0 112.096 169.44 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 49.99 46.4 24.43 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.587 1.955 . . . . 0.0 113.587 -171.57 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.4 mmtt -122.21 162.4 21.46 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 127.33 2.252 . . . . 0.0 112.223 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -76.62 145.54 38.81 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.081 0.952 . . . . 0.0 109.305 167.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -133.13 138.05 9.83 Favored Glycine 0 N--CA 1.472 1.086 0 C-N-CA 124.501 1.048 . . . . 0.0 114.643 -179.131 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -149.81 141.74 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 125.368 1.467 . . . . 0.0 110.538 -172.075 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 84.0 m -78.55 116.83 19.2 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -179.519 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 -98.62 94.06 6.46 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.754 1.622 . . . . 0.0 109.466 168.718 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 63.24 -96.14 0.16 Allowed Glycine 0 CA--C 1.529 0.924 0 C-N-CA 125.188 1.375 . . . . 0.0 111.323 -176.724 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.7 p -118.58 14.97 13.68 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 127.52 2.328 . . . . 0.0 113.874 -173.108 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -138.58 168.6 19.44 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 127.25 2.22 . . . . 0.0 112.683 174.22 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 28.9 t -98.09 141.81 30.57 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.415 1.486 . . . . 0.0 110.733 171.28 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -128.87 120.56 26.45 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.081 1.352 . . . . 0.0 109.238 179.005 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 60.9 m -87.32 128.77 35.17 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.153 0.798 . . . . 0.0 113.153 -177.043 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -99.12 -126.82 5.75 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 126.522 2.01 . . . . 0.0 114.238 -169.533 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 16.8 m -75.9 152.74 84.77 Favored Pre-proline 0 N--CA 1.473 0.694 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 177.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo . . . . . 0 CA--C 1.535 0.574 0 C-N-CA 124.158 3.239 . . . . 0.0 110.987 174.137 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 . . . . . 0 N--CA 1.477 0.892 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 56.27 12.05 0.92 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.268 1.827 . . . . 0.0 115.471 -177.364 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.53 0.73 84.95 Favored Glycine 0 CA--C 1.541 1.712 0 N-CA-C 115.401 0.92 . . . . 0.0 115.401 -169.559 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 89.0 m -85.15 139.81 31.41 Favored 'General case' 0 C--O 1.236 0.39 0 O-C-N 121.037 -1.272 . . . . 0.0 112.421 178.509 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -151.12 131.01 13.28 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 167.475 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 44.49 55.0 6.02 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.43 1.892 . . . . 0.0 112.994 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 56.0 m-80 64.01 16.48 9.96 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 127.003 2.121 . . . . 0.0 116.173 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 19.8 t -124.93 147.45 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 O-C-N 120.935 -1.103 . . . . 0.0 111.396 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.85 37.4 0.18 Allowed 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 127.414 2.286 . . . . 0.0 112.493 176.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -68.32 -45.36 82.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 -168.369 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 25.4 mmmt -101.92 -14.24 17.29 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 -169.312 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 171.98 168.95 34.17 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-N 119.376 0.989 . . . . 0.0 115.19 174.467 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -87.5 81.3 7.82 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.02 1.728 . . . . 0.0 113.398 -171.078 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -46.28 -26.95 0.9 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 127.066 2.146 . . . . 0.0 113.831 171.281 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -32.37 -48.82 0.19 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.79 2.036 . . . . 0.0 112.485 166.447 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 55.2 mtm180 -66.57 -36.73 83.35 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 -171.588 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 15.7 t60 -68.64 -33.46 74.06 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-N 120.081 1.309 . . . . 0.0 112.3 176.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 71.5 m -80.76 -39.17 27.33 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 121.588 -0.695 . . . . 0.0 111.488 175.303 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -62.19 -32.8 73.49 Favored 'General case' 0 CA--C 1.53 0.206 0 O-C-N 120.54 -1.35 . . . . 0.0 112.072 177.403 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.1 -22.35 50.31 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.433 1.093 . . . . 0.0 113.595 174.76 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -121.27 23.04 10.65 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.874 1.669 . . . . 0.0 111.807 177.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 31.3 t0 56.57 55.79 6.14 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.957 1.703 . . . . 0.0 112.728 177.55 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm -138.77 151.62 47.24 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 127.647 2.379 . . . . 0.0 111.805 177.588 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -72.35 145.0 48.05 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 166.413 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -118.08 134.71 11.18 Favored Glycine 0 N--CA 1.469 0.846 0 C-N-CA 124.076 0.846 . . . . 0.0 112.607 175.172 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -144.07 140.18 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 125.201 1.401 . . . . 0.0 110.35 -177.572 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 99.9 m -78.68 114.82 17.92 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -174.687 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -107.63 103.06 12.27 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 126.879 2.072 . . . . 0.0 108.64 173.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 61.83 -116.59 9.57 Favored Glycine 0 CA--C 1.532 1.099 0 N-CA-C 111.109 -0.797 . . . . 0.0 111.109 -173.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 76.0 p -101.21 14.32 32.34 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 125.333 1.453 . . . . 0.0 114.128 175.01 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -127.69 165.13 20.61 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.989 1.715 . . . . 0.0 112.503 -173.642 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 46.8 t -104.45 121.41 43.37 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.382 1.073 . . . . 0.0 110.405 177.404 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 48.7 tptt -97.08 120.86 38.23 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 126.746 2.018 . . . . 0.0 106.693 177.326 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 59.5 m -84.85 137.9 32.88 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 123.612 0.57 . . . . 0.0 111.617 171.672 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -119.64 -124.96 3.29 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 126.158 1.837 . . . . 0.0 114.526 -169.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 15.3 m -83.59 157.54 64.21 Favored Pre-proline 0 N--CA 1.47 0.562 0 C-N-CA 125.966 1.706 . . . . 0.0 113.585 -179.084 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo . . . . . 0 CA--C 1.537 0.649 0 C-N-CA 123.862 3.041 . . . . 0.0 114.44 -178.035 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 . . . . . 0 N--CA 1.476 0.875 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 54.15 19.45 2.14 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 126.193 1.797 . . . . 0.0 114.24 -172.268 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 76.34 -2.98 55.51 Favored Glycine 0 CA--C 1.542 1.721 0 C-N-CA 124.955 1.264 . . . . 0.0 115.692 -170.506 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 78.4 m -77.28 134.89 38.43 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.689 1.196 . . . . 0.0 112.132 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -146.14 136.28 23.69 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.655 0.782 . . . . 0.0 111.575 168.774 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 44.83 49.3 9.05 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.264 1.425 . . . . 0.0 112.744 -176.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 63.61 26.03 14.52 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 126.742 2.017 . . . . 0.0 115.023 175.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 49.7 t -136.97 145.99 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 125.996 1.718 . . . . 0.0 111.027 178.78 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -75.69 49.31 0.5 Allowed 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 126.041 1.736 . . . . 0.0 113.645 174.254 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -71.44 -51.53 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 O-C-N 120.166 -1.584 . . . . 0.0 113.894 -173.656 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -91.16 -9.19 46.36 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.02 0.928 . . . . 0.0 113.249 -172.662 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 176.01 172.98 41.29 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 126.512 2.006 . . . . 0.0 111.048 169.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -94.06 144.41 25.5 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 179.385 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 44.0 t -100.52 -10.66 20.83 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.144 0.977 . . . . 0.0 112.236 169.393 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -51.19 -43.23 61.3 Favored 'General case' 0 N--CA 1.466 0.337 0 O-C-N 120.799 -1.188 . . . . 0.0 111.663 178.291 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.5 mtm180 -56.39 -41.83 76.9 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 175.716 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 11.7 t60 -61.47 -46.76 88.67 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.621 0.768 . . . . 0.0 111.156 177.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 92.2 m -80.12 -29.2 38.91 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -178.383 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 23.8 tptp -67.71 -22.95 65.23 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 120.764 -1.21 . . . . 0.0 113.008 175.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.18 -27.26 69.24 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 118.793 0.724 . . . . 0.0 112.305 168.787 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -101.95 7.78 41.29 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 126.952 2.101 . . . . 0.0 111.984 171.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . 0.28 1.8 t70 54.63 33.61 19.62 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 129.1 2.96 . . . . 0.0 115.8 -175.576 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 28.9 mttt -109.66 163.22 13.68 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 127.603 2.361 . . . . 0.0 113.168 174.353 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -69.89 144.05 52.59 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.202 1.401 . . . . 0.0 109.18 167.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -95.45 151.72 20.11 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 123.875 0.75 . . . . 0.0 112.371 169.152 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.41 117.96 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 118.686 1.243 . . . . 0.0 110.777 -178.669 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 98.4 m -82.06 108.42 15.53 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.294 171.679 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 27.6 p80 -104.91 8.55 34.65 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 176.144 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 170.76 -134.45 3.13 Favored Glycine 0 CA--C 1.523 0.566 0 C-N-CA 123.83 0.729 . . . . 0.0 111.93 179.266 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 42.6 p -82.04 13.95 3.09 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 126.663 1.985 . . . . 0.0 112.289 168.496 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -149.22 170.37 18.63 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 128.978 2.911 . . . . 0.0 109.413 -172.745 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 14.9 t -128.76 173.68 10.12 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.022 1.329 . . . . 0.0 113.255 -176.431 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.0 mtpt -155.74 169.32 24.64 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 130.097 3.359 . . . . 0.0 107.244 178.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 59.8 m -104.27 148.81 25.92 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.87 0.868 . . . . 0.0 112.365 168.223 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -98.19 -119.9 4.11 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 126.985 2.231 . . . . 0.0 112.589 -177.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 19.5 m -100.59 159.03 30.77 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 126.499 1.92 . . . . 0.0 112.765 175.141 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo . . . . . 0 CA--C 1.542 0.901 0 C-N-CA 124.997 3.798 . . . . 0.0 113.912 168.5 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 . . . . . 0 CA--C 1.542 0.652 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 56.61 17.78 3.26 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.468 1.907 . . . . 0.0 114.581 -177.156 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 84.11 -9.32 63.9 Favored Glycine 0 CA--C 1.538 1.506 0 C-N-CA 124.771 1.176 . . . . 0.0 115.135 -170.72 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 92.7 m -80.35 139.33 36.62 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.436 1.094 . . . . 0.0 113.05 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -152.35 134.35 14.9 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.666 0.786 . . . . 0.0 110.61 168.2 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 49.6 49.32 20.18 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.675 1.19 . . . . 0.0 113.996 178.22 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 60.32 21.11 10.61 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 126.32 1.848 . . . . 0.0 115.547 -178.112 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 69.4 t -132.08 149.37 32.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 125.523 1.529 . . . . 0.0 110.035 -178.345 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.39 39.0 0.19 Allowed 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 126.806 2.043 . . . . 0.0 111.749 178.801 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -58.67 -44.5 89.92 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 N-CA-C 115.243 1.571 . . . . 0.0 115.243 -165.825 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -91.98 -26.44 18.38 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.954 0.902 . . . . 0.0 111.469 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 173.14 173.99 39.91 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 125.843 1.687 . . . . 0.0 112.959 178.112 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -84.3 142.81 29.95 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.065 0.946 . . . . 0.0 112.957 175.744 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.7 p -102.18 -0.03 33.84 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.786 1.234 . . . . 0.0 114.151 174.01 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.4 tmmm? -53.36 -45.1 69.04 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 118.138 -0.934 . . . . 0.0 111.136 173.629 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 44.4 mtm180 -60.63 -37.21 80.72 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.543 1.065 . . . . 0.0 113.261 -176.634 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 10.7 t60 -61.76 -46.57 89.0 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.272 1.029 . . . . 0.0 112.313 173.461 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 84.9 m -72.95 -31.29 64.48 Favored 'General case' 0 CA--C 1.545 0.783 0 O-C-N 121.187 -0.946 . . . . 0.0 112.308 176.347 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 41.3 tptt -65.24 -21.59 66.76 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 126.023 1.729 . . . . 0.0 112.764 177.201 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.86 -17.63 17.56 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.755 0.822 . . . . 0.0 112.765 168.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -123.56 15.25 9.54 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 126.766 2.027 . . . . 0.0 112.699 172.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 22.5 t70 65.04 14.85 9.64 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 128.395 2.678 . . . . 0.0 115.387 -175.642 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.3 mmtp -84.17 149.38 26.2 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 126.526 1.93 . . . . 0.0 111.637 178.04 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -71.37 137.32 48.29 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 124.245 1.018 . . . . 0.0 108.559 167.715 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -110.76 128.89 8.99 Favored Glycine 0 N--CA 1.471 1.013 0 C-N-CA 123.907 0.765 . . . . 0.0 111.927 173.731 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.37 143.07 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 124.501 1.12 . . . . 0.0 111.152 -177.513 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 77.7 m -79.13 115.13 18.6 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -174.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 27.7 m-70 -112.22 104.17 12.35 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.36 1.464 . . . . 0.0 108.568 168.132 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.79 -122.79 23.06 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 124.226 0.917 . . . . 0.0 111.933 -173.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 40.1 p -101.7 21.34 14.61 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 127.054 2.141 . . . . 0.0 113.088 178.581 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -139.15 163.21 33.04 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 126.137 1.775 . . . . 0.0 112.169 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 6.4 t -86.05 157.41 20.08 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.429 168.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 6.0 tmtm? -131.65 126.35 34.44 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 168.764 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 79.4 m -83.88 130.53 34.91 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 120.805 0.335 . . . . 0.0 110.849 173.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -97.97 -131.6 7.2 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 125.468 1.508 . . . . 0.0 113.502 -171.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 28.9 m -87.31 168.2 18.44 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 125.054 1.341 . . . . 0.0 109.983 168.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo . . . . . 0 CA--C 1.542 0.88 0 C-N-CA 123.854 3.036 . . . . 0.0 113.301 169.293 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 . . . . . 0 N--CA 1.47 0.557 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 59.71 5.19 0.65 Allowed 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 115.853 1.797 . . . . 0.0 115.853 -175.625 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 92.13 -3.62 76.81 Favored Glycine 0 CA--C 1.542 1.752 0 C-N-CA 125.401 1.477 . . . . 0.0 114.657 -168.253 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 96.3 m -78.7 136.82 37.53 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -154.63 141.49 19.14 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.401 1.08 . . . . 0.0 111.316 165.653 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 51.53 40.48 27.05 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.961 1.304 . . . . 0.0 114.391 177.597 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 24.7 m-20 64.62 21.11 12.35 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 126.504 1.922 . . . . 0.0 115.917 -174.159 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 40.4 t -134.42 147.08 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 125.164 1.386 . . . . 0.0 112.458 -176.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -76.94 53.32 0.93 Allowed 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 127.029 2.132 . . . . 0.0 112.113 173.318 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -80.4 -36.43 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 124.929 1.292 . . . . 0.0 114.239 -174.443 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -96.98 -3.65 41.23 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.47 1.108 . . . . 0.0 112.995 177.189 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 159.47 170.18 23.72 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 125.769 1.652 . . . . 0.0 113.049 172.237 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -87.35 107.98 18.77 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.332 1.053 . . . . 0.0 113.398 -176.415 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -62.06 -26.14 68.09 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.751 1.621 . . . . 0.0 112.356 174.644 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -43.71 -44.69 6.69 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.278 1.431 . . . . 0.0 110.416 167.666 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 8.7 ttm180 -64.14 -26.24 68.44 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 115.058 1.503 . . . . 0.0 115.058 -178.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 67.4 t60 -77.05 -42.73 37.24 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 120.596 -1.315 . . . . 0.0 111.428 171.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 92.2 m -70.84 -29.43 65.56 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 121.817 -0.552 . . . . 0.0 111.91 175.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 51.7 tptt -68.54 -27.1 65.79 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.726 2.01 . . . . 0.0 114.16 177.484 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.17 -16.16 61.34 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.615 0.766 . . . . 0.0 112.783 169.423 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -110.8 4.28 19.75 Favored 'General case' 0 CA--C 1.556 1.205 0 C-N-CA 127.296 2.238 . . . . 0.0 112.018 170.483 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . 0.287 3.7 t70 59.61 37.6 22.48 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 129.258 3.023 . . . . 0.0 115.211 -173.804 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.4 mttp -116.12 160.29 20.55 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.868 2.067 . . . . 0.0 115.145 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -66.69 144.4 56.39 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.209 1.403 . . . . 0.0 109.003 167.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -131.1 136.1 8.62 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 125.043 1.306 . . . . 0.0 115.297 178.742 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -138.55 138.27 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 124.171 0.988 . . . . 0.0 112.057 -179.367 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 90.9 m -77.28 104.7 7.94 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.872 0.869 . . . . 0.0 113.123 -178.344 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 27.5 m-70 -90.77 92.52 8.84 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 123.662 0.785 . . . . 0.0 109.004 167.728 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.9 -116.57 6.91 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 124.628 1.108 . . . . 0.0 112.417 -172.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 63.4 p -99.95 11.8 38.39 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.965 1.706 . . . . 0.0 113.993 177.492 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -129.97 160.19 34.38 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.208 1.403 . . . . 0.0 111.541 178.739 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 34.6 t -98.32 147.52 24.59 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.976 1.31 . . . . 0.0 110.647 179.638 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 30.9 ttmt -141.53 124.76 16.44 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 125.073 1.349 . . . . 0.0 108.191 -178.129 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 19.4 m -89.15 144.64 25.97 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -171.838 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -107.08 -131.01 6.58 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 126.569 2.033 . . . . 0.0 113.212 -175.823 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.6 m -73.42 158.96 85.86 Favored Pre-proline 0 N--CA 1.473 0.692 0 C-N-CA 124.209 1.003 . . . . 0.0 113.668 172.351 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo . . . . . 0 CA--C 1.535 0.526 0 C-N-CA 123.503 2.802 . . . . 0.0 111.248 171.696 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 . . . . . 0 C--O 1.224 -0.245 0 CA-C-O 121.506 0.67 . . . . 0.0 111.477 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 61.26 -2.22 0.24 Allowed 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.583 1.553 . . . . 0.0 114.7 -174.252 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 96.18 -9.1 67.53 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 125.489 1.519 . . . . 0.0 113.831 -169.036 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 70.9 m -89.46 141.6 28.42 Favored 'General case' 0 C--O 1.236 0.354 0 O-C-N 121.511 -0.994 . . . . 0.0 113.469 -175.652 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -154.38 139.83 17.76 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.173 0.989 . . . . 0.0 109.93 165.613 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 51.55 44.7 28.92 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.788 1.235 . . . . 0.0 114.189 177.006 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 60.51 17.34 7.23 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 126.223 1.809 . . . . 0.0 115.602 -174.325 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 41.6 t -126.75 148.05 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.865 1.266 . . . . 0.0 111.881 -177.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -76.0 40.37 0.2 Allowed 'General case' 0 CA--C 1.558 1.271 0 C-N-CA 128.686 2.794 . . . . 0.0 111.947 177.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -74.89 -54.53 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 C-N-CA 126.105 1.762 . . . . 0.0 113.544 -170.02 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -78.71 -7.46 57.75 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.106 1.363 . . . . 0.0 112.545 -172.226 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 162.1 -171.09 37.92 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 125.863 1.697 . . . . 0.0 111.482 175.1 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -95.75 120.95 36.92 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -176.173 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.5 t -77.59 -20.17 54.42 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.667 1.187 . . . . 0.0 112.636 170.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 8.8 tppt? -44.92 -50.78 10.3 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.594 1.558 . . . . 0.0 111.013 172.412 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 42.4 mtm180 -64.77 -26.64 68.44 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 115.676 1.732 . . . . 0.0 115.676 -173.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 59.6 t60 -72.81 -37.06 67.64 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 119.272 0.942 . . . . 0.0 112.032 174.679 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 93.0 m -84.88 -29.72 25.01 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.437 0.695 . . . . 0.0 112.863 177.216 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.76 -29.12 66.52 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 126.138 1.775 . . . . 0.0 112.317 171.533 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.99 -19.77 54.13 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.5 1.12 . . . . 0.0 113.859 171.016 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -114.38 9.34 16.84 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 127.192 2.197 . . . . 0.0 111.789 176.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.4 t70 57.18 38.96 29.14 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 126.815 2.046 . . . . 0.0 113.594 -171.586 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.9 mmtp -119.23 156.85 29.16 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 128.175 2.59 . . . . 0.0 112.073 -176.499 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -76.68 147.71 37.27 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 124.199 0.999 . . . . 0.0 109.643 168.497 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.16 154.56 19.11 Favored Glycine 0 CA--C 1.542 1.755 0 C-N-CA 125.059 1.314 . . . . 0.0 114.247 173.662 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -151.67 136.87 10.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 125.954 1.701 . . . . 0.0 110.211 175.254 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 93.9 m -84.18 118.02 23.87 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -174.677 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -101.96 91.4 4.34 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.347 1.859 . . . . 0.0 108.956 168.607 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 64.71 -118.7 13.01 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.392 0.996 . . . . 0.0 112.112 -176.27 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 54.2 p -89.84 11.63 19.66 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 126.633 1.973 . . . . 0.0 113.846 174.523 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm -131.08 166.57 20.77 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 126.306 1.843 . . . . 0.0 112.14 -171.764 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 47.3 t -121.47 135.2 55.06 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.452 1.501 . . . . 0.0 111.26 -175.667 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 12.4 tptt -123.16 153.65 39.74 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 128.762 2.825 . . . . 0.0 107.776 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 63.9 m -111.93 127.64 55.92 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 113.707 1.002 . . . . 0.0 113.707 -173.182 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -87.39 -130.7 3.17 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 126.518 2.009 . . . . 0.0 113.95 -176.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 25.4 m -80.57 161.1 65.52 Favored Pre-proline 0 CA--C 1.532 0.285 0 C-N-CA 125.726 1.611 . . . . 0.0 112.711 176.354 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo . . . . . 0 CA--C 1.537 0.626 0 C-N-CA 123.992 3.128 . . . . 0.0 112.411 168.077 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 . . . . . 0 N--CA 1.474 0.737 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 54.54 20.11 2.7 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.111 1.365 . . . . 0.0 114.024 -169.46 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 71.58 0.11 37.77 Favored Glycine 0 CA--C 1.534 1.279 0 O-C-N 120.684 -1.26 . . . . 0.0 115.04 -177.261 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 72.8 m -88.29 136.82 32.8 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.984 0.913 . . . . 0.0 112.847 -175.118 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -150.4 139.09 20.72 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.253 1.021 . . . . 0.0 111.263 166.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 48.65 48.34 19.89 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.145 1.378 . . . . 0.0 113.64 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 47.8 m-20 65.48 12.97 8.57 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 126.164 1.786 . . . . 0.0 115.668 -177.287 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.9 t -130.34 146.4 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 124.615 1.166 . . . . 0.0 112.002 -175.371 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -74.24 43.23 0.17 Allowed 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 127.422 2.289 . . . . 0.0 113.951 172.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -69.56 -39.22 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 O-C-N 120.892 -1.13 . . . . 0.0 113.689 -174.329 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -92.66 -19.18 22.11 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -174.749 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 176.5 -150.06 10.2 Favored Glycine 0 CA--C 1.534 1.278 0 N-CA-C 115.882 1.113 . . . . 0.0 115.882 178.259 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -105.65 135.21 47.48 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.572 1.549 . . . . 0.0 113.961 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -109.47 -24.06 11.2 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 129.049 2.94 . . . . 0.0 110.633 170.248 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 12.9 tppt? -40.15 -52.6 2.56 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 126.083 1.753 . . . . 0.0 111.975 169.321 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 60.5 mtm180 -61.8 -30.54 70.88 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 114.527 1.306 . . . . 0.0 114.527 -174.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 68.7 t60 -69.55 -44.08 71.64 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 118.99 0.814 . . . . 0.0 111.62 175.075 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 91.4 m -78.09 -30.65 49.66 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 179.226 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 49.8 tptt -65.8 -20.75 66.37 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.441 1.896 . . . . 0.0 113.387 176.595 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.65 -29.99 70.15 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.906 0.882 . . . . 0.0 111.929 169.012 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 -91.22 6.35 45.48 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 126.166 1.786 . . . . 0.0 111.674 168.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.6 t70 52.8 36.68 22.0 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 127.825 2.45 . . . . 0.0 113.999 -170.173 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.8 mttt -112.61 160.03 18.27 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.777 2.031 . . . . 0.0 113.004 178.439 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 53.4 mm-40 -67.74 142.93 56.12 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 124.62 1.168 . . . . 0.0 109.907 167.472 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -113.77 135.15 12.3 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 125.276 1.417 . . . . 0.0 113.795 175.019 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -142.35 132.73 24.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 124.463 1.105 . . . . 0.0 110.633 -170.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 84.5 m -78.2 113.93 16.61 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -173.3 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 22.4 m-70 -105.78 104.78 14.57 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.917 1.687 . . . . 0.0 108.088 169.415 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 70.84 -118.12 7.37 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 125.034 1.302 . . . . 0.0 111.322 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 63.0 p -103.83 16.27 26.74 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.455 1.502 . . . . 0.0 112.544 174.065 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 49.5 mmtm -132.45 163.84 27.88 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.169 1.788 . . . . 0.0 112.104 -173.737 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 11.0 t -87.87 156.48 19.36 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.052 0.941 . . . . 0.0 111.083 170.597 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.73 145.06 30.71 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 127.645 2.378 . . . . 0.0 105.91 170.718 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 38.4 m -98.81 143.55 29.03 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -178.476 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -98.64 -117.14 3.78 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 126.712 2.101 . . . . 0.0 113.893 -175.721 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.5 m -103.4 162.55 19.7 Favored Pre-proline 0 CA--C 1.538 0.492 0 C-N-CA 126.906 2.082 . . . . 0.0 111.78 176.378 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_exo . . . . . 0 CA--C 1.537 0.627 0 C-N-CA 124.743 3.629 . . . . 0.0 112.914 168.958 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.914 0 CA-C-O 118.198 -0.906 . . . . 0.0 110.117 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -146.69 -14.67 0.43 Allowed 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 115.984 1.846 . . . . 0.0 115.984 -178.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -77.36 -37.82 51.48 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 119.319 0.963 . . . . 0.0 112.75 175.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -137.65 -0.92 2.1 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 172.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 57.16 23.64 8.85 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.679 1.191 . . . . 0.0 114.043 -178.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 75.58 -6.18 33.02 Favored Glycine 0 CA--C 1.538 1.508 0 C-N-CA 123.93 0.776 . . . . 0.0 114.879 -173.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 84.2 m -80.96 143.87 32.27 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.088 1.355 . . . . 0.0 112.009 -179.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -151.43 142.77 23.39 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.938 0.895 . . . . 0.0 109.897 168.063 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 49.25 37.41 11.24 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 178.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 70.98 15.99 6.56 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 126.044 1.738 . . . . 0.0 115.531 -175.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 34.9 t -132.15 148.25 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 125.036 1.335 . . . . 0.0 112.396 -173.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.53 42.66 0.17 Allowed 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 127.455 2.302 . . . . 0.0 113.096 174.046 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -67.42 -51.27 54.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 O-C-N 120.048 -1.657 . . . . 0.0 112.579 -173.438 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 27.3 mtpt -90.07 -21.81 22.13 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -175.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 179.31 -176.9 48.11 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 125.294 1.426 . . . . 0.0 112.724 174.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -95.27 151.2 19.45 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.843 1.257 . . . . 0.0 112.822 176.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 40.4 t -98.26 -12.28 21.76 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.423 1.089 . . . . 0.0 111.387 167.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -53.69 -36.04 61.76 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 120.663 -1.273 . . . . 0.0 112.174 -178.098 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -63.06 -30.26 71.46 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 115.423 1.638 . . . . 0.0 115.423 174.108 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 56.4 t60 -75.41 -43.27 50.89 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 119.574 1.079 . . . . 0.0 111.614 172.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 93.2 m -80.76 -27.38 36.78 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -177.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.3 -31.08 71.64 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 120.28 -1.512 . . . . 0.0 111.705 173.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.91 -18.95 64.94 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.237 1.015 . . . . 0.0 113.397 171.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -97.25 6.14 48.87 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 126.799 2.039 . . . . 0.0 111.065 169.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.4 t0 54.19 32.51 16.11 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 127.702 2.401 . . . . 0.0 114.488 -169.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.4 mttp -119.24 161.48 20.32 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 126.901 2.08 . . . . 0.0 113.934 -173.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -70.99 146.44 49.42 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 167.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -108.3 139.61 15.19 Favored Glycine 0 N--CA 1.472 1.078 0 C-N-CA 124.65 1.119 . . . . 0.0 111.717 169.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -144.73 126.12 8.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 118.219 1.01 . . . . 0.0 112.022 -177.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 87.8 m -73.69 111.85 9.22 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.825 0.85 . . . . 0.0 112.671 -176.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 38.7 m-70 -108.62 102.92 11.94 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.009 1.323 . . . . 0.0 109.383 169.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.59 -123.86 14.4 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 125.67 1.605 . . . . 0.0 112.934 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 61.2 p -97.05 14.89 24.1 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 126.856 2.062 . . . . 0.0 113.038 175.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -136.28 -173.87 3.52 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 128.938 2.895 . . . . 0.0 111.185 179.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 41.8 t -132.05 161.39 33.33 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.931 1.292 . . . . 0.0 111.488 177.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 67.4 mttt -133.81 142.15 47.74 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 128.503 2.721 . . . . 0.0 106.457 171.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 84.3 m -83.99 134.67 34.63 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 168.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -85.78 -141.53 6.01 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 124.935 1.255 . . . . 0.0 110.961 176.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.9 m -71.7 154.72 92.92 Favored Pre-proline 0 N--CA 1.472 0.669 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 177.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -62.47 137.24 63.59 Favored 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 123.747 2.964 . . . . 0.0 110.184 169.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.5 pp -73.33 -33.72 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 C-N-CA 123.275 0.63 . . . . 0.0 110.87 -172.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 66.3 m -74.49 130.26 39.27 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 125.936 1.694 . . . . 0.0 112.042 -174.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 28.8 p90 -149.47 145.99 27.18 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 123.92 0.888 . . . . 0.0 112.625 173.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 68.7 tp . . . . . 0 C--O 1.252 1.22 0 C-N-CA 126.586 1.955 . . . . 0.0 111.423 179.849 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.636 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -137.04 -33.27 0.77 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.885 1.674 . . . . 0.0 112.749 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 23.1 p30 -68.69 -37.88 79.9 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.46 1.504 . . . . 0.0 113.342 -176.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -88.01 3.16 49.87 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.111 1.365 . . . . 0.0 111.903 172.143 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 57.98 9.79 1.01 Allowed 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 125.43 1.492 . . . . 0.0 114.191 -170.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 86.65 -3.96 86.6 Favored Glycine 0 CA--C 1.539 1.573 0 C-N-CA 124.757 1.17 . . . . 0.0 115.685 -169.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 79.6 m -80.01 140.5 36.54 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 119.013 1.406 . . . . 0.0 112.727 -179.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -154.28 142.42 20.36 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.591 0.756 . . . . 0.0 110.49 166.023 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 51.26 37.76 19.5 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -178.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 62.59 20.78 12.24 Favored 'General case' 0 CA--C 1.548 0.904 0 N-CA-C 116.04 1.867 . . . . 0.0 116.04 -174.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 59.3 t -125.64 147.75 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 125.825 1.65 . . . . 0.0 111.355 -177.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -76.93 43.92 0.37 Allowed 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 126.326 1.85 . . . . 0.0 112.913 177.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.5 m -69.18 -56.34 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 O-C-N 120.633 -1.292 . . . . 0.0 114.163 -169.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -86.56 -11.62 51.03 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.176 0.99 . . . . 0.0 113.602 -179.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 179.71 171.8 43.07 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.67 1.128 . . . . 0.0 112.134 174.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.416 ' OD1' ' HE3' ' A' ' 18' ' ' LYS . 36.7 t70 -98.02 115.56 28.45 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.141 0.976 . . . . 0.0 112.772 -169.355 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 16.3 t -68.5 -30.72 69.61 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 121.153 -0.967 . . . . 0.0 112.762 177.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.416 ' HE3' ' OD1' ' A' ' 16' ' ' ASP . 0.0 OUTLIER -54.48 -37.25 65.04 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 117.932 -1.032 . . . . 0.0 111.716 171.763 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 24.9 ttm180 -60.39 -36.33 77.83 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 120.717 1.598 . . . . 0.0 114.788 177.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 36.2 t60 -68.61 -44.75 73.64 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 118.478 0.581 . . . . 0.0 110.968 172.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 89.0 m -76.64 -27.43 55.67 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -177.55 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.8 tppp? -60.72 -34.11 73.91 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.33 1.452 . . . . 0.0 111.51 173.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.1 -23.66 65.86 Favored 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 173.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -94.95 7.55 45.68 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.258 1.423 . . . . 0.0 112.409 170.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 51.74 40.18 27.01 Favored 'General case' 0 CA--C 1.556 1.178 0 C-N-CA 126.744 2.018 . . . . 0.0 112.745 -172.021 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 37.1 mttt -122.03 167.15 13.45 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 127.73 2.412 . . . . 0.0 112.6 178.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -83.3 155.84 23.39 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.548 1.139 . . . . 0.0 109.054 168.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -114.12 163.48 12.16 Favored Glycine 0 CA--C 1.546 1.993 0 C-N-CA 125.338 1.446 . . . . 0.0 115.502 -178.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -150.34 128.2 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 126.616 1.966 . . . . 0.0 112.077 177.054 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 69.4 m -85.32 101.64 12.72 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.654 0.781 . . . . 0.0 110.701 170.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.505 ' CD2' ' HB2' ' A' ' 36' ' ' LYS . 10.4 p80 -91.59 98.8 11.87 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 122.688 1.233 . . . . 0.0 108.983 170.307 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 66.36 -105.84 1.42 Allowed Glycine 0 CA--C 1.53 0.988 0 C-N-CA 125.065 1.317 . . . . 0.0 112.03 -174.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 52.0 p -112.78 14.22 19.88 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 126.925 2.09 . . . . 0.0 113.563 -176.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 21.2 mmmt -134.95 161.24 35.83 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.065 1.346 . . . . 0.0 110.817 177.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 52.8 t -101.32 157.14 17.01 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.649 1.18 . . . . 0.0 111.278 177.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.505 ' HB2' ' CD2' ' A' ' 31' ' ' HIS . 3.5 ttmt -147.65 169.72 19.05 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 128.341 2.656 . . . . 0.0 107.107 169.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 39.5 m -101.38 156.39 17.48 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 122.786 1.279 . . . . 0.0 113.25 172.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -105.72 -133.95 7.72 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 127.365 2.412 . . . . 0.0 110.751 175.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.8 m -78.99 156.31 77.05 Favored Pre-proline 0 CA--C 1.538 0.517 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 175.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -51.0 147.21 19.83 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 124.486 3.458 . . . . 0.0 112.598 167.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.8 pp -64.6 -27.32 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 N-CA-C 115.892 1.812 . . . . 0.0 115.892 -169.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -160.98 29.86 0.14 Allowed 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.395 1.078 . . . . 0.0 112.251 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -132.25 15.8 4.58 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 125.64 1.576 . . . . 0.0 114.347 -168.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.3 tp . . . . . 0 C--O 1.253 1.267 0 C-N-CA 126.335 1.854 . . . . 0.0 111.365 173.229 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.769 0 N-CA-C 110.515 -0.18 . . . . 0.0 110.515 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -117.05 -46.37 2.72 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.288 1.435 . . . . 0.0 112.06 177.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 36.9 p30 -156.21 -37.35 0.08 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.628 1.171 . . . . 0.0 113.915 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -121.54 3.04 10.2 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 -171.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 55.82 21.01 4.45 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.297 1.439 . . . . 0.0 114.149 -174.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 77.66 -4.67 55.76 Favored Glycine 0 CA--C 1.542 1.771 0 C-N-CA 124.031 0.824 . . . . 0.0 114.986 -171.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 94.8 m -80.59 140.0 35.99 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.134 1.374 . . . . 0.0 112.763 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -151.42 134.12 15.61 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.636 0.775 . . . . 0.0 110.788 166.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 47.01 51.33 13.02 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.851 1.26 . . . . 0.0 113.054 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 26.7 m-20 61.07 7.36 1.53 Allowed 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 117.199 2.296 . . . . 0.0 117.199 -175.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.4 t -116.58 140.11 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 O-C-N 120.648 -1.283 . . . . 0.0 111.335 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -77.74 66.74 3.49 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.883 1.273 . . . . 0.0 110.977 169.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -82.3 -41.94 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 125.227 1.411 . . . . 0.0 112.955 178.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -89.97 -16.87 28.98 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.052 0.941 . . . . 0.0 112.534 178.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 164.94 165.34 22.06 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 125.236 1.398 . . . . 0.0 112.119 172.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -78.01 140.21 39.15 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 117.95 0.875 . . . . 0.0 113.055 177.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -89.13 -23.77 22.39 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.162 1.785 . . . . 0.0 111.173 175.295 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -55.08 -32.73 62.18 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 117.759 -1.115 . . . . 0.0 113.205 176.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.81 -35.35 66.25 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 120.609 1.549 . . . . 0.0 114.48 171.239 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 40.6 t60 -75.03 -28.41 60.45 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 119.666 1.121 . . . . 0.0 112.731 176.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 86.3 m -79.54 -36.76 37.88 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.888 1.275 . . . . 0.0 112.673 173.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 70.9 tttt -59.31 -32.09 69.74 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.15 1.78 . . . . 0.0 113.157 -178.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.61 -14.83 63.28 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 114.236 1.198 . . . . 0.0 114.236 176.052 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -117.66 19.33 13.91 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.926 1.69 . . . . 0.0 112.572 175.187 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.8 t70 56.16 63.61 1.96 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.378 1.471 . . . . 0.0 111.049 -175.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm -147.77 146.52 29.22 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 126.383 1.873 . . . . 0.0 112.803 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 57.1 mm-40 -75.43 156.34 35.42 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 163.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -134.16 150.43 20.0 Favored Glycine 0 N--CA 1.473 1.147 0 O-C-N 121.019 -1.051 . . . . 0.0 113.234 178.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -150.5 143.06 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 125.069 1.348 . . . . 0.0 110.084 -173.411 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 70.7 m -80.71 117.66 21.58 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 121.248 -0.908 . . . . 0.0 112.483 -175.164 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 -107.83 97.69 7.38 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.898 1.279 . . . . 0.0 108.353 169.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.06 -114.68 4.86 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 125.213 1.387 . . . . 0.0 112.233 -172.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 72.8 p -112.89 20.6 16.27 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 127.56 2.344 . . . . 0.0 112.143 178.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 22.5 mmtm -136.25 169.33 17.81 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 128.043 2.537 . . . . 0.0 112.169 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 34.7 t -105.81 139.1 40.9 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.642 1.577 . . . . 0.0 112.481 -174.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -123.31 124.62 43.37 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 126.924 2.09 . . . . 0.0 107.605 177.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 73.4 m -83.53 141.6 31.5 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 121.936 0.874 . . . . 0.0 113.358 176.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -111.77 -145.73 10.03 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 127.522 2.486 . . . . 0.0 113.035 -178.302 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.5 m -63.44 156.07 72.15 Favored Pre-proline 0 N--CA 1.476 0.834 0 C-N-CA 124.546 1.139 . . . . 0.0 114.025 175.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -66.69 149.22 83.86 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 123.629 2.886 . . . . 0.0 113.233 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.4 pp -77.21 -8.27 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.842 0.857 . . . . 0.0 113.052 178.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.0 m -79.99 74.06 6.76 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.557 1.543 . . . . 0.0 112.093 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -81.49 -43.93 18.13 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.259 1.424 . . . . 0.0 113.628 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.3 pp . . . . . 0 C--O 1.251 1.173 0 C-N-CA 125.872 1.669 . . . . 0.0 112.995 -169.811 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.982 0 CA-C-O 119.498 -0.287 . . . . 0.0 110.305 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -131.04 -33.84 1.51 Allowed 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 114.639 1.348 . . . . 0.0 114.639 -169.169 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -137.7 -50.28 0.6 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.946 0.898 . . . . 0.0 112.943 -178.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -127.43 4.53 6.25 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 115.366 1.617 . . . . 0.0 115.366 -169.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 54.54 29.77 11.88 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.57 1.148 . . . . 0.0 112.929 -172.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.25 -5.56 6.65 Favored Glycine 0 CA--C 1.542 1.749 0 N-CA-C 116.188 1.235 . . . . 0.0 116.188 -171.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 96.5 m -80.98 138.85 36.07 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 118.791 1.295 . . . . 0.0 114.224 -177.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -152.43 141.17 20.96 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.547 0.739 . . . . 0.0 110.287 165.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 47.55 47.35 17.55 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.863 1.265 . . . . 0.0 112.914 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 24.7 m-20 57.71 20.91 6.82 Favored 'General case' 0 CA--C 1.552 1.032 0 N-CA-C 116.33 1.974 . . . . 0.0 116.33 -174.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 62.2 t -130.14 149.7 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 CA-C-N 120.673 1.579 . . . . 0.0 112.137 -177.391 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.58 53.03 0.68 Allowed 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 127.131 2.172 . . . . 0.0 111.402 174.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -76.98 -50.55 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 O-C-N 119.863 -1.773 . . . . 0.0 112.804 -174.386 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -84.11 -25.93 29.34 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.799 0.839 . . . . 0.0 112.968 -178.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -179.03 -178.55 48.33 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.108 1.337 . . . . 0.0 112.701 177.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -101.65 104.16 14.99 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 122.496 1.141 . . . . 0.0 112.842 -176.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -63.71 -32.1 73.48 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.659 1.584 . . . . 0.0 113.144 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 5.6 tmmm? -58.82 -20.89 54.5 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 117.538 -1.22 . . . . 0.0 113.106 175.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.3 tpp180 -62.18 -36.32 81.51 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 120.786 1.63 . . . . 0.0 113.4 171.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 8.3 t60 -68.73 -44.52 73.67 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.633 0.773 . . . . 0.0 111.13 173.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 72.0 m -67.0 -37.78 84.82 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 121.496 -0.752 . . . . 0.0 112.252 176.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -63.16 -30.27 71.45 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 120.988 -1.07 . . . . 0.0 112.025 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.37 -23.87 65.64 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.302 1.041 . . . . 0.0 113.298 171.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -93.3 6.27 48.68 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.388 1.475 . . . . 0.0 113.023 170.324 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . 0.267 0.3 OUTLIER 64.88 35.55 8.37 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 127.547 2.339 . . . . 0.0 114.445 -172.14 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.4 mmtp -127.66 152.81 47.21 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 127.966 2.506 . . . . 0.0 113.391 -174.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -76.79 159.09 30.4 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.256 -0.903 . . . . 0.0 108.913 167.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -140.78 145.21 15.8 Favored Glycine 0 N--CA 1.474 1.187 0 C-N-CA 125.022 1.296 . . . . 0.0 114.547 -178.438 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -145.37 141.63 22.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 124.878 1.271 . . . . 0.0 110.803 -176.214 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 90.8 m -77.61 120.48 22.62 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.906 0.86 . . . . 0.0 113.315 -175.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -113.75 100.82 8.75 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.817 1.647 . . . . 0.0 109.404 169.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 64.88 -126.99 32.81 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 125.238 1.399 . . . . 0.0 111.086 -172.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 34.9 p -89.94 19.56 4.78 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 126.31 1.844 . . . . 0.0 114.011 177.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -141.86 163.17 33.63 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.385 1.474 . . . . 0.0 112.22 -174.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.7 t -88.56 157.9 18.46 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.627 1.171 . . . . 0.0 111.674 173.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.6 121.75 15.81 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 126.448 1.899 . . . . 0.0 107.461 171.384 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 63.3 m -86.11 134.47 33.81 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 -178.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -102.88 -122.63 5.13 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 127.684 2.564 . . . . 0.0 114.727 -169.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.6 m -87.22 156.82 54.19 Favored Pre-proline 0 N--CA 1.477 0.884 0 C-N-CA 125.765 1.626 . . . . 0.0 113.723 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -63.7 146.34 92.14 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 124.16 3.24 . . . . 0.0 113.322 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.8 pp -78.31 -16.55 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 N-CA-C 115.528 1.677 . . . . 0.0 115.528 -171.193 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.2 p -63.15 117.38 6.44 Favored 'General case' 0 C--O 1.238 0.478 0 O-C-N 121.185 -0.947 . . . . 0.0 111.733 -178.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -89.68 63.95 6.37 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.938 1.295 . . . . 0.0 111.267 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.2 pp . . . . . 0 C--O 1.25 1.098 0 C-N-CA 126.842 2.057 . . . . 0.0 113.195 174.791 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.699 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -144.08 134.62 24.79 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.67 1.588 . . . . 0.0 110.793 -173.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 12.3 m-80 63.64 -20.68 0.06 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 128.945 2.898 . . . . 0.0 115.876 175.016 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -132.63 8.22 4.18 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 57.5 12.9 1.64 Allowed 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 115.098 1.518 . . . . 0.0 115.098 -175.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 85.08 -5.23 83.71 Favored Glycine 0 CA--C 1.54 1.602 0 C-N-CA 124.739 1.162 . . . . 0.0 115.173 -168.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 81.7 m -84.01 141.36 31.24 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.842 1.321 . . . . 0.0 113.46 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -151.06 134.17 15.98 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.357 0.663 . . . . 0.0 111.129 164.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 47.2 54.64 9.15 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.113 1.365 . . . . 0.0 112.542 -176.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 61.3 m-20 64.69 9.72 5.42 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 116.308 1.966 . . . . 0.0 116.308 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 49.4 t -125.57 147.87 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 CA-C-N 120.547 1.521 . . . . 0.0 111.893 -175.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -74.08 46.66 0.25 Allowed 'General case' 0 CA--C 1.557 1.249 0 C-N-CA 127.083 2.153 . . . . 0.0 112.466 175.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -73.12 -37.02 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 O-C-N 119.738 -1.851 . . . . 0.0 114.73 -170.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 63.7 mtpt -99.58 -18.18 17.48 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.717 1.207 . . . . 0.0 113.233 178.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 179.46 167.34 36.66 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 124.638 1.113 . . . . 0.0 112.53 175.095 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -87.37 109.37 19.5 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.99 1.716 . . . . 0.0 113.103 -174.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -61.65 -24.56 66.81 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.489 1.515 . . . . 0.0 113.63 176.32 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.4 tmmm? -50.39 -35.72 29.52 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 120.981 -1.074 . . . . 0.0 111.916 171.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 55.8 ttm-85 -58.61 -41.12 85.15 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 126.483 1.913 . . . . 0.0 114.203 -177.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 36.8 t60 -67.62 -42.98 81.47 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.426 1.09 . . . . 0.0 111.495 175.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 72.0 m -77.26 -27.13 53.1 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.41 -36.8 81.33 Favored 'General case' 0 N--CA 1.476 0.839 0 O-C-N 120.62 -1.3 . . . . 0.0 110.782 169.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.2 -15.06 63.43 Favored 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 171.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -99.78 1.81 43.5 Favored 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 126.34 1.856 . . . . 0.0 111.36 169.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . 0.269 3.4 t0 51.98 44.21 29.68 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 128.188 2.595 . . . . 0.0 114.212 -169.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.4 mttt -126.92 172.8 10.12 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 129.13 2.972 . . . . 0.0 112.845 -178.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -85.55 153.84 22.15 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.89 1.276 . . . . 0.0 109.653 167.183 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -131.79 151.4 19.78 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 125.525 1.536 . . . . 0.0 114.887 -178.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -153.32 137.31 8.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 125.268 1.427 . . . . 0.0 111.056 -176.105 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 87.3 m -79.92 120.76 24.57 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.28 -0.887 . . . . 0.0 112.137 -177.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 15.9 m-70 -111.58 103.1 11.4 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.667 1.587 . . . . 0.0 109.223 168.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 67.86 -114.79 6.4 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 124.869 1.224 . . . . 0.0 112.112 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 82.7 p -104.06 17.2 24.6 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 126.155 1.782 . . . . 0.0 112.615 173.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 44.9 mmtm -127.96 159.91 33.52 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.448 1.899 . . . . 0.0 112.093 -178.265 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 43.3 t -100.02 146.0 27.25 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.603 1.161 . . . . 0.0 110.226 170.041 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -130.35 126.49 37.25 Favored 'General case' 0 C--N 1.333 -0.11 0 C-N-CA 126.392 1.877 . . . . 0.0 106.998 -178.145 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 61.2 m -87.95 137.27 32.48 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.832 0.825 . . . . 0.0 112.164 176.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -97.16 -137.28 9.48 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 127.35 2.405 . . . . 0.0 112.228 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 33.1 m -73.39 155.14 89.88 Favored Pre-proline 0 CA--C 1.535 0.37 0 N-CA-C 113.939 1.088 . . . . 0.0 113.939 178.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -51.86 146.96 26.77 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 124.541 3.494 . . . . 0.0 111.407 166.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.5 pp -59.55 -25.18 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 114.944 1.461 . . . . 0.0 114.944 -174.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 8.6 t 48.25 110.85 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 127.458 2.303 . . . . 0.0 116.922 169.25 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -70.67 -2.61 15.02 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.706 1.203 . . . . 0.0 114.019 171.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 58.8 tp . . . . . 0 C--O 1.253 1.246 0 C-N-CA 126.172 1.789 . . . . 0.0 109.257 168.326 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.992 0 CA-C-O 119.869 -0.11 . . . . 0.0 110.865 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -124.73 -40.51 2.19 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 -168.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 30.8 p-10 -161.91 -35.32 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 114.903 1.446 . . . . 0.0 114.903 -177.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -117.7 3.73 12.32 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 115.103 1.52 . . . . 0.0 115.103 -171.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 54.65 15.54 1.1 Allowed 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 -171.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 81.17 -5.11 68.18 Favored Glycine 0 CA--C 1.544 1.906 0 C-N-CA 124.646 1.117 . . . . 0.0 115.263 -168.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 74.5 m -77.44 141.52 39.69 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.065 1.346 . . . . 0.0 113.068 178.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -152.15 131.98 13.28 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.098 0.959 . . . . 0.0 112.113 166.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 48.19 54.5 10.15 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.773 1.629 . . . . 0.0 112.745 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 42.4 m-20 62.57 15.35 7.85 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 116.485 2.032 . . . . 0.0 116.485 -179.119 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 38.4 t -129.07 147.26 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 125.048 1.339 . . . . 0.0 111.079 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 28.0 p-10 -76.33 33.95 0.13 Allowed 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 128.354 2.661 . . . . 0.0 114.266 176.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -58.78 -30.92 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 N-CA-C 116.362 1.986 . . . . 0.0 116.362 -168.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -109.5 -10.14 14.89 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 125.189 1.395 . . . . 0.0 113.133 175.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 168.81 153.53 8.38 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 125.798 1.666 . . . . 0.0 112.252 173.519 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -85.3 138.54 32.24 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.089 0.956 . . . . 0.0 112.137 175.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.2 p -94.95 -1.43 52.53 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -178.256 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -63.21 -28.65 70.18 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 120.956 -1.09 . . . . 0.0 112.978 177.315 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.04 -37.4 85.76 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 121.045 1.748 . . . . 0.0 113.148 173.132 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 13.1 t60 -62.68 -36.37 82.67 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.34 1.056 . . . . 0.0 111.715 170.287 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 57.7 m -75.38 -27.83 59.26 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 121.087 -1.008 . . . . 0.0 113.402 171.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 21.6 tptp -66.28 -20.32 66.07 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.188 1.395 . . . . 0.0 112.907 173.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.53 -18.11 64.53 Favored 'General case' 0 CA--C 1.55 0.955 0 O-C-N 121.704 -0.623 . . . . 0.0 112.308 168.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -110.68 15.12 22.16 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 126.953 2.101 . . . . 0.0 111.899 168.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 15.4 t0 56.18 26.32 10.16 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 127.771 2.428 . . . . 0.0 115.2 -174.025 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 38.8 mttt -109.91 159.57 17.13 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.79 1.636 . . . . 0.0 114.339 -174.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -70.59 149.9 46.61 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 114.727 -1.124 . . . . 0.0 108.006 166.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -136.62 141.63 12.68 Favored Glycine 0 N--CA 1.472 1.069 0 C-N-CA 124.798 1.19 . . . . 0.0 114.83 -176.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.06 131.78 55.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 125.638 1.575 . . . . 0.0 111.903 -168.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 96.9 m -73.07 107.89 5.66 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.208 1.003 . . . . 0.0 112.045 177.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 9.5 m-70 -95.5 91.76 6.33 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.866 2.066 . . . . 0.0 110.069 169.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 66.27 -109.0 2.64 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 124.613 1.101 . . . . 0.0 112.037 -178.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 47.5 p -109.94 26.71 10.35 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 125.938 1.695 . . . . 0.0 113.209 173.302 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 36.4 mmtm -139.31 174.23 10.73 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 126.977 2.111 . . . . 0.0 111.932 174.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 13.1 t -117.48 157.71 25.79 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.697 1.199 . . . . 0.0 112.388 176.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.9 mtpt -144.47 155.67 43.83 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 128.08 2.552 . . . . 0.0 107.646 172.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 23.8 m -107.0 149.11 27.89 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -95.32 -117.47 3.13 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 127.034 2.254 . . . . 0.0 113.779 -176.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.9 m -106.41 163.87 16.09 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 126.399 1.88 . . . . 0.0 111.432 169.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_exo -48.66 142.91 17.49 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 124.494 3.463 . . . . 0.0 113.849 170.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.7 pp -65.8 -14.78 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 N-CA-C 115.065 1.505 . . . . 0.0 115.065 -175.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.3 p -51.91 129.74 27.62 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.264 1.426 . . . . 0.0 113.124 -172.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -81.19 -14.83 57.17 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.403 1.481 . . . . 0.0 113.523 -176.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 57.7 tp . . . . . 0 C--O 1.253 1.237 0 C-N-CA 126.582 1.953 . . . . 0.0 110.276 175.297 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.047 0 N-CA-C 112.033 0.382 . . . . 0.0 112.033 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -152.66 -38.61 0.11 Allowed 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.813 1.245 . . . . 0.0 113.995 178.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 28.4 p30 -146.83 -40.37 0.2 Allowed 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 125.566 1.546 . . . . 0.0 114.737 -169.231 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -124.05 24.5 8.2 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.494 1.917 . . . . 0.0 113.072 177.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 53.77 26.13 5.73 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.919 1.288 . . . . 0.0 113.535 -173.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.02 0.72 21.99 Favored Glycine 0 CA--C 1.539 1.567 0 O-C-N 121.057 -1.027 . . . . 0.0 115.445 -171.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 76.2 m -97.7 141.92 30.13 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.16 1.384 . . . . 0.0 113.713 -170.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -150.6 132.46 15.08 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.161 167.049 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 47.36 54.67 9.24 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.628 1.571 . . . . 0.0 113.331 178.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 64.03 14.84 8.79 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 116.811 2.152 . . . . 0.0 116.811 -177.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.5 t -131.58 146.66 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 O-C-N 120.567 -1.333 . . . . 0.0 111.827 -177.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -76.51 50.13 0.65 Allowed 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.852 1.661 . . . . 0.0 112.179 170.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -77.93 -30.79 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 125.618 1.567 . . . . 0.0 114.073 -177.453 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 23.4 mmmt -95.26 -30.72 13.83 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -174.13 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -175.61 -138.69 2.88 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 124.958 1.266 . . . . 0.0 112.62 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -124.78 140.25 53.1 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -108.27 -19.57 13.43 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 129.276 3.03 . . . . 0.0 111.369 174.232 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 11.6 tppt? -38.64 -51.57 1.65 Allowed 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 127.199 2.199 . . . . 0.0 112.321 169.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 42.3 mtm180 -63.4 -25.56 68.34 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 -176.235 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 65.1 t60 -73.75 -45.71 50.22 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 119.186 0.903 . . . . 0.0 111.975 173.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 71.1 m -76.13 -28.63 57.5 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 178.262 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.421 ' HA ' ' HE2' ' A' ' 22' ' ' LYS . 0.5 OUTLIER -63.05 -28.43 70.08 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.747 1.219 . . . . 0.0 112.267 175.729 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.24 -26.45 63.85 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.391 1.076 . . . . 0.0 113.258 172.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -88.2 8.53 26.65 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 125.844 1.657 . . . . 0.0 111.615 168.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . 0.265 11.5 t0 56.18 31.3 18.08 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 128.167 2.587 . . . . 0.0 115.061 -173.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 36.3 mttt -117.22 169.17 9.67 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 127.453 2.301 . . . . 0.0 113.798 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -79.65 150.91 30.8 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.421 1.488 . . . . 0.0 108.477 167.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -110.99 151.03 17.8 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 125.755 1.645 . . . . 0.0 113.708 175.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -150.41 137.88 13.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 125.346 1.458 . . . . 0.0 109.002 175.097 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 68.3 m -77.93 126.34 30.69 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 121.046 -1.034 . . . . 0.0 112.878 -174.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -122.08 114.43 20.9 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.211 1.404 . . . . 0.0 109.229 169.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 64.13 -124.51 30.28 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 124.464 1.03 . . . . 0.0 111.721 -173.386 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 70.3 p -104.6 29.2 6.33 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 125.997 1.719 . . . . 0.0 112.405 170.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 41.2 mmtm -136.73 165.07 26.78 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.405 1.882 . . . . 0.0 110.686 -176.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 12.6 t -92.19 160.37 15.2 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.633 1.173 . . . . 0.0 110.294 173.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.0 tmtt? -145.97 137.92 25.17 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 127.024 2.13 . . . . 0.0 106.294 173.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 57.2 m -93.48 135.45 34.72 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -176.304 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -85.31 -127.35 1.79 Allowed Glycine 0 CA--C 1.528 0.866 0 C-N-CA 126.538 2.018 . . . . 0.0 112.286 178.026 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 31.5 m -89.03 155.08 49.81 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 124.666 1.186 . . . . 0.0 113.014 176.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -53.1 142.05 55.88 Favored 'Trans proline' 0 C--O 1.239 0.525 0 C-N-CA 124.742 3.628 . . . . 0.0 111.309 167.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.0 pp -68.36 -32.95 57.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-O 119.022 -0.513 . . . . 0.0 111.925 -178.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.9 t -68.38 134.13 49.77 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 123.494 0.718 . . . . 0.0 111.979 -173.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -90.23 -6.52 55.14 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.866 0.866 . . . . 0.0 113.174 177.297 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.255 1.378 0 C-N-CA 128.129 2.571 . . . . 0.0 112.688 176.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.839 0 N-CA-C 111.448 0.166 . . . . 0.0 111.448 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.1 tpmt? -141.29 -51.02 0.43 Allowed 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -167.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -66.91 -30.22 70.31 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 119.837 1.199 . . . . 0.0 111.873 -168.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -131.01 16.54 5.13 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.205 1.402 . . . . 0.0 111.617 165.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 50.75 16.78 0.34 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.477 1.911 . . . . 0.0 115.223 -172.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 71.35 0.67 39.01 Favored Glycine 0 CA--C 1.535 1.294 0 O-C-N 120.965 -1.084 . . . . 0.0 115.002 -173.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 99.8 m -90.74 137.09 32.63 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 118.2 1.0 . . . . 0.0 112.835 -173.017 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -151.7 141.97 22.38 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.303 1.041 . . . . 0.0 110.175 165.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 51.15 39.08 22.66 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 178.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 57.88 28.44 16.07 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 126.281 1.832 . . . . 0.0 114.786 -173.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 46.2 t -132.01 145.03 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 125.416 1.486 . . . . 0.0 110.585 179.047 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -77.51 50.85 0.84 Allowed 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.598 1.559 . . . . 0.0 112.236 173.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -75.94 -41.95 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 124.963 1.305 . . . . 0.0 113.722 -175.162 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 25.0 mmmt -90.04 -19.4 24.44 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.012 0.925 . . . . 0.0 112.797 -173.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -178.5 -146.76 6.67 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 124.701 1.143 . . . . 0.0 112.588 178.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 -124.22 126.97 47.01 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.881 1.272 . . . . 0.0 113.947 177.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -86.49 -18.42 31.68 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.635 1.974 . . . . 0.0 111.56 171.584 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -48.46 -51.32 27.61 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 117.408 -1.282 . . . . 0.0 111.378 169.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -52.82 -42.58 65.26 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-N 120.267 1.394 . . . . 0.0 113.104 -175.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 71.8 t60 -63.18 -43.53 97.95 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.161 0.984 . . . . 0.0 112.235 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 92.9 m -84.24 -25.71 29.21 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.57 -35.55 78.11 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 120.833 -1.167 . . . . 0.0 110.221 173.621 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.06 -12.85 61.59 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 171.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -102.4 7.88 40.29 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 126.564 1.946 . . . . 0.0 112.193 169.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . 0.261 2.6 t0 58.22 35.87 25.3 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 128.263 2.625 . . . . 0.0 114.198 -172.628 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.2 mttt -129.89 164.17 24.76 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 127.588 2.355 . . . . 0.0 115.37 -172.315 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -69.29 144.96 53.44 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.045 1.738 . . . . 0.0 109.383 165.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -109.41 141.11 15.96 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 125.413 1.482 . . . . 0.0 112.599 169.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.45 135.37 31.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-N 118.666 1.233 . . . . 0.0 111.239 174.6 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 86.6 m -74.8 115.36 14.3 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 122.078 0.942 . . . . 0.0 113.262 -176.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 5.0 m-70 -100.07 100.28 11.13 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 126.24 1.816 . . . . 0.0 107.65 168.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 63.55 -114.41 6.83 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 124.411 1.005 . . . . 0.0 111.977 -178.176 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 44.8 p -102.42 16.49 26.12 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 126.168 1.787 . . . . 0.0 113.653 174.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 48.8 mmtm -130.25 165.6 22.08 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.867 2.067 . . . . 0.0 111.019 -175.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 20.4 t -97.6 157.61 15.94 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.042 0.937 . . . . 0.0 110.868 172.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.14 126.5 14.0 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 126.151 1.78 . . . . 0.0 106.314 175.405 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 39.4 m -82.26 142.34 32.19 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 119.119 0.872 . . . . 0.0 112.141 -178.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -102.28 -118.48 4.42 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 125.725 1.631 . . . . 0.0 113.456 -173.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.9 m -91.55 159.68 38.26 Favored Pre-proline 0 N--CA 1.472 0.658 0 C-N-CA 126.314 1.846 . . . . 0.0 112.559 174.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -65.89 157.79 57.31 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 124.098 3.198 . . . . 0.0 112.556 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.1 pp -71.17 -0.34 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 175.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 55.9 m -70.75 56.71 0.18 Allowed 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 129.253 3.021 . . . . 0.0 113.508 175.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -60.92 -20.54 62.27 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 124.97 1.308 . . . . 0.0 114.469 -171.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.6 pt? . . . . . 0 C--O 1.255 1.348 0 C-N-CA 126.645 1.978 . . . . 0.0 113.198 174.996 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.999 0 CA-C-O 118.478 -0.773 . . . . 0.0 110.834 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -146.56 -37.79 0.23 Allowed 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 115.146 1.536 . . . . 0.0 115.146 175.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 18.1 p30 -142.38 -46.16 0.33 Allowed 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.753 1.221 . . . . 0.0 113.96 178.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -114.65 16.92 17.45 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.699 1.6 . . . . 0.0 112.742 177.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 54.16 15.74 1.0 Allowed 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 -177.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.36 4.87 52.88 Favored Glycine 0 CA--C 1.537 1.425 0 O-C-N 121.179 -0.95 . . . . 0.0 114.842 -173.021 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 92.0 m -91.28 135.78 33.56 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.458 1.103 . . . . 0.0 112.084 -179.194 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -151.68 135.38 16.3 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.096 0.958 . . . . 0.0 111.955 167.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 48.46 52.77 13.1 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.3 1.44 . . . . 0.0 112.72 -179.29 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 57.3 m-20 63.71 8.26 3.63 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 127.254 2.222 . . . . 0.0 116.686 -177.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.0 t -126.24 147.85 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 CA-C-N 119.592 1.087 . . . . 0.0 111.504 -176.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -77.44 39.46 0.26 Allowed 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 126.916 2.086 . . . . 0.0 113.06 172.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -63.06 -26.74 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 126.054 1.741 . . . . 0.0 113.907 -178.667 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.5 mmmm -104.65 -13.76 15.84 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.237 1.415 . . . . 0.0 114.519 -175.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 166.94 -141.13 6.71 Favored Glycine 0 N--CA 1.471 0.992 0 CA-C-N 120.112 1.324 . . . . 0.0 114.699 174.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -117.13 124.28 48.82 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.704 1.201 . . . . 0.0 113.718 -170.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -104.54 -30.35 10.07 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 127.53 2.332 . . . . 0.0 111.284 176.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.3 tmmm? -53.16 -40.21 64.13 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 121.11 -0.994 . . . . 0.0 112.391 175.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 43.9 mtp180 -64.3 -27.69 69.21 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 63.7 t60 -70.68 -46.65 62.78 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 118.867 0.758 . . . . 0.0 111.335 170.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 86.8 m -72.34 -30.31 64.62 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.471 ' HA ' ' HE2' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -62.55 -30.69 71.5 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 120.536 -1.352 . . . . 0.0 112.14 173.996 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -75.47 -11.98 60.15 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 124.304 1.042 . . . . 0.0 112.902 173.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -102.79 4.91 38.41 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 126.528 1.931 . . . . 0.0 111.378 168.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . 0.273 5.7 t0 57.68 40.37 26.58 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 129.354 3.061 . . . . 0.0 115.886 -171.425 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.7 mttt -129.96 171.59 12.61 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.303 1.841 . . . . 0.0 113.871 -177.214 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -79.11 156.47 28.28 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.921 1.688 . . . . 0.0 109.141 166.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -126.58 144.92 15.42 Favored Glycine 0 CA--C 1.537 1.46 0 C-N-CA 125.332 1.444 . . . . 0.0 115.102 176.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -147.43 144.06 19.68 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 124.558 1.143 . . . . 0.0 109.564 -178.445 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 88.8 m -86.76 122.91 31.31 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.112 -0.993 . . . . 0.0 112.86 -174.292 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 19.0 m-70 -114.71 104.22 11.76 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 125.582 1.553 . . . . 0.0 110.019 169.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 60.65 -121.52 26.87 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 123.827 0.727 . . . . 0.0 111.67 -173.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 60.7 p -91.42 8.8 34.51 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 126.215 1.806 . . . . 0.0 114.167 179.13 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -131.91 160.96 34.21 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.709 1.603 . . . . 0.0 112.94 -172.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 38.7 t -93.23 140.06 29.94 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.828 1.251 . . . . 0.0 110.766 172.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.63 121.13 29.66 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 127.142 2.177 . . . . 0.0 105.799 178.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 57.2 m -78.03 141.73 38.68 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 119.043 0.838 . . . . 0.0 112.687 -177.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -89.68 -135.11 5.64 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 126.549 2.023 . . . . 0.0 111.868 175.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 33.7 m -83.93 159.61 59.83 Favored Pre-proline 0 CA--C 1.539 0.534 0 C-N-CA 123.99 0.916 . . . . 0.0 113.318 -178.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -54.47 144.9 60.22 Favored 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 124.63 3.553 . . . . 0.0 111.516 167.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.7 pp -70.56 -7.02 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 N-CA-C 117.098 2.258 . . . . 0.0 117.098 -167.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 85.2 p -94.38 15.29 18.01 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.562 1.545 . . . . 0.0 114.421 169.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 50.39 63.52 2.17 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 129.713 3.205 . . . . 0.0 114.837 171.211 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.3 mp . . . . . 0 C--O 1.248 1.005 0 C-N-CA 126.232 1.813 . . . . 0.0 112.871 179.425 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.927 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -143.95 -33.49 0.41 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 126.998 2.119 . . . . 0.0 113.043 178.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -78.43 -40.89 34.48 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.263 1.025 . . . . 0.0 112.211 -177.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -105.55 3.21 29.09 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.456 1.025 . . . . 0.0 113.725 168.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 56.09 14.14 1.38 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.505 1.522 . . . . 0.0 114.169 -174.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 83.69 -7.43 69.53 Favored Glycine 0 CA--C 1.538 1.493 0 C-N-CA 125.347 1.451 . . . . 0.0 115.0 -171.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 82.8 m -76.33 143.79 40.57 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.229 1.011 . . . . 0.0 113.232 177.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -156.36 139.97 15.97 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.988 1.315 . . . . 0.0 109.953 166.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 48.92 44.33 22.24 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.667 1.187 . . . . 0.0 113.859 -179.199 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 16.7 m-20 61.18 15.91 6.76 Favored 'General case' 0 CA--C 1.553 1.074 0 N-CA-C 116.316 1.969 . . . . 0.0 116.316 -174.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 59.4 t -126.49 149.92 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 125.379 1.472 . . . . 0.0 111.849 -176.006 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -79.06 42.33 0.47 Allowed 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 127.082 2.153 . . . . 0.0 114.61 178.103 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -64.22 -42.62 96.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 O-C-N 120.584 -1.322 . . . . 0.0 113.566 -171.412 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 36.2 mmtm -96.36 -19.19 19.4 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 174.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 172.3 168.48 33.78 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 124.343 0.973 . . . . 0.0 112.694 177.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -98.37 129.67 45.02 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.474 0.709 . . . . 0.0 112.715 -174.06 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -64.34 -15.55 60.56 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 126.641 1.976 . . . . 0.0 113.507 171.245 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? -41.98 -51.49 4.42 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.52 1.528 . . . . 0.0 112.113 168.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 60.1 mtm180 -68.55 -25.57 64.98 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.047 1.128 . . . . 0.0 114.047 -168.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -81.88 -36.53 28.07 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.932 1.293 . . . . 0.0 112.789 174.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 99.1 m -79.25 -33.24 43.73 Favored 'General case' 0 CA--C 1.546 0.817 0 O-C-N 121.06 -1.025 . . . . 0.0 113.08 174.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 18.8 tptp -63.64 -28.57 70.0 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.67 1.188 . . . . 0.0 112.422 177.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.69 -25.91 66.74 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.874 1.27 . . . . 0.0 113.365 171.139 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -103.76 10.2 36.73 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.842 1.657 . . . . 0.0 112.067 174.278 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 64.78 30.3 12.34 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 128.28 2.632 . . . . 0.0 115.312 -177.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.2 mttp -115.93 163.48 15.82 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 126.648 1.979 . . . . 0.0 112.869 177.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -78.79 152.27 31.51 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 166.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -107.75 159.98 14.19 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 125.836 1.684 . . . . 0.0 113.226 172.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -150.14 135.9 11.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 124.906 1.282 . . . . 0.0 111.011 171.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 91.4 m -76.91 118.81 19.87 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.449 0.642 . . . . 0.0 112.273 -179.152 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 19.3 m-70 -116.2 111.58 20.39 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.627 1.571 . . . . 0.0 109.125 169.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 63.5 -117.08 10.21 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 125.964 1.745 . . . . 0.0 111.228 -173.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.4 p -108.44 23.93 13.79 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.636 1.574 . . . . 0.0 112.377 173.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 42.0 mmtm -138.59 169.27 18.09 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.934 1.294 . . . . 0.0 112.913 -178.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 41.7 t -99.59 148.11 24.65 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.372 1.469 . . . . 0.0 111.937 -178.24 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -139.9 133.78 30.71 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 126.902 2.081 . . . . 0.0 105.974 174.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 63.0 m -84.73 142.67 29.68 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 119.592 1.087 . . . . 0.0 112.834 -178.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -89.71 -138.36 6.95 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 126.26 1.886 . . . . 0.0 111.239 171.296 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.6 m -77.86 154.48 80.62 Favored Pre-proline 0 CA--C 1.537 0.475 0 N-CA-C 114.055 1.131 . . . . 0.0 114.055 178.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -54.73 137.1 73.7 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 124.238 3.292 . . . . 0.0 110.758 166.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.5 pp -62.99 -22.92 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 O-C-N 120.971 -1.081 . . . . 0.0 113.731 -174.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.2 m 53.72 45.19 28.47 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 118.033 2.605 . . . . 0.0 118.033 167.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -115.24 -17.1 11.43 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 125.025 1.33 . . . . 0.0 114.574 169.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 34.0 tp . . . . . 0 C--O 1.25 1.091 0 C-N-CA 126.163 1.785 . . . . 0.0 111.163 -178.145 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.788 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -146.78 -28.0 0.39 Allowed 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 114.879 1.437 . . . . 0.0 114.879 -177.193 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 39.9 p30 -82.11 -38.98 24.0 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 -176.213 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -117.64 0.93 12.17 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.745 1.218 . . . . 0.0 112.708 169.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 60.58 7.96 1.55 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.52 1.928 . . . . 0.0 114.975 -178.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 88.02 -3.18 85.83 Favored Glycine 0 CA--C 1.543 1.84 0 C-N-CA 124.701 1.143 . . . . 0.0 114.729 -168.077 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 87.3 m -79.03 141.88 37.04 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.553 1.141 . . . . 0.0 112.01 175.401 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -152.4 135.8 15.94 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.798 0.839 . . . . 0.0 110.714 168.168 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 47.95 51.47 14.39 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.405 1.482 . . . . 0.0 113.228 179.097 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 62.62 11.22 4.62 Favored 'General case' 0 CA--C 1.551 1.017 0 N-CA-C 117.389 2.366 . . . . 0.0 117.389 -175.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 38.2 t -124.2 146.53 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 CA-C-N 119.73 1.15 . . . . 0.0 111.965 -177.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -74.91 35.92 0.11 Allowed 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 127.698 2.399 . . . . 0.0 113.483 177.163 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -60.1 -43.8 93.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 -168.652 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -96.97 -18.05 19.68 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 178.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 171.4 169.64 34.55 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 125.553 1.549 . . . . 0.0 113.002 174.146 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -86.84 142.81 27.8 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 121.959 0.885 . . . . 0.0 112.996 175.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.8 p -97.79 -10.66 24.41 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.628 1.171 . . . . 0.0 113.149 169.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.1 tmmm? -63.3 -28.09 69.78 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-O 118.115 -0.945 . . . . 0.0 113.251 -176.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 44.9 mtm180 -63.81 -35.23 79.92 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 120.013 1.279 . . . . 0.0 113.596 170.271 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -67.76 -35.41 78.66 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.433 1.093 . . . . 0.0 111.904 174.311 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 90.0 m -75.21 -39.02 60.44 Favored 'General case' 0 CA--C 1.547 0.865 0 O-C-N 120.909 -1.119 . . . . 0.0 112.533 170.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -62.28 -28.63 69.85 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 120.748 -1.22 . . . . 0.0 112.791 178.21 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.57 -25.89 60.64 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.47 1.108 . . . . 0.0 113.152 171.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -115.47 21.01 14.38 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.684 1.594 . . . . 0.0 112.048 -179.042 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.2 t0 56.96 60.56 2.96 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 126.407 1.883 . . . . 0.0 111.431 -175.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 31.9 mmtm -145.44 147.68 32.47 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 126.071 1.748 . . . . 0.0 113.308 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -72.53 156.42 39.03 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 162.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -141.6 136.11 7.2 Favored Glycine 0 N--CA 1.468 0.788 0 C-N-CA 124.385 0.993 . . . . 0.0 112.684 -179.515 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.0 140.18 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 C-N-CA 124.595 1.158 . . . . 0.0 110.675 -172.123 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 73.0 m -68.13 118.07 10.8 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.019 0.528 . . . . 0.0 112.408 -177.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 -108.63 98.69 8.16 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.965 1.706 . . . . 0.0 108.783 169.289 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 61.35 -114.81 7.07 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 124.176 0.893 . . . . 0.0 111.402 -174.506 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 58.6 p -107.01 27.43 9.0 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 127.337 2.255 . . . . 0.0 114.045 174.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -137.95 174.27 10.74 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 126.726 2.01 . . . . 0.0 111.219 172.012 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 9.1 t -97.17 166.68 11.46 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.746 1.218 . . . . 0.0 111.435 172.526 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.55 118.57 8.23 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.337 1.455 . . . . 0.0 108.633 173.116 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 73.9 m -84.48 129.57 34.84 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -178.272 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -99.72 -139.32 10.75 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 127.407 2.432 . . . . 0.0 113.941 -175.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.6 m -72.8 154.78 91.1 Favored Pre-proline 0 N--CA 1.473 0.722 0 C-N-CA 125.051 1.34 . . . . 0.0 113.398 176.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.53 157.79 52.12 Favored 'Trans proline' 0 CA--C 1.532 0.4 0 C-N-CA 124.28 3.32 . . . . 0.0 114.031 -178.078 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.5 pp -104.27 -39.58 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -168.42 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 21.3 m -63.01 130.4 44.53 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.102 0.961 . . . . 0.0 111.962 -169.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 8.4 p90 -139.68 -4.97 1.38 Allowed 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 114.967 1.469 . . . . 0.0 114.967 -169.586 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.8 pp . . . . . 0 C--O 1.257 1.468 0 C-N-CA 126.982 2.113 . . . . 0.0 112.581 170.719 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.699 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 23.1 ttpp -108.88 -35.26 6.42 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.953 1.701 . . . . 0.0 112.053 -168.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -71.59 -18.3 62.24 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.693 -0.629 . . . . 0.0 112.566 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -103.23 -2.34 27.4 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.346 0.658 . . . . 0.0 111.873 167.471 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 56.44 28.52 13.78 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.811 1.245 . . . . 0.0 113.662 -177.264 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 71.51 -5.14 11.34 Favored Glycine 0 CA--C 1.541 1.691 0 N-CA-C 115.411 0.924 . . . . 0.0 115.411 -174.306 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 74.4 m -79.46 135.0 36.54 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.705 1.202 . . . . 0.0 112.792 -178.48 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -148.08 134.97 20.12 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.214 1.006 . . . . 0.0 111.104 167.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 47.66 49.08 16.75 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.09 1.356 . . . . 0.0 113.65 179.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 65.96 10.93 7.35 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 127.436 2.294 . . . . 0.0 116.513 -176.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.9 t -126.06 147.95 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 124.951 1.3 . . . . 0.0 112.288 -176.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -78.72 40.64 0.39 Allowed 'General case' 0 CA--C 1.558 1.264 0 C-N-CA 127.234 2.214 . . . . 0.0 113.708 176.029 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.5 m -70.86 -23.39 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 C-N-CA 125.777 1.631 . . . . 0.0 115.325 -172.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -109.05 -8.81 15.12 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.696 1.198 . . . . 0.0 112.984 173.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 158.09 169.33 21.55 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 125.452 1.501 . . . . 0.0 112.435 174.025 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -89.19 144.93 25.75 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.157 0.983 . . . . 0.0 112.706 177.27 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 42.4 t -92.65 -15.23 27.05 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.455 0.702 . . . . 0.0 112.375 170.299 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -53.29 -35.39 60.05 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 120.679 -1.263 . . . . 0.0 111.709 177.497 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 11.9 mtp-105 -55.77 -43.31 76.6 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 115.071 1.508 . . . . 0.0 115.071 169.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 62.4 t60 -67.83 -40.04 83.83 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 119.845 1.202 . . . . 0.0 112.302 177.593 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 93.0 m -75.61 -32.28 60.22 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 123.54 0.736 . . . . 0.0 112.443 177.335 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.437 ' O ' ' HE2' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -62.01 -30.4 70.93 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 127.132 2.173 . . . . 0.0 112.168 174.825 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.19 -24.89 67.47 Favored 'General case' 0 CA--C 1.549 0.918 0 O-C-N 121.554 -0.716 . . . . 0.0 112.534 173.453 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -107.95 18.88 20.73 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.416 1.886 . . . . 0.0 113.597 168.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 60.66 26.32 16.05 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 126.114 1.765 . . . . 0.0 115.724 177.286 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.6 mttp -110.22 162.12 14.91 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 127.653 2.381 . . . . 0.0 113.272 175.028 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -76.39 153.2 35.93 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.96 0.904 . . . . 0.0 110.1 166.068 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -125.49 142.66 13.94 Favored Glycine 0 N--CA 1.475 1.276 0 C-N-CA 125.726 1.631 . . . . 0.0 113.506 173.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.93 133.09 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 124.883 1.273 . . . . 0.0 111.322 -170.307 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 74.5 m -75.07 114.82 14.0 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.132 0.492 . . . . 0.0 111.677 -179.305 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 7.6 m-70 -107.76 100.98 10.31 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.726 2.01 . . . . 0.0 109.134 172.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 64.19 -115.62 8.11 Favored Glycine 0 CA--C 1.527 0.844 0 C-N-CA 124.839 1.209 . . . . 0.0 112.055 -177.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 75.9 p -105.38 15.76 26.7 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.97 1.308 . . . . 0.0 112.586 178.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -141.35 -171.09 3.22 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 128.651 2.78 . . . . 0.0 110.47 -175.064 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 52.7 t -134.71 158.08 45.05 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 114.282 1.215 . . . . 0.0 114.282 -176.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 68.6 mttt -136.19 149.86 48.77 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 129.49 3.116 . . . . 0.0 107.908 169.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 78.3 m -89.81 152.8 21.11 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 121.626 0.727 . . . . 0.0 112.073 170.461 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -107.71 -112.82 3.66 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 126.205 1.859 . . . . 0.0 114.124 -172.356 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.9 m -104.9 157.35 34.39 Favored Pre-proline 0 N--CA 1.475 0.788 0 C-N-CA 126.522 1.929 . . . . 0.0 113.155 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -64.69 141.55 73.01 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 124.083 3.188 . . . . 0.0 111.413 173.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.7 pp -69.42 -8.97 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 N-CA-C 115.386 1.624 . . . . 0.0 115.386 -172.053 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 78.6 p -90.16 8.5 32.64 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.66 1.584 . . . . 0.0 114.464 169.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 41.44 58.36 2.7 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 129.61 3.164 . . . . 0.0 114.379 172.506 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 78.3 mt . . . . . 0 C--O 1.251 1.137 0 C-N-CA 126.639 1.976 . . . . 0.0 113.257 -176.482 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.877 0 N-CA-C 110.365 -0.235 . . . . 0.0 110.365 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -134.45 -40.78 0.8 Allowed 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -169.431 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -163.03 -40.76 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 114.62 1.341 . . . . 0.0 114.62 -169.305 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -127.41 1.22 6.3 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -169.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 55.71 24.81 7.56 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.301 1.44 . . . . 0.0 114.132 -175.389 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 72.93 -4.69 21.81 Favored Glycine 0 CA--C 1.542 1.723 0 O-C-N 121.23 -0.919 . . . . 0.0 115.226 -171.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 88.0 m -84.33 142.62 30.06 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.057 1.343 . . . . 0.0 112.644 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -153.29 140.94 19.94 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.289 1.035 . . . . 0.0 110.278 167.119 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 46.51 47.58 14.22 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.201 1.4 . . . . 0.0 113.543 178.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 21.6 m-20 64.52 17.4 10.83 Favored 'General case' 0 CA--C 1.551 0.985 0 N-CA-C 116.132 1.901 . . . . 0.0 116.132 -177.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 40.7 t -132.81 148.19 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.57 1.148 . . . . 0.0 112.498 -176.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -73.15 37.52 0.08 Allowed 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 128.055 2.542 . . . . 0.0 114.092 173.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -63.76 -33.38 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 O-C-N 120.28 -1.513 . . . . 0.0 114.293 -171.423 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -104.53 -19.92 13.85 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.426 1.091 . . . . 0.0 113.725 178.444 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 173.5 177.06 42.45 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 124.951 1.262 . . . . 0.0 112.491 174.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -87.18 158.13 19.2 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 117.737 0.768 . . . . 0.0 111.987 174.169 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.6 p -120.61 -5.31 9.75 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 170.333 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -61.16 -31.72 71.45 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 117.519 -1.229 . . . . 0.0 112.025 177.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 47.6 mtm180 -58.32 -38.94 78.11 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-N 120.458 1.481 . . . . 0.0 113.622 170.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 18.6 t60 -65.2 -38.83 91.7 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 119.261 0.937 . . . . 0.0 112.628 174.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 97.3 m -72.89 -33.0 65.77 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 118.801 0.728 . . . . 0.0 112.727 171.117 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -66.34 -27.62 68.03 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 120.322 -1.486 . . . . 0.0 111.848 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.65 -5.63 16.65 Favored 'General case' 0 CA--C 1.551 1.008 0 N-CA-C 114.044 1.127 . . . . 0.0 114.044 169.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -121.86 19.21 10.98 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 127.583 2.353 . . . . 0.0 112.017 171.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 61.46 29.52 18.46 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.277 1.431 . . . . 0.0 113.518 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.3 mmtp -124.01 153.55 41.15 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 128.222 2.609 . . . . 0.0 112.538 -175.273 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -78.53 158.52 28.54 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.282 1.033 . . . . 0.0 108.361 166.255 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -138.7 145.66 17.11 Favored Glycine 0 N--CA 1.476 1.328 0 C-N-CA 124.943 1.259 . . . . 0.0 114.745 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -147.37 147.63 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 126.077 1.751 . . . . 0.0 110.882 -172.309 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 71.1 m -77.51 116.94 18.48 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 113.731 1.012 . . . . 0.0 113.731 -174.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -109.03 103.59 12.65 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.477 1.511 . . . . 0.0 108.562 168.326 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 66.34 -114.86 6.86 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 124.142 0.877 . . . . 0.0 111.85 -176.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 69.8 p -107.22 22.04 16.6 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.993 1.717 . . . . 0.0 112.384 175.123 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 37.0 mmtm -139.67 170.33 16.09 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.42 1.888 . . . . 0.0 112.29 -172.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 16.7 t -109.49 133.22 53.34 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.347 1.059 . . . . 0.0 112.576 -178.009 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.8 tptt -118.71 129.4 55.25 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 126.615 1.966 . . . . 0.0 107.137 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 68.6 m -86.46 145.4 26.84 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.39 -125.8 5.14 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 127.161 2.315 . . . . 0.0 113.752 -172.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 28.9 m -84.08 160.45 57.63 Favored Pre-proline 0 N--CA 1.471 0.583 0 C-N-CA 124.993 1.317 . . . . 0.0 113.242 177.658 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -51.74 152.43 13.15 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 124.426 3.418 . . . . 0.0 113.564 168.082 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.9 pp -83.37 -9.08 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 N-CA-C 116.049 1.87 . . . . 0.0 116.049 -177.399 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 25.7 t -49.77 130.13 20.8 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 126.657 1.983 . . . . 0.0 114.557 -170.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -143.97 -178.72 6.07 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.017 1.727 . . . . 0.0 112.454 -176.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.4 pt? . . . . . 0 C--O 1.252 1.233 0 C-N-CA 125.404 1.482 . . . . 0.0 113.835 173.771 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.794 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -111.62 -37.2 5.26 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 127.867 2.467 . . . . 0.0 112.172 -175.544 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 35.5 m120 -65.56 -29.57 70.2 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.638 1.175 . . . . 0.0 111.048 177.465 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -84.25 -0.99 54.46 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.549 1.14 . . . . 0.0 113.072 168.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 59.04 19.0 6.81 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.423 1.489 . . . . 0.0 114.62 -171.08 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 73.86 -0.29 52.15 Favored Glycine 0 CA--C 1.552 2.38 0 N-CA-C 115.803 1.081 . . . . 0.0 115.803 -168.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 97.8 m -81.81 137.47 35.29 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 120.84 -1.388 . . . . 0.0 113.095 178.327 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -151.12 134.32 16.04 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.247 1.019 . . . . 0.0 111.337 166.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 48.74 51.71 15.28 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.814 1.646 . . . . 0.0 113.736 -178.107 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 61.12 13.82 5.0 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 126.905 2.082 . . . . 0.0 116.398 -175.095 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.4 t -127.26 144.72 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-N 119.683 1.129 . . . . 0.0 111.663 -177.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -72.8 31.83 0.06 Allowed 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.595 1.558 . . . . 0.0 114.493 175.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -53.71 -32.08 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 O-C-N 120.327 -1.483 . . . . 0.0 114.601 -171.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -106.0 -6.96 18.37 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 177.572 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 167.37 150.83 6.65 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-N 119.599 1.09 . . . . 0.0 114.547 169.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -71.55 108.92 5.18 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.603 1.161 . . . . 0.0 113.777 -174.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -69.37 -29.91 67.8 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.787 2.035 . . . . 0.0 113.034 176.528 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.66 -34.11 67.03 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 120.745 -1.222 . . . . 0.0 112.132 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.3 mtm180 -60.74 -36.29 78.52 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 175.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 51.7 t60 -64.43 -39.71 94.35 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.885 0.874 . . . . 0.0 111.381 176.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 80.6 m -79.36 -32.73 43.28 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.246 0.619 . . . . 0.0 112.474 175.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.92 -31.25 71.55 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 120.503 -1.373 . . . . 0.0 111.697 173.003 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.5 -9.21 40.14 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.495 1.118 . . . . 0.0 113.832 171.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -116.91 12.5 14.71 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.298 1.839 . . . . 0.0 112.096 169.44 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 49.99 46.4 24.43 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.587 1.955 . . . . 0.0 113.587 -171.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.4 mmtt -122.21 162.4 21.46 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 127.33 2.252 . . . . 0.0 112.223 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -76.62 145.54 38.81 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.081 0.952 . . . . 0.0 109.305 167.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -133.13 138.05 9.83 Favored Glycine 0 N--CA 1.472 1.086 0 C-N-CA 124.501 1.048 . . . . 0.0 114.643 -179.131 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -149.81 141.74 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 125.368 1.467 . . . . 0.0 110.538 -172.075 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 84.0 m -78.55 116.83 19.2 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -179.519 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 -98.62 94.06 6.46 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.754 1.622 . . . . 0.0 109.466 168.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 63.24 -96.14 0.16 Allowed Glycine 0 CA--C 1.529 0.924 0 C-N-CA 125.188 1.375 . . . . 0.0 111.323 -176.724 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.7 p -118.58 14.97 13.68 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 127.52 2.328 . . . . 0.0 113.874 -173.108 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -138.58 168.6 19.44 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 127.25 2.22 . . . . 0.0 112.683 174.22 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 28.9 t -98.09 141.81 30.57 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.415 1.486 . . . . 0.0 110.733 171.28 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -128.87 120.56 26.45 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.081 1.352 . . . . 0.0 109.238 179.005 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 60.9 m -87.32 128.77 35.17 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.153 0.798 . . . . 0.0 113.153 -177.043 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -99.12 -126.82 5.75 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 126.522 2.01 . . . . 0.0 114.238 -169.533 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 16.8 m -75.9 152.74 84.77 Favored Pre-proline 0 N--CA 1.473 0.694 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 177.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -69.35 149.14 69.13 Favored 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 124.158 3.239 . . . . 0.0 110.987 174.137 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.0 pp -70.79 -13.9 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 -169.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 13.4 p -86.17 9.59 17.05 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.748 1.619 . . . . 0.0 114.537 168.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 46.06 33.66 1.77 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 130.339 3.456 . . . . 0.0 116.135 172.363 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 19.3 tp . . . . . 0 C--O 1.255 1.378 0 C-N-CA 125.89 1.676 . . . . 0.0 111.624 174.748 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.76 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 7.5 mmpt? -145.21 -37.66 0.27 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.429 1.492 . . . . 0.0 113.902 -168.113 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -70.54 -26.63 63.65 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 118.669 -0.681 . . . . 0.0 112.762 -169.101 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -138.14 5.01 2.51 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.184 0.994 . . . . 0.0 112.593 166.274 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 56.27 12.05 0.92 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.268 1.827 . . . . 0.0 115.471 -177.364 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.53 0.73 84.95 Favored Glycine 0 CA--C 1.541 1.712 0 N-CA-C 115.401 0.92 . . . . 0.0 115.401 -169.559 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 89.0 m -85.15 139.81 31.41 Favored 'General case' 0 C--O 1.236 0.39 0 O-C-N 121.037 -1.272 . . . . 0.0 112.421 178.509 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -151.12 131.01 13.28 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 167.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 44.49 55.0 6.02 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.43 1.892 . . . . 0.0 112.994 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 56.0 m-80 64.01 16.48 9.96 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 127.003 2.121 . . . . 0.0 116.173 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 19.8 t -124.93 147.45 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 O-C-N 120.935 -1.103 . . . . 0.0 111.396 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.85 37.4 0.18 Allowed 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 127.414 2.286 . . . . 0.0 112.493 176.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -68.32 -45.36 82.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 -168.369 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 25.4 mmmt -101.92 -14.24 17.29 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 -169.312 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 171.98 168.95 34.17 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-N 119.376 0.989 . . . . 0.0 115.19 174.467 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -87.5 81.3 7.82 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.02 1.728 . . . . 0.0 113.398 -171.078 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -46.28 -26.95 0.9 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 127.066 2.146 . . . . 0.0 113.831 171.281 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -32.37 -48.82 0.19 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.79 2.036 . . . . 0.0 112.485 166.447 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 55.2 mtm180 -66.57 -36.73 83.35 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 -171.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 15.7 t60 -68.64 -33.46 74.06 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-N 120.081 1.309 . . . . 0.0 112.3 176.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 71.5 m -80.76 -39.17 27.33 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 121.588 -0.695 . . . . 0.0 111.488 175.303 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -62.19 -32.8 73.49 Favored 'General case' 0 CA--C 1.53 0.206 0 O-C-N 120.54 -1.35 . . . . 0.0 112.072 177.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.1 -22.35 50.31 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.433 1.093 . . . . 0.0 113.595 174.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -121.27 23.04 10.65 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.874 1.669 . . . . 0.0 111.807 177.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 31.3 t0 56.57 55.79 6.14 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.957 1.703 . . . . 0.0 112.728 177.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm -138.77 151.62 47.24 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 127.647 2.379 . . . . 0.0 111.805 177.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -72.35 145.0 48.05 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 166.413 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -118.08 134.71 11.18 Favored Glycine 0 N--CA 1.469 0.846 0 C-N-CA 124.076 0.846 . . . . 0.0 112.607 175.172 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -144.07 140.18 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 125.201 1.401 . . . . 0.0 110.35 -177.572 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 99.9 m -78.68 114.82 17.92 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -174.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -107.63 103.06 12.27 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 126.879 2.072 . . . . 0.0 108.64 173.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 61.83 -116.59 9.57 Favored Glycine 0 CA--C 1.532 1.099 0 N-CA-C 111.109 -0.797 . . . . 0.0 111.109 -173.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 76.0 p -101.21 14.32 32.34 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 125.333 1.453 . . . . 0.0 114.128 175.01 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -127.69 165.13 20.61 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.989 1.715 . . . . 0.0 112.503 -173.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 46.8 t -104.45 121.41 43.37 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.382 1.073 . . . . 0.0 110.405 177.404 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 48.7 tptt -97.08 120.86 38.23 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 126.746 2.018 . . . . 0.0 106.693 177.326 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 59.5 m -84.85 137.9 32.88 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 123.612 0.57 . . . . 0.0 111.617 171.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -119.64 -124.96 3.29 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 126.158 1.837 . . . . 0.0 114.526 -169.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 15.3 m -83.59 157.54 64.21 Favored Pre-proline 0 N--CA 1.47 0.562 0 C-N-CA 125.966 1.706 . . . . 0.0 113.585 -179.084 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -65.17 159.55 46.36 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 123.862 3.041 . . . . 0.0 114.44 -178.035 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.53 HD12 ' H ' ' A' ' 43' ' ' TYR . 2.4 pp -114.74 -35.48 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -173.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 13.6 m 46.73 31.5 1.44 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 127.407 2.283 . . . . 0.0 116.993 174.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.53 ' H ' HD12 ' A' ' 41' ' ' ILE . 7.3 p90 -131.27 167.08 19.82 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 126.965 2.106 . . . . 0.0 112.326 170.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.5 pt? . . . . . 0 C--O 1.252 1.219 0 N-CA-C 116.089 1.885 . . . . 0.0 116.089 -175.549 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.592 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -92.65 -23.9 18.83 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.629 1.571 . . . . 0.0 112.491 -168.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -62.62 -28.08 69.66 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.189 0.596 . . . . 0.0 112.142 167.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -99.46 -1.59 38.15 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 168.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 54.15 19.45 2.14 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 126.193 1.797 . . . . 0.0 114.24 -172.268 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 76.34 -2.98 55.51 Favored Glycine 0 CA--C 1.542 1.721 0 C-N-CA 124.955 1.264 . . . . 0.0 115.692 -170.506 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 78.4 m -77.28 134.89 38.43 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.689 1.196 . . . . 0.0 112.132 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -146.14 136.28 23.69 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.655 0.782 . . . . 0.0 111.575 168.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 44.83 49.3 9.05 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.264 1.425 . . . . 0.0 112.744 -176.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 63.61 26.03 14.52 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 126.742 2.017 . . . . 0.0 115.023 175.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 49.7 t -136.97 145.99 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 125.996 1.718 . . . . 0.0 111.027 178.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -75.69 49.31 0.5 Allowed 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 126.041 1.736 . . . . 0.0 113.645 174.254 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -71.44 -51.53 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 O-C-N 120.166 -1.584 . . . . 0.0 113.894 -173.656 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -91.16 -9.19 46.36 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.02 0.928 . . . . 0.0 113.249 -172.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 176.01 172.98 41.29 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 126.512 2.006 . . . . 0.0 111.048 169.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -94.06 144.41 25.5 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 179.385 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 44.0 t -100.52 -10.66 20.83 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.144 0.977 . . . . 0.0 112.236 169.393 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -51.19 -43.23 61.3 Favored 'General case' 0 N--CA 1.466 0.337 0 O-C-N 120.799 -1.188 . . . . 0.0 111.663 178.291 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.5 mtm180 -56.39 -41.83 76.9 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 175.716 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 11.7 t60 -61.47 -46.76 88.67 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.621 0.768 . . . . 0.0 111.156 177.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 92.2 m -80.12 -29.2 38.91 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -178.383 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 23.8 tptp -67.71 -22.95 65.23 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 120.764 -1.21 . . . . 0.0 113.008 175.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.18 -27.26 69.24 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 118.793 0.724 . . . . 0.0 112.305 168.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -101.95 7.78 41.29 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 126.952 2.101 . . . . 0.0 111.984 171.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . 0.28 1.8 t70 54.63 33.61 19.62 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 129.1 2.96 . . . . 0.0 115.8 -175.576 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 28.9 mttt -109.66 163.22 13.68 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 127.603 2.361 . . . . 0.0 113.168 174.353 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -69.89 144.05 52.59 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.202 1.401 . . . . 0.0 109.18 167.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -95.45 151.72 20.11 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 123.875 0.75 . . . . 0.0 112.371 169.152 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.41 117.96 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 118.686 1.243 . . . . 0.0 110.777 -178.669 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 98.4 m -82.06 108.42 15.53 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.294 171.679 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 27.6 p80 -104.91 8.55 34.65 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 176.144 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 170.76 -134.45 3.13 Favored Glycine 0 CA--C 1.523 0.566 0 C-N-CA 123.83 0.729 . . . . 0.0 111.93 179.266 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 42.6 p -82.04 13.95 3.09 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 126.663 1.985 . . . . 0.0 112.289 168.496 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -149.22 170.37 18.63 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 128.978 2.911 . . . . 0.0 109.413 -172.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 14.9 t -128.76 173.68 10.12 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.022 1.329 . . . . 0.0 113.255 -176.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.0 mtpt -155.74 169.32 24.64 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 130.097 3.359 . . . . 0.0 107.244 178.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 59.8 m -104.27 148.81 25.92 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.87 0.868 . . . . 0.0 112.365 168.223 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -98.19 -119.9 4.11 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 126.985 2.231 . . . . 0.0 112.589 -177.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 19.5 m -100.59 159.03 30.77 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 126.499 1.92 . . . . 0.0 112.765 175.141 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -50.27 140.35 34.11 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 124.997 3.798 . . . . 0.0 113.912 168.5 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.7 pp -82.1 -25.84 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 O-C-N 121.417 -0.802 . . . . 0.0 113.018 -177.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 7.3 m 43.57 40.77 3.04 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 128.757 2.823 . . . . 0.0 117.808 168.643 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -147.39 -29.5 0.35 Allowed 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 115.694 1.738 . . . . 0.0 115.694 178.712 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 17.8 tp . . . . . 0 C--O 1.245 0.842 0 C-N-CA 126.977 2.111 . . . . 0.0 111.123 179.595 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.829 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -133.99 -31.18 1.16 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.714 1.606 . . . . 0.0 112.762 -178.121 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -87.46 -21.49 25.5 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.35 0.871 . . . . 0.0 113.35 -170.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -131.94 -4.56 3.56 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.696 0.798 . . . . 0.0 112.533 166.671 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 56.61 17.78 3.26 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.468 1.907 . . . . 0.0 114.581 -177.156 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 84.11 -9.32 63.9 Favored Glycine 0 CA--C 1.538 1.506 0 C-N-CA 124.771 1.176 . . . . 0.0 115.135 -170.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 92.7 m -80.35 139.33 36.62 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.436 1.094 . . . . 0.0 113.05 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -152.35 134.35 14.9 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.666 0.786 . . . . 0.0 110.61 168.2 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 49.6 49.32 20.18 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.675 1.19 . . . . 0.0 113.996 178.22 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 60.32 21.11 10.61 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 126.32 1.848 . . . . 0.0 115.547 -178.112 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 69.4 t -132.08 149.37 32.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 125.523 1.529 . . . . 0.0 110.035 -178.345 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.39 39.0 0.19 Allowed 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 126.806 2.043 . . . . 0.0 111.749 178.801 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -58.67 -44.5 89.92 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 N-CA-C 115.243 1.571 . . . . 0.0 115.243 -165.825 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -91.98 -26.44 18.38 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.954 0.902 . . . . 0.0 111.469 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 173.14 173.99 39.91 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 125.843 1.687 . . . . 0.0 112.959 178.112 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -84.3 142.81 29.95 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.065 0.946 . . . . 0.0 112.957 175.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.7 p -102.18 -0.03 33.84 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.786 1.234 . . . . 0.0 114.151 174.01 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.4 tmmm? -53.36 -45.1 69.04 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 118.138 -0.934 . . . . 0.0 111.136 173.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 44.4 mtm180 -60.63 -37.21 80.72 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.543 1.065 . . . . 0.0 113.261 -176.634 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 10.7 t60 -61.76 -46.57 89.0 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.272 1.029 . . . . 0.0 112.313 173.461 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 84.9 m -72.95 -31.29 64.48 Favored 'General case' 0 CA--C 1.545 0.783 0 O-C-N 121.187 -0.946 . . . . 0.0 112.308 176.347 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 41.3 tptt -65.24 -21.59 66.76 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 126.023 1.729 . . . . 0.0 112.764 177.201 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.86 -17.63 17.56 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.755 0.822 . . . . 0.0 112.765 168.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -123.56 15.25 9.54 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 126.766 2.027 . . . . 0.0 112.699 172.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 22.5 t70 65.04 14.85 9.64 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 128.395 2.678 . . . . 0.0 115.387 -175.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.3 mmtp -84.17 149.38 26.2 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 126.526 1.93 . . . . 0.0 111.637 178.04 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -71.37 137.32 48.29 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 124.245 1.018 . . . . 0.0 108.559 167.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -110.76 128.89 8.99 Favored Glycine 0 N--CA 1.471 1.013 0 C-N-CA 123.907 0.765 . . . . 0.0 111.927 173.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.37 143.07 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 124.501 1.12 . . . . 0.0 111.152 -177.513 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 77.7 m -79.13 115.13 18.6 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -174.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 27.7 m-70 -112.22 104.17 12.35 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.36 1.464 . . . . 0.0 108.568 168.132 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.79 -122.79 23.06 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 124.226 0.917 . . . . 0.0 111.933 -173.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 40.1 p -101.7 21.34 14.61 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 127.054 2.141 . . . . 0.0 113.088 178.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -139.15 163.21 33.04 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 126.137 1.775 . . . . 0.0 112.169 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 6.4 t -86.05 157.41 20.08 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.429 168.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 6.0 tmtm? -131.65 126.35 34.44 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 168.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 79.4 m -83.88 130.53 34.91 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 120.805 0.335 . . . . 0.0 110.849 173.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -97.97 -131.6 7.2 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 125.468 1.508 . . . . 0.0 113.502 -171.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 28.9 m -87.31 168.2 18.44 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 125.054 1.341 . . . . 0.0 109.983 168.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -46.75 144.15 8.22 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 123.854 3.036 . . . . 0.0 113.301 169.293 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.495 HD12 ' N ' ' A' ' 42' ' ' SER . 2.6 pp -58.26 -46.89 88.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -170.607 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.495 ' N ' HD12 ' A' ' 41' ' ' ILE 0.266 24.0 p 59.39 22.55 10.99 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 118.795 2.887 . . . . 0.0 118.795 -176.913 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 20.8 p90 -142.39 -75.77 0.28 Allowed 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 126.459 1.903 . . . . 0.0 113.259 169.627 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 56.5 tp . . . . . 0 C--O 1.252 1.211 0 C-N-CA 126.148 1.779 . . . . 0.0 112.941 -172.42 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.795 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -140.73 112.16 7.38 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.806 1.642 . . . . 0.0 111.894 -171.364 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 28.2 m-20 61.39 -19.58 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 128.756 2.823 . . . . 0.0 117.404 174.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -123.36 2.87 9.12 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.939 1.295 . . . . 0.0 113.311 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 59.71 5.19 0.65 Allowed 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 115.853 1.797 . . . . 0.0 115.853 -175.625 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 92.13 -3.62 76.81 Favored Glycine 0 CA--C 1.542 1.752 0 C-N-CA 125.401 1.477 . . . . 0.0 114.657 -168.253 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 96.3 m -78.7 136.82 37.53 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -154.63 141.49 19.14 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.401 1.08 . . . . 0.0 111.316 165.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 51.53 40.48 27.05 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.961 1.304 . . . . 0.0 114.391 177.597 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 24.7 m-20 64.62 21.11 12.35 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 126.504 1.922 . . . . 0.0 115.917 -174.159 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 40.4 t -134.42 147.08 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 125.164 1.386 . . . . 0.0 112.458 -176.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -76.94 53.32 0.93 Allowed 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 127.029 2.132 . . . . 0.0 112.113 173.318 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -80.4 -36.43 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 124.929 1.292 . . . . 0.0 114.239 -174.443 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -96.98 -3.65 41.23 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.47 1.108 . . . . 0.0 112.995 177.189 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 159.47 170.18 23.72 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 125.769 1.652 . . . . 0.0 113.049 172.237 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -87.35 107.98 18.77 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.332 1.053 . . . . 0.0 113.398 -176.415 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -62.06 -26.14 68.09 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.751 1.621 . . . . 0.0 112.356 174.644 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -43.71 -44.69 6.69 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.278 1.431 . . . . 0.0 110.416 167.666 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 8.7 ttm180 -64.14 -26.24 68.44 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 115.058 1.503 . . . . 0.0 115.058 -178.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 67.4 t60 -77.05 -42.73 37.24 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 120.596 -1.315 . . . . 0.0 111.428 171.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 92.2 m -70.84 -29.43 65.56 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 121.817 -0.552 . . . . 0.0 111.91 175.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 51.7 tptt -68.54 -27.1 65.79 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.726 2.01 . . . . 0.0 114.16 177.484 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.17 -16.16 61.34 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.615 0.766 . . . . 0.0 112.783 169.423 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -110.8 4.28 19.75 Favored 'General case' 0 CA--C 1.556 1.205 0 C-N-CA 127.296 2.238 . . . . 0.0 112.018 170.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . 0.287 3.7 t70 59.61 37.6 22.48 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 129.258 3.023 . . . . 0.0 115.211 -173.804 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.4 mttp -116.12 160.29 20.55 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.868 2.067 . . . . 0.0 115.145 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -66.69 144.4 56.39 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.209 1.403 . . . . 0.0 109.003 167.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -131.1 136.1 8.62 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 125.043 1.306 . . . . 0.0 115.297 178.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -138.55 138.27 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 124.171 0.988 . . . . 0.0 112.057 -179.367 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 90.9 m -77.28 104.7 7.94 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.872 0.869 . . . . 0.0 113.123 -178.344 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 27.5 m-70 -90.77 92.52 8.84 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 123.662 0.785 . . . . 0.0 109.004 167.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.9 -116.57 6.91 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 124.628 1.108 . . . . 0.0 112.417 -172.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 63.4 p -99.95 11.8 38.39 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.965 1.706 . . . . 0.0 113.993 177.492 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -129.97 160.19 34.38 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.208 1.403 . . . . 0.0 111.541 178.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 34.6 t -98.32 147.52 24.59 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.976 1.31 . . . . 0.0 110.647 179.638 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 30.9 ttmt -141.53 124.76 16.44 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 125.073 1.349 . . . . 0.0 108.191 -178.129 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 19.4 m -89.15 144.64 25.97 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -171.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -107.08 -131.01 6.58 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 126.569 2.033 . . . . 0.0 113.212 -175.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.6 m -73.42 158.96 85.86 Favored Pre-proline 0 N--CA 1.473 0.692 0 C-N-CA 124.209 1.003 . . . . 0.0 113.668 172.351 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -64.56 149.75 89.36 Favored 'Trans proline' 0 CA--C 1.535 0.526 0 C-N-CA 123.503 2.802 . . . . 0.0 111.248 171.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.603 HD12 ' H ' ' A' ' 43' ' ' TYR . 2.2 pp -77.24 -29.47 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 O-C-N 121.532 -0.73 . . . . 0.0 112.688 -174.698 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.0 m 45.21 33.65 1.21 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 128.803 2.841 . . . . 0.0 118.344 169.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.603 ' H ' HD12 ' A' ' 41' ' ' ILE . 1.4 p90 -147.4 -64.14 0.27 Allowed 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 114.513 1.301 . . . . 0.0 114.513 173.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.252 1.187 0 CA-C-N 120.575 1.534 . . . . 0.0 113.108 -178.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.083 0 CA-C-O 118.909 -0.567 . . . . 0.0 110.72 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -140.69 -148.88 0.26 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.287 1.035 . . . . 0.0 111.708 -178.09 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 16.4 p-10 -49.43 -39.88 34.54 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 127.84 2.456 . . . . 0.0 112.603 178.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -110.28 19.91 18.37 Favored 'General case' 0 C--O 1.224 -0.245 0 C-N-CA 125.401 1.48 . . . . 0.0 111.477 -179.426 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 61.26 -2.22 0.24 Allowed 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.583 1.553 . . . . 0.0 114.7 -174.252 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 96.18 -9.1 67.53 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 125.489 1.519 . . . . 0.0 113.831 -169.036 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 70.9 m -89.46 141.6 28.42 Favored 'General case' 0 C--O 1.236 0.354 0 O-C-N 121.511 -0.994 . . . . 0.0 113.469 -175.652 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -154.38 139.83 17.76 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.173 0.989 . . . . 0.0 109.93 165.613 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 51.55 44.7 28.92 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.788 1.235 . . . . 0.0 114.189 177.006 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 60.51 17.34 7.23 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 126.223 1.809 . . . . 0.0 115.602 -174.325 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 41.6 t -126.75 148.05 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.865 1.266 . . . . 0.0 111.881 -177.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -76.0 40.37 0.2 Allowed 'General case' 0 CA--C 1.558 1.271 0 C-N-CA 128.686 2.794 . . . . 0.0 111.947 177.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -74.89 -54.53 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 C-N-CA 126.105 1.762 . . . . 0.0 113.544 -170.02 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -78.71 -7.46 57.75 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.106 1.363 . . . . 0.0 112.545 -172.226 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 162.1 -171.09 37.92 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 125.863 1.697 . . . . 0.0 111.482 175.1 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -95.75 120.95 36.92 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -176.173 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.5 t -77.59 -20.17 54.42 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.667 1.187 . . . . 0.0 112.636 170.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 8.8 tppt? -44.92 -50.78 10.3 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.594 1.558 . . . . 0.0 111.013 172.412 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 42.4 mtm180 -64.77 -26.64 68.44 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 115.676 1.732 . . . . 0.0 115.676 -173.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 59.6 t60 -72.81 -37.06 67.64 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 119.272 0.942 . . . . 0.0 112.032 174.679 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 93.0 m -84.88 -29.72 25.01 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.437 0.695 . . . . 0.0 112.863 177.216 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.76 -29.12 66.52 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 126.138 1.775 . . . . 0.0 112.317 171.533 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.99 -19.77 54.13 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.5 1.12 . . . . 0.0 113.859 171.016 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -114.38 9.34 16.84 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 127.192 2.197 . . . . 0.0 111.789 176.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.4 t70 57.18 38.96 29.14 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 126.815 2.046 . . . . 0.0 113.594 -171.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.9 mmtp -119.23 156.85 29.16 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 128.175 2.59 . . . . 0.0 112.073 -176.499 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -76.68 147.71 37.27 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 124.199 0.999 . . . . 0.0 109.643 168.497 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.16 154.56 19.11 Favored Glycine 0 CA--C 1.542 1.755 0 C-N-CA 125.059 1.314 . . . . 0.0 114.247 173.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -151.67 136.87 10.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 125.954 1.701 . . . . 0.0 110.211 175.254 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 93.9 m -84.18 118.02 23.87 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -174.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -101.96 91.4 4.34 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.347 1.859 . . . . 0.0 108.956 168.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 64.71 -118.7 13.01 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.392 0.996 . . . . 0.0 112.112 -176.27 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 54.2 p -89.84 11.63 19.66 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 126.633 1.973 . . . . 0.0 113.846 174.523 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm -131.08 166.57 20.77 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 126.306 1.843 . . . . 0.0 112.14 -171.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 47.3 t -121.47 135.2 55.06 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.452 1.501 . . . . 0.0 111.26 -175.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 12.4 tptt -123.16 153.65 39.74 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 128.762 2.825 . . . . 0.0 107.776 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 63.9 m -111.93 127.64 55.92 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 113.707 1.002 . . . . 0.0 113.707 -173.182 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -87.39 -130.7 3.17 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 126.518 2.009 . . . . 0.0 113.95 -176.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 25.4 m -80.57 161.1 65.52 Favored Pre-proline 0 CA--C 1.532 0.285 0 C-N-CA 125.726 1.611 . . . . 0.0 112.711 176.354 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo -52.19 145.6 34.19 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 123.992 3.128 . . . . 0.0 112.411 168.077 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.582 HD12 ' N ' ' A' ' 42' ' ' SER . 2.7 pp -66.36 -47.01 85.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 -169.849 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.582 ' N ' HD12 ' A' ' 41' ' ' ILE 0.258 68.6 m 44.3 25.43 0.12 Allowed 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 119.035 2.976 . . . . 0.0 119.035 -177.932 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -153.51 -49.71 0.1 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.506 1.923 . . . . 0.0 113.181 167.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 18.0 tp . . . . . 0 C--O 1.254 1.294 0 CA-C-O 115.822 -2.037 . . . . 0.0 113.848 178.588 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.919 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -135.85 -59.08 0.76 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.922 1.289 . . . . 0.0 113.646 -172.077 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 38.4 p-10 -136.24 -35.34 0.76 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.33 1.452 . . . . 0.0 114.621 -168.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -133.96 14.86 3.93 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.398 1.879 . . . . 0.0 112.977 -179.428 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 54.54 20.11 2.7 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.111 1.365 . . . . 0.0 114.024 -169.46 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 71.58 0.11 37.77 Favored Glycine 0 CA--C 1.534 1.279 0 O-C-N 120.684 -1.26 . . . . 0.0 115.04 -177.261 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 72.8 m -88.29 136.82 32.8 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.984 0.913 . . . . 0.0 112.847 -175.118 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -150.4 139.09 20.72 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.253 1.021 . . . . 0.0 111.263 166.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 48.65 48.34 19.89 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.145 1.378 . . . . 0.0 113.64 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 47.8 m-20 65.48 12.97 8.57 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 126.164 1.786 . . . . 0.0 115.668 -177.287 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.9 t -130.34 146.4 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 124.615 1.166 . . . . 0.0 112.002 -175.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -74.24 43.23 0.17 Allowed 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 127.422 2.289 . . . . 0.0 113.951 172.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -69.56 -39.22 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 O-C-N 120.892 -1.13 . . . . 0.0 113.689 -174.329 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -92.66 -19.18 22.11 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -174.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 176.5 -150.06 10.2 Favored Glycine 0 CA--C 1.534 1.278 0 N-CA-C 115.882 1.113 . . . . 0.0 115.882 178.259 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -105.65 135.21 47.48 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.572 1.549 . . . . 0.0 113.961 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -109.47 -24.06 11.2 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 129.049 2.94 . . . . 0.0 110.633 170.248 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 12.9 tppt? -40.15 -52.6 2.56 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 126.083 1.753 . . . . 0.0 111.975 169.321 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 60.5 mtm180 -61.8 -30.54 70.88 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 114.527 1.306 . . . . 0.0 114.527 -174.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 68.7 t60 -69.55 -44.08 71.64 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 118.99 0.814 . . . . 0.0 111.62 175.075 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 91.4 m -78.09 -30.65 49.66 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 179.226 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 49.8 tptt -65.8 -20.75 66.37 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.441 1.896 . . . . 0.0 113.387 176.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.65 -29.99 70.15 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.906 0.882 . . . . 0.0 111.929 169.012 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 -91.22 6.35 45.48 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 126.166 1.786 . . . . 0.0 111.674 168.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.6 t70 52.8 36.68 22.0 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 127.825 2.45 . . . . 0.0 113.999 -170.173 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.8 mttt -112.61 160.03 18.27 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.777 2.031 . . . . 0.0 113.004 178.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 53.4 mm-40 -67.74 142.93 56.12 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 124.62 1.168 . . . . 0.0 109.907 167.472 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -113.77 135.15 12.3 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 125.276 1.417 . . . . 0.0 113.795 175.019 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -142.35 132.73 24.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 124.463 1.105 . . . . 0.0 110.633 -170.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 84.5 m -78.2 113.93 16.61 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -173.3 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 22.4 m-70 -105.78 104.78 14.57 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.917 1.687 . . . . 0.0 108.088 169.415 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 70.84 -118.12 7.37 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 125.034 1.302 . . . . 0.0 111.322 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 63.0 p -103.83 16.27 26.74 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.455 1.502 . . . . 0.0 112.544 174.065 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 49.5 mmtm -132.45 163.84 27.88 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.169 1.788 . . . . 0.0 112.104 -173.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 11.0 t -87.87 156.48 19.36 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.052 0.941 . . . . 0.0 111.083 170.597 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.73 145.06 30.71 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 127.645 2.378 . . . . 0.0 105.91 170.718 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 38.4 m -98.81 143.55 29.03 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -178.476 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -98.64 -117.14 3.78 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 126.712 2.101 . . . . 0.0 113.893 -175.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.5 m -103.4 162.55 19.7 Favored Pre-proline 0 CA--C 1.538 0.492 0 C-N-CA 126.906 2.082 . . . . 0.0 111.78 176.378 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_exo -47.3 141.21 14.03 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 124.743 3.629 . . . . 0.0 112.914 168.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.505 HD12 ' N ' ' A' ' 42' ' ' SER . 2.5 pp -67.47 -32.76 58.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 O-C-N 121.359 -0.838 . . . . 0.0 112.301 -178.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.505 ' N ' HD12 ' A' ' 41' ' ' ILE . 0.3 OUTLIER 55.4 17.27 2.09 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 129.469 3.108 . . . . 0.0 118.34 169.689 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -161.51 -31.84 0.05 OUTLIER 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 117.956 2.576 . . . . 0.0 117.956 172.204 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.5 tm? . . . . . 0 C--O 1.254 1.336 0 C-N-CA 125.76 1.624 . . . . 0.0 112.265 -171.553 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 . . . . . 0 N--CA 1.474 0.727 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 57.16 23.64 8.85 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.679 1.191 . . . . 0.0 114.043 -178.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 75.58 -6.18 33.02 Favored Glycine 0 CA--C 1.538 1.508 0 C-N-CA 123.93 0.776 . . . . 0.0 114.879 -173.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 84.2 m -80.96 143.87 32.27 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.088 1.355 . . . . 0.0 112.009 -179.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -151.43 142.77 23.39 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.938 0.895 . . . . 0.0 109.897 168.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 49.25 37.41 11.24 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 178.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 70.98 15.99 6.56 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 126.044 1.738 . . . . 0.0 115.531 -175.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 34.9 t -132.15 148.25 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 125.036 1.335 . . . . 0.0 112.396 -173.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.53 42.66 0.17 Allowed 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 127.455 2.302 . . . . 0.0 113.096 174.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -67.42 -51.27 54.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 O-C-N 120.048 -1.657 . . . . 0.0 112.579 -173.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 27.3 mtpt -90.07 -21.81 22.13 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -175.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 179.31 -176.9 48.11 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 125.294 1.426 . . . . 0.0 112.724 174.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -95.27 151.2 19.45 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.843 1.257 . . . . 0.0 112.822 176.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 40.4 t -98.26 -12.28 21.76 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.423 1.089 . . . . 0.0 111.387 167.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -53.69 -36.04 61.76 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 120.663 -1.273 . . . . 0.0 112.174 -178.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -63.06 -30.26 71.46 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 115.423 1.638 . . . . 0.0 115.423 174.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 56.4 t60 -75.41 -43.27 50.89 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 119.574 1.079 . . . . 0.0 111.614 172.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 93.2 m -80.76 -27.38 36.78 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -177.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.3 -31.08 71.64 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 120.28 -1.512 . . . . 0.0 111.705 173.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.91 -18.95 64.94 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.237 1.015 . . . . 0.0 113.397 171.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -97.25 6.14 48.87 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 126.799 2.039 . . . . 0.0 111.065 169.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.4 t0 54.19 32.51 16.11 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 127.702 2.401 . . . . 0.0 114.488 -169.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.4 mttp -119.24 161.48 20.32 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 126.901 2.08 . . . . 0.0 113.934 -173.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -70.99 146.44 49.42 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 167.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -108.3 139.61 15.19 Favored Glycine 0 N--CA 1.472 1.078 0 C-N-CA 124.65 1.119 . . . . 0.0 111.717 169.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -144.73 126.12 8.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 118.219 1.01 . . . . 0.0 112.022 -177.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 87.8 m -73.69 111.85 9.22 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.825 0.85 . . . . 0.0 112.671 -176.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 38.7 m-70 -108.62 102.92 11.94 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.009 1.323 . . . . 0.0 109.383 169.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.59 -123.86 14.4 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 125.67 1.605 . . . . 0.0 112.934 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 61.2 p -97.05 14.89 24.1 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 126.856 2.062 . . . . 0.0 113.038 175.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -136.28 -173.87 3.52 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 128.938 2.895 . . . . 0.0 111.185 179.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 41.8 t -132.05 161.39 33.33 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.931 1.292 . . . . 0.0 111.488 177.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 67.4 mttt -133.81 142.15 47.74 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 128.503 2.721 . . . . 0.0 106.457 171.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 84.3 m -83.99 134.67 34.63 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 168.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -85.78 -141.53 6.01 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 124.935 1.255 . . . . 0.0 110.961 176.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.9 m -71.7 154.72 92.92 Favored Pre-proline 0 N--CA 1.472 0.669 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 177.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo . . . . . 0 CA--C 1.536 0.58 0 C-N-CA 123.747 2.964 . . . . 0.0 110.184 169.66 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 . . . . . 0 CA--C 1.542 0.658 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 57.98 9.79 1.01 Allowed 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 125.43 1.492 . . . . 0.0 114.191 -170.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 86.65 -3.96 86.6 Favored Glycine 0 CA--C 1.539 1.573 0 C-N-CA 124.757 1.17 . . . . 0.0 115.685 -169.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 79.6 m -80.01 140.5 36.54 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 119.013 1.406 . . . . 0.0 112.727 -179.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -154.28 142.42 20.36 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.591 0.756 . . . . 0.0 110.49 166.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 51.26 37.76 19.5 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -178.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.535 ' ND2' ' H ' ' A' ' 32' ' ' GLY . 12.9 m120 62.59 20.78 12.24 Favored 'General case' 0 CA--C 1.548 0.904 0 N-CA-C 116.04 1.867 . . . . 0.0 116.04 -174.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 59.3 t -125.64 147.75 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 125.825 1.65 . . . . 0.0 111.355 -177.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -76.93 43.92 0.37 Allowed 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 126.326 1.85 . . . . 0.0 112.913 177.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.5 m -69.18 -56.34 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 O-C-N 120.633 -1.292 . . . . 0.0 114.163 -169.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -86.56 -11.62 51.03 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.176 0.99 . . . . 0.0 113.602 -179.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 179.71 171.8 43.07 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.67 1.128 . . . . 0.0 112.134 174.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.416 ' OD1' ' HE3' ' A' ' 18' ' ' LYS . 36.7 t70 -98.02 115.56 28.45 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.141 0.976 . . . . 0.0 112.772 -169.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 16.3 t -68.5 -30.72 69.61 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 121.153 -0.967 . . . . 0.0 112.762 177.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.416 ' HE3' ' OD1' ' A' ' 16' ' ' ASP . 0.0 OUTLIER -54.48 -37.25 65.04 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 117.932 -1.032 . . . . 0.0 111.716 171.763 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 24.9 ttm180 -60.39 -36.33 77.83 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 120.717 1.598 . . . . 0.0 114.788 177.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 36.2 t60 -68.61 -44.75 73.64 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 118.478 0.581 . . . . 0.0 110.968 172.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 89.0 m -76.64 -27.43 55.67 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -177.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.8 tppp? -60.72 -34.11 73.91 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.33 1.452 . . . . 0.0 111.51 173.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.1 -23.66 65.86 Favored 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 173.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -94.95 7.55 45.68 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.258 1.423 . . . . 0.0 112.409 170.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 51.74 40.18 27.01 Favored 'General case' 0 CA--C 1.556 1.178 0 C-N-CA 126.744 2.018 . . . . 0.0 112.745 -172.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 37.1 mttt -122.03 167.15 13.45 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 127.73 2.412 . . . . 0.0 112.6 178.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -83.3 155.84 23.39 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.548 1.139 . . . . 0.0 109.054 168.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -114.12 163.48 12.16 Favored Glycine 0 CA--C 1.546 1.993 0 C-N-CA 125.338 1.446 . . . . 0.0 115.502 -178.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -150.34 128.2 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 126.616 1.966 . . . . 0.0 112.077 177.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 69.4 m -85.32 101.64 12.72 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.654 0.781 . . . . 0.0 110.701 170.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.505 ' CD2' ' HB2' ' A' ' 36' ' ' LYS . 10.4 p80 -91.59 98.8 11.87 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 122.688 1.233 . . . . 0.0 108.983 170.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.535 ' H ' ' ND2' ' A' ' 10' ' ' ASN . . . 66.36 -105.84 1.42 Allowed Glycine 0 CA--C 1.53 0.988 0 C-N-CA 125.065 1.317 . . . . 0.0 112.03 -174.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 52.0 p -112.78 14.22 19.88 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 126.925 2.09 . . . . 0.0 113.563 -176.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 21.2 mmmt -134.95 161.24 35.83 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.065 1.346 . . . . 0.0 110.817 177.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 52.8 t -101.32 157.14 17.01 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.649 1.18 . . . . 0.0 111.278 177.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.505 ' HB2' ' CD2' ' A' ' 31' ' ' HIS . 3.5 ttmt -147.65 169.72 19.05 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 128.341 2.656 . . . . 0.0 107.107 169.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 39.5 m -101.38 156.39 17.48 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 122.786 1.279 . . . . 0.0 113.25 172.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -105.72 -133.95 7.72 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 127.365 2.412 . . . . 0.0 110.751 175.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.8 m -78.99 156.31 77.05 Favored Pre-proline 0 CA--C 1.538 0.517 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 175.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo . . . . . 0 CA--C 1.54 0.817 0 C-N-CA 124.486 3.458 . . . . 0.0 112.598 167.743 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 . . . . . 0 CA--C 1.54 0.569 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 55.82 21.01 4.45 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.297 1.439 . . . . 0.0 114.149 -174.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 77.66 -4.67 55.76 Favored Glycine 0 CA--C 1.542 1.771 0 C-N-CA 124.031 0.824 . . . . 0.0 114.986 -171.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 94.8 m -80.59 140.0 35.99 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.134 1.374 . . . . 0.0 112.763 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -151.42 134.12 15.61 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.636 0.775 . . . . 0.0 110.788 166.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 47.01 51.33 13.02 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.851 1.26 . . . . 0.0 113.054 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 26.7 m-20 61.07 7.36 1.53 Allowed 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 117.199 2.296 . . . . 0.0 117.199 -175.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.4 t -116.58 140.11 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 O-C-N 120.648 -1.283 . . . . 0.0 111.335 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -77.74 66.74 3.49 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.883 1.273 . . . . 0.0 110.977 169.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -82.3 -41.94 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 125.227 1.411 . . . . 0.0 112.955 178.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -89.97 -16.87 28.98 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.052 0.941 . . . . 0.0 112.534 178.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 164.94 165.34 22.06 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 125.236 1.398 . . . . 0.0 112.119 172.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -78.01 140.21 39.15 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 117.95 0.875 . . . . 0.0 113.055 177.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -89.13 -23.77 22.39 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.162 1.785 . . . . 0.0 111.173 175.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -55.08 -32.73 62.18 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 117.759 -1.115 . . . . 0.0 113.205 176.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.81 -35.35 66.25 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 120.609 1.549 . . . . 0.0 114.48 171.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 40.6 t60 -75.03 -28.41 60.45 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 119.666 1.121 . . . . 0.0 112.731 176.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 86.3 m -79.54 -36.76 37.88 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.888 1.275 . . . . 0.0 112.673 173.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 70.9 tttt -59.31 -32.09 69.74 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.15 1.78 . . . . 0.0 113.157 -178.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.61 -14.83 63.28 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 114.236 1.198 . . . . 0.0 114.236 176.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -117.66 19.33 13.91 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.926 1.69 . . . . 0.0 112.572 175.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.8 t70 56.16 63.61 1.96 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.378 1.471 . . . . 0.0 111.049 -175.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm -147.77 146.52 29.22 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 126.383 1.873 . . . . 0.0 112.803 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 57.1 mm-40 -75.43 156.34 35.42 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 163.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -134.16 150.43 20.0 Favored Glycine 0 N--CA 1.473 1.147 0 O-C-N 121.019 -1.051 . . . . 0.0 113.234 178.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -150.5 143.06 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 125.069 1.348 . . . . 0.0 110.084 -173.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 70.7 m -80.71 117.66 21.58 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 121.248 -0.908 . . . . 0.0 112.483 -175.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 -107.83 97.69 7.38 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.898 1.279 . . . . 0.0 108.353 169.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.06 -114.68 4.86 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 125.213 1.387 . . . . 0.0 112.233 -172.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 72.8 p -112.89 20.6 16.27 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 127.56 2.344 . . . . 0.0 112.143 178.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 22.5 mmtm -136.25 169.33 17.81 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 128.043 2.537 . . . . 0.0 112.169 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 34.7 t -105.81 139.1 40.9 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.642 1.577 . . . . 0.0 112.481 -174.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -123.31 124.62 43.37 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 126.924 2.09 . . . . 0.0 107.605 177.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 73.4 m -83.53 141.6 31.5 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 121.936 0.874 . . . . 0.0 113.358 176.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -111.77 -145.73 10.03 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 127.522 2.486 . . . . 0.0 113.035 -178.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.5 m -63.44 156.07 72.15 Favored Pre-proline 0 N--CA 1.476 0.834 0 C-N-CA 124.546 1.139 . . . . 0.0 114.025 175.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo . . . . . 0 N--CA 1.46 -0.446 0 C-N-CA 123.629 2.886 . . . . 0.0 113.233 179.416 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 . . . . . 0 N--CA 1.469 0.514 0 N-CA-C 115.366 1.617 . . . . 0.0 115.366 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 54.54 29.77 11.88 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.57 1.148 . . . . 0.0 112.929 -172.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.25 -5.56 6.65 Favored Glycine 0 CA--C 1.542 1.749 0 N-CA-C 116.188 1.235 . . . . 0.0 116.188 -171.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 96.5 m -80.98 138.85 36.07 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 118.791 1.295 . . . . 0.0 114.224 -177.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -152.43 141.17 20.96 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.547 0.739 . . . . 0.0 110.287 165.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 47.55 47.35 17.55 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.863 1.265 . . . . 0.0 112.914 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 24.7 m-20 57.71 20.91 6.82 Favored 'General case' 0 CA--C 1.552 1.032 0 N-CA-C 116.33 1.974 . . . . 0.0 116.33 -174.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 62.2 t -130.14 149.7 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 CA-C-N 120.673 1.579 . . . . 0.0 112.137 -177.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.58 53.03 0.68 Allowed 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 127.131 2.172 . . . . 0.0 111.402 174.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -76.98 -50.55 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 O-C-N 119.863 -1.773 . . . . 0.0 112.804 -174.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -84.11 -25.93 29.34 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.799 0.839 . . . . 0.0 112.968 -178.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -179.03 -178.55 48.33 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.108 1.337 . . . . 0.0 112.701 177.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -101.65 104.16 14.99 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 122.496 1.141 . . . . 0.0 112.842 -176.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -63.71 -32.1 73.48 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.659 1.584 . . . . 0.0 113.144 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 5.6 tmmm? -58.82 -20.89 54.5 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 117.538 -1.22 . . . . 0.0 113.106 175.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.3 tpp180 -62.18 -36.32 81.51 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 120.786 1.63 . . . . 0.0 113.4 171.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 8.3 t60 -68.73 -44.52 73.67 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.633 0.773 . . . . 0.0 111.13 173.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 72.0 m -67.0 -37.78 84.82 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 121.496 -0.752 . . . . 0.0 112.252 176.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -63.16 -30.27 71.45 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 120.988 -1.07 . . . . 0.0 112.025 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.37 -23.87 65.64 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.302 1.041 . . . . 0.0 113.298 171.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -93.3 6.27 48.68 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.388 1.475 . . . . 0.0 113.023 170.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . 0.267 0.3 OUTLIER 64.88 35.55 8.37 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 127.547 2.339 . . . . 0.0 114.445 -172.14 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.4 mmtp -127.66 152.81 47.21 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 127.966 2.506 . . . . 0.0 113.391 -174.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -76.79 159.09 30.4 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.256 -0.903 . . . . 0.0 108.913 167.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -140.78 145.21 15.8 Favored Glycine 0 N--CA 1.474 1.187 0 C-N-CA 125.022 1.296 . . . . 0.0 114.547 -178.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -145.37 141.63 22.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 124.878 1.271 . . . . 0.0 110.803 -176.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 90.8 m -77.61 120.48 22.62 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.906 0.86 . . . . 0.0 113.315 -175.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -113.75 100.82 8.75 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.817 1.647 . . . . 0.0 109.404 169.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 64.88 -126.99 32.81 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 125.238 1.399 . . . . 0.0 111.086 -172.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 34.9 p -89.94 19.56 4.78 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 126.31 1.844 . . . . 0.0 114.011 177.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -141.86 163.17 33.63 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.385 1.474 . . . . 0.0 112.22 -174.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.7 t -88.56 157.9 18.46 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.627 1.171 . . . . 0.0 111.674 173.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.6 121.75 15.81 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 126.448 1.899 . . . . 0.0 107.461 171.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 63.3 m -86.11 134.47 33.81 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 -178.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -102.88 -122.63 5.13 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 127.684 2.564 . . . . 0.0 114.727 -169.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.6 m -87.22 156.82 54.19 Favored Pre-proline 0 N--CA 1.477 0.884 0 C-N-CA 125.765 1.626 . . . . 0.0 113.723 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo . . . . . 0 CA--C 1.541 0.845 0 C-N-CA 124.16 3.24 . . . . 0.0 113.322 179.887 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 . . . . . 0 CA--C 1.538 0.501 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 57.5 12.9 1.64 Allowed 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 115.098 1.518 . . . . 0.0 115.098 -175.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 85.08 -5.23 83.71 Favored Glycine 0 CA--C 1.54 1.602 0 C-N-CA 124.739 1.162 . . . . 0.0 115.173 -168.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 81.7 m -84.01 141.36 31.24 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.842 1.321 . . . . 0.0 113.46 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -151.06 134.17 15.98 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.357 0.663 . . . . 0.0 111.129 164.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 47.2 54.64 9.15 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.113 1.365 . . . . 0.0 112.542 -176.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 61.3 m-20 64.69 9.72 5.42 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 116.308 1.966 . . . . 0.0 116.308 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 49.4 t -125.57 147.87 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 CA-C-N 120.547 1.521 . . . . 0.0 111.893 -175.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -74.08 46.66 0.25 Allowed 'General case' 0 CA--C 1.557 1.249 0 C-N-CA 127.083 2.153 . . . . 0.0 112.466 175.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -73.12 -37.02 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 O-C-N 119.738 -1.851 . . . . 0.0 114.73 -170.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 63.7 mtpt -99.58 -18.18 17.48 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.717 1.207 . . . . 0.0 113.233 178.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 179.46 167.34 36.66 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 124.638 1.113 . . . . 0.0 112.53 175.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -87.37 109.37 19.5 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.99 1.716 . . . . 0.0 113.103 -174.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -61.65 -24.56 66.81 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.489 1.515 . . . . 0.0 113.63 176.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.4 tmmm? -50.39 -35.72 29.52 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 120.981 -1.074 . . . . 0.0 111.916 171.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 55.8 ttm-85 -58.61 -41.12 85.15 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 126.483 1.913 . . . . 0.0 114.203 -177.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 36.8 t60 -67.62 -42.98 81.47 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.426 1.09 . . . . 0.0 111.495 175.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 72.0 m -77.26 -27.13 53.1 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.41 -36.8 81.33 Favored 'General case' 0 N--CA 1.476 0.839 0 O-C-N 120.62 -1.3 . . . . 0.0 110.782 169.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.2 -15.06 63.43 Favored 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 171.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -99.78 1.81 43.5 Favored 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 126.34 1.856 . . . . 0.0 111.36 169.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . 0.269 3.4 t0 51.98 44.21 29.68 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 128.188 2.595 . . . . 0.0 114.212 -169.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.4 mttt -126.92 172.8 10.12 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 129.13 2.972 . . . . 0.0 112.845 -178.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -85.55 153.84 22.15 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.89 1.276 . . . . 0.0 109.653 167.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -131.79 151.4 19.78 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 125.525 1.536 . . . . 0.0 114.887 -178.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -153.32 137.31 8.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 125.268 1.427 . . . . 0.0 111.056 -176.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 87.3 m -79.92 120.76 24.57 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.28 -0.887 . . . . 0.0 112.137 -177.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 15.9 m-70 -111.58 103.1 11.4 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.667 1.587 . . . . 0.0 109.223 168.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 67.86 -114.79 6.4 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 124.869 1.224 . . . . 0.0 112.112 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 82.7 p -104.06 17.2 24.6 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 126.155 1.782 . . . . 0.0 112.615 173.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 44.9 mmtm -127.96 159.91 33.52 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.448 1.899 . . . . 0.0 112.093 -178.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 43.3 t -100.02 146.0 27.25 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.603 1.161 . . . . 0.0 110.226 170.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -130.35 126.49 37.25 Favored 'General case' 0 C--N 1.333 -0.11 0 C-N-CA 126.392 1.877 . . . . 0.0 106.998 -178.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 61.2 m -87.95 137.27 32.48 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.832 0.825 . . . . 0.0 112.164 176.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -97.16 -137.28 9.48 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 127.35 2.405 . . . . 0.0 112.228 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 33.1 m -73.39 155.14 89.88 Favored Pre-proline 0 CA--C 1.535 0.37 0 N-CA-C 113.939 1.088 . . . . 0.0 113.939 178.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo . . . . . 0 CA--C 1.54 0.784 0 C-N-CA 124.541 3.494 . . . . 0.0 111.407 166.97 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 . . . . . 0 CA--C 1.537 0.446 0 N-CA-C 115.103 1.52 . . . . 0.0 115.103 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 54.65 15.54 1.1 Allowed 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 -171.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 81.17 -5.11 68.18 Favored Glycine 0 CA--C 1.544 1.906 0 C-N-CA 124.646 1.117 . . . . 0.0 115.263 -168.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 74.5 m -77.44 141.52 39.69 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.065 1.346 . . . . 0.0 113.068 178.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -152.15 131.98 13.28 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.098 0.959 . . . . 0.0 112.113 166.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 48.19 54.5 10.15 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.773 1.629 . . . . 0.0 112.745 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 42.4 m-20 62.57 15.35 7.85 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 116.485 2.032 . . . . 0.0 116.485 -179.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 38.4 t -129.07 147.26 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 125.048 1.339 . . . . 0.0 111.079 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 28.0 p-10 -76.33 33.95 0.13 Allowed 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 128.354 2.661 . . . . 0.0 114.266 176.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -58.78 -30.92 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 N-CA-C 116.362 1.986 . . . . 0.0 116.362 -168.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -109.5 -10.14 14.89 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 125.189 1.395 . . . . 0.0 113.133 175.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 168.81 153.53 8.38 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 125.798 1.666 . . . . 0.0 112.252 173.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -85.3 138.54 32.24 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.089 0.956 . . . . 0.0 112.137 175.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.2 p -94.95 -1.43 52.53 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -178.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -63.21 -28.65 70.18 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 120.956 -1.09 . . . . 0.0 112.978 177.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.04 -37.4 85.76 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 121.045 1.748 . . . . 0.0 113.148 173.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 13.1 t60 -62.68 -36.37 82.67 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.34 1.056 . . . . 0.0 111.715 170.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 57.7 m -75.38 -27.83 59.26 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 121.087 -1.008 . . . . 0.0 113.402 171.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 21.6 tptp -66.28 -20.32 66.07 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.188 1.395 . . . . 0.0 112.907 173.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.53 -18.11 64.53 Favored 'General case' 0 CA--C 1.55 0.955 0 O-C-N 121.704 -0.623 . . . . 0.0 112.308 168.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -110.68 15.12 22.16 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 126.953 2.101 . . . . 0.0 111.899 168.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 15.4 t0 56.18 26.32 10.16 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 127.771 2.428 . . . . 0.0 115.2 -174.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 38.8 mttt -109.91 159.57 17.13 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.79 1.636 . . . . 0.0 114.339 -174.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -70.59 149.9 46.61 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 114.727 -1.124 . . . . 0.0 108.006 166.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -136.62 141.63 12.68 Favored Glycine 0 N--CA 1.472 1.069 0 C-N-CA 124.798 1.19 . . . . 0.0 114.83 -176.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.06 131.78 55.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 125.638 1.575 . . . . 0.0 111.903 -168.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 96.9 m -73.07 107.89 5.66 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.208 1.003 . . . . 0.0 112.045 177.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 9.5 m-70 -95.5 91.76 6.33 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.866 2.066 . . . . 0.0 110.069 169.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 66.27 -109.0 2.64 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 124.613 1.101 . . . . 0.0 112.037 -178.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 47.5 p -109.94 26.71 10.35 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 125.938 1.695 . . . . 0.0 113.209 173.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 36.4 mmtm -139.31 174.23 10.73 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 126.977 2.111 . . . . 0.0 111.932 174.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 13.1 t -117.48 157.71 25.79 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.697 1.199 . . . . 0.0 112.388 176.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.9 mtpt -144.47 155.67 43.83 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 128.08 2.552 . . . . 0.0 107.646 172.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 23.8 m -107.0 149.11 27.89 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -95.32 -117.47 3.13 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 127.034 2.254 . . . . 0.0 113.779 -176.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.9 m -106.41 163.87 16.09 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 126.399 1.88 . . . . 0.0 111.432 169.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_exo . . . . . 0 CA--C 1.538 0.682 0 C-N-CA 124.494 3.463 . . . . 0.0 113.849 170.434 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 . . . . . 0 CA--C 1.54 0.593 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 53.77 26.13 5.73 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.919 1.288 . . . . 0.0 113.535 -173.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.02 0.72 21.99 Favored Glycine 0 CA--C 1.539 1.567 0 O-C-N 121.057 -1.027 . . . . 0.0 115.445 -171.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 76.2 m -97.7 141.92 30.13 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.16 1.384 . . . . 0.0 113.713 -170.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -150.6 132.46 15.08 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.161 167.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 47.36 54.67 9.24 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.628 1.571 . . . . 0.0 113.331 178.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 64.03 14.84 8.79 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 116.811 2.152 . . . . 0.0 116.811 -177.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.5 t -131.58 146.66 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 O-C-N 120.567 -1.333 . . . . 0.0 111.827 -177.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -76.51 50.13 0.65 Allowed 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.852 1.661 . . . . 0.0 112.179 170.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -77.93 -30.79 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 125.618 1.567 . . . . 0.0 114.073 -177.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 23.4 mmmt -95.26 -30.72 13.83 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -174.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -175.61 -138.69 2.88 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 124.958 1.266 . . . . 0.0 112.62 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -124.78 140.25 53.1 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -108.27 -19.57 13.43 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 129.276 3.03 . . . . 0.0 111.369 174.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 11.6 tppt? -38.64 -51.57 1.65 Allowed 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 127.199 2.199 . . . . 0.0 112.321 169.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 42.3 mtm180 -63.4 -25.56 68.34 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 -176.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 65.1 t60 -73.75 -45.71 50.22 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 119.186 0.903 . . . . 0.0 111.975 173.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 71.1 m -76.13 -28.63 57.5 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 178.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.421 ' HA ' ' HE2' ' A' ' 22' ' ' LYS . 0.5 OUTLIER -63.05 -28.43 70.08 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.747 1.219 . . . . 0.0 112.267 175.729 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.24 -26.45 63.85 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.391 1.076 . . . . 0.0 113.258 172.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -88.2 8.53 26.65 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 125.844 1.657 . . . . 0.0 111.615 168.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . 0.265 11.5 t0 56.18 31.3 18.08 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 128.167 2.587 . . . . 0.0 115.061 -173.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 36.3 mttt -117.22 169.17 9.67 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 127.453 2.301 . . . . 0.0 113.798 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -79.65 150.91 30.8 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.421 1.488 . . . . 0.0 108.477 167.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -110.99 151.03 17.8 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 125.755 1.645 . . . . 0.0 113.708 175.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -150.41 137.88 13.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 125.346 1.458 . . . . 0.0 109.002 175.097 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 68.3 m -77.93 126.34 30.69 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 121.046 -1.034 . . . . 0.0 112.878 -174.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -122.08 114.43 20.9 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.211 1.404 . . . . 0.0 109.229 169.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 64.13 -124.51 30.28 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 124.464 1.03 . . . . 0.0 111.721 -173.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 70.3 p -104.6 29.2 6.33 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 125.997 1.719 . . . . 0.0 112.405 170.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 41.2 mmtm -136.73 165.07 26.78 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.405 1.882 . . . . 0.0 110.686 -176.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 12.6 t -92.19 160.37 15.2 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.633 1.173 . . . . 0.0 110.294 173.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.0 tmtt? -145.97 137.92 25.17 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 127.024 2.13 . . . . 0.0 106.294 173.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 57.2 m -93.48 135.45 34.72 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -176.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -85.31 -127.35 1.79 Allowed Glycine 0 CA--C 1.528 0.866 0 C-N-CA 126.538 2.018 . . . . 0.0 112.286 178.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 31.5 m -89.03 155.08 49.81 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 124.666 1.186 . . . . 0.0 113.014 176.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo . . . . . 0 C--O 1.239 0.525 0 C-N-CA 124.742 3.628 . . . . 0.0 111.309 167.462 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 . . . . . 0 N--CA 1.476 0.854 0 CA-C-O 121.431 0.634 . . . . 0.0 111.617 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 50.75 16.78 0.34 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.477 1.911 . . . . 0.0 115.223 -172.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 71.35 0.67 39.01 Favored Glycine 0 CA--C 1.535 1.294 0 O-C-N 120.965 -1.084 . . . . 0.0 115.002 -173.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 99.8 m -90.74 137.09 32.63 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 118.2 1.0 . . . . 0.0 112.835 -173.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -151.7 141.97 22.38 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.303 1.041 . . . . 0.0 110.175 165.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 51.15 39.08 22.66 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 178.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 57.88 28.44 16.07 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 126.281 1.832 . . . . 0.0 114.786 -173.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 46.2 t -132.01 145.03 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 125.416 1.486 . . . . 0.0 110.585 179.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -77.51 50.85 0.84 Allowed 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.598 1.559 . . . . 0.0 112.236 173.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -75.94 -41.95 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 124.963 1.305 . . . . 0.0 113.722 -175.162 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 25.0 mmmt -90.04 -19.4 24.44 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.012 0.925 . . . . 0.0 112.797 -173.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -178.5 -146.76 6.67 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 124.701 1.143 . . . . 0.0 112.588 178.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 -124.22 126.97 47.01 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.881 1.272 . . . . 0.0 113.947 177.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -86.49 -18.42 31.68 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.635 1.974 . . . . 0.0 111.56 171.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -48.46 -51.32 27.61 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 117.408 -1.282 . . . . 0.0 111.378 169.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -52.82 -42.58 65.26 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-N 120.267 1.394 . . . . 0.0 113.104 -175.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 71.8 t60 -63.18 -43.53 97.95 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.161 0.984 . . . . 0.0 112.235 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 92.9 m -84.24 -25.71 29.21 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.57 -35.55 78.11 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 120.833 -1.167 . . . . 0.0 110.221 173.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.06 -12.85 61.59 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 171.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -102.4 7.88 40.29 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 126.564 1.946 . . . . 0.0 112.193 169.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . 0.261 2.6 t0 58.22 35.87 25.3 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 128.263 2.625 . . . . 0.0 114.198 -172.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.2 mttt -129.89 164.17 24.76 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 127.588 2.355 . . . . 0.0 115.37 -172.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -69.29 144.96 53.44 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.045 1.738 . . . . 0.0 109.383 165.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -109.41 141.11 15.96 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 125.413 1.482 . . . . 0.0 112.599 169.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.45 135.37 31.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-N 118.666 1.233 . . . . 0.0 111.239 174.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 86.6 m -74.8 115.36 14.3 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 122.078 0.942 . . . . 0.0 113.262 -176.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 5.0 m-70 -100.07 100.28 11.13 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 126.24 1.816 . . . . 0.0 107.65 168.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 63.55 -114.41 6.83 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 124.411 1.005 . . . . 0.0 111.977 -178.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 44.8 p -102.42 16.49 26.12 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 126.168 1.787 . . . . 0.0 113.653 174.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 48.8 mmtm -130.25 165.6 22.08 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.867 2.067 . . . . 0.0 111.019 -175.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 20.4 t -97.6 157.61 15.94 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.042 0.937 . . . . 0.0 110.868 172.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.14 126.5 14.0 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 126.151 1.78 . . . . 0.0 106.314 175.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 39.4 m -82.26 142.34 32.19 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 119.119 0.872 . . . . 0.0 112.141 -178.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -102.28 -118.48 4.42 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 125.725 1.631 . . . . 0.0 113.456 -173.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.9 m -91.55 159.68 38.26 Favored Pre-proline 0 N--CA 1.472 0.658 0 C-N-CA 126.314 1.846 . . . . 0.0 112.559 174.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo . . . . . 0 CA--C 1.536 0.621 0 C-N-CA 124.098 3.198 . . . . 0.0 112.556 179.288 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 . . . . . 0 N--CA 1.478 0.942 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 54.16 15.74 1.0 Allowed 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 -177.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.36 4.87 52.88 Favored Glycine 0 CA--C 1.537 1.425 0 O-C-N 121.179 -0.95 . . . . 0.0 114.842 -173.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 92.0 m -91.28 135.78 33.56 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.458 1.103 . . . . 0.0 112.084 -179.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -151.68 135.38 16.3 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.096 0.958 . . . . 0.0 111.955 167.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 48.46 52.77 13.1 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.3 1.44 . . . . 0.0 112.72 -179.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 57.3 m-20 63.71 8.26 3.63 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 127.254 2.222 . . . . 0.0 116.686 -177.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.0 t -126.24 147.85 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 CA-C-N 119.592 1.087 . . . . 0.0 111.504 -176.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -77.44 39.46 0.26 Allowed 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 126.916 2.086 . . . . 0.0 113.06 172.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -63.06 -26.74 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 126.054 1.741 . . . . 0.0 113.907 -178.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.5 mmmm -104.65 -13.76 15.84 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.237 1.415 . . . . 0.0 114.519 -175.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 166.94 -141.13 6.71 Favored Glycine 0 N--CA 1.471 0.992 0 CA-C-N 120.112 1.324 . . . . 0.0 114.699 174.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -117.13 124.28 48.82 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.704 1.201 . . . . 0.0 113.718 -170.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -104.54 -30.35 10.07 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 127.53 2.332 . . . . 0.0 111.284 176.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.3 tmmm? -53.16 -40.21 64.13 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 121.11 -0.994 . . . . 0.0 112.391 175.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 43.9 mtp180 -64.3 -27.69 69.21 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 63.7 t60 -70.68 -46.65 62.78 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 118.867 0.758 . . . . 0.0 111.335 170.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 86.8 m -72.34 -30.31 64.62 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.471 ' HA ' ' HE2' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -62.55 -30.69 71.5 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 120.536 -1.352 . . . . 0.0 112.14 173.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -75.47 -11.98 60.15 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 124.304 1.042 . . . . 0.0 112.902 173.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -102.79 4.91 38.41 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 126.528 1.931 . . . . 0.0 111.378 168.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . 0.273 5.7 t0 57.68 40.37 26.58 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 129.354 3.061 . . . . 0.0 115.886 -171.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.7 mttt -129.96 171.59 12.61 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.303 1.841 . . . . 0.0 113.871 -177.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -79.11 156.47 28.28 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.921 1.688 . . . . 0.0 109.141 166.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -126.58 144.92 15.42 Favored Glycine 0 CA--C 1.537 1.46 0 C-N-CA 125.332 1.444 . . . . 0.0 115.102 176.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -147.43 144.06 19.68 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 124.558 1.143 . . . . 0.0 109.564 -178.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 88.8 m -86.76 122.91 31.31 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.112 -0.993 . . . . 0.0 112.86 -174.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 19.0 m-70 -114.71 104.22 11.76 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 125.582 1.553 . . . . 0.0 110.019 169.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 60.65 -121.52 26.87 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 123.827 0.727 . . . . 0.0 111.67 -173.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 60.7 p -91.42 8.8 34.51 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 126.215 1.806 . . . . 0.0 114.167 179.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -131.91 160.96 34.21 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.709 1.603 . . . . 0.0 112.94 -172.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 38.7 t -93.23 140.06 29.94 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.828 1.251 . . . . 0.0 110.766 172.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.63 121.13 29.66 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 127.142 2.177 . . . . 0.0 105.799 178.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 57.2 m -78.03 141.73 38.68 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 119.043 0.838 . . . . 0.0 112.687 -177.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -89.68 -135.11 5.64 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 126.549 2.023 . . . . 0.0 111.868 175.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 33.7 m -83.93 159.61 59.83 Favored Pre-proline 0 CA--C 1.539 0.534 0 C-N-CA 123.99 0.916 . . . . 0.0 113.318 -178.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo . . . . . 0 CA--C 1.536 0.58 0 C-N-CA 124.63 3.553 . . . . 0.0 111.516 167.608 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 . . . . . 0 N--CA 1.471 0.592 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 56.09 14.14 1.38 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.505 1.522 . . . . 0.0 114.169 -174.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 83.69 -7.43 69.53 Favored Glycine 0 CA--C 1.538 1.493 0 C-N-CA 125.347 1.451 . . . . 0.0 115.0 -171.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 82.8 m -76.33 143.79 40.57 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.229 1.011 . . . . 0.0 113.232 177.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -156.36 139.97 15.97 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.988 1.315 . . . . 0.0 109.953 166.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 48.92 44.33 22.24 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.667 1.187 . . . . 0.0 113.859 -179.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 16.7 m-20 61.18 15.91 6.76 Favored 'General case' 0 CA--C 1.553 1.074 0 N-CA-C 116.316 1.969 . . . . 0.0 116.316 -174.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 59.4 t -126.49 149.92 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 125.379 1.472 . . . . 0.0 111.849 -176.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -79.06 42.33 0.47 Allowed 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 127.082 2.153 . . . . 0.0 114.61 178.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -64.22 -42.62 96.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 O-C-N 120.584 -1.322 . . . . 0.0 113.566 -171.412 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 36.2 mmtm -96.36 -19.19 19.4 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 174.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 172.3 168.48 33.78 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 124.343 0.973 . . . . 0.0 112.694 177.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -98.37 129.67 45.02 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.474 0.709 . . . . 0.0 112.715 -174.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -64.34 -15.55 60.56 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 126.641 1.976 . . . . 0.0 113.507 171.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? -41.98 -51.49 4.42 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.52 1.528 . . . . 0.0 112.113 168.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 60.1 mtm180 -68.55 -25.57 64.98 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.047 1.128 . . . . 0.0 114.047 -168.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -81.88 -36.53 28.07 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.932 1.293 . . . . 0.0 112.789 174.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 99.1 m -79.25 -33.24 43.73 Favored 'General case' 0 CA--C 1.546 0.817 0 O-C-N 121.06 -1.025 . . . . 0.0 113.08 174.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 18.8 tptp -63.64 -28.57 70.0 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.67 1.188 . . . . 0.0 112.422 177.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.69 -25.91 66.74 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.874 1.27 . . . . 0.0 113.365 171.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -103.76 10.2 36.73 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.842 1.657 . . . . 0.0 112.067 174.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 64.78 30.3 12.34 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 128.28 2.632 . . . . 0.0 115.312 -177.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.2 mttp -115.93 163.48 15.82 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 126.648 1.979 . . . . 0.0 112.869 177.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -78.79 152.27 31.51 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 166.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -107.75 159.98 14.19 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 125.836 1.684 . . . . 0.0 113.226 172.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -150.14 135.9 11.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 124.906 1.282 . . . . 0.0 111.011 171.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 91.4 m -76.91 118.81 19.87 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.449 0.642 . . . . 0.0 112.273 -179.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 19.3 m-70 -116.2 111.58 20.39 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.627 1.571 . . . . 0.0 109.125 169.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 63.5 -117.08 10.21 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 125.964 1.745 . . . . 0.0 111.228 -173.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.4 p -108.44 23.93 13.79 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.636 1.574 . . . . 0.0 112.377 173.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 42.0 mmtm -138.59 169.27 18.09 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.934 1.294 . . . . 0.0 112.913 -178.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 41.7 t -99.59 148.11 24.65 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.372 1.469 . . . . 0.0 111.937 -178.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -139.9 133.78 30.71 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 126.902 2.081 . . . . 0.0 105.974 174.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 63.0 m -84.73 142.67 29.68 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 119.592 1.087 . . . . 0.0 112.834 -178.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -89.71 -138.36 6.95 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 126.26 1.886 . . . . 0.0 111.239 171.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.6 m -77.86 154.48 80.62 Favored Pre-proline 0 CA--C 1.537 0.475 0 N-CA-C 114.055 1.131 . . . . 0.0 114.055 178.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo . . . . . 0 CA--C 1.54 0.798 0 C-N-CA 124.238 3.292 . . . . 0.0 110.758 166.306 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 . . . . . 0 N--CA 1.468 0.446 0 N-CA-C 112.708 0.632 . . . . 0.0 112.708 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 60.58 7.96 1.55 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.52 1.928 . . . . 0.0 114.975 -178.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 88.02 -3.18 85.83 Favored Glycine 0 CA--C 1.543 1.84 0 C-N-CA 124.701 1.143 . . . . 0.0 114.729 -168.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 87.3 m -79.03 141.88 37.04 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.553 1.141 . . . . 0.0 112.01 175.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -152.4 135.8 15.94 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.798 0.839 . . . . 0.0 110.714 168.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 47.95 51.47 14.39 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.405 1.482 . . . . 0.0 113.228 179.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 62.62 11.22 4.62 Favored 'General case' 0 CA--C 1.551 1.017 0 N-CA-C 117.389 2.366 . . . . 0.0 117.389 -175.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 38.2 t -124.2 146.53 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 CA-C-N 119.73 1.15 . . . . 0.0 111.965 -177.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -74.91 35.92 0.11 Allowed 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 127.698 2.399 . . . . 0.0 113.483 177.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -60.1 -43.8 93.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 -168.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -96.97 -18.05 19.68 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 178.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 171.4 169.64 34.55 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 125.553 1.549 . . . . 0.0 113.002 174.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -86.84 142.81 27.8 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 121.959 0.885 . . . . 0.0 112.996 175.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.8 p -97.79 -10.66 24.41 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.628 1.171 . . . . 0.0 113.149 169.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.1 tmmm? -63.3 -28.09 69.78 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-O 118.115 -0.945 . . . . 0.0 113.251 -176.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 44.9 mtm180 -63.81 -35.23 79.92 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 120.013 1.279 . . . . 0.0 113.596 170.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -67.76 -35.41 78.66 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.433 1.093 . . . . 0.0 111.904 174.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 90.0 m -75.21 -39.02 60.44 Favored 'General case' 0 CA--C 1.547 0.865 0 O-C-N 120.909 -1.119 . . . . 0.0 112.533 170.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -62.28 -28.63 69.85 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 120.748 -1.22 . . . . 0.0 112.791 178.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.57 -25.89 60.64 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.47 1.108 . . . . 0.0 113.152 171.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -115.47 21.01 14.38 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.684 1.594 . . . . 0.0 112.048 -179.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.2 t0 56.96 60.56 2.96 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 126.407 1.883 . . . . 0.0 111.431 -175.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 31.9 mmtm -145.44 147.68 32.47 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 126.071 1.748 . . . . 0.0 113.308 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -72.53 156.42 39.03 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 162.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -141.6 136.11 7.2 Favored Glycine 0 N--CA 1.468 0.788 0 C-N-CA 124.385 0.993 . . . . 0.0 112.684 -179.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.0 140.18 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 C-N-CA 124.595 1.158 . . . . 0.0 110.675 -172.123 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 73.0 m -68.13 118.07 10.8 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.019 0.528 . . . . 0.0 112.408 -177.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 -108.63 98.69 8.16 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.965 1.706 . . . . 0.0 108.783 169.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 61.35 -114.81 7.07 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 124.176 0.893 . . . . 0.0 111.402 -174.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 58.6 p -107.01 27.43 9.0 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 127.337 2.255 . . . . 0.0 114.045 174.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -137.95 174.27 10.74 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 126.726 2.01 . . . . 0.0 111.219 172.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 9.1 t -97.17 166.68 11.46 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.746 1.218 . . . . 0.0 111.435 172.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.55 118.57 8.23 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.337 1.455 . . . . 0.0 108.633 173.116 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 73.9 m -84.48 129.57 34.84 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -178.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -99.72 -139.32 10.75 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 127.407 2.432 . . . . 0.0 113.941 -175.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.6 m -72.8 154.78 91.1 Favored Pre-proline 0 N--CA 1.473 0.722 0 C-N-CA 125.051 1.34 . . . . 0.0 113.398 176.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo . . . . . 0 CA--C 1.532 0.4 0 C-N-CA 124.28 3.32 . . . . 0.0 114.031 -178.078 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 . . . . . 0 CA--C 1.539 0.537 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 56.44 28.52 13.78 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.811 1.245 . . . . 0.0 113.662 -177.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 71.51 -5.14 11.34 Favored Glycine 0 CA--C 1.541 1.691 0 N-CA-C 115.411 0.924 . . . . 0.0 115.411 -174.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 74.4 m -79.46 135.0 36.54 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.705 1.202 . . . . 0.0 112.792 -178.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -148.08 134.97 20.12 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.214 1.006 . . . . 0.0 111.104 167.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 47.66 49.08 16.75 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.09 1.356 . . . . 0.0 113.65 179.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 65.96 10.93 7.35 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 127.436 2.294 . . . . 0.0 116.513 -176.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.9 t -126.06 147.95 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 124.951 1.3 . . . . 0.0 112.288 -176.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -78.72 40.64 0.39 Allowed 'General case' 0 CA--C 1.558 1.264 0 C-N-CA 127.234 2.214 . . . . 0.0 113.708 176.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.5 m -70.86 -23.39 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 C-N-CA 125.777 1.631 . . . . 0.0 115.325 -172.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -109.05 -8.81 15.12 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.696 1.198 . . . . 0.0 112.984 173.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 158.09 169.33 21.55 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 125.452 1.501 . . . . 0.0 112.435 174.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -89.19 144.93 25.75 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.157 0.983 . . . . 0.0 112.706 177.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 42.4 t -92.65 -15.23 27.05 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.455 0.702 . . . . 0.0 112.375 170.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -53.29 -35.39 60.05 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 120.679 -1.263 . . . . 0.0 111.709 177.497 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 11.9 mtp-105 -55.77 -43.31 76.6 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 115.071 1.508 . . . . 0.0 115.071 169.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 62.4 t60 -67.83 -40.04 83.83 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 119.845 1.202 . . . . 0.0 112.302 177.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 93.0 m -75.61 -32.28 60.22 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 123.54 0.736 . . . . 0.0 112.443 177.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.437 ' O ' ' HE2' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -62.01 -30.4 70.93 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 127.132 2.173 . . . . 0.0 112.168 174.825 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.19 -24.89 67.47 Favored 'General case' 0 CA--C 1.549 0.918 0 O-C-N 121.554 -0.716 . . . . 0.0 112.534 173.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -107.95 18.88 20.73 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.416 1.886 . . . . 0.0 113.597 168.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 60.66 26.32 16.05 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 126.114 1.765 . . . . 0.0 115.724 177.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.6 mttp -110.22 162.12 14.91 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 127.653 2.381 . . . . 0.0 113.272 175.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -76.39 153.2 35.93 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.96 0.904 . . . . 0.0 110.1 166.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -125.49 142.66 13.94 Favored Glycine 0 N--CA 1.475 1.276 0 C-N-CA 125.726 1.631 . . . . 0.0 113.506 173.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.93 133.09 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 124.883 1.273 . . . . 0.0 111.322 -170.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 74.5 m -75.07 114.82 14.0 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.132 0.492 . . . . 0.0 111.677 -179.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 7.6 m-70 -107.76 100.98 10.31 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.726 2.01 . . . . 0.0 109.134 172.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 64.19 -115.62 8.11 Favored Glycine 0 CA--C 1.527 0.844 0 C-N-CA 124.839 1.209 . . . . 0.0 112.055 -177.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 75.9 p -105.38 15.76 26.7 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.97 1.308 . . . . 0.0 112.586 178.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -141.35 -171.09 3.22 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 128.651 2.78 . . . . 0.0 110.47 -175.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 52.7 t -134.71 158.08 45.05 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 114.282 1.215 . . . . 0.0 114.282 -176.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 68.6 mttt -136.19 149.86 48.77 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 129.49 3.116 . . . . 0.0 107.908 169.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 78.3 m -89.81 152.8 21.11 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 121.626 0.727 . . . . 0.0 112.073 170.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -107.71 -112.82 3.66 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 126.205 1.859 . . . . 0.0 114.124 -172.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.9 m -104.9 157.35 34.39 Favored Pre-proline 0 N--CA 1.475 0.788 0 C-N-CA 126.522 1.929 . . . . 0.0 113.155 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo . . . . . 0 CA--C 1.537 0.645 0 C-N-CA 124.083 3.188 . . . . 0.0 111.413 173.725 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 . . . . . 0 N--CA 1.473 0.715 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 55.71 24.81 7.56 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.301 1.44 . . . . 0.0 114.132 -175.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 72.93 -4.69 21.81 Favored Glycine 0 CA--C 1.542 1.723 0 O-C-N 121.23 -0.919 . . . . 0.0 115.226 -171.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 88.0 m -84.33 142.62 30.06 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.057 1.343 . . . . 0.0 112.644 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -153.29 140.94 19.94 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.289 1.035 . . . . 0.0 110.278 167.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 46.51 47.58 14.22 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.201 1.4 . . . . 0.0 113.543 178.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 21.6 m-20 64.52 17.4 10.83 Favored 'General case' 0 CA--C 1.551 0.985 0 N-CA-C 116.132 1.901 . . . . 0.0 116.132 -177.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 40.7 t -132.81 148.19 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.57 1.148 . . . . 0.0 112.498 -176.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -73.15 37.52 0.08 Allowed 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 128.055 2.542 . . . . 0.0 114.092 173.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -63.76 -33.38 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 O-C-N 120.28 -1.513 . . . . 0.0 114.293 -171.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -104.53 -19.92 13.85 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.426 1.091 . . . . 0.0 113.725 178.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 173.5 177.06 42.45 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 124.951 1.262 . . . . 0.0 112.491 174.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -87.18 158.13 19.2 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 117.737 0.768 . . . . 0.0 111.987 174.169 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.6 p -120.61 -5.31 9.75 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 170.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -61.16 -31.72 71.45 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 117.519 -1.229 . . . . 0.0 112.025 177.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 47.6 mtm180 -58.32 -38.94 78.11 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-N 120.458 1.481 . . . . 0.0 113.622 170.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 18.6 t60 -65.2 -38.83 91.7 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 119.261 0.937 . . . . 0.0 112.628 174.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 97.3 m -72.89 -33.0 65.77 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 118.801 0.728 . . . . 0.0 112.727 171.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -66.34 -27.62 68.03 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 120.322 -1.486 . . . . 0.0 111.848 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.65 -5.63 16.65 Favored 'General case' 0 CA--C 1.551 1.008 0 N-CA-C 114.044 1.127 . . . . 0.0 114.044 169.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -121.86 19.21 10.98 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 127.583 2.353 . . . . 0.0 112.017 171.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 61.46 29.52 18.46 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.277 1.431 . . . . 0.0 113.518 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.3 mmtp -124.01 153.55 41.15 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 128.222 2.609 . . . . 0.0 112.538 -175.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -78.53 158.52 28.54 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.282 1.033 . . . . 0.0 108.361 166.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -138.7 145.66 17.11 Favored Glycine 0 N--CA 1.476 1.328 0 C-N-CA 124.943 1.259 . . . . 0.0 114.745 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -147.37 147.63 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 126.077 1.751 . . . . 0.0 110.882 -172.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 71.1 m -77.51 116.94 18.48 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 113.731 1.012 . . . . 0.0 113.731 -174.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -109.03 103.59 12.65 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.477 1.511 . . . . 0.0 108.562 168.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 66.34 -114.86 6.86 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 124.142 0.877 . . . . 0.0 111.85 -176.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 69.8 p -107.22 22.04 16.6 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.993 1.717 . . . . 0.0 112.384 175.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 37.0 mmtm -139.67 170.33 16.09 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.42 1.888 . . . . 0.0 112.29 -172.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 16.7 t -109.49 133.22 53.34 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.347 1.059 . . . . 0.0 112.576 -178.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.8 tptt -118.71 129.4 55.25 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 126.615 1.966 . . . . 0.0 107.137 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 68.6 m -86.46 145.4 26.84 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.39 -125.8 5.14 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 127.161 2.315 . . . . 0.0 113.752 -172.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 28.9 m -84.08 160.45 57.63 Favored Pre-proline 0 N--CA 1.471 0.583 0 C-N-CA 124.993 1.317 . . . . 0.0 113.242 177.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo . . . . . 0 CA--C 1.538 0.717 0 C-N-CA 124.426 3.418 . . . . 0.0 113.564 168.082 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 . . . . . 0 N--CA 1.472 0.658 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 59.04 19.0 6.81 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.423 1.489 . . . . 0.0 114.62 -171.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 73.86 -0.29 52.15 Favored Glycine 0 CA--C 1.552 2.38 0 N-CA-C 115.803 1.081 . . . . 0.0 115.803 -168.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 97.8 m -81.81 137.47 35.29 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 120.84 -1.388 . . . . 0.0 113.095 178.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -151.12 134.32 16.04 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.247 1.019 . . . . 0.0 111.337 166.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 48.74 51.71 15.28 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.814 1.646 . . . . 0.0 113.736 -178.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 61.12 13.82 5.0 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 126.905 2.082 . . . . 0.0 116.398 -175.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.4 t -127.26 144.72 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-N 119.683 1.129 . . . . 0.0 111.663 -177.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -72.8 31.83 0.06 Allowed 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.595 1.558 . . . . 0.0 114.493 175.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -53.71 -32.08 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 O-C-N 120.327 -1.483 . . . . 0.0 114.601 -171.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -106.0 -6.96 18.37 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 177.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 167.37 150.83 6.65 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-N 119.599 1.09 . . . . 0.0 114.547 169.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -71.55 108.92 5.18 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.603 1.161 . . . . 0.0 113.777 -174.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -69.37 -29.91 67.8 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.787 2.035 . . . . 0.0 113.034 176.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.66 -34.11 67.03 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 120.745 -1.222 . . . . 0.0 112.132 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.3 mtm180 -60.74 -36.29 78.52 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 175.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 51.7 t60 -64.43 -39.71 94.35 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.885 0.874 . . . . 0.0 111.381 176.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 80.6 m -79.36 -32.73 43.28 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.246 0.619 . . . . 0.0 112.474 175.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.92 -31.25 71.55 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 120.503 -1.373 . . . . 0.0 111.697 173.003 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.5 -9.21 40.14 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.495 1.118 . . . . 0.0 113.832 171.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -116.91 12.5 14.71 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.298 1.839 . . . . 0.0 112.096 169.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 49.99 46.4 24.43 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.587 1.955 . . . . 0.0 113.587 -171.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.4 mmtt -122.21 162.4 21.46 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 127.33 2.252 . . . . 0.0 112.223 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -76.62 145.54 38.81 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.081 0.952 . . . . 0.0 109.305 167.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -133.13 138.05 9.83 Favored Glycine 0 N--CA 1.472 1.086 0 C-N-CA 124.501 1.048 . . . . 0.0 114.643 -179.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -149.81 141.74 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 125.368 1.467 . . . . 0.0 110.538 -172.075 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 84.0 m -78.55 116.83 19.2 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -179.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 -98.62 94.06 6.46 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.754 1.622 . . . . 0.0 109.466 168.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 63.24 -96.14 0.16 Allowed Glycine 0 CA--C 1.529 0.924 0 C-N-CA 125.188 1.375 . . . . 0.0 111.323 -176.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.7 p -118.58 14.97 13.68 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 127.52 2.328 . . . . 0.0 113.874 -173.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -138.58 168.6 19.44 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 127.25 2.22 . . . . 0.0 112.683 174.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 28.9 t -98.09 141.81 30.57 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.415 1.486 . . . . 0.0 110.733 171.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -128.87 120.56 26.45 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.081 1.352 . . . . 0.0 109.238 179.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 60.9 m -87.32 128.77 35.17 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.153 0.798 . . . . 0.0 113.153 -177.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -99.12 -126.82 5.75 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 126.522 2.01 . . . . 0.0 114.238 -169.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 16.8 m -75.9 152.74 84.77 Favored Pre-proline 0 N--CA 1.473 0.694 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 177.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo . . . . . 0 CA--C 1.535 0.574 0 C-N-CA 124.158 3.239 . . . . 0.0 110.987 174.137 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 . . . . . 0 N--CA 1.477 0.892 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 56.27 12.05 0.92 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.268 1.827 . . . . 0.0 115.471 -177.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.53 0.73 84.95 Favored Glycine 0 CA--C 1.541 1.712 0 N-CA-C 115.401 0.92 . . . . 0.0 115.401 -169.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 89.0 m -85.15 139.81 31.41 Favored 'General case' 0 C--O 1.236 0.39 0 O-C-N 121.037 -1.272 . . . . 0.0 112.421 178.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -151.12 131.01 13.28 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 167.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 44.49 55.0 6.02 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.43 1.892 . . . . 0.0 112.994 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 56.0 m-80 64.01 16.48 9.96 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 127.003 2.121 . . . . 0.0 116.173 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 19.8 t -124.93 147.45 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 O-C-N 120.935 -1.103 . . . . 0.0 111.396 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.85 37.4 0.18 Allowed 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 127.414 2.286 . . . . 0.0 112.493 176.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -68.32 -45.36 82.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 -168.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 25.4 mmmt -101.92 -14.24 17.29 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 -169.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 171.98 168.95 34.17 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-N 119.376 0.989 . . . . 0.0 115.19 174.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -87.5 81.3 7.82 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.02 1.728 . . . . 0.0 113.398 -171.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -46.28 -26.95 0.9 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 127.066 2.146 . . . . 0.0 113.831 171.281 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -32.37 -48.82 0.19 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.79 2.036 . . . . 0.0 112.485 166.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 55.2 mtm180 -66.57 -36.73 83.35 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 -171.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 15.7 t60 -68.64 -33.46 74.06 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-N 120.081 1.309 . . . . 0.0 112.3 176.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 71.5 m -80.76 -39.17 27.33 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 121.588 -0.695 . . . . 0.0 111.488 175.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -62.19 -32.8 73.49 Favored 'General case' 0 CA--C 1.53 0.206 0 O-C-N 120.54 -1.35 . . . . 0.0 112.072 177.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.1 -22.35 50.31 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.433 1.093 . . . . 0.0 113.595 174.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -121.27 23.04 10.65 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.874 1.669 . . . . 0.0 111.807 177.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 31.3 t0 56.57 55.79 6.14 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.957 1.703 . . . . 0.0 112.728 177.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm -138.77 151.62 47.24 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 127.647 2.379 . . . . 0.0 111.805 177.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -72.35 145.0 48.05 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 166.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -118.08 134.71 11.18 Favored Glycine 0 N--CA 1.469 0.846 0 C-N-CA 124.076 0.846 . . . . 0.0 112.607 175.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -144.07 140.18 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 125.201 1.401 . . . . 0.0 110.35 -177.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 99.9 m -78.68 114.82 17.92 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -174.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -107.63 103.06 12.27 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 126.879 2.072 . . . . 0.0 108.64 173.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 61.83 -116.59 9.57 Favored Glycine 0 CA--C 1.532 1.099 0 N-CA-C 111.109 -0.797 . . . . 0.0 111.109 -173.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 76.0 p -101.21 14.32 32.34 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 125.333 1.453 . . . . 0.0 114.128 175.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -127.69 165.13 20.61 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.989 1.715 . . . . 0.0 112.503 -173.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 46.8 t -104.45 121.41 43.37 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.382 1.073 . . . . 0.0 110.405 177.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 48.7 tptt -97.08 120.86 38.23 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 126.746 2.018 . . . . 0.0 106.693 177.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 59.5 m -84.85 137.9 32.88 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 123.612 0.57 . . . . 0.0 111.617 171.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -119.64 -124.96 3.29 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 126.158 1.837 . . . . 0.0 114.526 -169.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 15.3 m -83.59 157.54 64.21 Favored Pre-proline 0 N--CA 1.47 0.562 0 C-N-CA 125.966 1.706 . . . . 0.0 113.585 -179.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo . . . . . 0 CA--C 1.537 0.649 0 C-N-CA 123.862 3.041 . . . . 0.0 114.44 -178.035 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 . . . . . 0 N--CA 1.476 0.875 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 54.15 19.45 2.14 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 126.193 1.797 . . . . 0.0 114.24 -172.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 76.34 -2.98 55.51 Favored Glycine 0 CA--C 1.542 1.721 0 C-N-CA 124.955 1.264 . . . . 0.0 115.692 -170.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 78.4 m -77.28 134.89 38.43 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.689 1.196 . . . . 0.0 112.132 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -146.14 136.28 23.69 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.655 0.782 . . . . 0.0 111.575 168.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 44.83 49.3 9.05 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.264 1.425 . . . . 0.0 112.744 -176.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 63.61 26.03 14.52 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 126.742 2.017 . . . . 0.0 115.023 175.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 49.7 t -136.97 145.99 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 125.996 1.718 . . . . 0.0 111.027 178.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -75.69 49.31 0.5 Allowed 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 126.041 1.736 . . . . 0.0 113.645 174.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -71.44 -51.53 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 O-C-N 120.166 -1.584 . . . . 0.0 113.894 -173.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -91.16 -9.19 46.36 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.02 0.928 . . . . 0.0 113.249 -172.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 176.01 172.98 41.29 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 126.512 2.006 . . . . 0.0 111.048 169.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -94.06 144.41 25.5 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 179.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 44.0 t -100.52 -10.66 20.83 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.144 0.977 . . . . 0.0 112.236 169.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -51.19 -43.23 61.3 Favored 'General case' 0 N--CA 1.466 0.337 0 O-C-N 120.799 -1.188 . . . . 0.0 111.663 178.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.5 mtm180 -56.39 -41.83 76.9 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 175.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 11.7 t60 -61.47 -46.76 88.67 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.621 0.768 . . . . 0.0 111.156 177.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 92.2 m -80.12 -29.2 38.91 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -178.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 23.8 tptp -67.71 -22.95 65.23 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 120.764 -1.21 . . . . 0.0 113.008 175.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.18 -27.26 69.24 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 118.793 0.724 . . . . 0.0 112.305 168.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -101.95 7.78 41.29 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 126.952 2.101 . . . . 0.0 111.984 171.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . 0.28 1.8 t70 54.63 33.61 19.62 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 129.1 2.96 . . . . 0.0 115.8 -175.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 28.9 mttt -109.66 163.22 13.68 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 127.603 2.361 . . . . 0.0 113.168 174.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -69.89 144.05 52.59 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.202 1.401 . . . . 0.0 109.18 167.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -95.45 151.72 20.11 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 123.875 0.75 . . . . 0.0 112.371 169.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.41 117.96 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 118.686 1.243 . . . . 0.0 110.777 -178.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 98.4 m -82.06 108.42 15.53 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.294 171.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 27.6 p80 -104.91 8.55 34.65 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 176.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 170.76 -134.45 3.13 Favored Glycine 0 CA--C 1.523 0.566 0 C-N-CA 123.83 0.729 . . . . 0.0 111.93 179.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 42.6 p -82.04 13.95 3.09 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 126.663 1.985 . . . . 0.0 112.289 168.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -149.22 170.37 18.63 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 128.978 2.911 . . . . 0.0 109.413 -172.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 14.9 t -128.76 173.68 10.12 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.022 1.329 . . . . 0.0 113.255 -176.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.0 mtpt -155.74 169.32 24.64 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 130.097 3.359 . . . . 0.0 107.244 178.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 59.8 m -104.27 148.81 25.92 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.87 0.868 . . . . 0.0 112.365 168.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -98.19 -119.9 4.11 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 126.985 2.231 . . . . 0.0 112.589 -177.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 19.5 m -100.59 159.03 30.77 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 126.499 1.92 . . . . 0.0 112.765 175.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo . . . . . 0 CA--C 1.542 0.901 0 C-N-CA 124.997 3.798 . . . . 0.0 113.912 168.5 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 . . . . . 0 CA--C 1.542 0.652 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 56.61 17.78 3.26 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.468 1.907 . . . . 0.0 114.581 -177.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 84.11 -9.32 63.9 Favored Glycine 0 CA--C 1.538 1.506 0 C-N-CA 124.771 1.176 . . . . 0.0 115.135 -170.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 92.7 m -80.35 139.33 36.62 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.436 1.094 . . . . 0.0 113.05 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -152.35 134.35 14.9 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.666 0.786 . . . . 0.0 110.61 168.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 49.6 49.32 20.18 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.675 1.19 . . . . 0.0 113.996 178.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 60.32 21.11 10.61 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 126.32 1.848 . . . . 0.0 115.547 -178.112 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 69.4 t -132.08 149.37 32.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 125.523 1.529 . . . . 0.0 110.035 -178.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.39 39.0 0.19 Allowed 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 126.806 2.043 . . . . 0.0 111.749 178.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -58.67 -44.5 89.92 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 N-CA-C 115.243 1.571 . . . . 0.0 115.243 -165.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -91.98 -26.44 18.38 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.954 0.902 . . . . 0.0 111.469 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 173.14 173.99 39.91 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 125.843 1.687 . . . . 0.0 112.959 178.112 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -84.3 142.81 29.95 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.065 0.946 . . . . 0.0 112.957 175.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.7 p -102.18 -0.03 33.84 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.786 1.234 . . . . 0.0 114.151 174.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.4 tmmm? -53.36 -45.1 69.04 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 118.138 -0.934 . . . . 0.0 111.136 173.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 44.4 mtm180 -60.63 -37.21 80.72 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.543 1.065 . . . . 0.0 113.261 -176.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 10.7 t60 -61.76 -46.57 89.0 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.272 1.029 . . . . 0.0 112.313 173.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 84.9 m -72.95 -31.29 64.48 Favored 'General case' 0 CA--C 1.545 0.783 0 O-C-N 121.187 -0.946 . . . . 0.0 112.308 176.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 41.3 tptt -65.24 -21.59 66.76 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 126.023 1.729 . . . . 0.0 112.764 177.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.86 -17.63 17.56 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.755 0.822 . . . . 0.0 112.765 168.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -123.56 15.25 9.54 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 126.766 2.027 . . . . 0.0 112.699 172.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 22.5 t70 65.04 14.85 9.64 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 128.395 2.678 . . . . 0.0 115.387 -175.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.3 mmtp -84.17 149.38 26.2 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 126.526 1.93 . . . . 0.0 111.637 178.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -71.37 137.32 48.29 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 124.245 1.018 . . . . 0.0 108.559 167.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -110.76 128.89 8.99 Favored Glycine 0 N--CA 1.471 1.013 0 C-N-CA 123.907 0.765 . . . . 0.0 111.927 173.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.37 143.07 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 124.501 1.12 . . . . 0.0 111.152 -177.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 77.7 m -79.13 115.13 18.6 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -174.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 27.7 m-70 -112.22 104.17 12.35 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.36 1.464 . . . . 0.0 108.568 168.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.79 -122.79 23.06 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 124.226 0.917 . . . . 0.0 111.933 -173.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 40.1 p -101.7 21.34 14.61 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 127.054 2.141 . . . . 0.0 113.088 178.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -139.15 163.21 33.04 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 126.137 1.775 . . . . 0.0 112.169 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 6.4 t -86.05 157.41 20.08 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.429 168.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 6.0 tmtm? -131.65 126.35 34.44 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 168.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 79.4 m -83.88 130.53 34.91 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 120.805 0.335 . . . . 0.0 110.849 173.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -97.97 -131.6 7.2 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 125.468 1.508 . . . . 0.0 113.502 -171.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 28.9 m -87.31 168.2 18.44 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 125.054 1.341 . . . . 0.0 109.983 168.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo . . . . . 0 CA--C 1.542 0.88 0 C-N-CA 123.854 3.036 . . . . 0.0 113.301 169.293 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 . . . . . 0 N--CA 1.47 0.557 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 59.71 5.19 0.65 Allowed 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 115.853 1.797 . . . . 0.0 115.853 -175.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 92.13 -3.62 76.81 Favored Glycine 0 CA--C 1.542 1.752 0 C-N-CA 125.401 1.477 . . . . 0.0 114.657 -168.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 96.3 m -78.7 136.82 37.53 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -154.63 141.49 19.14 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.401 1.08 . . . . 0.0 111.316 165.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 51.53 40.48 27.05 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.961 1.304 . . . . 0.0 114.391 177.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 24.7 m-20 64.62 21.11 12.35 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 126.504 1.922 . . . . 0.0 115.917 -174.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 40.4 t -134.42 147.08 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 125.164 1.386 . . . . 0.0 112.458 -176.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -76.94 53.32 0.93 Allowed 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 127.029 2.132 . . . . 0.0 112.113 173.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -80.4 -36.43 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 124.929 1.292 . . . . 0.0 114.239 -174.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -96.98 -3.65 41.23 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.47 1.108 . . . . 0.0 112.995 177.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 159.47 170.18 23.72 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 125.769 1.652 . . . . 0.0 113.049 172.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -87.35 107.98 18.77 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.332 1.053 . . . . 0.0 113.398 -176.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -62.06 -26.14 68.09 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.751 1.621 . . . . 0.0 112.356 174.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -43.71 -44.69 6.69 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.278 1.431 . . . . 0.0 110.416 167.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 8.7 ttm180 -64.14 -26.24 68.44 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 115.058 1.503 . . . . 0.0 115.058 -178.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 67.4 t60 -77.05 -42.73 37.24 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 120.596 -1.315 . . . . 0.0 111.428 171.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 92.2 m -70.84 -29.43 65.56 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 121.817 -0.552 . . . . 0.0 111.91 175.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 51.7 tptt -68.54 -27.1 65.79 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.726 2.01 . . . . 0.0 114.16 177.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.17 -16.16 61.34 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.615 0.766 . . . . 0.0 112.783 169.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -110.8 4.28 19.75 Favored 'General case' 0 CA--C 1.556 1.205 0 C-N-CA 127.296 2.238 . . . . 0.0 112.018 170.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . 0.287 3.7 t70 59.61 37.6 22.48 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 129.258 3.023 . . . . 0.0 115.211 -173.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.4 mttp -116.12 160.29 20.55 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.868 2.067 . . . . 0.0 115.145 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -66.69 144.4 56.39 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.209 1.403 . . . . 0.0 109.003 167.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -131.1 136.1 8.62 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 125.043 1.306 . . . . 0.0 115.297 178.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -138.55 138.27 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 124.171 0.988 . . . . 0.0 112.057 -179.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 90.9 m -77.28 104.7 7.94 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.872 0.869 . . . . 0.0 113.123 -178.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 27.5 m-70 -90.77 92.52 8.84 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 123.662 0.785 . . . . 0.0 109.004 167.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.9 -116.57 6.91 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 124.628 1.108 . . . . 0.0 112.417 -172.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 63.4 p -99.95 11.8 38.39 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.965 1.706 . . . . 0.0 113.993 177.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -129.97 160.19 34.38 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.208 1.403 . . . . 0.0 111.541 178.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 34.6 t -98.32 147.52 24.59 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.976 1.31 . . . . 0.0 110.647 179.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 30.9 ttmt -141.53 124.76 16.44 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 125.073 1.349 . . . . 0.0 108.191 -178.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 19.4 m -89.15 144.64 25.97 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -171.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -107.08 -131.01 6.58 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 126.569 2.033 . . . . 0.0 113.212 -175.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.6 m -73.42 158.96 85.86 Favored Pre-proline 0 N--CA 1.473 0.692 0 C-N-CA 124.209 1.003 . . . . 0.0 113.668 172.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo . . . . . 0 CA--C 1.535 0.526 0 C-N-CA 123.503 2.802 . . . . 0.0 111.248 171.696 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 . . . . . 0 C--O 1.224 -0.245 0 CA-C-O 121.506 0.67 . . . . 0.0 111.477 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 61.26 -2.22 0.24 Allowed 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.583 1.553 . . . . 0.0 114.7 -174.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 96.18 -9.1 67.53 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 125.489 1.519 . . . . 0.0 113.831 -169.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 70.9 m -89.46 141.6 28.42 Favored 'General case' 0 C--O 1.236 0.354 0 O-C-N 121.511 -0.994 . . . . 0.0 113.469 -175.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -154.38 139.83 17.76 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.173 0.989 . . . . 0.0 109.93 165.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 51.55 44.7 28.92 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.788 1.235 . . . . 0.0 114.189 177.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 60.51 17.34 7.23 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 126.223 1.809 . . . . 0.0 115.602 -174.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 41.6 t -126.75 148.05 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.865 1.266 . . . . 0.0 111.881 -177.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -76.0 40.37 0.2 Allowed 'General case' 0 CA--C 1.558 1.271 0 C-N-CA 128.686 2.794 . . . . 0.0 111.947 177.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -74.89 -54.53 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 C-N-CA 126.105 1.762 . . . . 0.0 113.544 -170.02 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -78.71 -7.46 57.75 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.106 1.363 . . . . 0.0 112.545 -172.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 162.1 -171.09 37.92 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 125.863 1.697 . . . . 0.0 111.482 175.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -95.75 120.95 36.92 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -176.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.5 t -77.59 -20.17 54.42 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.667 1.187 . . . . 0.0 112.636 170.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 8.8 tppt? -44.92 -50.78 10.3 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.594 1.558 . . . . 0.0 111.013 172.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 42.4 mtm180 -64.77 -26.64 68.44 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 115.676 1.732 . . . . 0.0 115.676 -173.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 59.6 t60 -72.81 -37.06 67.64 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 119.272 0.942 . . . . 0.0 112.032 174.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 93.0 m -84.88 -29.72 25.01 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.437 0.695 . . . . 0.0 112.863 177.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.76 -29.12 66.52 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 126.138 1.775 . . . . 0.0 112.317 171.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.99 -19.77 54.13 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.5 1.12 . . . . 0.0 113.859 171.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -114.38 9.34 16.84 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 127.192 2.197 . . . . 0.0 111.789 176.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.4 t70 57.18 38.96 29.14 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 126.815 2.046 . . . . 0.0 113.594 -171.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.9 mmtp -119.23 156.85 29.16 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 128.175 2.59 . . . . 0.0 112.073 -176.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -76.68 147.71 37.27 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 124.199 0.999 . . . . 0.0 109.643 168.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.16 154.56 19.11 Favored Glycine 0 CA--C 1.542 1.755 0 C-N-CA 125.059 1.314 . . . . 0.0 114.247 173.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -151.67 136.87 10.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 125.954 1.701 . . . . 0.0 110.211 175.254 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 93.9 m -84.18 118.02 23.87 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -174.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -101.96 91.4 4.34 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.347 1.859 . . . . 0.0 108.956 168.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 64.71 -118.7 13.01 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.392 0.996 . . . . 0.0 112.112 -176.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 54.2 p -89.84 11.63 19.66 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 126.633 1.973 . . . . 0.0 113.846 174.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm -131.08 166.57 20.77 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 126.306 1.843 . . . . 0.0 112.14 -171.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 47.3 t -121.47 135.2 55.06 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.452 1.501 . . . . 0.0 111.26 -175.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 12.4 tptt -123.16 153.65 39.74 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 128.762 2.825 . . . . 0.0 107.776 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 63.9 m -111.93 127.64 55.92 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 113.707 1.002 . . . . 0.0 113.707 -173.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -87.39 -130.7 3.17 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 126.518 2.009 . . . . 0.0 113.95 -176.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 25.4 m -80.57 161.1 65.52 Favored Pre-proline 0 CA--C 1.532 0.285 0 C-N-CA 125.726 1.611 . . . . 0.0 112.711 176.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo . . . . . 0 CA--C 1.537 0.626 0 C-N-CA 123.992 3.128 . . . . 0.0 112.411 168.077 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 . . . . . 0 N--CA 1.474 0.737 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 54.54 20.11 2.7 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.111 1.365 . . . . 0.0 114.024 -169.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 71.58 0.11 37.77 Favored Glycine 0 CA--C 1.534 1.279 0 O-C-N 120.684 -1.26 . . . . 0.0 115.04 -177.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 72.8 m -88.29 136.82 32.8 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.984 0.913 . . . . 0.0 112.847 -175.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -150.4 139.09 20.72 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.253 1.021 . . . . 0.0 111.263 166.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 48.65 48.34 19.89 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.145 1.378 . . . . 0.0 113.64 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 47.8 m-20 65.48 12.97 8.57 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 126.164 1.786 . . . . 0.0 115.668 -177.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.9 t -130.34 146.4 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 124.615 1.166 . . . . 0.0 112.002 -175.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -74.24 43.23 0.17 Allowed 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 127.422 2.289 . . . . 0.0 113.951 172.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -69.56 -39.22 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 O-C-N 120.892 -1.13 . . . . 0.0 113.689 -174.329 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -92.66 -19.18 22.11 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -174.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 176.5 -150.06 10.2 Favored Glycine 0 CA--C 1.534 1.278 0 N-CA-C 115.882 1.113 . . . . 0.0 115.882 178.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -105.65 135.21 47.48 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.572 1.549 . . . . 0.0 113.961 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -109.47 -24.06 11.2 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 129.049 2.94 . . . . 0.0 110.633 170.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 12.9 tppt? -40.15 -52.6 2.56 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 126.083 1.753 . . . . 0.0 111.975 169.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 60.5 mtm180 -61.8 -30.54 70.88 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 114.527 1.306 . . . . 0.0 114.527 -174.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 68.7 t60 -69.55 -44.08 71.64 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 118.99 0.814 . . . . 0.0 111.62 175.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 91.4 m -78.09 -30.65 49.66 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 179.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 49.8 tptt -65.8 -20.75 66.37 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.441 1.896 . . . . 0.0 113.387 176.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.65 -29.99 70.15 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.906 0.882 . . . . 0.0 111.929 169.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 -91.22 6.35 45.48 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 126.166 1.786 . . . . 0.0 111.674 168.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.6 t70 52.8 36.68 22.0 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 127.825 2.45 . . . . 0.0 113.999 -170.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.8 mttt -112.61 160.03 18.27 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.777 2.031 . . . . 0.0 113.004 178.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 53.4 mm-40 -67.74 142.93 56.12 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 124.62 1.168 . . . . 0.0 109.907 167.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -113.77 135.15 12.3 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 125.276 1.417 . . . . 0.0 113.795 175.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -142.35 132.73 24.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 124.463 1.105 . . . . 0.0 110.633 -170.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 84.5 m -78.2 113.93 16.61 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -173.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 22.4 m-70 -105.78 104.78 14.57 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.917 1.687 . . . . 0.0 108.088 169.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 70.84 -118.12 7.37 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 125.034 1.302 . . . . 0.0 111.322 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 63.0 p -103.83 16.27 26.74 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.455 1.502 . . . . 0.0 112.544 174.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 49.5 mmtm -132.45 163.84 27.88 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.169 1.788 . . . . 0.0 112.104 -173.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 11.0 t -87.87 156.48 19.36 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.052 0.941 . . . . 0.0 111.083 170.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.73 145.06 30.71 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 127.645 2.378 . . . . 0.0 105.91 170.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 38.4 m -98.81 143.55 29.03 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -178.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -98.64 -117.14 3.78 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 126.712 2.101 . . . . 0.0 113.893 -175.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.5 m -103.4 162.55 19.7 Favored Pre-proline 0 CA--C 1.538 0.492 0 C-N-CA 126.906 2.082 . . . . 0.0 111.78 176.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_exo . . . . . 0 CA--C 1.537 0.627 0 C-N-CA 124.743 3.629 . . . . 0.0 112.914 168.958 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.914 0 CA-C-O 118.198 -0.906 . . . . 0.0 110.117 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -146.69 -14.67 0.43 Allowed 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 115.984 1.846 . . . . 0.0 115.984 -178.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -77.36 -37.82 51.48 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 119.319 0.963 . . . . 0.0 112.75 175.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -137.65 -0.92 2.1 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 172.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 57.16 23.64 8.85 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.679 1.191 . . . . 0.0 114.043 -178.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 75.58 -6.18 33.02 Favored Glycine 0 CA--C 1.538 1.508 0 C-N-CA 123.93 0.776 . . . . 0.0 114.879 -173.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 84.2 m -80.96 143.87 32.27 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.088 1.355 . . . . 0.0 112.009 -179.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -151.43 142.77 23.39 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.938 0.895 . . . . 0.0 109.897 168.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 49.25 37.41 11.24 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 178.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 70.98 15.99 6.56 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 126.044 1.738 . . . . 0.0 115.531 -175.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 34.9 t -132.15 148.25 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 125.036 1.335 . . . . 0.0 112.396 -173.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.53 42.66 0.17 Allowed 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 127.455 2.302 . . . . 0.0 113.096 174.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -67.42 -51.27 54.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 O-C-N 120.048 -1.657 . . . . 0.0 112.579 -173.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 27.3 mtpt -90.07 -21.81 22.13 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -175.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 179.31 -176.9 48.11 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 125.294 1.426 . . . . 0.0 112.724 174.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -95.27 151.2 19.45 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.843 1.257 . . . . 0.0 112.822 176.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 40.4 t -98.26 -12.28 21.76 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.423 1.089 . . . . 0.0 111.387 167.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -53.69 -36.04 61.76 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 120.663 -1.273 . . . . 0.0 112.174 -178.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -63.06 -30.26 71.46 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 115.423 1.638 . . . . 0.0 115.423 174.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 56.4 t60 -75.41 -43.27 50.89 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 119.574 1.079 . . . . 0.0 111.614 172.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 93.2 m -80.76 -27.38 36.78 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -177.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.3 -31.08 71.64 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 120.28 -1.512 . . . . 0.0 111.705 173.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.91 -18.95 64.94 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.237 1.015 . . . . 0.0 113.397 171.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -97.25 6.14 48.87 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 126.799 2.039 . . . . 0.0 111.065 169.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.4 t0 54.19 32.51 16.11 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 127.702 2.401 . . . . 0.0 114.488 -169.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.4 mttp -119.24 161.48 20.32 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 126.901 2.08 . . . . 0.0 113.934 -173.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -70.99 146.44 49.42 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 167.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -108.3 139.61 15.19 Favored Glycine 0 N--CA 1.472 1.078 0 C-N-CA 124.65 1.119 . . . . 0.0 111.717 169.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -144.73 126.12 8.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 118.219 1.01 . . . . 0.0 112.022 -177.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 87.8 m -73.69 111.85 9.22 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.825 0.85 . . . . 0.0 112.671 -176.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 38.7 m-70 -108.62 102.92 11.94 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.009 1.323 . . . . 0.0 109.383 169.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.59 -123.86 14.4 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 125.67 1.605 . . . . 0.0 112.934 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 61.2 p -97.05 14.89 24.1 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 126.856 2.062 . . . . 0.0 113.038 175.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -136.28 -173.87 3.52 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 128.938 2.895 . . . . 0.0 111.185 179.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 41.8 t -132.05 161.39 33.33 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.931 1.292 . . . . 0.0 111.488 177.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 67.4 mttt -133.81 142.15 47.74 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 128.503 2.721 . . . . 0.0 106.457 171.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 84.3 m -83.99 134.67 34.63 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 168.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -85.78 -141.53 6.01 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 124.935 1.255 . . . . 0.0 110.961 176.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.9 m -71.7 154.72 92.92 Favored Pre-proline 0 N--CA 1.472 0.669 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 177.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -62.47 137.24 63.59 Favored 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 123.747 2.964 . . . . 0.0 110.184 169.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.5 pp -73.33 -33.72 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 C-N-CA 123.275 0.63 . . . . 0.0 110.87 -172.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 66.3 m -74.49 130.26 39.27 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 125.936 1.694 . . . . 0.0 112.042 -174.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 28.8 p90 -149.47 145.99 27.18 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 123.92 0.888 . . . . 0.0 112.625 173.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 68.7 tp . . . . . 0 C--O 1.252 1.22 0 C-N-CA 126.586 1.955 . . . . 0.0 111.423 179.849 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.636 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -137.04 -33.27 0.77 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.885 1.674 . . . . 0.0 112.749 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 23.1 p30 -68.69 -37.88 79.9 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.46 1.504 . . . . 0.0 113.342 -176.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -88.01 3.16 49.87 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.111 1.365 . . . . 0.0 111.903 172.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 57.98 9.79 1.01 Allowed 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 125.43 1.492 . . . . 0.0 114.191 -170.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 86.65 -3.96 86.6 Favored Glycine 0 CA--C 1.539 1.573 0 C-N-CA 124.757 1.17 . . . . 0.0 115.685 -169.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 79.6 m -80.01 140.5 36.54 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 119.013 1.406 . . . . 0.0 112.727 -179.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -154.28 142.42 20.36 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.591 0.756 . . . . 0.0 110.49 166.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 51.26 37.76 19.5 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -178.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.535 ' ND2' ' H ' ' A' ' 32' ' ' GLY . 12.9 m120 62.59 20.78 12.24 Favored 'General case' 0 CA--C 1.548 0.904 0 N-CA-C 116.04 1.867 . . . . 0.0 116.04 -174.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 59.3 t -125.64 147.75 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 125.825 1.65 . . . . 0.0 111.355 -177.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -76.93 43.92 0.37 Allowed 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 126.326 1.85 . . . . 0.0 112.913 177.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.5 m -69.18 -56.34 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 O-C-N 120.633 -1.292 . . . . 0.0 114.163 -169.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -86.56 -11.62 51.03 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.176 0.99 . . . . 0.0 113.602 -179.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 179.71 171.8 43.07 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.67 1.128 . . . . 0.0 112.134 174.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.416 ' OD1' ' HE3' ' A' ' 18' ' ' LYS . 36.7 t70 -98.02 115.56 28.45 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.141 0.976 . . . . 0.0 112.772 -169.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 16.3 t -68.5 -30.72 69.61 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 121.153 -0.967 . . . . 0.0 112.762 177.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.416 ' HE3' ' OD1' ' A' ' 16' ' ' ASP . 0.0 OUTLIER -54.48 -37.25 65.04 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 117.932 -1.032 . . . . 0.0 111.716 171.763 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 24.9 ttm180 -60.39 -36.33 77.83 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 120.717 1.598 . . . . 0.0 114.788 177.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 36.2 t60 -68.61 -44.75 73.64 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 118.478 0.581 . . . . 0.0 110.968 172.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 89.0 m -76.64 -27.43 55.67 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -177.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.8 tppp? -60.72 -34.11 73.91 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.33 1.452 . . . . 0.0 111.51 173.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.1 -23.66 65.86 Favored 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 173.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -94.95 7.55 45.68 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.258 1.423 . . . . 0.0 112.409 170.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 51.74 40.18 27.01 Favored 'General case' 0 CA--C 1.556 1.178 0 C-N-CA 126.744 2.018 . . . . 0.0 112.745 -172.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 37.1 mttt -122.03 167.15 13.45 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 127.73 2.412 . . . . 0.0 112.6 178.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -83.3 155.84 23.39 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.548 1.139 . . . . 0.0 109.054 168.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -114.12 163.48 12.16 Favored Glycine 0 CA--C 1.546 1.993 0 C-N-CA 125.338 1.446 . . . . 0.0 115.502 -178.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -150.34 128.2 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 126.616 1.966 . . . . 0.0 112.077 177.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 69.4 m -85.32 101.64 12.72 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.654 0.781 . . . . 0.0 110.701 170.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.505 ' CD2' ' HB2' ' A' ' 36' ' ' LYS . 10.4 p80 -91.59 98.8 11.87 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 122.688 1.233 . . . . 0.0 108.983 170.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.535 ' H ' ' ND2' ' A' ' 10' ' ' ASN . . . 66.36 -105.84 1.42 Allowed Glycine 0 CA--C 1.53 0.988 0 C-N-CA 125.065 1.317 . . . . 0.0 112.03 -174.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 52.0 p -112.78 14.22 19.88 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 126.925 2.09 . . . . 0.0 113.563 -176.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 21.2 mmmt -134.95 161.24 35.83 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.065 1.346 . . . . 0.0 110.817 177.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 52.8 t -101.32 157.14 17.01 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.649 1.18 . . . . 0.0 111.278 177.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.505 ' HB2' ' CD2' ' A' ' 31' ' ' HIS . 3.5 ttmt -147.65 169.72 19.05 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 128.341 2.656 . . . . 0.0 107.107 169.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 39.5 m -101.38 156.39 17.48 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 122.786 1.279 . . . . 0.0 113.25 172.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -105.72 -133.95 7.72 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 127.365 2.412 . . . . 0.0 110.751 175.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.8 m -78.99 156.31 77.05 Favored Pre-proline 0 CA--C 1.538 0.517 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 175.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -51.0 147.21 19.83 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 124.486 3.458 . . . . 0.0 112.598 167.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.8 pp -64.6 -27.32 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 N-CA-C 115.892 1.812 . . . . 0.0 115.892 -169.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -160.98 29.86 0.14 Allowed 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.395 1.078 . . . . 0.0 112.251 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -132.25 15.8 4.58 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 125.64 1.576 . . . . 0.0 114.347 -168.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.3 tp . . . . . 0 C--O 1.253 1.267 0 C-N-CA 126.335 1.854 . . . . 0.0 111.365 173.229 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.769 0 N-CA-C 110.515 -0.18 . . . . 0.0 110.515 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -117.05 -46.37 2.72 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.288 1.435 . . . . 0.0 112.06 177.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 36.9 p30 -156.21 -37.35 0.08 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.628 1.171 . . . . 0.0 113.915 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -121.54 3.04 10.2 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 -171.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 55.82 21.01 4.45 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.297 1.439 . . . . 0.0 114.149 -174.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 77.66 -4.67 55.76 Favored Glycine 0 CA--C 1.542 1.771 0 C-N-CA 124.031 0.824 . . . . 0.0 114.986 -171.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 94.8 m -80.59 140.0 35.99 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.134 1.374 . . . . 0.0 112.763 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -151.42 134.12 15.61 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.636 0.775 . . . . 0.0 110.788 166.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 47.01 51.33 13.02 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.851 1.26 . . . . 0.0 113.054 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 26.7 m-20 61.07 7.36 1.53 Allowed 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 117.199 2.296 . . . . 0.0 117.199 -175.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.4 t -116.58 140.11 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 O-C-N 120.648 -1.283 . . . . 0.0 111.335 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -77.74 66.74 3.49 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.883 1.273 . . . . 0.0 110.977 169.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -82.3 -41.94 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 125.227 1.411 . . . . 0.0 112.955 178.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -89.97 -16.87 28.98 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.052 0.941 . . . . 0.0 112.534 178.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 164.94 165.34 22.06 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 125.236 1.398 . . . . 0.0 112.119 172.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -78.01 140.21 39.15 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 117.95 0.875 . . . . 0.0 113.055 177.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -89.13 -23.77 22.39 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.162 1.785 . . . . 0.0 111.173 175.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -55.08 -32.73 62.18 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 117.759 -1.115 . . . . 0.0 113.205 176.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.81 -35.35 66.25 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 120.609 1.549 . . . . 0.0 114.48 171.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 40.6 t60 -75.03 -28.41 60.45 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 119.666 1.121 . . . . 0.0 112.731 176.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 86.3 m -79.54 -36.76 37.88 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.888 1.275 . . . . 0.0 112.673 173.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 70.9 tttt -59.31 -32.09 69.74 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.15 1.78 . . . . 0.0 113.157 -178.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.61 -14.83 63.28 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 114.236 1.198 . . . . 0.0 114.236 176.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -117.66 19.33 13.91 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.926 1.69 . . . . 0.0 112.572 175.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.8 t70 56.16 63.61 1.96 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.378 1.471 . . . . 0.0 111.049 -175.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm -147.77 146.52 29.22 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 126.383 1.873 . . . . 0.0 112.803 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 57.1 mm-40 -75.43 156.34 35.42 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 163.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -134.16 150.43 20.0 Favored Glycine 0 N--CA 1.473 1.147 0 O-C-N 121.019 -1.051 . . . . 0.0 113.234 178.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -150.5 143.06 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 125.069 1.348 . . . . 0.0 110.084 -173.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 70.7 m -80.71 117.66 21.58 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 121.248 -0.908 . . . . 0.0 112.483 -175.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 -107.83 97.69 7.38 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.898 1.279 . . . . 0.0 108.353 169.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.06 -114.68 4.86 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 125.213 1.387 . . . . 0.0 112.233 -172.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 72.8 p -112.89 20.6 16.27 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 127.56 2.344 . . . . 0.0 112.143 178.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 22.5 mmtm -136.25 169.33 17.81 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 128.043 2.537 . . . . 0.0 112.169 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 34.7 t -105.81 139.1 40.9 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.642 1.577 . . . . 0.0 112.481 -174.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -123.31 124.62 43.37 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 126.924 2.09 . . . . 0.0 107.605 177.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 73.4 m -83.53 141.6 31.5 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 121.936 0.874 . . . . 0.0 113.358 176.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -111.77 -145.73 10.03 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 127.522 2.486 . . . . 0.0 113.035 -178.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.5 m -63.44 156.07 72.15 Favored Pre-proline 0 N--CA 1.476 0.834 0 C-N-CA 124.546 1.139 . . . . 0.0 114.025 175.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -66.69 149.22 83.86 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 123.629 2.886 . . . . 0.0 113.233 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.4 pp -77.21 -8.27 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.842 0.857 . . . . 0.0 113.052 178.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.0 m -79.99 74.06 6.76 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.557 1.543 . . . . 0.0 112.093 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -81.49 -43.93 18.13 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.259 1.424 . . . . 0.0 113.628 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.3 pp . . . . . 0 C--O 1.251 1.173 0 C-N-CA 125.872 1.669 . . . . 0.0 112.995 -169.811 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.982 0 CA-C-O 119.498 -0.287 . . . . 0.0 110.305 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -131.04 -33.84 1.51 Allowed 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 114.639 1.348 . . . . 0.0 114.639 -169.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -137.7 -50.28 0.6 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.946 0.898 . . . . 0.0 112.943 -178.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -127.43 4.53 6.25 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 115.366 1.617 . . . . 0.0 115.366 -169.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 54.54 29.77 11.88 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.57 1.148 . . . . 0.0 112.929 -172.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.25 -5.56 6.65 Favored Glycine 0 CA--C 1.542 1.749 0 N-CA-C 116.188 1.235 . . . . 0.0 116.188 -171.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 96.5 m -80.98 138.85 36.07 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 118.791 1.295 . . . . 0.0 114.224 -177.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -152.43 141.17 20.96 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.547 0.739 . . . . 0.0 110.287 165.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 47.55 47.35 17.55 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.863 1.265 . . . . 0.0 112.914 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 24.7 m-20 57.71 20.91 6.82 Favored 'General case' 0 CA--C 1.552 1.032 0 N-CA-C 116.33 1.974 . . . . 0.0 116.33 -174.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 62.2 t -130.14 149.7 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 CA-C-N 120.673 1.579 . . . . 0.0 112.137 -177.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.58 53.03 0.68 Allowed 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 127.131 2.172 . . . . 0.0 111.402 174.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -76.98 -50.55 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 O-C-N 119.863 -1.773 . . . . 0.0 112.804 -174.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -84.11 -25.93 29.34 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.799 0.839 . . . . 0.0 112.968 -178.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -179.03 -178.55 48.33 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.108 1.337 . . . . 0.0 112.701 177.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -101.65 104.16 14.99 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 122.496 1.141 . . . . 0.0 112.842 -176.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -63.71 -32.1 73.48 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.659 1.584 . . . . 0.0 113.144 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 5.6 tmmm? -58.82 -20.89 54.5 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 117.538 -1.22 . . . . 0.0 113.106 175.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.3 tpp180 -62.18 -36.32 81.51 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 120.786 1.63 . . . . 0.0 113.4 171.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 8.3 t60 -68.73 -44.52 73.67 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.633 0.773 . . . . 0.0 111.13 173.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 72.0 m -67.0 -37.78 84.82 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 121.496 -0.752 . . . . 0.0 112.252 176.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -63.16 -30.27 71.45 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 120.988 -1.07 . . . . 0.0 112.025 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.37 -23.87 65.64 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.302 1.041 . . . . 0.0 113.298 171.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -93.3 6.27 48.68 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.388 1.475 . . . . 0.0 113.023 170.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . 0.267 0.3 OUTLIER 64.88 35.55 8.37 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 127.547 2.339 . . . . 0.0 114.445 -172.14 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.4 mmtp -127.66 152.81 47.21 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 127.966 2.506 . . . . 0.0 113.391 -174.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -76.79 159.09 30.4 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.256 -0.903 . . . . 0.0 108.913 167.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -140.78 145.21 15.8 Favored Glycine 0 N--CA 1.474 1.187 0 C-N-CA 125.022 1.296 . . . . 0.0 114.547 -178.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -145.37 141.63 22.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 124.878 1.271 . . . . 0.0 110.803 -176.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 90.8 m -77.61 120.48 22.62 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.906 0.86 . . . . 0.0 113.315 -175.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -113.75 100.82 8.75 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.817 1.647 . . . . 0.0 109.404 169.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 64.88 -126.99 32.81 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 125.238 1.399 . . . . 0.0 111.086 -172.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 34.9 p -89.94 19.56 4.78 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 126.31 1.844 . . . . 0.0 114.011 177.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -141.86 163.17 33.63 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.385 1.474 . . . . 0.0 112.22 -174.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.7 t -88.56 157.9 18.46 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.627 1.171 . . . . 0.0 111.674 173.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.6 121.75 15.81 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 126.448 1.899 . . . . 0.0 107.461 171.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 63.3 m -86.11 134.47 33.81 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 -178.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -102.88 -122.63 5.13 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 127.684 2.564 . . . . 0.0 114.727 -169.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.6 m -87.22 156.82 54.19 Favored Pre-proline 0 N--CA 1.477 0.884 0 C-N-CA 125.765 1.626 . . . . 0.0 113.723 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -63.7 146.34 92.14 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 124.16 3.24 . . . . 0.0 113.322 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.8 pp -78.31 -16.55 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 N-CA-C 115.528 1.677 . . . . 0.0 115.528 -171.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.2 p -63.15 117.38 6.44 Favored 'General case' 0 C--O 1.238 0.478 0 O-C-N 121.185 -0.947 . . . . 0.0 111.733 -178.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -89.68 63.95 6.37 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.938 1.295 . . . . 0.0 111.267 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.2 pp . . . . . 0 C--O 1.25 1.098 0 C-N-CA 126.842 2.057 . . . . 0.0 113.195 174.791 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.699 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -144.08 134.62 24.79 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.67 1.588 . . . . 0.0 110.793 -173.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 12.3 m-80 63.64 -20.68 0.06 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 128.945 2.898 . . . . 0.0 115.876 175.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -132.63 8.22 4.18 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 57.5 12.9 1.64 Allowed 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 115.098 1.518 . . . . 0.0 115.098 -175.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 85.08 -5.23 83.71 Favored Glycine 0 CA--C 1.54 1.602 0 C-N-CA 124.739 1.162 . . . . 0.0 115.173 -168.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 81.7 m -84.01 141.36 31.24 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.842 1.321 . . . . 0.0 113.46 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -151.06 134.17 15.98 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.357 0.663 . . . . 0.0 111.129 164.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 47.2 54.64 9.15 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.113 1.365 . . . . 0.0 112.542 -176.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 61.3 m-20 64.69 9.72 5.42 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 116.308 1.966 . . . . 0.0 116.308 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 49.4 t -125.57 147.87 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 CA-C-N 120.547 1.521 . . . . 0.0 111.893 -175.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -74.08 46.66 0.25 Allowed 'General case' 0 CA--C 1.557 1.249 0 C-N-CA 127.083 2.153 . . . . 0.0 112.466 175.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -73.12 -37.02 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 O-C-N 119.738 -1.851 . . . . 0.0 114.73 -170.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 63.7 mtpt -99.58 -18.18 17.48 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.717 1.207 . . . . 0.0 113.233 178.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 179.46 167.34 36.66 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 124.638 1.113 . . . . 0.0 112.53 175.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -87.37 109.37 19.5 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.99 1.716 . . . . 0.0 113.103 -174.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -61.65 -24.56 66.81 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.489 1.515 . . . . 0.0 113.63 176.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.4 tmmm? -50.39 -35.72 29.52 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 120.981 -1.074 . . . . 0.0 111.916 171.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 55.8 ttm-85 -58.61 -41.12 85.15 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 126.483 1.913 . . . . 0.0 114.203 -177.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 36.8 t60 -67.62 -42.98 81.47 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.426 1.09 . . . . 0.0 111.495 175.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 72.0 m -77.26 -27.13 53.1 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.41 -36.8 81.33 Favored 'General case' 0 N--CA 1.476 0.839 0 O-C-N 120.62 -1.3 . . . . 0.0 110.782 169.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.2 -15.06 63.43 Favored 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 171.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -99.78 1.81 43.5 Favored 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 126.34 1.856 . . . . 0.0 111.36 169.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . 0.269 3.4 t0 51.98 44.21 29.68 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 128.188 2.595 . . . . 0.0 114.212 -169.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.4 mttt -126.92 172.8 10.12 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 129.13 2.972 . . . . 0.0 112.845 -178.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -85.55 153.84 22.15 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.89 1.276 . . . . 0.0 109.653 167.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -131.79 151.4 19.78 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 125.525 1.536 . . . . 0.0 114.887 -178.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -153.32 137.31 8.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 125.268 1.427 . . . . 0.0 111.056 -176.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 87.3 m -79.92 120.76 24.57 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.28 -0.887 . . . . 0.0 112.137 -177.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 15.9 m-70 -111.58 103.1 11.4 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.667 1.587 . . . . 0.0 109.223 168.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 67.86 -114.79 6.4 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 124.869 1.224 . . . . 0.0 112.112 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 82.7 p -104.06 17.2 24.6 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 126.155 1.782 . . . . 0.0 112.615 173.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 44.9 mmtm -127.96 159.91 33.52 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.448 1.899 . . . . 0.0 112.093 -178.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 43.3 t -100.02 146.0 27.25 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.603 1.161 . . . . 0.0 110.226 170.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -130.35 126.49 37.25 Favored 'General case' 0 C--N 1.333 -0.11 0 C-N-CA 126.392 1.877 . . . . 0.0 106.998 -178.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 61.2 m -87.95 137.27 32.48 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.832 0.825 . . . . 0.0 112.164 176.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -97.16 -137.28 9.48 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 127.35 2.405 . . . . 0.0 112.228 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 33.1 m -73.39 155.14 89.88 Favored Pre-proline 0 CA--C 1.535 0.37 0 N-CA-C 113.939 1.088 . . . . 0.0 113.939 178.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -51.86 146.96 26.77 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 124.541 3.494 . . . . 0.0 111.407 166.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.5 pp -59.55 -25.18 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 114.944 1.461 . . . . 0.0 114.944 -174.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 8.6 t 48.25 110.85 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 127.458 2.303 . . . . 0.0 116.922 169.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -70.67 -2.61 15.02 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.706 1.203 . . . . 0.0 114.019 171.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 58.8 tp . . . . . 0 C--O 1.253 1.246 0 C-N-CA 126.172 1.789 . . . . 0.0 109.257 168.326 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.992 0 CA-C-O 119.869 -0.11 . . . . 0.0 110.865 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -124.73 -40.51 2.19 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 -168.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 30.8 p-10 -161.91 -35.32 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 114.903 1.446 . . . . 0.0 114.903 -177.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -117.7 3.73 12.32 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 115.103 1.52 . . . . 0.0 115.103 -171.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 54.65 15.54 1.1 Allowed 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 -171.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 81.17 -5.11 68.18 Favored Glycine 0 CA--C 1.544 1.906 0 C-N-CA 124.646 1.117 . . . . 0.0 115.263 -168.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 74.5 m -77.44 141.52 39.69 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.065 1.346 . . . . 0.0 113.068 178.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -152.15 131.98 13.28 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.098 0.959 . . . . 0.0 112.113 166.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 48.19 54.5 10.15 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.773 1.629 . . . . 0.0 112.745 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 42.4 m-20 62.57 15.35 7.85 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 116.485 2.032 . . . . 0.0 116.485 -179.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 38.4 t -129.07 147.26 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 125.048 1.339 . . . . 0.0 111.079 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 28.0 p-10 -76.33 33.95 0.13 Allowed 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 128.354 2.661 . . . . 0.0 114.266 176.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -58.78 -30.92 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 N-CA-C 116.362 1.986 . . . . 0.0 116.362 -168.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -109.5 -10.14 14.89 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 125.189 1.395 . . . . 0.0 113.133 175.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 168.81 153.53 8.38 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 125.798 1.666 . . . . 0.0 112.252 173.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -85.3 138.54 32.24 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.089 0.956 . . . . 0.0 112.137 175.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.2 p -94.95 -1.43 52.53 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -178.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -63.21 -28.65 70.18 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 120.956 -1.09 . . . . 0.0 112.978 177.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.04 -37.4 85.76 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 121.045 1.748 . . . . 0.0 113.148 173.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 13.1 t60 -62.68 -36.37 82.67 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.34 1.056 . . . . 0.0 111.715 170.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 57.7 m -75.38 -27.83 59.26 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 121.087 -1.008 . . . . 0.0 113.402 171.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 21.6 tptp -66.28 -20.32 66.07 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.188 1.395 . . . . 0.0 112.907 173.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.53 -18.11 64.53 Favored 'General case' 0 CA--C 1.55 0.955 0 O-C-N 121.704 -0.623 . . . . 0.0 112.308 168.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -110.68 15.12 22.16 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 126.953 2.101 . . . . 0.0 111.899 168.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 15.4 t0 56.18 26.32 10.16 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 127.771 2.428 . . . . 0.0 115.2 -174.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 38.8 mttt -109.91 159.57 17.13 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.79 1.636 . . . . 0.0 114.339 -174.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -70.59 149.9 46.61 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 114.727 -1.124 . . . . 0.0 108.006 166.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -136.62 141.63 12.68 Favored Glycine 0 N--CA 1.472 1.069 0 C-N-CA 124.798 1.19 . . . . 0.0 114.83 -176.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.06 131.78 55.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 125.638 1.575 . . . . 0.0 111.903 -168.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 96.9 m -73.07 107.89 5.66 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.208 1.003 . . . . 0.0 112.045 177.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 9.5 m-70 -95.5 91.76 6.33 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.866 2.066 . . . . 0.0 110.069 169.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 66.27 -109.0 2.64 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 124.613 1.101 . . . . 0.0 112.037 -178.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 47.5 p -109.94 26.71 10.35 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 125.938 1.695 . . . . 0.0 113.209 173.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 36.4 mmtm -139.31 174.23 10.73 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 126.977 2.111 . . . . 0.0 111.932 174.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 13.1 t -117.48 157.71 25.79 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.697 1.199 . . . . 0.0 112.388 176.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.9 mtpt -144.47 155.67 43.83 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 128.08 2.552 . . . . 0.0 107.646 172.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 23.8 m -107.0 149.11 27.89 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -95.32 -117.47 3.13 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 127.034 2.254 . . . . 0.0 113.779 -176.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.9 m -106.41 163.87 16.09 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 126.399 1.88 . . . . 0.0 111.432 169.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_exo -48.66 142.91 17.49 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 124.494 3.463 . . . . 0.0 113.849 170.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.7 pp -65.8 -14.78 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 N-CA-C 115.065 1.505 . . . . 0.0 115.065 -175.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.3 p -51.91 129.74 27.62 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.264 1.426 . . . . 0.0 113.124 -172.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -81.19 -14.83 57.17 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.403 1.481 . . . . 0.0 113.523 -176.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 57.7 tp . . . . . 0 C--O 1.253 1.237 0 C-N-CA 126.582 1.953 . . . . 0.0 110.276 175.297 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.047 0 N-CA-C 112.033 0.382 . . . . 0.0 112.033 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -152.66 -38.61 0.11 Allowed 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.813 1.245 . . . . 0.0 113.995 178.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 28.4 p30 -146.83 -40.37 0.2 Allowed 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 125.566 1.546 . . . . 0.0 114.737 -169.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -124.05 24.5 8.2 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.494 1.917 . . . . 0.0 113.072 177.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 53.77 26.13 5.73 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.919 1.288 . . . . 0.0 113.535 -173.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.02 0.72 21.99 Favored Glycine 0 CA--C 1.539 1.567 0 O-C-N 121.057 -1.027 . . . . 0.0 115.445 -171.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 76.2 m -97.7 141.92 30.13 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.16 1.384 . . . . 0.0 113.713 -170.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -150.6 132.46 15.08 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.161 167.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 47.36 54.67 9.24 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.628 1.571 . . . . 0.0 113.331 178.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 64.03 14.84 8.79 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 116.811 2.152 . . . . 0.0 116.811 -177.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.5 t -131.58 146.66 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 O-C-N 120.567 -1.333 . . . . 0.0 111.827 -177.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -76.51 50.13 0.65 Allowed 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.852 1.661 . . . . 0.0 112.179 170.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -77.93 -30.79 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 125.618 1.567 . . . . 0.0 114.073 -177.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 23.4 mmmt -95.26 -30.72 13.83 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -174.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -175.61 -138.69 2.88 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 124.958 1.266 . . . . 0.0 112.62 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -124.78 140.25 53.1 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -108.27 -19.57 13.43 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 129.276 3.03 . . . . 0.0 111.369 174.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 11.6 tppt? -38.64 -51.57 1.65 Allowed 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 127.199 2.199 . . . . 0.0 112.321 169.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 42.3 mtm180 -63.4 -25.56 68.34 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 -176.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 65.1 t60 -73.75 -45.71 50.22 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 119.186 0.903 . . . . 0.0 111.975 173.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 71.1 m -76.13 -28.63 57.5 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 178.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.421 ' HA ' ' HE2' ' A' ' 22' ' ' LYS . 0.5 OUTLIER -63.05 -28.43 70.08 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.747 1.219 . . . . 0.0 112.267 175.729 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.24 -26.45 63.85 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.391 1.076 . . . . 0.0 113.258 172.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -88.2 8.53 26.65 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 125.844 1.657 . . . . 0.0 111.615 168.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . 0.265 11.5 t0 56.18 31.3 18.08 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 128.167 2.587 . . . . 0.0 115.061 -173.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 36.3 mttt -117.22 169.17 9.67 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 127.453 2.301 . . . . 0.0 113.798 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -79.65 150.91 30.8 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.421 1.488 . . . . 0.0 108.477 167.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -110.99 151.03 17.8 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 125.755 1.645 . . . . 0.0 113.708 175.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -150.41 137.88 13.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 125.346 1.458 . . . . 0.0 109.002 175.097 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 68.3 m -77.93 126.34 30.69 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 121.046 -1.034 . . . . 0.0 112.878 -174.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -122.08 114.43 20.9 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.211 1.404 . . . . 0.0 109.229 169.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 64.13 -124.51 30.28 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 124.464 1.03 . . . . 0.0 111.721 -173.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 70.3 p -104.6 29.2 6.33 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 125.997 1.719 . . . . 0.0 112.405 170.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 41.2 mmtm -136.73 165.07 26.78 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.405 1.882 . . . . 0.0 110.686 -176.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 12.6 t -92.19 160.37 15.2 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.633 1.173 . . . . 0.0 110.294 173.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.0 tmtt? -145.97 137.92 25.17 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 127.024 2.13 . . . . 0.0 106.294 173.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 57.2 m -93.48 135.45 34.72 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -176.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -85.31 -127.35 1.79 Allowed Glycine 0 CA--C 1.528 0.866 0 C-N-CA 126.538 2.018 . . . . 0.0 112.286 178.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 31.5 m -89.03 155.08 49.81 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 124.666 1.186 . . . . 0.0 113.014 176.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -53.1 142.05 55.88 Favored 'Trans proline' 0 C--O 1.239 0.525 0 C-N-CA 124.742 3.628 . . . . 0.0 111.309 167.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.0 pp -68.36 -32.95 57.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-O 119.022 -0.513 . . . . 0.0 111.925 -178.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.9 t -68.38 134.13 49.77 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 123.494 0.718 . . . . 0.0 111.979 -173.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -90.23 -6.52 55.14 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.866 0.866 . . . . 0.0 113.174 177.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.255 1.378 0 C-N-CA 128.129 2.571 . . . . 0.0 112.688 176.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.839 0 N-CA-C 111.448 0.166 . . . . 0.0 111.448 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.1 tpmt? -141.29 -51.02 0.43 Allowed 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -167.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -66.91 -30.22 70.31 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 119.837 1.199 . . . . 0.0 111.873 -168.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -131.01 16.54 5.13 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.205 1.402 . . . . 0.0 111.617 165.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 50.75 16.78 0.34 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.477 1.911 . . . . 0.0 115.223 -172.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 71.35 0.67 39.01 Favored Glycine 0 CA--C 1.535 1.294 0 O-C-N 120.965 -1.084 . . . . 0.0 115.002 -173.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 99.8 m -90.74 137.09 32.63 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 118.2 1.0 . . . . 0.0 112.835 -173.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -151.7 141.97 22.38 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.303 1.041 . . . . 0.0 110.175 165.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 51.15 39.08 22.66 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 178.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 57.88 28.44 16.07 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 126.281 1.832 . . . . 0.0 114.786 -173.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 46.2 t -132.01 145.03 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 125.416 1.486 . . . . 0.0 110.585 179.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -77.51 50.85 0.84 Allowed 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.598 1.559 . . . . 0.0 112.236 173.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -75.94 -41.95 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 124.963 1.305 . . . . 0.0 113.722 -175.162 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 25.0 mmmt -90.04 -19.4 24.44 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.012 0.925 . . . . 0.0 112.797 -173.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -178.5 -146.76 6.67 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 124.701 1.143 . . . . 0.0 112.588 178.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 -124.22 126.97 47.01 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.881 1.272 . . . . 0.0 113.947 177.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -86.49 -18.42 31.68 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.635 1.974 . . . . 0.0 111.56 171.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -48.46 -51.32 27.61 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 117.408 -1.282 . . . . 0.0 111.378 169.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -52.82 -42.58 65.26 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-N 120.267 1.394 . . . . 0.0 113.104 -175.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 71.8 t60 -63.18 -43.53 97.95 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.161 0.984 . . . . 0.0 112.235 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 92.9 m -84.24 -25.71 29.21 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.57 -35.55 78.11 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 120.833 -1.167 . . . . 0.0 110.221 173.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.06 -12.85 61.59 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 171.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -102.4 7.88 40.29 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 126.564 1.946 . . . . 0.0 112.193 169.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . 0.261 2.6 t0 58.22 35.87 25.3 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 128.263 2.625 . . . . 0.0 114.198 -172.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.2 mttt -129.89 164.17 24.76 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 127.588 2.355 . . . . 0.0 115.37 -172.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -69.29 144.96 53.44 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.045 1.738 . . . . 0.0 109.383 165.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -109.41 141.11 15.96 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 125.413 1.482 . . . . 0.0 112.599 169.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.45 135.37 31.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-N 118.666 1.233 . . . . 0.0 111.239 174.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 86.6 m -74.8 115.36 14.3 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 122.078 0.942 . . . . 0.0 113.262 -176.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 5.0 m-70 -100.07 100.28 11.13 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 126.24 1.816 . . . . 0.0 107.65 168.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 63.55 -114.41 6.83 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 124.411 1.005 . . . . 0.0 111.977 -178.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 44.8 p -102.42 16.49 26.12 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 126.168 1.787 . . . . 0.0 113.653 174.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 48.8 mmtm -130.25 165.6 22.08 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.867 2.067 . . . . 0.0 111.019 -175.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 20.4 t -97.6 157.61 15.94 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.042 0.937 . . . . 0.0 110.868 172.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.14 126.5 14.0 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 126.151 1.78 . . . . 0.0 106.314 175.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 39.4 m -82.26 142.34 32.19 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 119.119 0.872 . . . . 0.0 112.141 -178.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -102.28 -118.48 4.42 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 125.725 1.631 . . . . 0.0 113.456 -173.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.9 m -91.55 159.68 38.26 Favored Pre-proline 0 N--CA 1.472 0.658 0 C-N-CA 126.314 1.846 . . . . 0.0 112.559 174.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -65.89 157.79 57.31 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 124.098 3.198 . . . . 0.0 112.556 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.1 pp -71.17 -0.34 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 175.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 55.9 m -70.75 56.71 0.18 Allowed 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 129.253 3.021 . . . . 0.0 113.508 175.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -60.92 -20.54 62.27 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 124.97 1.308 . . . . 0.0 114.469 -171.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.6 pt? . . . . . 0 C--O 1.255 1.348 0 C-N-CA 126.645 1.978 . . . . 0.0 113.198 174.996 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.999 0 CA-C-O 118.478 -0.773 . . . . 0.0 110.834 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -146.56 -37.79 0.23 Allowed 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 115.146 1.536 . . . . 0.0 115.146 175.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 18.1 p30 -142.38 -46.16 0.33 Allowed 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.753 1.221 . . . . 0.0 113.96 178.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -114.65 16.92 17.45 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.699 1.6 . . . . 0.0 112.742 177.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 54.16 15.74 1.0 Allowed 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 -177.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.36 4.87 52.88 Favored Glycine 0 CA--C 1.537 1.425 0 O-C-N 121.179 -0.95 . . . . 0.0 114.842 -173.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 92.0 m -91.28 135.78 33.56 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.458 1.103 . . . . 0.0 112.084 -179.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -151.68 135.38 16.3 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.096 0.958 . . . . 0.0 111.955 167.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 48.46 52.77 13.1 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.3 1.44 . . . . 0.0 112.72 -179.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 57.3 m-20 63.71 8.26 3.63 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 127.254 2.222 . . . . 0.0 116.686 -177.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.0 t -126.24 147.85 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 CA-C-N 119.592 1.087 . . . . 0.0 111.504 -176.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -77.44 39.46 0.26 Allowed 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 126.916 2.086 . . . . 0.0 113.06 172.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -63.06 -26.74 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 126.054 1.741 . . . . 0.0 113.907 -178.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.5 mmmm -104.65 -13.76 15.84 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.237 1.415 . . . . 0.0 114.519 -175.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 166.94 -141.13 6.71 Favored Glycine 0 N--CA 1.471 0.992 0 CA-C-N 120.112 1.324 . . . . 0.0 114.699 174.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -117.13 124.28 48.82 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.704 1.201 . . . . 0.0 113.718 -170.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -104.54 -30.35 10.07 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 127.53 2.332 . . . . 0.0 111.284 176.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.3 tmmm? -53.16 -40.21 64.13 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 121.11 -0.994 . . . . 0.0 112.391 175.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 43.9 mtp180 -64.3 -27.69 69.21 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 63.7 t60 -70.68 -46.65 62.78 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 118.867 0.758 . . . . 0.0 111.335 170.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 86.8 m -72.34 -30.31 64.62 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.471 ' HA ' ' HE2' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -62.55 -30.69 71.5 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 120.536 -1.352 . . . . 0.0 112.14 173.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -75.47 -11.98 60.15 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 124.304 1.042 . . . . 0.0 112.902 173.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -102.79 4.91 38.41 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 126.528 1.931 . . . . 0.0 111.378 168.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . 0.273 5.7 t0 57.68 40.37 26.58 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 129.354 3.061 . . . . 0.0 115.886 -171.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.7 mttt -129.96 171.59 12.61 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.303 1.841 . . . . 0.0 113.871 -177.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -79.11 156.47 28.28 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.921 1.688 . . . . 0.0 109.141 166.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -126.58 144.92 15.42 Favored Glycine 0 CA--C 1.537 1.46 0 C-N-CA 125.332 1.444 . . . . 0.0 115.102 176.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -147.43 144.06 19.68 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 124.558 1.143 . . . . 0.0 109.564 -178.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 88.8 m -86.76 122.91 31.31 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.112 -0.993 . . . . 0.0 112.86 -174.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 19.0 m-70 -114.71 104.22 11.76 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 125.582 1.553 . . . . 0.0 110.019 169.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 60.65 -121.52 26.87 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 123.827 0.727 . . . . 0.0 111.67 -173.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 60.7 p -91.42 8.8 34.51 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 126.215 1.806 . . . . 0.0 114.167 179.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -131.91 160.96 34.21 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.709 1.603 . . . . 0.0 112.94 -172.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 38.7 t -93.23 140.06 29.94 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.828 1.251 . . . . 0.0 110.766 172.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.63 121.13 29.66 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 127.142 2.177 . . . . 0.0 105.799 178.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 57.2 m -78.03 141.73 38.68 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 119.043 0.838 . . . . 0.0 112.687 -177.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -89.68 -135.11 5.64 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 126.549 2.023 . . . . 0.0 111.868 175.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 33.7 m -83.93 159.61 59.83 Favored Pre-proline 0 CA--C 1.539 0.534 0 C-N-CA 123.99 0.916 . . . . 0.0 113.318 -178.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -54.47 144.9 60.22 Favored 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 124.63 3.553 . . . . 0.0 111.516 167.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.7 pp -70.56 -7.02 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 N-CA-C 117.098 2.258 . . . . 0.0 117.098 -167.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 85.2 p -94.38 15.29 18.01 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.562 1.545 . . . . 0.0 114.421 169.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 50.39 63.52 2.17 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 129.713 3.205 . . . . 0.0 114.837 171.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.3 mp . . . . . 0 C--O 1.248 1.005 0 C-N-CA 126.232 1.813 . . . . 0.0 112.871 179.425 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.927 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -143.95 -33.49 0.41 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 126.998 2.119 . . . . 0.0 113.043 178.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -78.43 -40.89 34.48 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.263 1.025 . . . . 0.0 112.211 -177.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -105.55 3.21 29.09 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.456 1.025 . . . . 0.0 113.725 168.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 56.09 14.14 1.38 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.505 1.522 . . . . 0.0 114.169 -174.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 83.69 -7.43 69.53 Favored Glycine 0 CA--C 1.538 1.493 0 C-N-CA 125.347 1.451 . . . . 0.0 115.0 -171.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 82.8 m -76.33 143.79 40.57 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.229 1.011 . . . . 0.0 113.232 177.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -156.36 139.97 15.97 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.988 1.315 . . . . 0.0 109.953 166.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 48.92 44.33 22.24 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.667 1.187 . . . . 0.0 113.859 -179.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 16.7 m-20 61.18 15.91 6.76 Favored 'General case' 0 CA--C 1.553 1.074 0 N-CA-C 116.316 1.969 . . . . 0.0 116.316 -174.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 59.4 t -126.49 149.92 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 125.379 1.472 . . . . 0.0 111.849 -176.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -79.06 42.33 0.47 Allowed 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 127.082 2.153 . . . . 0.0 114.61 178.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -64.22 -42.62 96.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 O-C-N 120.584 -1.322 . . . . 0.0 113.566 -171.412 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 36.2 mmtm -96.36 -19.19 19.4 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 174.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 172.3 168.48 33.78 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 124.343 0.973 . . . . 0.0 112.694 177.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -98.37 129.67 45.02 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.474 0.709 . . . . 0.0 112.715 -174.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -64.34 -15.55 60.56 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 126.641 1.976 . . . . 0.0 113.507 171.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? -41.98 -51.49 4.42 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.52 1.528 . . . . 0.0 112.113 168.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 60.1 mtm180 -68.55 -25.57 64.98 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.047 1.128 . . . . 0.0 114.047 -168.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -81.88 -36.53 28.07 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.932 1.293 . . . . 0.0 112.789 174.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 99.1 m -79.25 -33.24 43.73 Favored 'General case' 0 CA--C 1.546 0.817 0 O-C-N 121.06 -1.025 . . . . 0.0 113.08 174.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 18.8 tptp -63.64 -28.57 70.0 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.67 1.188 . . . . 0.0 112.422 177.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.69 -25.91 66.74 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.874 1.27 . . . . 0.0 113.365 171.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -103.76 10.2 36.73 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.842 1.657 . . . . 0.0 112.067 174.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 64.78 30.3 12.34 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 128.28 2.632 . . . . 0.0 115.312 -177.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.2 mttp -115.93 163.48 15.82 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 126.648 1.979 . . . . 0.0 112.869 177.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -78.79 152.27 31.51 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 166.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -107.75 159.98 14.19 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 125.836 1.684 . . . . 0.0 113.226 172.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -150.14 135.9 11.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 124.906 1.282 . . . . 0.0 111.011 171.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 91.4 m -76.91 118.81 19.87 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.449 0.642 . . . . 0.0 112.273 -179.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 19.3 m-70 -116.2 111.58 20.39 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.627 1.571 . . . . 0.0 109.125 169.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 63.5 -117.08 10.21 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 125.964 1.745 . . . . 0.0 111.228 -173.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.4 p -108.44 23.93 13.79 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.636 1.574 . . . . 0.0 112.377 173.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 42.0 mmtm -138.59 169.27 18.09 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.934 1.294 . . . . 0.0 112.913 -178.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 41.7 t -99.59 148.11 24.65 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.372 1.469 . . . . 0.0 111.937 -178.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -139.9 133.78 30.71 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 126.902 2.081 . . . . 0.0 105.974 174.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 63.0 m -84.73 142.67 29.68 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 119.592 1.087 . . . . 0.0 112.834 -178.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -89.71 -138.36 6.95 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 126.26 1.886 . . . . 0.0 111.239 171.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.6 m -77.86 154.48 80.62 Favored Pre-proline 0 CA--C 1.537 0.475 0 N-CA-C 114.055 1.131 . . . . 0.0 114.055 178.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -54.73 137.1 73.7 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 124.238 3.292 . . . . 0.0 110.758 166.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.5 pp -62.99 -22.92 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 O-C-N 120.971 -1.081 . . . . 0.0 113.731 -174.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.2 m 53.72 45.19 28.47 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 118.033 2.605 . . . . 0.0 118.033 167.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -115.24 -17.1 11.43 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 125.025 1.33 . . . . 0.0 114.574 169.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 34.0 tp . . . . . 0 C--O 1.25 1.091 0 C-N-CA 126.163 1.785 . . . . 0.0 111.163 -178.145 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.788 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -146.78 -28.0 0.39 Allowed 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 114.879 1.437 . . . . 0.0 114.879 -177.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 39.9 p30 -82.11 -38.98 24.0 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 -176.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -117.64 0.93 12.17 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.745 1.218 . . . . 0.0 112.708 169.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 60.58 7.96 1.55 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.52 1.928 . . . . 0.0 114.975 -178.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 88.02 -3.18 85.83 Favored Glycine 0 CA--C 1.543 1.84 0 C-N-CA 124.701 1.143 . . . . 0.0 114.729 -168.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 87.3 m -79.03 141.88 37.04 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.553 1.141 . . . . 0.0 112.01 175.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -152.4 135.8 15.94 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.798 0.839 . . . . 0.0 110.714 168.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 47.95 51.47 14.39 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.405 1.482 . . . . 0.0 113.228 179.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 62.62 11.22 4.62 Favored 'General case' 0 CA--C 1.551 1.017 0 N-CA-C 117.389 2.366 . . . . 0.0 117.389 -175.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 38.2 t -124.2 146.53 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 CA-C-N 119.73 1.15 . . . . 0.0 111.965 -177.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -74.91 35.92 0.11 Allowed 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 127.698 2.399 . . . . 0.0 113.483 177.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -60.1 -43.8 93.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 -168.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -96.97 -18.05 19.68 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 178.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 171.4 169.64 34.55 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 125.553 1.549 . . . . 0.0 113.002 174.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -86.84 142.81 27.8 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 121.959 0.885 . . . . 0.0 112.996 175.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.8 p -97.79 -10.66 24.41 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.628 1.171 . . . . 0.0 113.149 169.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.1 tmmm? -63.3 -28.09 69.78 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-O 118.115 -0.945 . . . . 0.0 113.251 -176.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 44.9 mtm180 -63.81 -35.23 79.92 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 120.013 1.279 . . . . 0.0 113.596 170.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -67.76 -35.41 78.66 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.433 1.093 . . . . 0.0 111.904 174.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 90.0 m -75.21 -39.02 60.44 Favored 'General case' 0 CA--C 1.547 0.865 0 O-C-N 120.909 -1.119 . . . . 0.0 112.533 170.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -62.28 -28.63 69.85 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 120.748 -1.22 . . . . 0.0 112.791 178.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.57 -25.89 60.64 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.47 1.108 . . . . 0.0 113.152 171.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -115.47 21.01 14.38 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.684 1.594 . . . . 0.0 112.048 -179.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.2 t0 56.96 60.56 2.96 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 126.407 1.883 . . . . 0.0 111.431 -175.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 31.9 mmtm -145.44 147.68 32.47 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 126.071 1.748 . . . . 0.0 113.308 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -72.53 156.42 39.03 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 162.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -141.6 136.11 7.2 Favored Glycine 0 N--CA 1.468 0.788 0 C-N-CA 124.385 0.993 . . . . 0.0 112.684 -179.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.0 140.18 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 C-N-CA 124.595 1.158 . . . . 0.0 110.675 -172.123 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 73.0 m -68.13 118.07 10.8 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.019 0.528 . . . . 0.0 112.408 -177.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 -108.63 98.69 8.16 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.965 1.706 . . . . 0.0 108.783 169.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 61.35 -114.81 7.07 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 124.176 0.893 . . . . 0.0 111.402 -174.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 58.6 p -107.01 27.43 9.0 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 127.337 2.255 . . . . 0.0 114.045 174.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -137.95 174.27 10.74 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 126.726 2.01 . . . . 0.0 111.219 172.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 9.1 t -97.17 166.68 11.46 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.746 1.218 . . . . 0.0 111.435 172.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.55 118.57 8.23 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.337 1.455 . . . . 0.0 108.633 173.116 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 73.9 m -84.48 129.57 34.84 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -178.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -99.72 -139.32 10.75 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 127.407 2.432 . . . . 0.0 113.941 -175.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.6 m -72.8 154.78 91.1 Favored Pre-proline 0 N--CA 1.473 0.722 0 C-N-CA 125.051 1.34 . . . . 0.0 113.398 176.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.53 157.79 52.12 Favored 'Trans proline' 0 CA--C 1.532 0.4 0 C-N-CA 124.28 3.32 . . . . 0.0 114.031 -178.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.5 pp -104.27 -39.58 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -168.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 21.3 m -63.01 130.4 44.53 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.102 0.961 . . . . 0.0 111.962 -169.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 8.4 p90 -139.68 -4.97 1.38 Allowed 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 114.967 1.469 . . . . 0.0 114.967 -169.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.8 pp . . . . . 0 C--O 1.257 1.468 0 C-N-CA 126.982 2.113 . . . . 0.0 112.581 170.719 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.699 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 23.1 ttpp -108.88 -35.26 6.42 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.953 1.701 . . . . 0.0 112.053 -168.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -71.59 -18.3 62.24 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.693 -0.629 . . . . 0.0 112.566 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -103.23 -2.34 27.4 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.346 0.658 . . . . 0.0 111.873 167.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 56.44 28.52 13.78 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.811 1.245 . . . . 0.0 113.662 -177.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 71.51 -5.14 11.34 Favored Glycine 0 CA--C 1.541 1.691 0 N-CA-C 115.411 0.924 . . . . 0.0 115.411 -174.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 74.4 m -79.46 135.0 36.54 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.705 1.202 . . . . 0.0 112.792 -178.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -148.08 134.97 20.12 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.214 1.006 . . . . 0.0 111.104 167.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 47.66 49.08 16.75 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.09 1.356 . . . . 0.0 113.65 179.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 65.96 10.93 7.35 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 127.436 2.294 . . . . 0.0 116.513 -176.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.9 t -126.06 147.95 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 124.951 1.3 . . . . 0.0 112.288 -176.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -78.72 40.64 0.39 Allowed 'General case' 0 CA--C 1.558 1.264 0 C-N-CA 127.234 2.214 . . . . 0.0 113.708 176.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.5 m -70.86 -23.39 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 C-N-CA 125.777 1.631 . . . . 0.0 115.325 -172.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -109.05 -8.81 15.12 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.696 1.198 . . . . 0.0 112.984 173.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 158.09 169.33 21.55 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 125.452 1.501 . . . . 0.0 112.435 174.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -89.19 144.93 25.75 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.157 0.983 . . . . 0.0 112.706 177.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 42.4 t -92.65 -15.23 27.05 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.455 0.702 . . . . 0.0 112.375 170.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -53.29 -35.39 60.05 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 120.679 -1.263 . . . . 0.0 111.709 177.497 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 11.9 mtp-105 -55.77 -43.31 76.6 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 115.071 1.508 . . . . 0.0 115.071 169.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 62.4 t60 -67.83 -40.04 83.83 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 119.845 1.202 . . . . 0.0 112.302 177.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 93.0 m -75.61 -32.28 60.22 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 123.54 0.736 . . . . 0.0 112.443 177.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.437 ' O ' ' HE2' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -62.01 -30.4 70.93 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 127.132 2.173 . . . . 0.0 112.168 174.825 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.19 -24.89 67.47 Favored 'General case' 0 CA--C 1.549 0.918 0 O-C-N 121.554 -0.716 . . . . 0.0 112.534 173.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -107.95 18.88 20.73 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.416 1.886 . . . . 0.0 113.597 168.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 60.66 26.32 16.05 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 126.114 1.765 . . . . 0.0 115.724 177.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.6 mttp -110.22 162.12 14.91 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 127.653 2.381 . . . . 0.0 113.272 175.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -76.39 153.2 35.93 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.96 0.904 . . . . 0.0 110.1 166.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -125.49 142.66 13.94 Favored Glycine 0 N--CA 1.475 1.276 0 C-N-CA 125.726 1.631 . . . . 0.0 113.506 173.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.93 133.09 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 124.883 1.273 . . . . 0.0 111.322 -170.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 74.5 m -75.07 114.82 14.0 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.132 0.492 . . . . 0.0 111.677 -179.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 7.6 m-70 -107.76 100.98 10.31 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.726 2.01 . . . . 0.0 109.134 172.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 64.19 -115.62 8.11 Favored Glycine 0 CA--C 1.527 0.844 0 C-N-CA 124.839 1.209 . . . . 0.0 112.055 -177.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 75.9 p -105.38 15.76 26.7 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.97 1.308 . . . . 0.0 112.586 178.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -141.35 -171.09 3.22 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 128.651 2.78 . . . . 0.0 110.47 -175.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 52.7 t -134.71 158.08 45.05 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 114.282 1.215 . . . . 0.0 114.282 -176.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 68.6 mttt -136.19 149.86 48.77 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 129.49 3.116 . . . . 0.0 107.908 169.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 78.3 m -89.81 152.8 21.11 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 121.626 0.727 . . . . 0.0 112.073 170.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -107.71 -112.82 3.66 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 126.205 1.859 . . . . 0.0 114.124 -172.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.9 m -104.9 157.35 34.39 Favored Pre-proline 0 N--CA 1.475 0.788 0 C-N-CA 126.522 1.929 . . . . 0.0 113.155 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -64.69 141.55 73.01 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 124.083 3.188 . . . . 0.0 111.413 173.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.7 pp -69.42 -8.97 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 N-CA-C 115.386 1.624 . . . . 0.0 115.386 -172.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 78.6 p -90.16 8.5 32.64 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.66 1.584 . . . . 0.0 114.464 169.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 41.44 58.36 2.7 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 129.61 3.164 . . . . 0.0 114.379 172.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 78.3 mt . . . . . 0 C--O 1.251 1.137 0 C-N-CA 126.639 1.976 . . . . 0.0 113.257 -176.482 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.877 0 N-CA-C 110.365 -0.235 . . . . 0.0 110.365 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -134.45 -40.78 0.8 Allowed 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -169.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -163.03 -40.76 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 114.62 1.341 . . . . 0.0 114.62 -169.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -127.41 1.22 6.3 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -169.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 55.71 24.81 7.56 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.301 1.44 . . . . 0.0 114.132 -175.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 72.93 -4.69 21.81 Favored Glycine 0 CA--C 1.542 1.723 0 O-C-N 121.23 -0.919 . . . . 0.0 115.226 -171.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 88.0 m -84.33 142.62 30.06 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.057 1.343 . . . . 0.0 112.644 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -153.29 140.94 19.94 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.289 1.035 . . . . 0.0 110.278 167.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 46.51 47.58 14.22 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.201 1.4 . . . . 0.0 113.543 178.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 21.6 m-20 64.52 17.4 10.83 Favored 'General case' 0 CA--C 1.551 0.985 0 N-CA-C 116.132 1.901 . . . . 0.0 116.132 -177.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 40.7 t -132.81 148.19 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.57 1.148 . . . . 0.0 112.498 -176.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -73.15 37.52 0.08 Allowed 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 128.055 2.542 . . . . 0.0 114.092 173.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -63.76 -33.38 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 O-C-N 120.28 -1.513 . . . . 0.0 114.293 -171.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -104.53 -19.92 13.85 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.426 1.091 . . . . 0.0 113.725 178.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 173.5 177.06 42.45 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 124.951 1.262 . . . . 0.0 112.491 174.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -87.18 158.13 19.2 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 117.737 0.768 . . . . 0.0 111.987 174.169 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.6 p -120.61 -5.31 9.75 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 170.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -61.16 -31.72 71.45 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 117.519 -1.229 . . . . 0.0 112.025 177.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 47.6 mtm180 -58.32 -38.94 78.11 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-N 120.458 1.481 . . . . 0.0 113.622 170.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 18.6 t60 -65.2 -38.83 91.7 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 119.261 0.937 . . . . 0.0 112.628 174.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 97.3 m -72.89 -33.0 65.77 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 118.801 0.728 . . . . 0.0 112.727 171.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -66.34 -27.62 68.03 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 120.322 -1.486 . . . . 0.0 111.848 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.65 -5.63 16.65 Favored 'General case' 0 CA--C 1.551 1.008 0 N-CA-C 114.044 1.127 . . . . 0.0 114.044 169.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -121.86 19.21 10.98 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 127.583 2.353 . . . . 0.0 112.017 171.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 61.46 29.52 18.46 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.277 1.431 . . . . 0.0 113.518 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.3 mmtp -124.01 153.55 41.15 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 128.222 2.609 . . . . 0.0 112.538 -175.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -78.53 158.52 28.54 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.282 1.033 . . . . 0.0 108.361 166.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -138.7 145.66 17.11 Favored Glycine 0 N--CA 1.476 1.328 0 C-N-CA 124.943 1.259 . . . . 0.0 114.745 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -147.37 147.63 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 126.077 1.751 . . . . 0.0 110.882 -172.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 71.1 m -77.51 116.94 18.48 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 113.731 1.012 . . . . 0.0 113.731 -174.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -109.03 103.59 12.65 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.477 1.511 . . . . 0.0 108.562 168.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 66.34 -114.86 6.86 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 124.142 0.877 . . . . 0.0 111.85 -176.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 69.8 p -107.22 22.04 16.6 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.993 1.717 . . . . 0.0 112.384 175.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 37.0 mmtm -139.67 170.33 16.09 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.42 1.888 . . . . 0.0 112.29 -172.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 16.7 t -109.49 133.22 53.34 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.347 1.059 . . . . 0.0 112.576 -178.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.8 tptt -118.71 129.4 55.25 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 126.615 1.966 . . . . 0.0 107.137 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 68.6 m -86.46 145.4 26.84 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.39 -125.8 5.14 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 127.161 2.315 . . . . 0.0 113.752 -172.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 28.9 m -84.08 160.45 57.63 Favored Pre-proline 0 N--CA 1.471 0.583 0 C-N-CA 124.993 1.317 . . . . 0.0 113.242 177.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -51.74 152.43 13.15 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 124.426 3.418 . . . . 0.0 113.564 168.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.9 pp -83.37 -9.08 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 N-CA-C 116.049 1.87 . . . . 0.0 116.049 -177.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 25.7 t -49.77 130.13 20.8 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 126.657 1.983 . . . . 0.0 114.557 -170.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -143.97 -178.72 6.07 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.017 1.727 . . . . 0.0 112.454 -176.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.4 pt? . . . . . 0 C--O 1.252 1.233 0 C-N-CA 125.404 1.482 . . . . 0.0 113.835 173.771 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.794 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -111.62 -37.2 5.26 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 127.867 2.467 . . . . 0.0 112.172 -175.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 35.5 m120 -65.56 -29.57 70.2 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.638 1.175 . . . . 0.0 111.048 177.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -84.25 -0.99 54.46 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.549 1.14 . . . . 0.0 113.072 168.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 59.04 19.0 6.81 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.423 1.489 . . . . 0.0 114.62 -171.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 73.86 -0.29 52.15 Favored Glycine 0 CA--C 1.552 2.38 0 N-CA-C 115.803 1.081 . . . . 0.0 115.803 -168.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 97.8 m -81.81 137.47 35.29 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 120.84 -1.388 . . . . 0.0 113.095 178.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -151.12 134.32 16.04 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.247 1.019 . . . . 0.0 111.337 166.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 48.74 51.71 15.28 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.814 1.646 . . . . 0.0 113.736 -178.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 61.12 13.82 5.0 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 126.905 2.082 . . . . 0.0 116.398 -175.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.4 t -127.26 144.72 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-N 119.683 1.129 . . . . 0.0 111.663 -177.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -72.8 31.83 0.06 Allowed 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.595 1.558 . . . . 0.0 114.493 175.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -53.71 -32.08 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 O-C-N 120.327 -1.483 . . . . 0.0 114.601 -171.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -106.0 -6.96 18.37 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 177.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 167.37 150.83 6.65 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-N 119.599 1.09 . . . . 0.0 114.547 169.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -71.55 108.92 5.18 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.603 1.161 . . . . 0.0 113.777 -174.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -69.37 -29.91 67.8 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.787 2.035 . . . . 0.0 113.034 176.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.66 -34.11 67.03 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 120.745 -1.222 . . . . 0.0 112.132 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.3 mtm180 -60.74 -36.29 78.52 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 175.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 51.7 t60 -64.43 -39.71 94.35 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.885 0.874 . . . . 0.0 111.381 176.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 80.6 m -79.36 -32.73 43.28 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.246 0.619 . . . . 0.0 112.474 175.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.92 -31.25 71.55 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 120.503 -1.373 . . . . 0.0 111.697 173.003 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.5 -9.21 40.14 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.495 1.118 . . . . 0.0 113.832 171.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -116.91 12.5 14.71 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.298 1.839 . . . . 0.0 112.096 169.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 49.99 46.4 24.43 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.587 1.955 . . . . 0.0 113.587 -171.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.4 mmtt -122.21 162.4 21.46 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 127.33 2.252 . . . . 0.0 112.223 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -76.62 145.54 38.81 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.081 0.952 . . . . 0.0 109.305 167.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -133.13 138.05 9.83 Favored Glycine 0 N--CA 1.472 1.086 0 C-N-CA 124.501 1.048 . . . . 0.0 114.643 -179.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -149.81 141.74 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 125.368 1.467 . . . . 0.0 110.538 -172.075 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 84.0 m -78.55 116.83 19.2 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -179.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 -98.62 94.06 6.46 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.754 1.622 . . . . 0.0 109.466 168.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 63.24 -96.14 0.16 Allowed Glycine 0 CA--C 1.529 0.924 0 C-N-CA 125.188 1.375 . . . . 0.0 111.323 -176.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.7 p -118.58 14.97 13.68 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 127.52 2.328 . . . . 0.0 113.874 -173.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -138.58 168.6 19.44 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 127.25 2.22 . . . . 0.0 112.683 174.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 28.9 t -98.09 141.81 30.57 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.415 1.486 . . . . 0.0 110.733 171.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -128.87 120.56 26.45 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.081 1.352 . . . . 0.0 109.238 179.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 60.9 m -87.32 128.77 35.17 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.153 0.798 . . . . 0.0 113.153 -177.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -99.12 -126.82 5.75 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 126.522 2.01 . . . . 0.0 114.238 -169.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 16.8 m -75.9 152.74 84.77 Favored Pre-proline 0 N--CA 1.473 0.694 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 177.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -69.35 149.14 69.13 Favored 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 124.158 3.239 . . . . 0.0 110.987 174.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.0 pp -70.79 -13.9 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 -169.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 13.4 p -86.17 9.59 17.05 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.748 1.619 . . . . 0.0 114.537 168.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 46.06 33.66 1.77 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 130.339 3.456 . . . . 0.0 116.135 172.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 19.3 tp . . . . . 0 C--O 1.255 1.378 0 C-N-CA 125.89 1.676 . . . . 0.0 111.624 174.748 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.76 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 7.5 mmpt? -145.21 -37.66 0.27 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.429 1.492 . . . . 0.0 113.902 -168.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -70.54 -26.63 63.65 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 118.669 -0.681 . . . . 0.0 112.762 -169.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -138.14 5.01 2.51 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.184 0.994 . . . . 0.0 112.593 166.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 56.27 12.05 0.92 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.268 1.827 . . . . 0.0 115.471 -177.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.53 0.73 84.95 Favored Glycine 0 CA--C 1.541 1.712 0 N-CA-C 115.401 0.92 . . . . 0.0 115.401 -169.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 89.0 m -85.15 139.81 31.41 Favored 'General case' 0 C--O 1.236 0.39 0 O-C-N 121.037 -1.272 . . . . 0.0 112.421 178.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -151.12 131.01 13.28 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 167.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 44.49 55.0 6.02 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.43 1.892 . . . . 0.0 112.994 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 56.0 m-80 64.01 16.48 9.96 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 127.003 2.121 . . . . 0.0 116.173 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 19.8 t -124.93 147.45 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 O-C-N 120.935 -1.103 . . . . 0.0 111.396 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.85 37.4 0.18 Allowed 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 127.414 2.286 . . . . 0.0 112.493 176.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -68.32 -45.36 82.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 -168.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 25.4 mmmt -101.92 -14.24 17.29 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 -169.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 171.98 168.95 34.17 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-N 119.376 0.989 . . . . 0.0 115.19 174.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -87.5 81.3 7.82 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.02 1.728 . . . . 0.0 113.398 -171.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -46.28 -26.95 0.9 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 127.066 2.146 . . . . 0.0 113.831 171.281 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -32.37 -48.82 0.19 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.79 2.036 . . . . 0.0 112.485 166.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 55.2 mtm180 -66.57 -36.73 83.35 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 -171.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 15.7 t60 -68.64 -33.46 74.06 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-N 120.081 1.309 . . . . 0.0 112.3 176.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 71.5 m -80.76 -39.17 27.33 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 121.588 -0.695 . . . . 0.0 111.488 175.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -62.19 -32.8 73.49 Favored 'General case' 0 CA--C 1.53 0.206 0 O-C-N 120.54 -1.35 . . . . 0.0 112.072 177.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.1 -22.35 50.31 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.433 1.093 . . . . 0.0 113.595 174.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -121.27 23.04 10.65 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.874 1.669 . . . . 0.0 111.807 177.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 31.3 t0 56.57 55.79 6.14 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.957 1.703 . . . . 0.0 112.728 177.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm -138.77 151.62 47.24 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 127.647 2.379 . . . . 0.0 111.805 177.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -72.35 145.0 48.05 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 166.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -118.08 134.71 11.18 Favored Glycine 0 N--CA 1.469 0.846 0 C-N-CA 124.076 0.846 . . . . 0.0 112.607 175.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -144.07 140.18 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 125.201 1.401 . . . . 0.0 110.35 -177.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 99.9 m -78.68 114.82 17.92 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -174.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -107.63 103.06 12.27 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 126.879 2.072 . . . . 0.0 108.64 173.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 61.83 -116.59 9.57 Favored Glycine 0 CA--C 1.532 1.099 0 N-CA-C 111.109 -0.797 . . . . 0.0 111.109 -173.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 76.0 p -101.21 14.32 32.34 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 125.333 1.453 . . . . 0.0 114.128 175.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -127.69 165.13 20.61 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.989 1.715 . . . . 0.0 112.503 -173.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 46.8 t -104.45 121.41 43.37 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.382 1.073 . . . . 0.0 110.405 177.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 48.7 tptt -97.08 120.86 38.23 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 126.746 2.018 . . . . 0.0 106.693 177.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 59.5 m -84.85 137.9 32.88 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 123.612 0.57 . . . . 0.0 111.617 171.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -119.64 -124.96 3.29 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 126.158 1.837 . . . . 0.0 114.526 -169.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 15.3 m -83.59 157.54 64.21 Favored Pre-proline 0 N--CA 1.47 0.562 0 C-N-CA 125.966 1.706 . . . . 0.0 113.585 -179.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -65.17 159.55 46.36 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 123.862 3.041 . . . . 0.0 114.44 -178.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.53 HD12 ' H ' ' A' ' 43' ' ' TYR . 2.4 pp -114.74 -35.48 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -173.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 13.6 m 46.73 31.5 1.44 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 127.407 2.283 . . . . 0.0 116.993 174.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.53 ' H ' HD12 ' A' ' 41' ' ' ILE . 7.3 p90 -131.27 167.08 19.82 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 126.965 2.106 . . . . 0.0 112.326 170.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.5 pt? . . . . . 0 C--O 1.252 1.219 0 N-CA-C 116.089 1.885 . . . . 0.0 116.089 -175.549 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.592 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -92.65 -23.9 18.83 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.629 1.571 . . . . 0.0 112.491 -168.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -62.62 -28.08 69.66 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.189 0.596 . . . . 0.0 112.142 167.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -99.46 -1.59 38.15 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 168.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 54.15 19.45 2.14 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 126.193 1.797 . . . . 0.0 114.24 -172.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 76.34 -2.98 55.51 Favored Glycine 0 CA--C 1.542 1.721 0 C-N-CA 124.955 1.264 . . . . 0.0 115.692 -170.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 78.4 m -77.28 134.89 38.43 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.689 1.196 . . . . 0.0 112.132 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -146.14 136.28 23.69 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.655 0.782 . . . . 0.0 111.575 168.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 44.83 49.3 9.05 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.264 1.425 . . . . 0.0 112.744 -176.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 63.61 26.03 14.52 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 126.742 2.017 . . . . 0.0 115.023 175.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 49.7 t -136.97 145.99 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 125.996 1.718 . . . . 0.0 111.027 178.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -75.69 49.31 0.5 Allowed 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 126.041 1.736 . . . . 0.0 113.645 174.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -71.44 -51.53 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 O-C-N 120.166 -1.584 . . . . 0.0 113.894 -173.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -91.16 -9.19 46.36 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.02 0.928 . . . . 0.0 113.249 -172.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 176.01 172.98 41.29 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 126.512 2.006 . . . . 0.0 111.048 169.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -94.06 144.41 25.5 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 179.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 44.0 t -100.52 -10.66 20.83 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.144 0.977 . . . . 0.0 112.236 169.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -51.19 -43.23 61.3 Favored 'General case' 0 N--CA 1.466 0.337 0 O-C-N 120.799 -1.188 . . . . 0.0 111.663 178.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.5 mtm180 -56.39 -41.83 76.9 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 175.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 11.7 t60 -61.47 -46.76 88.67 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.621 0.768 . . . . 0.0 111.156 177.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 92.2 m -80.12 -29.2 38.91 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -178.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 23.8 tptp -67.71 -22.95 65.23 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 120.764 -1.21 . . . . 0.0 113.008 175.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.18 -27.26 69.24 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 118.793 0.724 . . . . 0.0 112.305 168.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -101.95 7.78 41.29 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 126.952 2.101 . . . . 0.0 111.984 171.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . 0.28 1.8 t70 54.63 33.61 19.62 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 129.1 2.96 . . . . 0.0 115.8 -175.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 28.9 mttt -109.66 163.22 13.68 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 127.603 2.361 . . . . 0.0 113.168 174.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -69.89 144.05 52.59 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.202 1.401 . . . . 0.0 109.18 167.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -95.45 151.72 20.11 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 123.875 0.75 . . . . 0.0 112.371 169.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.41 117.96 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 118.686 1.243 . . . . 0.0 110.777 -178.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 98.4 m -82.06 108.42 15.53 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.294 171.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 27.6 p80 -104.91 8.55 34.65 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 176.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 170.76 -134.45 3.13 Favored Glycine 0 CA--C 1.523 0.566 0 C-N-CA 123.83 0.729 . . . . 0.0 111.93 179.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 42.6 p -82.04 13.95 3.09 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 126.663 1.985 . . . . 0.0 112.289 168.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -149.22 170.37 18.63 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 128.978 2.911 . . . . 0.0 109.413 -172.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 14.9 t -128.76 173.68 10.12 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.022 1.329 . . . . 0.0 113.255 -176.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.0 mtpt -155.74 169.32 24.64 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 130.097 3.359 . . . . 0.0 107.244 178.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 59.8 m -104.27 148.81 25.92 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.87 0.868 . . . . 0.0 112.365 168.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -98.19 -119.9 4.11 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 126.985 2.231 . . . . 0.0 112.589 -177.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 19.5 m -100.59 159.03 30.77 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 126.499 1.92 . . . . 0.0 112.765 175.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -50.27 140.35 34.11 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 124.997 3.798 . . . . 0.0 113.912 168.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.7 pp -82.1 -25.84 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 O-C-N 121.417 -0.802 . . . . 0.0 113.018 -177.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 7.3 m 43.57 40.77 3.04 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 128.757 2.823 . . . . 0.0 117.808 168.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -147.39 -29.5 0.35 Allowed 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 115.694 1.738 . . . . 0.0 115.694 178.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 17.8 tp . . . . . 0 C--O 1.245 0.842 0 C-N-CA 126.977 2.111 . . . . 0.0 111.123 179.595 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.829 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -133.99 -31.18 1.16 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.714 1.606 . . . . 0.0 112.762 -178.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -87.46 -21.49 25.5 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.35 0.871 . . . . 0.0 113.35 -170.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -131.94 -4.56 3.56 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.696 0.798 . . . . 0.0 112.533 166.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 56.61 17.78 3.26 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.468 1.907 . . . . 0.0 114.581 -177.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 84.11 -9.32 63.9 Favored Glycine 0 CA--C 1.538 1.506 0 C-N-CA 124.771 1.176 . . . . 0.0 115.135 -170.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 92.7 m -80.35 139.33 36.62 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.436 1.094 . . . . 0.0 113.05 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -152.35 134.35 14.9 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.666 0.786 . . . . 0.0 110.61 168.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 49.6 49.32 20.18 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.675 1.19 . . . . 0.0 113.996 178.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 60.32 21.11 10.61 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 126.32 1.848 . . . . 0.0 115.547 -178.112 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 69.4 t -132.08 149.37 32.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 125.523 1.529 . . . . 0.0 110.035 -178.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.39 39.0 0.19 Allowed 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 126.806 2.043 . . . . 0.0 111.749 178.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -58.67 -44.5 89.92 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 N-CA-C 115.243 1.571 . . . . 0.0 115.243 -165.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -91.98 -26.44 18.38 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.954 0.902 . . . . 0.0 111.469 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 173.14 173.99 39.91 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 125.843 1.687 . . . . 0.0 112.959 178.112 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -84.3 142.81 29.95 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.065 0.946 . . . . 0.0 112.957 175.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.7 p -102.18 -0.03 33.84 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.786 1.234 . . . . 0.0 114.151 174.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.4 tmmm? -53.36 -45.1 69.04 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 118.138 -0.934 . . . . 0.0 111.136 173.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 44.4 mtm180 -60.63 -37.21 80.72 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.543 1.065 . . . . 0.0 113.261 -176.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 10.7 t60 -61.76 -46.57 89.0 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.272 1.029 . . . . 0.0 112.313 173.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 84.9 m -72.95 -31.29 64.48 Favored 'General case' 0 CA--C 1.545 0.783 0 O-C-N 121.187 -0.946 . . . . 0.0 112.308 176.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 41.3 tptt -65.24 -21.59 66.76 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 126.023 1.729 . . . . 0.0 112.764 177.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.86 -17.63 17.56 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.755 0.822 . . . . 0.0 112.765 168.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -123.56 15.25 9.54 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 126.766 2.027 . . . . 0.0 112.699 172.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 22.5 t70 65.04 14.85 9.64 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 128.395 2.678 . . . . 0.0 115.387 -175.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.3 mmtp -84.17 149.38 26.2 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 126.526 1.93 . . . . 0.0 111.637 178.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -71.37 137.32 48.29 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 124.245 1.018 . . . . 0.0 108.559 167.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -110.76 128.89 8.99 Favored Glycine 0 N--CA 1.471 1.013 0 C-N-CA 123.907 0.765 . . . . 0.0 111.927 173.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.37 143.07 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 124.501 1.12 . . . . 0.0 111.152 -177.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 77.7 m -79.13 115.13 18.6 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -174.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 27.7 m-70 -112.22 104.17 12.35 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.36 1.464 . . . . 0.0 108.568 168.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.79 -122.79 23.06 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 124.226 0.917 . . . . 0.0 111.933 -173.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 40.1 p -101.7 21.34 14.61 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 127.054 2.141 . . . . 0.0 113.088 178.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -139.15 163.21 33.04 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 126.137 1.775 . . . . 0.0 112.169 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 6.4 t -86.05 157.41 20.08 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.429 168.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 6.0 tmtm? -131.65 126.35 34.44 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 168.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 79.4 m -83.88 130.53 34.91 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 120.805 0.335 . . . . 0.0 110.849 173.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -97.97 -131.6 7.2 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 125.468 1.508 . . . . 0.0 113.502 -171.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 28.9 m -87.31 168.2 18.44 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 125.054 1.341 . . . . 0.0 109.983 168.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -46.75 144.15 8.22 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 123.854 3.036 . . . . 0.0 113.301 169.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.495 HD12 ' N ' ' A' ' 42' ' ' SER . 2.6 pp -58.26 -46.89 88.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -170.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.495 ' N ' HD12 ' A' ' 41' ' ' ILE 0.266 24.0 p 59.39 22.55 10.99 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 118.795 2.887 . . . . 0.0 118.795 -176.913 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 20.8 p90 -142.39 -75.77 0.28 Allowed 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 126.459 1.903 . . . . 0.0 113.259 169.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 56.5 tp . . . . . 0 C--O 1.252 1.211 0 C-N-CA 126.148 1.779 . . . . 0.0 112.941 -172.42 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.795 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -140.73 112.16 7.38 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.806 1.642 . . . . 0.0 111.894 -171.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 28.2 m-20 61.39 -19.58 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 128.756 2.823 . . . . 0.0 117.404 174.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -123.36 2.87 9.12 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.939 1.295 . . . . 0.0 113.311 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 59.71 5.19 0.65 Allowed 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 115.853 1.797 . . . . 0.0 115.853 -175.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 92.13 -3.62 76.81 Favored Glycine 0 CA--C 1.542 1.752 0 C-N-CA 125.401 1.477 . . . . 0.0 114.657 -168.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 96.3 m -78.7 136.82 37.53 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -154.63 141.49 19.14 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.401 1.08 . . . . 0.0 111.316 165.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 51.53 40.48 27.05 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.961 1.304 . . . . 0.0 114.391 177.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 24.7 m-20 64.62 21.11 12.35 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 126.504 1.922 . . . . 0.0 115.917 -174.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 40.4 t -134.42 147.08 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 125.164 1.386 . . . . 0.0 112.458 -176.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -76.94 53.32 0.93 Allowed 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 127.029 2.132 . . . . 0.0 112.113 173.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -80.4 -36.43 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 124.929 1.292 . . . . 0.0 114.239 -174.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -96.98 -3.65 41.23 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.47 1.108 . . . . 0.0 112.995 177.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 159.47 170.18 23.72 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 125.769 1.652 . . . . 0.0 113.049 172.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -87.35 107.98 18.77 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.332 1.053 . . . . 0.0 113.398 -176.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -62.06 -26.14 68.09 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.751 1.621 . . . . 0.0 112.356 174.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -43.71 -44.69 6.69 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.278 1.431 . . . . 0.0 110.416 167.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 8.7 ttm180 -64.14 -26.24 68.44 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 115.058 1.503 . . . . 0.0 115.058 -178.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 67.4 t60 -77.05 -42.73 37.24 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 120.596 -1.315 . . . . 0.0 111.428 171.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 92.2 m -70.84 -29.43 65.56 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 121.817 -0.552 . . . . 0.0 111.91 175.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 51.7 tptt -68.54 -27.1 65.79 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.726 2.01 . . . . 0.0 114.16 177.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.17 -16.16 61.34 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.615 0.766 . . . . 0.0 112.783 169.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -110.8 4.28 19.75 Favored 'General case' 0 CA--C 1.556 1.205 0 C-N-CA 127.296 2.238 . . . . 0.0 112.018 170.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . 0.287 3.7 t70 59.61 37.6 22.48 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 129.258 3.023 . . . . 0.0 115.211 -173.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.4 mttp -116.12 160.29 20.55 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.868 2.067 . . . . 0.0 115.145 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -66.69 144.4 56.39 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.209 1.403 . . . . 0.0 109.003 167.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -131.1 136.1 8.62 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 125.043 1.306 . . . . 0.0 115.297 178.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -138.55 138.27 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 124.171 0.988 . . . . 0.0 112.057 -179.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 90.9 m -77.28 104.7 7.94 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.872 0.869 . . . . 0.0 113.123 -178.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 27.5 m-70 -90.77 92.52 8.84 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 123.662 0.785 . . . . 0.0 109.004 167.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.9 -116.57 6.91 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 124.628 1.108 . . . . 0.0 112.417 -172.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 63.4 p -99.95 11.8 38.39 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.965 1.706 . . . . 0.0 113.993 177.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -129.97 160.19 34.38 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.208 1.403 . . . . 0.0 111.541 178.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 34.6 t -98.32 147.52 24.59 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.976 1.31 . . . . 0.0 110.647 179.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 30.9 ttmt -141.53 124.76 16.44 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 125.073 1.349 . . . . 0.0 108.191 -178.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 19.4 m -89.15 144.64 25.97 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -171.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -107.08 -131.01 6.58 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 126.569 2.033 . . . . 0.0 113.212 -175.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.6 m -73.42 158.96 85.86 Favored Pre-proline 0 N--CA 1.473 0.692 0 C-N-CA 124.209 1.003 . . . . 0.0 113.668 172.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -64.56 149.75 89.36 Favored 'Trans proline' 0 CA--C 1.535 0.526 0 C-N-CA 123.503 2.802 . . . . 0.0 111.248 171.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.603 HD12 ' H ' ' A' ' 43' ' ' TYR . 2.2 pp -77.24 -29.47 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 O-C-N 121.532 -0.73 . . . . 0.0 112.688 -174.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.0 m 45.21 33.65 1.21 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 128.803 2.841 . . . . 0.0 118.344 169.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.603 ' H ' HD12 ' A' ' 41' ' ' ILE . 1.4 p90 -147.4 -64.14 0.27 Allowed 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 114.513 1.301 . . . . 0.0 114.513 173.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.252 1.187 0 CA-C-N 120.575 1.534 . . . . 0.0 113.108 -178.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.083 0 CA-C-O 118.909 -0.567 . . . . 0.0 110.72 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -140.69 -148.88 0.26 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.287 1.035 . . . . 0.0 111.708 -178.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 16.4 p-10 -49.43 -39.88 34.54 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 127.84 2.456 . . . . 0.0 112.603 178.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -110.28 19.91 18.37 Favored 'General case' 0 C--O 1.224 -0.245 0 C-N-CA 125.401 1.48 . . . . 0.0 111.477 -179.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 61.26 -2.22 0.24 Allowed 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.583 1.553 . . . . 0.0 114.7 -174.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 96.18 -9.1 67.53 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 125.489 1.519 . . . . 0.0 113.831 -169.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 70.9 m -89.46 141.6 28.42 Favored 'General case' 0 C--O 1.236 0.354 0 O-C-N 121.511 -0.994 . . . . 0.0 113.469 -175.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -154.38 139.83 17.76 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.173 0.989 . . . . 0.0 109.93 165.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 51.55 44.7 28.92 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.788 1.235 . . . . 0.0 114.189 177.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 60.51 17.34 7.23 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 126.223 1.809 . . . . 0.0 115.602 -174.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 41.6 t -126.75 148.05 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.865 1.266 . . . . 0.0 111.881 -177.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -76.0 40.37 0.2 Allowed 'General case' 0 CA--C 1.558 1.271 0 C-N-CA 128.686 2.794 . . . . 0.0 111.947 177.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -74.89 -54.53 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 C-N-CA 126.105 1.762 . . . . 0.0 113.544 -170.02 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -78.71 -7.46 57.75 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.106 1.363 . . . . 0.0 112.545 -172.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 162.1 -171.09 37.92 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 125.863 1.697 . . . . 0.0 111.482 175.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -95.75 120.95 36.92 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -176.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.5 t -77.59 -20.17 54.42 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.667 1.187 . . . . 0.0 112.636 170.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 8.8 tppt? -44.92 -50.78 10.3 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.594 1.558 . . . . 0.0 111.013 172.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 42.4 mtm180 -64.77 -26.64 68.44 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 115.676 1.732 . . . . 0.0 115.676 -173.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 59.6 t60 -72.81 -37.06 67.64 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 119.272 0.942 . . . . 0.0 112.032 174.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 93.0 m -84.88 -29.72 25.01 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.437 0.695 . . . . 0.0 112.863 177.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.76 -29.12 66.52 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 126.138 1.775 . . . . 0.0 112.317 171.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.99 -19.77 54.13 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.5 1.12 . . . . 0.0 113.859 171.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -114.38 9.34 16.84 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 127.192 2.197 . . . . 0.0 111.789 176.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.4 t70 57.18 38.96 29.14 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 126.815 2.046 . . . . 0.0 113.594 -171.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.9 mmtp -119.23 156.85 29.16 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 128.175 2.59 . . . . 0.0 112.073 -176.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -76.68 147.71 37.27 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 124.199 0.999 . . . . 0.0 109.643 168.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.16 154.56 19.11 Favored Glycine 0 CA--C 1.542 1.755 0 C-N-CA 125.059 1.314 . . . . 0.0 114.247 173.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -151.67 136.87 10.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 125.954 1.701 . . . . 0.0 110.211 175.254 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 93.9 m -84.18 118.02 23.87 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -174.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -101.96 91.4 4.34 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.347 1.859 . . . . 0.0 108.956 168.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 64.71 -118.7 13.01 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.392 0.996 . . . . 0.0 112.112 -176.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 54.2 p -89.84 11.63 19.66 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 126.633 1.973 . . . . 0.0 113.846 174.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm -131.08 166.57 20.77 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 126.306 1.843 . . . . 0.0 112.14 -171.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 47.3 t -121.47 135.2 55.06 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.452 1.501 . . . . 0.0 111.26 -175.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 12.4 tptt -123.16 153.65 39.74 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 128.762 2.825 . . . . 0.0 107.776 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 63.9 m -111.93 127.64 55.92 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 113.707 1.002 . . . . 0.0 113.707 -173.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -87.39 -130.7 3.17 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 126.518 2.009 . . . . 0.0 113.95 -176.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 25.4 m -80.57 161.1 65.52 Favored Pre-proline 0 CA--C 1.532 0.285 0 C-N-CA 125.726 1.611 . . . . 0.0 112.711 176.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo -52.19 145.6 34.19 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 123.992 3.128 . . . . 0.0 112.411 168.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.582 HD12 ' N ' ' A' ' 42' ' ' SER . 2.7 pp -66.36 -47.01 85.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 -169.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.582 ' N ' HD12 ' A' ' 41' ' ' ILE 0.258 68.6 m 44.3 25.43 0.12 Allowed 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 119.035 2.976 . . . . 0.0 119.035 -177.932 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -153.51 -49.71 0.1 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.506 1.923 . . . . 0.0 113.181 167.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 18.0 tp . . . . . 0 C--O 1.254 1.294 0 CA-C-O 115.822 -2.037 . . . . 0.0 113.848 178.588 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.919 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -135.85 -59.08 0.76 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.922 1.289 . . . . 0.0 113.646 -172.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 38.4 p-10 -136.24 -35.34 0.76 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.33 1.452 . . . . 0.0 114.621 -168.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -133.96 14.86 3.93 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.398 1.879 . . . . 0.0 112.977 -179.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 54.54 20.11 2.7 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.111 1.365 . . . . 0.0 114.024 -169.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 71.58 0.11 37.77 Favored Glycine 0 CA--C 1.534 1.279 0 O-C-N 120.684 -1.26 . . . . 0.0 115.04 -177.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 72.8 m -88.29 136.82 32.8 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.984 0.913 . . . . 0.0 112.847 -175.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -150.4 139.09 20.72 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.253 1.021 . . . . 0.0 111.263 166.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 48.65 48.34 19.89 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.145 1.378 . . . . 0.0 113.64 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 47.8 m-20 65.48 12.97 8.57 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 126.164 1.786 . . . . 0.0 115.668 -177.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.9 t -130.34 146.4 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 124.615 1.166 . . . . 0.0 112.002 -175.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -74.24 43.23 0.17 Allowed 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 127.422 2.289 . . . . 0.0 113.951 172.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -69.56 -39.22 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 O-C-N 120.892 -1.13 . . . . 0.0 113.689 -174.329 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -92.66 -19.18 22.11 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -174.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 176.5 -150.06 10.2 Favored Glycine 0 CA--C 1.534 1.278 0 N-CA-C 115.882 1.113 . . . . 0.0 115.882 178.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -105.65 135.21 47.48 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.572 1.549 . . . . 0.0 113.961 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -109.47 -24.06 11.2 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 129.049 2.94 . . . . 0.0 110.633 170.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 12.9 tppt? -40.15 -52.6 2.56 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 126.083 1.753 . . . . 0.0 111.975 169.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 60.5 mtm180 -61.8 -30.54 70.88 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 114.527 1.306 . . . . 0.0 114.527 -174.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 68.7 t60 -69.55 -44.08 71.64 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 118.99 0.814 . . . . 0.0 111.62 175.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 91.4 m -78.09 -30.65 49.66 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 179.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 49.8 tptt -65.8 -20.75 66.37 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.441 1.896 . . . . 0.0 113.387 176.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.65 -29.99 70.15 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.906 0.882 . . . . 0.0 111.929 169.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 -91.22 6.35 45.48 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 126.166 1.786 . . . . 0.0 111.674 168.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.6 t70 52.8 36.68 22.0 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 127.825 2.45 . . . . 0.0 113.999 -170.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.8 mttt -112.61 160.03 18.27 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.777 2.031 . . . . 0.0 113.004 178.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 53.4 mm-40 -67.74 142.93 56.12 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 124.62 1.168 . . . . 0.0 109.907 167.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -113.77 135.15 12.3 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 125.276 1.417 . . . . 0.0 113.795 175.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -142.35 132.73 24.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 124.463 1.105 . . . . 0.0 110.633 -170.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 84.5 m -78.2 113.93 16.61 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -173.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 22.4 m-70 -105.78 104.78 14.57 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.917 1.687 . . . . 0.0 108.088 169.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 70.84 -118.12 7.37 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 125.034 1.302 . . . . 0.0 111.322 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 63.0 p -103.83 16.27 26.74 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.455 1.502 . . . . 0.0 112.544 174.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 49.5 mmtm -132.45 163.84 27.88 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.169 1.788 . . . . 0.0 112.104 -173.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 11.0 t -87.87 156.48 19.36 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.052 0.941 . . . . 0.0 111.083 170.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.73 145.06 30.71 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 127.645 2.378 . . . . 0.0 105.91 170.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 38.4 m -98.81 143.55 29.03 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -178.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -98.64 -117.14 3.78 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 126.712 2.101 . . . . 0.0 113.893 -175.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.5 m -103.4 162.55 19.7 Favored Pre-proline 0 CA--C 1.538 0.492 0 C-N-CA 126.906 2.082 . . . . 0.0 111.78 176.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_exo -47.3 141.21 14.03 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 124.743 3.629 . . . . 0.0 112.914 168.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.505 HD12 ' N ' ' A' ' 42' ' ' SER . 2.5 pp -67.47 -32.76 58.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 O-C-N 121.359 -0.838 . . . . 0.0 112.301 -178.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.505 ' N ' HD12 ' A' ' 41' ' ' ILE . 0.3 OUTLIER 55.4 17.27 2.09 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 129.469 3.108 . . . . 0.0 118.34 169.689 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -161.51 -31.84 0.05 OUTLIER 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 117.956 2.576 . . . . 0.0 117.956 172.204 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.5 tm? . . . . . 0 C--O 1.254 1.336 0 C-N-CA 125.76 1.624 . . . . 0.0 112.265 -171.553 . . . . . . . . 0 0 . 1 stop_ save_